
<html lang="en"     class="pb-page"  data-request-id="1c63f0ac-976c-487f-a46e-0731c7e94598"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;issue:issue:10.1021/jmcmar.2012.55.issue-14;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;article:article:10.1021/jm300542e"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Novel Trisubstituted Harmine Derivatives with Original in Vitro Anticancer Activity" /></meta><meta name="dc.Creator" content="Raphaël  Frédérick" /></meta><meta name="dc.Creator" content="Céline  Bruyère" /></meta><meta name="dc.Creator" content="Christelle  Vancraeynest" /></meta><meta name="dc.Creator" content="Jérémy  Reniers" /></meta><meta name="dc.Creator" content="Céline  Meinguet" /></meta><meta name="dc.Creator" content="Lionel  Pochet" /></meta><meta name="dc.Creator" content="Anders  Backlund" /></meta><meta name="dc.Creator" content="Bernard  Masereel" /></meta><meta name="dc.Creator" content="Robert  Kiss" /></meta><meta name="dc.Creator" content="Johan  Wouters" /></meta><meta name="dc.Description" content="To overcome the intrinsic resistance of cancer cells to apoptotic stimuli, we designed and synthesized approximately 50 novel β-carbolines structurally related to harmine. Harmine is known for its ..." /></meta><meta name="Description" content="To overcome the intrinsic resistance of cancer cells to apoptotic stimuli, we designed and synthesized approximately 50 novel β-carbolines structurally related to harmine. Harmine is known for its ..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="July 18, 2012" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm300542e" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2012 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm300542e" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm300542e" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm300542e" /></link>
        
    
    

<title>Novel Trisubstituted Harmine Derivatives with Original in Vitro Anticancer Activity | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm300542e" /></meta><meta property="og:title" content="Novel Trisubstituted Harmine Derivatives with Original in Vitro Anticancer Activity" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-14/jm300542e/production/images/large/jm-2012-00542e_0007.jpeg" /></meta><meta property="og:description" content="To overcome the intrinsic resistance of cancer cells to apoptotic stimuli, we designed and synthesized approximately 50 novel β-carbolines structurally related to harmine. Harmine is known for its anticancer properties and is a DYRK1A inhibitor. Of the synthesized compounds, the most active in terms of growth inhibition of five cancer cell lines are cytostatic and approximately 100 times more potent than harmine but demonstrated no DYRK1A inhibitory activity. These novel β-carbolines display similar growth inhibitory activity in cancer cells that are sensitive and resistant to apoptotic stimuli. Using ChemGPS-NP, we found that the more active β-carbolines are all more lipophilic and larger than the less active compounds. Lastly, on the basis of the NCI human tumor cell line anticancer drug screen and the NCI COMPARE algorithm, it appears that some of these compounds, including 5a and 5k, seem to act as protein synthesis inhibitors." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm300542e"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm300542e">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm300542e&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm300542e&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm300542e&amp;href=/doi/10.1021/jm300542e" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2012</span><span class="cit-fg-volume">, 55</span><span class="cit-fg-issue">, 14</span><span class="cit-fg-pageRange">, 6489-6501</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/55/14" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm300503b" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm300557t" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Novel Trisubstituted Harmine Derivatives with Original in Vitro Anticancer Activity</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Rapha%C3%ABl++Fr%C3%A9d%C3%A9rick">Raphaël Frédérick</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=C%C3%A9line++Bruy%C3%A8re">Céline Bruyère</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Christelle++Vancraeynest">Christelle Vancraeynest</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=J%C3%A9r%C3%A9my++Reniers">Jérémy Reniers</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=C%C3%A9line++Meinguet">Céline Meinguet</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Lionel++Pochet">Lionel Pochet</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Anders++Backlund">Anders Backlund</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Bernard++Masereel">Bernard Masereel</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Robert++Kiss">Robert Kiss</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Johan++Wouters">Johan Wouters</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Namur Medicine and Drug Innovation Center (NAMEDIC-NARILIS), University of Namur (FUNDP), 61, Rue de Bruxelles, 5000 Namur, Belgium</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">Laboratoire de Toxicologie, Faculté de Pharmacie, Université Libre de Bruxelles (ULB), Boulevard du Triomphe, 1050 Brussels, Belgium</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">§</span> <span class="aff-text">Department of Medicinal Chemistry, Biomedical Centre, Division of Pharmacognosy, Uppsala University, 751 23 Uppsala, Sweden</span></div><div class="corresp-info"><strong>*</strong>For R.F. (medicinal chemistry): phone, +32 81 72 42 90; e-mail, <a href="/cdn-cgi/l/email-protection#7b091a0b131a1e17551d091e1f1e091218103b1d0e151f0b551a1855191e"><span class="__cf_email__" data-cfemail="205241504841454c0e46524544455249434b6046554e44500e41430e4245">[email protected]</span></a>. For R.K. (pharmacology): phone, +32 477 62 20 83; e-mail, <a href="/cdn-cgi/l/email-protection#acdec7c5dfdfecd9c0ce82cdcf82cec9"><span class="__cf_email__" data-cfemail="3f4d54564c4c7f4a535d115e5c115d5a">[email protected]</span></a>. For J.W. (chemistry): phone, +32 81 72 45 50; e-mail, <a href="/cdn-cgi/l/email-protection#e88287808986c69f879d9c8d9a9ba88e9d868c98c6898bc68a8d"><span class="__cf_email__" data-cfemail="72181d1a131c5c051d07061700013214071c16025c13115c1017">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm300542e&amp;href=/doi/10.1021%2Fjm300542e" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2012</span></span><span class="cit-volume">, 55</span><span class="cit-issue">, 14</span><span class="cit-pageRange">, 6489–6501</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">July 9, 2012</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>17 April 2012</li><li><span class="item_label"><b>Published</b> online</span>18 July 2012</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 26 July 2012</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm300542e" title="DOI URL">https://doi.org/10.1021/jm300542e</a></div><div class="article_header-article-copyright"><strong>Copyright © 2012 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D6489%26pageCount%3D13%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DRapha%25C3%25ABl%2BFr%25C3%25A9d%25C3%25A9rick%252C%2BC%25C3%25A9line%2BBruy%25C3%25A8re%252C%2BChristelle%2BVancraeynest%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D55%26issueNum%3D14%26contentID%3Djm300542e%26title%3DNovel%2BTrisubstituted%2BHarmine%2BDerivatives%2Bwith%2BOriginal%2Bin%2BVitro%2BAnticancer%2BActivity%26numPages%3D13%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D6501%26publicationDate%3DJuly%2B2012">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm300542e"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1965</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">58</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm300542e" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Novel Trisubstituted Harmine Derivatives with Original in Vitro Anticancer Activity&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Raphaël&quot;,&quot;last_name&quot;:&quot;Frédérick&quot;},{&quot;first_name&quot;:&quot;Céline&quot;,&quot;last_name&quot;:&quot;Bruyère&quot;},{&quot;first_name&quot;:&quot;Christelle&quot;,&quot;last_name&quot;:&quot;Vancraeynest&quot;},{&quot;first_name&quot;:&quot;Jérémy&quot;,&quot;last_name&quot;:&quot;Reniers&quot;},{&quot;first_name&quot;:&quot;Céline&quot;,&quot;last_name&quot;:&quot;Meinguet&quot;},{&quot;first_name&quot;:&quot;Lionel&quot;,&quot;last_name&quot;:&quot;Pochet&quot;},{&quot;first_name&quot;:&quot;Anders&quot;,&quot;last_name&quot;:&quot;Backlund&quot;},{&quot;first_name&quot;:&quot;Bernard&quot;,&quot;last_name&quot;:&quot;Masereel&quot;},{&quot;first_name&quot;:&quot;Robert&quot;,&quot;last_name&quot;:&quot;Kiss&quot;},{&quot;first_name&quot;:&quot;Johan&quot;,&quot;last_name&quot;:&quot;Wouters&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2012&quot;,&quot;month&quot;:&quot;07&quot;,&quot;day&quot;:&quot;18&quot;,&quot;issue&quot;:&quot;14&quot;,&quot;volume&quot;:&quot;55&quot;,&quot;pages&quot;:&quot;6489-6501&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm300542e&quot;},&quot;abstract&quot;:&quot;To overcome the intrinsic resistance of cancer cells to apoptotic stimuli, we designed and synthesized approximately 50 novel β-carbolines structurally related to harmine. Harmine is known for its anticancer properties and is a DYRK1A inhibitor. Of the synthesized compounds, the most active in terms of growth inhibition of five cancer cell lines are cytostatic and approximately 100 times more potent than harmine but demonstrated no DYRK1A inhibitory activity. These novel β-carbolines display similar growth inhibitory activity in cancer cells that are sensitive and resistant to apoptotic stimuli. Using ChemGPS-NP, we found that the more active β-carbolines are all more lipophilic and larger than the less active compounds. Lastly, on the basis of the NCI human tumor cell line anticancer drug screen and the NCI COMPARE algorithm, it appears that some of these compounds, including 5a and 5k, seem to act as protein synthesis inhibitors.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm300542e&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm300542e" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm300542e&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm300542e" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm300542e&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm300542e" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm300542e&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm300542e&amp;href=/doi/10.1021/jm300542e" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm300542e" /></input><a href="/doi/pdf/10.1021/jm300542e" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (3 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm300542e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm300542e%26sid%3Dliteratum%253Aachs%26pmid%3D22770529%26genre%3Darticle%26aulast%3DFr%25C3%25A9d%25C3%25A9rick%26date%3D2012%26atitle%3DNovel%2BTrisubstituted%2BHarmine%2BDerivatives%2Bwith%2BOriginal%2Bin%2BVitro%2BAnticancer%2BActivity%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D55%26issue%3D14%26spage%3D6489%26epage%3D6501%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=290896" title="Cells">Cells</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=292258" title="Cancer">Cancer</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/55/14" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-14/jmcmar.2012.55.issue-14/production/jmcmar.2012.55.issue-14.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-14/jm300542e/production/images/medium/jm-2012-00542e_0007.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-14/jm300542e/production/images/large/jm-2012-00542e_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300542e&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">To overcome the intrinsic resistance of cancer cells to apoptotic stimuli, we designed and synthesized approximately 50 novel β-carbolines structurally related to harmine. Harmine is known for its anticancer properties and is a DYRK1A inhibitor. Of the synthesized compounds, the most active in terms of growth inhibition of five cancer cell lines are cytostatic and approximately 100 times more potent than harmine but demonstrated no DYRK1A inhibitory activity. These novel β-carbolines display similar growth inhibitory activity in cancer cells that are sensitive and resistant to apoptotic stimuli. Using ChemGPS-NP, we found that the more active β-carbolines are all more lipophilic and larger than the less active compounds. Lastly, on the basis of the NCI human tumor cell line anticancer drug screen and the NCI COMPARE algorithm, it appears that some of these compounds, including <b>5a</b> and <b>5k</b>, seem to act as protein synthesis inhibitors.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div class="extra-info-sec articleNote"><h4><span>∥</span> Author Contributions</h4><p class="last">R.F. and C.B. contributed equally.</p></div><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_87236" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_87236" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Cancer is becoming an increasingly important cause of death, and more than 80% of all anticancer drugs target the apoptosis pathways of tumor cells.<a onclick="showRef(event, 'cit1a cit1b cit1c'); return false;" href="javascript:void(0);" class="ref cit1a cit1b cit1c">(1a-1c)</a> However, as emphasized by Wong,<a onclick="showRef(event, 'cit1c'); return false;" href="javascript:void(0);" class="ref cit1c">(1c)</a> cancer is a disease in which too little apoptosis occurs, resulting in malignant cells that will not die. In addition, the mechanisms underlying apoptosis are complex and involve multiple pathways in which many defects can occur in cancer cells (e.g., p53 mutations that occur in approximately 50% of cancers<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a>), leading to resistance to anticancer drugs.<a onclick="showRef(event, 'cit1c'); return false;" href="javascript:void(0);" class="ref cit1c">(1c)</a> However, drug resistance is also seen in cancers expressing wild-type p53.<a onclick="showRef(event, 'cit1c'); return false;" href="javascript:void(0);" class="ref cit1c">(1c)</a> In fact, in addition to defects in the normal regulation of apoptotic pathways, cancer cells also develop resistance to cytotoxic molecules via the activation of membrane transporters that actively pump drugs out of the cells (the so-called “multidrug resistance” (MDR) phenotype), changes in the glutathione system and altered metabolism.<a onclick="showRef(event, 'cit3a cit3b'); return false;" href="javascript:void(0);" class="ref cit3a cit3b">(3a, 3b)</a> Finally, several cancer types are also able to develop resistance to receptor tyrosine kinase inhibitors (RTKIs), to RTK-targeting antibodies, and to antibodies that inactivate ligands for RTKs.<a onclick="showRef(event, 'cit3a'); return false;" href="javascript:void(0);" class="ref cit3a">(3a)</a> Brain cancers (e.g., glioblastoma,),<a onclick="showRef(event, 'cit4a'); return false;" href="javascript:void(0);" class="ref cit4a">(4a)</a> esophageal cancers,<a onclick="showRef(event, 'cit4b cit4c'); return false;" href="javascript:void(0);" class="ref cit4b cit4c">(4b, 4c)</a> melanomas,<a onclick="showRef(event, 'cit4d'); return false;" href="javascript:void(0);" class="ref cit4d">(4d)</a> pancreatic cancers,<a onclick="showRef(event, 'cit4e'); return false;" href="javascript:void(0);" class="ref cit4e">(4e)</a> and non-small-cell lung cancers (NSCLCs)<a onclick="showRef(event, 'cit4f'); return false;" href="javascript:void(0);" class="ref cit4f">(4f)</a> are among the cancers associated with the worst prognoses because of their ability to resist most if not all of the current chemotherapies. It should therefore be emphasized that we have made use of glioblastoma and esophageal cancer models to characterize the in vitro anticancer effects of the compounds developed in this study.</div><div class="NLM_p">We designed a novel strategy to try to overcome, at least partly, the intrinsic resistance of cancer cells to apoptotic stimuli. We synthesized novel molecules that are structurally related to harmine, which is a naturally occurring β-carboline that was previously isolated from plants, including the Middle Eastern grass harmal or Syrian rue (<i>Peganum harmala</i>) and the South American vine ayahuasca (<i>Banisteriopsis caapi</i>).<a onclick="showRef(event, 'cit5a cit5b'); return false;" href="javascript:void(0);" class="ref cit5a cit5b">(5a, 5b)</a> We chose harmine as a scaffold to generate novel derivatives because (i) harmine is associated with anticancer activity,<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> (ii) harmine has been repeatedly shown to inhibit the protein kinase DYRK1A (dual specificity tyrosine-phosphorylated and regulated kinase 1a),<a onclick="showRef(event, 'cit7a cit7b cit7c'); return false;" href="javascript:void(0);" class="ref cit7a cit7b cit7c">(7a-7c)</a> (iii) overexpression of DYRK1A has been implicated in multiple diseases, tumorigenesis, and uncontrolled cell proliferation,<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> (iv) harmine-mediated inhibition of DYRK1A induces the activation of caspase-9, which leads to massive apoptosis in different human cell types,<a onclick="showRef(event, 'cit7c'); return false;" href="javascript:void(0);" class="ref cit7c">(7c)</a> and (v) melanomas that are intrinsically resistant to apoptotic stimuli overexpress DYRK1A.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> In addition, it has been recently shown that harmine can reverse resistance to anticancer drugs by inhibiting the breast cancer resistance protein BCRP.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a></div><div class="NLM_p last">Recently, our group reported the inhibitory activity of a series of 7-substituted harmine derivatives against monoamine oxidase A (MAO-A).<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> In the present work, we examined a larger series of compounds and investigated the in vitro growth inhibitory effects of these compounds using both the colorimetric MTT assay<a onclick="showRef(event, 'cit12a cit12b cit12c cit12d'); return false;" href="javascript:void(0);" class="ref cit12a cit12b cit12c cit12d">(12a-12d)</a> and computer-assisted phase-contrast microscopy (i.e., quantitative videomicroscopy).<a onclick="showRef(event, 'cit13a cit13b cit13c cit13d'); return false;" href="javascript:void(0);" class="ref cit13a cit13b cit13c cit13d">(13a-13d)</a> Three glioma and two esophageal cancer lines were used for the MTT assays, including the U373 glioma<a onclick="showRef(event, 'cit12c ref14'); return false;" href="javascript:void(0);" class="ref cit12c ref14">(12c, 14)</a> and the OE21 esophageal<a onclick="showRef(event, 'cit4c'); return false;" href="javascript:void(0);" class="ref cit4c">(4c)</a> cancer cell lines that display significant levels of resistance to apoptotic stimuli. Harmine was used as a reference compound. The U373 glioma cell line was used for the quantitative videomicroscopy analyses. Several compounds were also biochemically assayed for their anti-DYRK1A activity. Several of the most potent compounds in terms of in vitro growth inhibitory activity were then evaluated in a 60-cancer-cell-line panel at the NCI (Developmental Therapeutic Program, Division of Cancer Treatment and Diagnosis) in order to compare their mechanism(s) of action to those of the over 763 000 compounds already available in the NCI database.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> Finally, we used a “ChemGPS-NP” approach,<a onclick="showRef(event, 'cit16a cit16b cit16c'); return false;" href="javascript:void(0);" class="ref cit16a cit16b cit16c">(16a-16c)</a> which is a global physicochemical space model, in order to investigate the region of chemical space where the examined series of compounds are localized.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_25210" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_25210" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Chemistry</h3><div class="NLM_p">The monosubstituted derivatives <b>3a</b>–<b>m</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>) were synthesized following a two-step procedure involving the demethylation of harmine (<b>1</b>) to the corresponding harmol (<b>2</b>), followed by realkylation to generate the corresponding 7-substituted β-carboline derivative <b>3a</b>–<b>m</b> (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>). The key intermediate <b>2</b> was generated via cleavage of the methyl ether present in harmine <b>1</b> with hydrobromic acid. The 7-substituted β-carbolines <b>3a</b>–<b>m</b> were obtained via O-alkylation of <b>2</b> in the presence of cesium carbonate with the corresponding alkyl halide. The 7,9-disubstituted compounds <b>4a</b>–<b>f</b> were obtained via simultaneous O<sub>7</sub>- and N<sub>9</sub>-alkylation of <b>2</b> using 2 equiv of alkyl halide and 5 equiv of potassium hydroxide in DMF. Compound <b>4a</b> was obtained via reduction using Pd/C. The 2,7,9-trisubstituted β-carbolin-2-ium bromides <b>5a</b>–<b>za</b> were obtained from the corresponding 7,9-disubstituted compound <b>4</b> following N<sub>2</sub>-alkylation in THF using 10 equiv of the corresponding alkyl bromide. The structure and the purity of each final compound were characterized via <sup>1</sup>H NMR, <sup>13</sup>C NMR, mass spectrometry (MS), elemental analyses, and HPLC.</div><figure id="sch1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-14/jm300542e/production/images/medium/jm-2012-00542e_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-14/jm300542e/production/images/large/jm-2012-00542e_0002.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of β-Carbolines <b>3a</b>–<b>n</b>, <b>4a</b>–<b>g</b>, and <b>5a</b>–<b>za</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-14/jm300542e/production/images/large/jm-2012-00542e_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300542e&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) HBr, HAc, reflux, overnight ; (b) Cs<sub>2</sub>CO<sub>3</sub>, R<sub>1</sub>X, DMF, rt or Δ ; (c) <b>3g</b>, NaH, iodopropane, DMF, 24 h; (d) KOH (5 equiv), DMF, rt, 30 min, then R<sub>1</sub>(=R<sub>2</sub>)-Br, rt, 24 h (procedure A); (e) R<sub>3</sub>-Br (10 equiv), THF, Δ, 48 h (procedure B), or microwave, 155 °C, 4 h (procedure C); (f) <b>4a</b>, Pd/C (10%), MeOH, rt, 48 h.</p></p></figure></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6"> Pharmacological Evaluation</h3><div id="sec2_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i7" class="anchor-spacer"></div><h4 class="article-section__title" id="_i7"> Determination of the in Vitro Growth Inhibitory Activity</h4><div class="NLM_p">The growth inhibitory potency of the approximately 50 synthesized compounds was evaluated in three glioma cell lines (U373, T98G and Hs683<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a>) and two esophageal cancer cell lines (OE21 and OE33<a onclick="showRef(event, 'cit4c'); return false;" href="javascript:void(0);" class="ref cit4c">(4c)</a>) using the MTT assay. The cells were cultured for 3 days in the absence (control) or presence of the synthesized compounds.<a onclick="showRef(event, 'cit12a cit12b cit12c cit12d'); return false;" href="javascript:void(0);" class="ref cit12a cit12b cit12c cit12d">(12a-12d)</a> Most of the 2,7,9-trisubstituted compounds <b>5a</b>–<b>za</b> (except <b>5e</b>, <b>5h</b>, <b>5r</b>, and <b>5t</b>; Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>) exhibited mean IC<sub>50</sub> values at least 10 times lower than that of harmine (<b>1</b>) (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>).</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Determination of the in Vitro IC<sub>50</sub> Growth Inhibitory Activity Associated with Each Compound That Has Been Cultured for 3 Days in the Presence (or the Absence, Control) of the Various Cancer Cell Lines<a class="ref internalNav" href="#tbl1-fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-14/jm300542e/production/images/medium/jm-2012-00542e_0009.gif" alt="" id="fx1" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-14/jm300542e/production/images/medium/jm-2012-00542e_0010.gif" alt="" id="GRAPHIC-d2169e535-autogenerated" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl1-fn1"><div class="footnote" id="tbl1-fn1"><sup>Table a</sup><p class="last">The dash indicates not determined.</p></div></div><div></div></div><div class="NLM_p">Among the 7-monosubstituted β-carbolines <b>3a</b>–<b>m</b>, the replacement of the 7-CH<sub>3</sub>O of harmine with various alkoxy groups <b>3a</b>–<b>e</b> generated molecules with a mean IC<sub>50</sub> ranging from 22 to >100 μM; the IC<sub>50</sub> of harmine was 28 μM (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). By contrast, the replacement of the methyl group of harmine (<b>1</b>) by a cyclohexylmethyl <b>3f</b>, a benzyl <b>3g</b>, a phenethyl <b>3h</b>, a 2′- and 4′-pyridyl-CH<sub>2</sub><b>3j</b>,<b>l</b>, or a naphthyl-CH<sub>2</sub> slightly augmented the growth inhibitory potency of these compounds when compared to <b>1</b> (the mean IC<sub>50</sub> ranged from 5 to 20 μM, Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>).</div><div class="NLM_p">The addition of a substituent in position 9 decreased the mean growth inhibitory potency when compared with the corresponding 7-monosubstituted β-carbolines (the following pairs of compounds should be compared: <b>3b</b>/<b>4e</b>, <b>3f</b>/<b>4d</b>, <b>3g</b>/<b>4a</b>, and <b>3g</b>/<b>4f</b>; Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). By contrast, the introduction of a second substituent on position 2 increased the in vitro growth inhibitory activity, as demonstrated by the 2,7-dibenzyl-β-carboline <b>4g</b> (IC<sub>50</sub> = 5 μM) when compared with the 7,9-dibenzyl derivative <b>4a</b> (IC<sub>50</sub> = 31 μM) or harmine (<b>1</b>, 28 μM).</div><div class="NLM_p">Finally, we synthesized β-carbolines bearing substituents in the 2, 7, and 9 positions, <b>5a</b>–<b>za</b>. Interestingly, apart from <b>5h</b> that was as potent as <b>1</b>, all of these trisubstituted molecules were more potent in inhibiting cancer cell line growth than the parent compound with a mean IC<sub>50</sub> ranging from 0.3 to 5 μM (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). Compounds <b>5a</b>, <b>5b</b>, <b>5g</b>, <b>5l</b>, <b>5o</b>, <b>5p</b>, <b>5s</b>, and <b>5v</b> displayed a mean IC<sub>50</sub> in the submicromolar range (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>).</div><div class="NLM_p">As shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>, the synthesized compounds display in vitro growth inhibitory effects that are similar in cancer cell lines and are sensitive to apoptotic stimuli (Hs683<a onclick="showRef(event, 'cit12c ref14'); return false;" href="javascript:void(0);" class="ref cit12c ref14">(12c, 14)</a> and OE33<a onclick="showRef(event, 'cit4c'); return false;" href="javascript:void(0);" class="ref cit4c">(4c)</a>) or resistant to apoptotic stimuli (U373<a onclick="showRef(event, 'cit12c ref14'); return false;" href="javascript:void(0);" class="ref cit12c ref14">(12c, 14)</a> and OE21<a onclick="showRef(event, 'cit4c'); return false;" href="javascript:void(0);" class="ref cit4c">(4c)</a>). While this finding strongly suggests that the growth inhibitory activity of the compounds is not due to the cytotoxic effects of the compounds or to the induction of apoptosis, quantitative videomicroscopy was used to evaluate the cytostatic and/or cytotoxic activity of selected β-carbolines in the human U373 glioma cell line as detailed below.</div><div class="NLM_p last">Interestingly, the 2,7,9-trisubstituted β-carbolin-2-ium bromides <b>5</b> were also characterized by higher aqueous solubility compared to the disubstituted compounds (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>, compare <b>5a</b>, <b>5k</b>, <b>5o</b> vs <b>4a</b>). This can certainly be attributed to the presence of a permanent positive charge on the trisubstituted compounds.</div></div><div id="sec2_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i9" class="anchor-spacer"></div><h4 class="article-section__title" id="_i9"> Evaluation of DYRK1a Kinase Inhibition</h4><div class="NLM_p">As harmine (<b>1</b>) has been reported to be a DYRK1A inhibitor, a panel of mono- (<b>3c</b>,<b>k)</b>, di- (<b>4a</b>, <b>4d</b>), and tri- (<b>5a</b>, <b>5o</b>) substituted β-carbolines was selected, and their DYRK1A inhibitory potency was evaluated using a radiometric protein kinase assay (<sup>33</sup>PanQinase Activity Assay). These compounds were also analyzed via quantitative videomicroscopy as detailed in the next section. The IC<sub>50</sub> values for the harmine derivatives were calculated using dose–response curves. These IC<sub>50</sub> values ranged from 10 to 43 μM; therefore, these compounds were much less active than harmine (IC<sub>50</sub> = 0.08 μM; Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). Surprisingly, the two most active compounds (<b>5a</b>, <b>5o</b>) in terms of growth inhibitory activity in U373 glioma cells (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>) were the worst inhibitors of DYRK1A (IC<sub>50</sub> of 21 and 43 μM, respectively).</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Pharmacological Analyses of Compounds <b>1</b>, <b>3c</b>, <b>3k</b>, <b>4a</b>, <b>4d</b>, <b>5a</b>, <b>5k</b>, and <b>5o</b></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">DYRK1A inhibition, IC<sub>50</sub> (μM)</th><th class="colsep0 rowsep0" align="center">mean in vitro growth inhibition concns determined by MTT colorimetric assay in five human cancer cell line (see Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>), IC<sub>50</sub> (μM)</th><th class="colsep0 rowsep0" align="center">global growth ratio (GGR index) (μM) determined by quantitative videomicroscopy in the U373 glioma cell line at the MTT colorimetric assay related IC<sub>50</sub> concn</th><th class="colsep0 rowsep0" align="center">global profile of the compound in terms of growth inhibition</th><th class="colsep0 rowsep0" align="center">solubility in PBS, pH 7.4, at rt (μM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b> (harmine)</td><td class="colsep0 rowsep0" align="left">0.08<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">28 ± 3</td><td class="colsep0 rowsep0" align="left">0.30 at 32</td><td class="colsep0 rowsep0" align="left">cytostatic</td><td class="colsep0 rowsep0" align="left">ND</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3c</b></td><td class="colsep0 rowsep0" align="left">16</td><td class="colsep0 rowsep0" align="left">60 ± 3</td><td class="colsep0 rowsep0" align="left">0.23 at 64</td><td class="colsep0 rowsep0" align="left">cytostatic</td><td class="colsep0 rowsep0" align="left">ND</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3k</b></td><td class="colsep0 rowsep0" align="left">10</td><td class="colsep0 rowsep0" align="left">29 ± 1</td><td class="colsep0 rowsep0" align="left">0.29 at 24</td><td class="colsep0 rowsep0" align="left">cytostatic</td><td class="colsep0 rowsep0" align="left">ND</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4a</b></td><td class="colsep0 rowsep0" align="left">16</td><td class="colsep0 rowsep0" align="left">31 ± 4</td><td class="colsep0 rowsep0" align="left">0.30 at 18</td><td class="colsep0 rowsep0" align="left">cytostatic</td><td class="colsep0 rowsep0" align="left"><3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4d</b></td><td class="colsep0 rowsep0" align="left">>10</td><td class="colsep0 rowsep0" align="left">25 ± 4</td><td class="colsep0 rowsep0" align="left">0.17 at 31</td><td class="colsep0 rowsep0" align="left">cytostatic</td><td class="colsep0 rowsep0" align="left">ND</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5a</b></td><td class="colsep0 rowsep0" align="left">21</td><td class="colsep0 rowsep0" align="left">0.7 ± 0.2</td><td class="colsep0 rowsep0" align="left">0.40 at 0.4</td><td class="colsep0 rowsep0" align="left">cytostatic</td><td class="colsep0 rowsep0" align="left">461</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5k</b></td><td class="colsep0 rowsep0" align="left"><a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">2.7 + 0.6</td><td class="colsep0 rowsep0" align="left">0.53 at 0.9</td><td class="colsep0 rowsep0" align="left">cytostatic</td><td class="colsep0 rowsep0" align="left">53</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5o</b></td><td class="colsep0 rowsep0" align="left">43</td><td class="colsep0 rowsep0" align="left">0.34 ± 0.05</td><td class="colsep0 rowsep0" align="left">0.25 at 0.4</td><td class="colsep0 rowsep0" align="left">cytostatic</td><td class="colsep0 rowsep0" align="left">123</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>a</sup><p class="last">Taken from ref <a onclick="showRef(event, 'cit7a'); return false;" href="javascript:void(0);" class="ref cit7a">7a</a>. The DYRK1A IC<sub>50</sub> concentration relating to each compound was determined by using 10 concentrations ranging from 10<sup>–4</sup> to 3 × 10<sup>–8</sup> M, in triplicate. Compound <b>4d</b> was tested in the range 5 × 10<sup>–5</sup> M to 1.5 × 10<sup>–9</sup> M, in triplicate. A radiometric protein kinase assay (<sup>33</sup>PanQinaseR activity assay) was used for measuring the kinase activity of DYRK1A protein kinase as detailed in the <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a>.</p></div><div class="footnote" id="t2fn2"><sup>b</sup><p class="last">Not determined</p></div></div></div></div><div id="sec2_2_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i11" class="anchor-spacer"></div><h4 class="article-section__title" id="_i11"> Cytotoxic and Cytostatic Effects of Various Compounds in U373 Glioma Cells</h4><div class="NLM_p">U373 glioma cells were seeded and cultured (T25 cm<sup>2</sup> flasks) for 72 h in the absence (control) or the presence of various β-carbolines at their growth inhibitory IC<sub>50</sub> (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). The compounds analyzed using quantitative videomicroscopy were those assayed for anti-DYRK1A activity. The quantitative videomicroscopy approach enabled an image of the bottom of the seeded flask to be taken every 4 min over the course of a 72 h observation period.<a onclick="showRef(event, 'cit13a cit13b cit13c cit13d'); return false;" href="javascript:void(0);" class="ref cit13a cit13b cit13c cit13d">(13a-13d)</a> Thus, 1080 digitized images were available for each experimental condition, which were run in triplicate, and an approximately 40 s movie was generated from these images. These movies clearly demonstrate that the analyzed compounds displayed cytostatic, not cytotoxic, effects in the U373 glioma cells. A morphological illustration of the cytostatic effects induced by <b>1</b> and <b>5a</b> is provided in Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>. For each compound analyzed (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>), a global growth ratio (the GGR index) was further calculated, resulting in a value that can be directly compared to the MTT-assay-determined IC<sub>50</sub> value. First, the global growth (GG) is calculated in each control and in each treated condition by dividing the number of cells on the last image by the number of cells on the first image. The GGR index is obtained for each compound by dividing the GG values calculated for treated U373 cells by the GG values calculated for the control. As shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>, the compounds appeared more inhibitory based on their IC<sub>50</sub> values calculated using the MTT assay when compared with the quantitative videomicroscopy results because the GGR indices were always less than 0.5. This could be because U373 cells grow faster in T25 cm<sup>2</sup> flasks (a final volume of 7 mL) than in 96-well plates (a final volume of 100 μL). However, even if the IC<sub>50</sub> values calculated based on the MTT assay resulted in GGR indices less than 0.5, these compounds displayed cytostatic, not cytotoxic, effects (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>, Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>).</div><figure id="fig1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-14/jm300542e/production/images/medium/jm-2012-00542e_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-14/jm300542e/production/images/large/jm-2012-00542e_0003.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Quantitative videomicroscopy analyses of the in vitro anticancer activity of harmine (<b>1</b>) and <b>5a</b> in the human U373 glioblastoma cell line. Compounds <b>1</b> and <b>5a</b> were assayed at their respective in vitro growth inhibitory IC<sub>50</sub> value, as determined using the MTT assay in U373 glioma cells (see Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-14/jm300542e/production/images/large/jm-2012-00542e_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300542e&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">As the most active compounds <b>5a</b>, <b>5k</b>, <b>5o</b> under study in terms of in vitro growth inhibitory activity in U373 glioma cells (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>) were the worst inhibitors of DYRK1A (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>) while these compounds displayed cytostatic, not cytotoxic, effects (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>), we submitted <b>5k</b> to a kinase profiling including 358 kinases and 10 lipid kinases (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). At 10 μM, <b>5k</b> decreased by >90% the activity of a dozen of kinases (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>) that are implicated in cell proliferation in general and more particularly in tumor cell proliferation, such as CAMK,<a onclick="showRef(event, 'cit18a cit18b'); return false;" href="javascript:void(0);" class="ref cit18a cit18b">(18a, 18b)</a> MYLK,<a onclick="showRef(event, 'cit18c'); return false;" href="javascript:void(0);" class="ref cit18c">(18c)</a> TGF-β receptors,<a onclick="showRef(event, 'cit18d cit18e'); return false;" href="javascript:void(0);" class="ref cit18d cit18e">(18d, 18e)</a> FER,<a onclick="showRef(event, 'cit18f'); return false;" href="javascript:void(0);" class="ref cit18f">(18f)</a> TEC,<a onclick="showRef(event, 'cit18g'); return false;" href="javascript:void(0);" class="ref cit18g">(18g)</a> and CSK,<a onclick="showRef(event, 'cit18h'); return false;" href="javascript:void(0);" class="ref cit18h">(18h)</a> a feature that can explain at least partly the <b>5k</b>-induced cytostatic effects in cancer cells (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). We choose <b>5k</b> instead of <b>5a</b> or <b>5o</b> for the kinase profiling because <b>5k</b> appeared less toxic in vivo (analyses of the maximal tolerated dose in healthy mice) than <b>5a</b> or <b>5o</b> (data not shown).</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Profiling of <b>5k</b> at 10 μM against 358 Protein Kinases and 10 Lipid Kinases<a class="ref internalNav" href="#tbl3-fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">kinase name</th><th class="colsep0 rowsep0" align="center">kinase family</th><th class="colsep0 rowsep0" align="center" char=".">mean residual activity (%) (duplicate measurements)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">STK17A</td><td class="colsep0 rowsep0" align="left">CAMK</td><td class="colsep0 rowsep0" align="char" char="."><1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CAMK2A</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char=".">1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CAMK2D</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char=".">2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MYLK</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char=".">2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MYLK2</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char=".">7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MKNK1</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char=".">10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">TGFB-R1</td><td class="colsep0 rowsep0" align="left">TKL</td><td class="colsep0 rowsep0" align="char" char=".">6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">TGFB-R2</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char=".">6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">FER</td><td class="colsep0 rowsep0" align="left">TK</td><td class="colsep0 rowsep0" align="char" char=".">7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">TEC</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char=".">8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CSK</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char=".">10</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl3-fn1"><div class="footnote" id="tbl3-fn1"><sup>a</sup><p class="last">Only kinases inhibited at >90% are shown.</p></div></div></div></div><div id="sec2_2_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i13" class="anchor-spacer"></div><h4 class="article-section__title" id="_i13"> Rationalization of the SAR Analyses</h4><div class="NLM_p">On the basis of these results, we have generated a series of compounds displaying in vitro cytostatic growth inhibitory activity against human cancer cell lines displaying various levels of resistance to apoptotic stimuli at the submicromolar range. Unexpectedly, we also found that these compounds, in fact, did not act as DYRK1A inhibitors. Moreover, structure–activity relationships (SARs) were not easy to infer, as aromatic, substituted or not, and alkyl substituents resulted in molecules with a wide range of activities (mean IC<sub>50</sub> from 0.34 to 5 μM). Therefore, to provide a possible explanation for the observed trend in the SAR analyses we reported above, we undertook an analysis using ChemGPS-NP.<a onclick="showRef(event, 'cit16a cit16b cit16c'); return false;" href="javascript:void(0);" class="ref cit16a cit16b cit16c">(16a-16c)</a></div><div class="NLM_p">ChemGPS-NP is a global model of chemical property space based on principal component analysis (PCA) that provides a positioning system tuned for the exploration of biologically relevant chemical space (i.e., those areas of chemical space most likely to enclose biologically active compounds). This is achieved by positioning the chemical compound properties using PCA score prediction onto a consistent eight-dimensional (8D) map based on structure-derived physicochemical characteristics for a reference set of compounds.<a onclick="showRef(event, 'cit16a cit16b cit16c'); return false;" href="javascript:void(0);" class="ref cit16a cit16b cit16c">(16a-16c)</a> As with any PCA, the largest variability in data occurs in the first principal component (PC1), with successfully decreasing information content in the following PCs. The first four dimensions of the ChemGPS-NP map, accounting for 77% of data variance, can be interpreted in such a way that PC1 primarily represents size, shape, and polarizability; PC2 corresponds to aromatic- and conjugation-related properties; PC3 describes lipophilicity, polarity, and H-bond capacity; and PC4 expresses flexibility and rigidity.<a onclick="showRef(event, 'cit16a cit16b cit16c'); return false;" href="javascript:void(0);" class="ref cit16a cit16b cit16c">(16a-16c)</a> For a more detailed explanation of ChemGPS-NP chemical property loadings, refer to the work by Rosen et al.<a onclick="showRef(event, 'cit16c'); return false;" href="javascript:void(0);" class="ref cit16c">(16c)</a> Any compound, real or virtual, with a known chemical structure can be positioned in ChemGPS-NP property space. From the resulting projections, properties of the compounds, together with trends and clusters of very large data sets, can be compared and easily interpreted. From this analysis (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>), we can see that all of the tested β-carbolines are comparably closely positioned in the chemical space; they are not particularly large (PC1 contribution), quite aromatic (PC2 contribution), and lipophilic (PC3 contribution). Interestingly, all the compounds with the greatest in vitro growth inhibitory activity (Tables <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a> and <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>), represented as red dots in Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>, are well separated from the less active compounds, represented as blue dots. The more active compounds are all more lipophilic and larger than the less active compounds, and the degree of aromaticity varies within approximately the same range. If we compare this series of β-carbolines with a set of approximately 20 000 compounds from the ZINC-NP (<a href="http://zinc.docking.org" class="extLink">http://zinc.docking.org</a>) database (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>B), which can be seen as a simple generalization of “druglike natural products”, one can see that the derivatives examined in this study are distinct from the majority of the compounds found in the ZINC-NP database. The internal structure visible in the ZINC-NP cloud is mainly due to different degrees of aromaticity.</div><figure id="fig2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-14/jm300542e/production/images/medium/jm-2012-00542e_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-14/jm300542e/production/images/large/jm-2012-00542e_0004.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. (A) ChemGPS-NP mapping of compounds investigated in the present study. Blue dots indicate the compounds with less in vitro growth inhibitory activity in five human cancer cell lines, and red dots indicate the compounds with more inhibitory activity (see Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). (B) ChemGPS-NP mapping of compounds investigated in this study combined with a small reference set of approximately 20 000 compounds from the ZINC-NP database (<a href="http://zinc.docking.org" class="extLink">http://zinc.docking.org</a>), which can be considered a simple generalization of “natural products”. The red box indicates PC1 (size, weight, etc.). The yellow box indicates PC2 (aromaticity, rigidity, etc.), and the green box indicates PC3 (lipophilicity, etc.).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-14/jm300542e/production/images/large/jm-2012-00542e_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300542e&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_2_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i14" class="anchor-spacer"></div><h4 class="article-section__title" id="_i14"> Analyses of the in Vitro Growth Inhibitory Activity Associated with <b>5a</b>, <b>5k</b>, and <b>5o</b> in the NCI 60-Cancer-Cell-Line Panel</h4><div class="NLM_p">Compounds <b>5a</b>, <b>5k</b>, and <b>5o</b> were first analyzed by the NCI in their 60-cell-line panel at 10 μM. As shown in Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>, revealed with the permission of the NCI, treatment with 10 μM <b>5a</b> resulted in 45% in vitro growth inhibition if the 60 cell lines are taken as a whole (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>A). However, the difference in the magnitude of growth inhibition between the less and more sensitive cancer cell lines at this concentration was over 2 logs (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>A). Quite similar data were obtained for <b>5k</b> (data not shown). By contrast, the in vitro growth inhibition profile of 10 μM <b>5o</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>B) differed from the profiles of both <b>5a</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>A) and <b>5k</b> (data not shown). As shown in Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>B, treatment with 10 μM <b>5o</b> resulted in approximately 80% in vitro growth inhibition if the 60 cell lines are taken as whole, and the magnitude of the difference in growth inhibition between the less and the more sensitive cancer cell lines was smaller. These data suggest that <b>5a</b> and <b>5k</b> could share relatively common mechanism(s) of action, at least in vitro, whereas the mechanism of action of <b>5o</b> likely differs from those of <b>5a</b> and <b>5k</b>, even if the three compounds were clearly identified as cytostatic compounds (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>, Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>).</div><figure id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-14/jm300542e/production/images/medium/jm-2012-00542e_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-14/jm300542e/production/images/large/jm-2012-00542e_0005.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Characterization of the effects induced by 10 μM <b>5a</b> (A) and 10 μM <b>5o</b> (B) in the NCI 60-cell-line panel.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-14/jm300542e/production/images/large/jm-2012-00542e_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300542e&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">We then calculated the “COMPARE correlation coefficients” for <b>5a</b>, <b>5k</b> and <b>5o</b> using the COMPARE software developed by the NCI (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>). The highest correlation coefficient for <b>5a</b> reached 0.83–0.85 for four compounds whose chemical structures are illustrated in Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>. The highest coefficient correlation found for <b>5k</b> was 0.82 and corresponded to <b>5a</b>. The highest correlation coefficient for <b>5o</b> reached 0.73–0.78 for four compounds whose chemical structures are also illustrated in Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>. In the discussion section, we detail the previously described mechanisms underlying the anticancer activity of these compounds, e.g., protein synthesis inhibition. We therefore wanted to validate at the biochemical level the theoretical analyses we performed using the COMPARE approach (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>). We thus analyzed by means of Western blotting the effects of <b>5a</b> and <b>5k</b> (which behave as protein synthesis inhibitors according to the data illustrated in Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>) and <b>5o</b> (which does not behave as a protein synthesis inhibitor according to the data illustrated in Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>) on the eukaryotic initiation factor 2 (eIF2) in Hs683 oligodendroglioma and U373 glioblastoma cells (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>). The data obtained show that <b>5a</b> and <b>5k</b> decreased both eIF2 activity (at its phosphorylation levels) and expression in Hs683 and U373 glioma cells after a treatment of 4 h at their respective IC<sub>50</sub> growth inhibitory concentrations (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>), while these effects appeared less pronounced, if any, with <b>5o</b> using the same experimental conditions (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>).</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Correlations of the Differential Cellular Sensitivities in the NCI 60-Cell-Line Screen Using the COMPARE Algorithm<a class="ref internalNav" href="#tbl4-fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-14/jm300542e/production/images/medium/jm-2012-00542e_0001.gif" alt="" id="fx4" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl4-fn1"><div class="footnote" id="tbl4-fn1"><sup>Table a</sup><p class="last">“COMPARE correlation coefficients” were generated by a computerized pattern recognition algorithm and serve as an indication of similarities in differential cellular sensitivities of characteristic fingerprints for each compound. The COMPARE coefficient of correlation reported in this table relies on the comparison of the growth inhibitory concentration by 50% (GI<sub>50</sub>) between “<i>xx</i>” cell lines (indicated in parentheses in Table 4) for either compound <b>5a</b> or <b>5o</b> versus the >763000 compounds already available in this data base. The four highest correlations found for either <b>5a</b> or <b>5o</b> among the ≳763000 analyzed compounds are reported in this table. Additional information about the DTP human tumor cell line screen is available at <a href="http://dtp.nci.nih.gov/branches/btb/ivclsp.html" class="extLink">http://dtp.nci.nih.gov/branches/btb/ivclsp.html</a>.</p></div></div><div></div></div><figure id="fig4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-14/jm300542e/production/images/medium/jm-2012-00542e_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-14/jm300542e/production/images/large/jm-2012-00542e_0006.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Western blotting analyses of the effects of <b>5a</b>, <b>5k</b>, and <b>5o</b> on the activity (phosphorylation levels) and expression of the eukaryotic initiation factor 2 (eIF2). Each compound was assayed at its IC<sub>50</sub> growth inhibitory concentration in Hs683 and U373 glioma cells as determined by means of the MTT colorimetric assay (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>), i.e., 0.5 μM <b>5a</b>, 5 μM <b>5k</b>, and 0.5 μM <b>5o</b> in Hs683 cancer cells and 0.5 μM <b>5a</b>, 1 μM <b>5k</b>, and 0.5 μM <b>5o</b> in U373 ones.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-14/jm300542e/production/images/large/jm-2012-00542e_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300542e&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i16">Discussion and Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_66305" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_66305" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">In an attempt to develop compounds to overcome the intrinsic resistance of cancer cells to apoptotic stimuli, we designed and synthesized novel β-carbolines that are structurally related to harmine. Harmine is known for its anticancer properties and is a DYRK1A inhibitor, an enzyme involved in uncontrolled cell proliferation<a onclick="showRef(event, 'cit7c ref8'); return false;" href="javascript:void(0);" class="ref cit7c ref8">(7c, 8)</a> and cancer cell chemoresistance<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> that is overexpressed in melanomas intrinsically resistant to apoptotic stimuli.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a></div><div class="NLM_p">The data we obtained in the current study indicate that we generated cytostatic compounds, with the more potent compounds approximately 2 orders of magnitude more active than harmine in inhibiting cancer cell proliferation. Importantly, these compounds inhibit the growth of apoptosis-resistant cancer cells, with growth inhibitory activity in the submicromolar range, but are weak DYRK1A inhibitors. Profiling the anti-kinase activity of <b>5k</b> revealed that <b>5k</b>-induced cytostatic effects (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>) relate to inhibition of the activity of kinases involved in tumor cell proliferation including a dozen of CAMK, TKL, and TK kinases (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). A 72 h stability study in cell culture medium without serum was performed with <b>5a</b> or <b>5o</b>, and we recovered greater than 95% of these two compounds (data not shown), suggesting that the cytostatic effects displayed by <b>5a</b> and <b>5o</b> are not the result of degradation products.</div><div class="NLM_p">The β-carbolines we synthesized seem to be located in a distinct chemical space when compared with approximately 20 000 previously analyzed compounds. While the ChemGPS-NP visualization provided initial insights in the physicochemical differences between the more and less active compounds (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>), its full predictive power has not yet been harnessed. This subsequent step would require interpreting the observed physicochemical differences and designing a novel set of harmine derivatives. One interpretational tool that could be used for this purpose is an orthogonal partial least squares discriminant analysis (OPLS-DA), which defines differences in properties between two groups (e.g., more and less active or active and nonactive compounds). The result from an OPLS-DA provides a plot of all 35 descriptors and describes their relative contribution to the differences between the analyzed subsets. With this information, a rational approach to further derivatization can be undertaken. In addition to this analysis, further insights can be gained by continuously predicting derivatives in the ChemGPS-NP chemical property space. This can easily be performed before the actual chemical reactions are performed if an educated guess regarding the structure of the novel product can be made. The SMILES string of the anticipated structure can then be obtained, and the position predicted and evaluated, with regard to the already identified top hits. At present, as shown in Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>, all of the most active compounds are significantly more lipophilic (larger values along PC3) than the less active compounds. Other properties also associated with PC3 apart from lipophilicity are polarity, H-bond capacity, mean electronegativity, and topological polar surface area with regard to N, O, S, and P, with all the latter negatively correlated in a significant way. An initial step to further explore and maybe optimize the harmine derivatives would be to probe if an even larger value along PC3 would result in compounds with even more activity and designing new derivatives with the above aspects.When compared with the small ZINC-NP reference set in Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>B, the tested harmine derivatives already display properties that place them on the border of the reference compound cloud. With a larger and more comprehensive set of natural products this is, however, no longer the case, and property-wise, we therefore still move in charted territories.</div><div class="NLM_p">We requested the help of the Developmental Therapeutic Program (Division of Cancer Treatment and Diagnosis, National Cancer Institute, Rockville, MD, U.S.)<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> to investigate whether the in vitro growth inhibitory activities of β-carbolines <b>5a</b>, <b>5k</b>, and <b>5o</b> match or do not match those of the more than 763 000 compounds already available in the NCI database. Indeed, the NCI has evaluated the in vitro growth inhibitory profiles of a large number of synthetic compounds, natural products, and plant extracts on 60 different cell lines.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> The growth inhibitory profile of novel compounds (such as the harmine derivatives examined in the current study) on each of the 60 cell lines is stored in a database that can be analyzed by the COMPARE algorithm, as this program ranks all entries for similarity of growth inhibitory profiles between investigational and reference compounds.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> The degree of similarity between the growth inhibitory profiles is expressed numerically as a Pearson correlation coefficient (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>).<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> As emphasized by Chan et al.,<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> the COMPARE algorithm has already been successfully used to identify novel inhibitors of tubulin polymerization,<a onclick="showRef(event, 'cit21a'); return false;" href="javascript:void(0);" class="ref cit21a">(21a)</a> inosine monophosphate dehydrogenase,<a onclick="showRef(event, 'cit21b'); return false;" href="javascript:void(0);" class="ref cit21b">(21b)</a> topoisomerase I,<a onclick="showRef(event, 'cit21c'); return false;" href="javascript:void(0);" class="ref cit21c">(21c)</a> and cyclin-dependent kinases.<a onclick="showRef(event, 'cit21d'); return false;" href="javascript:void(0);" class="ref cit21d">(21d)</a> Chan et al.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> used the same approach to search for novel inhibitors of protein synthesis, and they identified 31 known protein synthesis inhibitors, including phyllantoside and nagilactone C. Using this approach, we found that the four highest Pearson correlation coefficients found for <b>5a</b> and <b>5k</b> related to protein synthesis inhibitors, including NSC634791, NSC267709 (undulatone), and NSC342443 (phyllantoside) (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>), which are among the 31 protein synthesis inhibitors identified by Chan et al.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> Phyllantoside was first isolated from an ethanolic extract prepared from the Central American tree <i>Phyllantus acuminatus</i> based on bioassay-guided cytotoxicity fractionation.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> We did not find any description of the mechanism of action of the fourth compound with a growth inhibitory profile similar to <b>5a</b> and <b>5k</b>, NSC644614 (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>). One of the four compounds with the highest correlation in terms of growth inhibitory profiles when compared with <b>5o</b> was NSC747162 (mitotempol), a superoxide dismutase mimetic that interferes with statin activity.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> Therefore, <b>5o</b> does not seem to act as a protein synthesis inhibitor, in contrast to <b>5a</b> and <b>5k</b>. Western bloting analyses revealed that <b>5a</b> and <b>5k</b>, but not <b>5o</b>, decreased both activity and expression of the eukaryotic initiation factor 2 (eIF2) in Hs683 and U373 glioma cells (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>).</div><div class="NLM_p">As emphasized by Chan et al.,<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> numerous studies have already indicated that deregulation of protein synthesis is a major contributor to cancer initiation and metastatic progression. The overexpression of some initiation factors can lead to malignant transformation, whereas down-regulation of these same factors can suppress the transformed phenotypes. Components of the translation machinery are frequently overexpressed or mutated in cancer cells, and key components of antiapoptotic pathways are also translationally regulated.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> A therapeutic index can be obtained with protein synthesis inhibitors because the transformed cells require higher levels of protein synthesis and because of the translational regulation of some of the proteins involved in cancer progression.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> Again, as emphasized by Chan et al.,<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> little effort has been made to systematically search for new inhibitors of eukaryotic protein synthesis, with most of the compounds that are currently used having been identified in chemical screens performed several decades ago.</div><div class="NLM_p last">In conclusion, having generated approximately 50 novel derivatives of harmine, a potent DYRK1A kinase inhibitor, we obtained several compounds that displayed significantly higher growth inhibitory activity than harmine while having lost anti-DYRK1A activity but keeping anti-kinase activity with respect to a dozen of CAMK, TLK, and TK kinases. The most active compounds from the current study display similar growth inhibitory activity in both cancer cells that are sensitive to apoptotic stimuli and cancer cells that are resistant apoptotic stimuli. Compared with the more than 763 000 compounds already present in the NCI database using the NCI COMPARE analysis, some of these compounds, including <b>5a</b> and <b>5k</b>, appear to act as protein synthesis inhibitors, a feature that has been biochemically validated with <b>5a</b> and <b>5k</b> that we showed to inhibit the activity of the eukaryotic initiation factor 2 (eIF2). We are now developing a biochemical assay to determine the mechanism of protein synthesis inhibition associated with each compound we generated in order to derive novel protein synthesis inhibitors with significant therapeutic indices between normal and cancer cells.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i17">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_84124" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_84124" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> Chemistry</h3><div class="NLM_p last">Melting points were measured by DSC with a Perkin-Elmer DSC 7.0 Pro apparatus and recorded with Pyris software. NMR spectra were recorded on a Jeol spectrometer (JNM ECX 400). The <sup>1</sup>H NMR, <sup>13</sup>C NMR, and <sup>19</sup>F NMR spectra were recorded at 400, 100, and 376 MHz, respectively. The chemical shifts are reported in parts per million (ppm) relative to the singlet at 7.26 ppm for chloroform in CDCl<sub>3</sub>, the singlet at 2.50 ppm from dimethyl sulfoxide in (CD<sub>3</sub>)<sub>2</sub>SO, and the singlet at 3.31 ppm for methanol in CD<sub>3</sub>OD, and the coupling constants are in Hz. The following abbreviations are used for spin multiplicity: s, singlet; d, doublet; t, triplet; q, quadruplet, qt, quintuplet; m, multiplet; b, broad. Routine thin-layer chromatography (TLC) was performed on silica gel plates (silica gel GF254, VWR). Column chromatography was performed on a BiotageSP1 25+M column (flow of 25 mL/min; spherical particle size 60–200 μm; MP Biomedicals) equipped with a UV spectrophotometer as a detector (wavelengths of 254 and 320 nm). Solvents from Aldrich and VWR were used without further purification. The purity of the compounds was evaluated via either microanalysis or LC–MS. This information is available in the <a class="ref internalNav" href="#notes-2" aria-label="Supporting Information">Supporting Information</a>. Analytical LC–MS analyses were performed on an Agilent 1100 series HPLC coupled with an MSD Trap SL system using UV detection at 220 and 254 nm. Mass spectra were recorded using electron spray ionization (ESI) operating in positive mode. The following methods were used: method A, injection of 10 μL of a 20 μg·mL<sup>–1</sup> solution onto a Agilent Zorbax Eclipse XDB C8 4.6 mm × 150 mm, 5 μm separation column using a 70:30 solution of 0.01 M butane sulfonate in water/0.01 M butane sulfonate in methanol as the eluent; method B, injection of 5 μL of a 50 μM CH<sub>3</sub>CN solution onto an Kinetex Hilic 100 mm × 2.1 mm, 2.6 μm separation column using a gradient of 100% B to 60% B within 8 min, then reversing to 100% B in 5 min (solution A, 25 mL of a 4% HAc/0.4% trifluoroacetic acid solution diluted in 500 mL water; solution B, 25 mL of a 4% HAc/0.4% trifluoroacetic acid diluted in 500 mL of acetonitrile). All new compounds were determined to be >95% pure by microanalysis or LC–MS.</div></div><div id="sec4_2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> General Synthetic Procedure A for Simultaneous O<sub>7</sub>- and N<sub>9</sub>-Alkylation of 1-Methyl-7-hydroxy-β-carboline</h3><div class="NLM_p last">The 1-methyl-7-hydroxy-β-carboline <b>2</b> (500 mg, 1.587 mmol) was dissolved in <i>N</i>,<i>N</i>-dimethylformamide (20 mL), and an amount of 5 equiv of potassium hydroxide was added. The mixture was stirred for 30 min under argon. Then an amount of 2 equiv of the alkyl bromide was added, and the mixture was stirred at room temperature for 24 h under argon. The reaction was followed by TLC (85:15 CH<sub>2</sub>Cl<sub>2</sub>/ethanol). At the end of the reaction, the reaction mixture was extracted using dichloromethane (30 mL). The organic layer was washed twice with brine (2 × 30 mL) and dried with MgSO<sub>4</sub>, which was collected by filtration. The organic layer was finally evaporated under vacuum to produce the crude product, which was purified via column chromatography as described in the general section with a mobile phase of cyclohexane/ethyl acetate (from 80:20 to 50:50) used as the eluent.</div></div><div id="sec4_2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> General Synthetic Procedure B for N<sub>2</sub>-Alkylation of 1-Methyl-O<sub>7</sub>-substituted-N<sub>9</sub>-substituted-7-hydroxy-β-carboline</h3><div class="NLM_p last">The 1-methyl-O<sub>7</sub>-substituted-N<sub>9</sub>-substituted-7-hydroxy-β-carboline (100 mg) was dissolved in THF (15 mL). An amount of 10 equiv of alkyl bromide was added, and the mixture was refluxed for 48 h under argon. The reaction was followed by TLC (85:15 CH<sub>2</sub>Cl<sub>2</sub>/ethanol). At the end of the reaction, the solvents were evaporated under vacuum to produce the crude product, which was further purified via column chromatography as described in the general section with a mobile phase of 95:5 dichloromethane/ethanol used as the eluent.</div></div><div id="sec4_2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> General Microwave-Assisted Synthetic Procedure C for the N<sub>2</sub>-Alkylation of 1-Methyl-O<sub>7</sub>-substituted-N<sub>9</sub>-substituted-7-hydroxy-β-carboline</h3><div class="NLM_p last">The 1-methyl-O<sub>7</sub>-substituted-N<sub>9</sub>-substituted-7-hydroxy-β-carboline (200 mg) was dissolved in THF (10 mL). An amount of 10 equiv of alkyl halide was added, and the mixture was placed in a microwave reactor at 155 °C for 4 h. At the end of the process, TLC (85:15 CH<sub>2</sub>Cl<sub>2</sub>/ethanol) was performed. The solvents were then evaporated under vacuum to produce the crude product, which was purified via column chromatography as described in the general section with a mobile phase of dichloromethane/ethanol (from 100:0 to 85:15) used as the eluent.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> Syntheses</h3><div class="NLM_p last">The synthesis of compounds <b>2</b> and <b>3a</b>–<b>m</b> has been previously reported.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> A full description of the synthesis of compounds <b>3n</b> and <b>5a</b>–<b>za</b> can be found in the <a class="ref internalNav" href="#notes-2" aria-label="Supporting Information">Supporting Information</a>.</div></div><div id="sec4_3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> 1-Methyl-7-benzyloxy-9-benzyl-β-carboline (<b>4a</b>)</h3><div class="NLM_p last">The title compound was synthesized according to the general synthetic procedure A from 1-methyl-7-hydroxy-β-carboline <b>2</b> (1.0 g, 3.173 mmol) in the presence of 1-bromomethylbenzene (1.085 g, 6.346 mmol). White powder, yield 66%; <i>R<sub>f</sub></i> = 0.88 (CH<sub>2</sub>Cl<sub>2</sub>/ethanol 85/15); mp 156 °C; <i>m</i>/<i>z</i> [MH<sup>+</sup>] 379.2. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ (ppm): 2.70 (s, 3H, CH<sub>3</sub>), 5.14 (s, 2H, O-CH<sub>2</sub>), 5.84 (s, 2H, N-CH<sub>2</sub>), 6.88 (d, 2H, 2ArH), 6.94 (dd, <i>J</i><sub>6–5</sub> = 8.7 Hz, <i>J</i><sub>6–8</sub> = 2.1 Hz, 1H, H-6), 7.17–7.43 (m, 9H, H-8 + 8ArH), 7.89 (d, <i>J</i><sub>4–3</sub> = 5.0 Hz, 1H, H-4), 8.11 (d, <i>J</i><sub>5–6</sub> = 8.7 Hz, 1H, H-5), 8.14 (d, <i>J</i><sub>3–4</sub> = 5.0 Hz, 1H, H-3). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub><i>6</i></sub>) δ (ppm): 23.2 (CH<sub>3</sub>), 47.7 (N-CH<sub>2</sub>), 70.2 (O-CH<sub>2</sub>), 95.4 (C-8), 110.4 (C-6), 112.9 (C-4), 114.9 (Cq), 123.1 (C-5), 125.8 (2C-ArH), 127.6 (C-ArH), 128.4 (C-ArH), 128.4 (C-ArH), 128.9 (C-ArH), 129.8 (C<sub>q</sub>), 129.3 (C-ArH), 135.5 (C<sub>q</sub>), 137.3 (C<sub>q</sub>), 138.6 (C-3), 139.5 (C<sub>q</sub>), 141.3 (C<sub>q</sub>), 143.7 (C<sub>q</sub>), 160.2 (C<sub>q</sub>).</div></div><div id="sec4_3_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> 1-Methyl-2-benzyl-7-benzyloxy-9-benzyl-β-carbolin-2-ium Bromide (<b>5a</b>)</h3><div class="NLM_p last">The title compound was synthesized according to the general synthetic procedure B from <b>4a</b> (0.07 g, 0.185 mmol) in the presence of 1-bromomethylbenzene (0.316 g, 1.850 mmol). Yellow powder; yield 36%; <i>R<sub>f</sub></i> = 0.30 (CH<sub>2</sub>Cl<sub>2</sub>/ethanol 85/15); mp 262 °C; <i>m</i>/<i>z</i> [MH<sup>+</sup>] = 469.3. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ (ppm): 2.81 (s, 3H, CH<sub>3</sub>), 5.23 (s, 2H, O-CH<sub>2</sub>), 5.96 (s, 2H, N-CH<sub>2</sub>), 5.98 (s, 2H, N-CH<sub>2</sub>), 6.94 (d, 2H, <i>J</i> = 7.1 Hz, ArH), 7.07 (d, 2H, <i>J</i> = 7.1 Hz, ArH), 7.18–7.45 (m, 12H, 11 ArH + H-6), 7.53 (s, 1H, H-8), 8.45 (d, 1H, <i>J</i><sub>5–6</sub> = 8.7 Hz, H-5), 8.69 (d, 1H, <i>J</i><sub>4–3</sub> = 6.4 Hz, H-4), 8.82 (d, 1H, <i>J</i><sub>3–4</sub> = 6.2 Hz, H-3). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub><i>6</i></sub>) δ (ppm): 16.5 (CH<sub>3</sub>), 48.8 (N-CH<sub>2</sub>), 60.3 (N-CH<sub>2</sub>), 70.6 (O-CH<sub>2</sub>), 95.5 (C-8), 113.3 (C<sub>q</sub>), 114.2 (C-6), 115.2 (C-4), 125.4 (C-5), 125.9 (C-ArH), 127.1 (C-ArH), 128.0 (C-ArH), 128.6 (C-ArH), 128.8 (C-ArH), 129.0 (C-ArH), 129.5 (C-ArH), 129.6 (C-ArH), 133.9 (C<sub>q</sub>), 135.2 (C<sub>q</sub>), 135.8 (C<sub>q</sub>), 136.7 (C-3), 136.7 (C<sub>q</sub>), 138.1 (C<sub>q</sub>), 140.1 (C<sub>q</sub>), 148.5 (C<sub>q</sub>), 163.3 (C<sub>q</sub>).</div></div><div id="sec4_3_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> 1-Methyl-2-(4-fluorobenzyl)-7-(3-fluorobenzyl)oxy-9-(3-fluorobenzyl)-β-carbolin-2-ium Bromide (<b>5k</b>)</h3><div class="NLM_p last">The title compound was synthesized according to the general synthetic procedure B from <b>4b</b> (0.125 g, 0.302 mmol) in the presence of 1-bromomethyl-4-fluorobenzene (0.570 g, 3.020 mmol).Yellow powder; yield 92%; <i>R<sub>f</sub></i> = 0.43 (CH<sub>2</sub>Cl<sub>2</sub>/ethanol 85/15); mp > 200 °C; <i>m</i>/<i>z</i> [MH<sup>+</sup>] = 523.1. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ (ppm): 2.90 (s, 3H, CH<sub>3</sub>), 5.25 (s, 2H, O-CH<sub>2</sub>), 5.92 (s, 2H, N-CH<sub>2</sub>), 5.95 (s, 2H, N-CH<sub>2</sub>), 6.74 (d, 1H, <i>J</i> = 9.6 Hz, ArH), 6.79 (d, 1H, <i>J</i> = 7.8 Hz, ArH), 6.97–7.03 (m, 2H, 2ArH), 7.10–7.35 (m, 10H, H-6 + H-8 + 8ArH), 8.37 (d, 1H, <i>J</i><sub>5–6</sub> = 9.4 Hz, H-5), 8.51 (d, 1H, <i>J</i><sub>4–3</sub> = 6.4 Hz, H-4), 8.64 (d, 1H, <i>J</i><sub>3–4</sub> = 6.6 Hz, H-3). <sup>13</sup>C NMR (100 MHz, CD<sub>3</sub>OD) δ (ppm): 15.4 (CH<sub>3</sub>), 49.2 (N-CH<sub>2</sub>), 59.7 (N-CH<sub>2</sub>), 69.4 (O-CH<sub>2</sub>), 94.4 (C-8), 112.2 (d, <i>J</i> = 23.0 Hz, C-ArH), 113.4 (C<sub>q</sub>), 113.8 (d, <i>J</i> = 23.0 Hz, C-ArH), 114.4 (C-4 + C-6), 114.5 (d, <i>J</i> = 15.3 Hz, 2C-ArH), 115.9 (d, <i>J</i> = 22.0 Hz, 2C-ArH), 121.0 (d, <i>J</i> = 2.9 Hz, C-ArH), 122.9 (d, <i>J</i> = 1.9 Hz, C-ArH), 124.5 (C-5), 128.8 (d, <i>J</i> = 8.6 Hz, 2C-ArH), 130.1 (d, <i>J</i> = 7.7 Hz, C-ArH), 130.1 (d, <i>J</i> = 2.9 Hz, C<sub>q</sub>), 131.0 (d, <i>J</i> = 8.6 Hz, C-ArH), 134.6 (C<sub>q</sub>), 135.8 (C-3), 136.13 (C<sub>q</sub>), 139.2 (d, <i>J</i> = 7.7 Hz, C<sub>q</sub>), 139.4 (C<sub>q</sub>), 139.7 (d, <i>J</i> = 6.7 Hz, C<sub>q</sub>), 148.5 (C<sub>q</sub>), 162.8 (d, <i>J</i> = 247.3 Hz, C<sub>q</sub>), 163.0 (d, <i>J</i> = 245.4 Hz, C<sub>q</sub>), 163.4 (d, <i>J</i> = 246.3 Hz, C<sub>q</sub>), 163.6 (C<sub>q</sub>). <sup>19</sup>F NMR (376 MHz, CD<sub>3</sub>OD) δ (ppm): −113.5 (s), −114.7 (s), −114.8 (s).</div></div><div id="sec4_3_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> 1-Methyl-2-benzyl-7-cyclohexylmethyloxy-9-cyclohexylmethyl-β-carbolin-2-ium Bromide (<b>5o</b>)</h3><div class="NLM_p last">The title compound was synthesized according to the general synthetic procedure B from <b>4d</b> (0.125 g, 0.32 mmol) in the presence of 1-bromomethylbenzene (0.547 g, 3.200 mmol). Yellow powder; yield 74%; <i>R<sub>f</sub></i> = 0.33 (CH<sub>2</sub>Cl<sub>2</sub>/ethanol 85/15); > 200 °C; <i>m</i>/<i>z</i> [MH<sup>+</sup>] = 480.3. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ (ppm): 1.07–1.44 (m, 12H, (cyclohexyl)), 1.61–1.95 (m, 10H, (cyclohexyl)), 3.10 (s, 3H, CH<sub>3</sub>), 4.00 (d, 2H, <i>J</i> = 6.2 Hz, O-CH<sub>2</sub>), 4.51 (d, 2H, <i>J</i> = 7.3 Hz, N-CH<sub>2</sub>), 6.00 (s, 2H, N-CH<sub>2</sub>), 7.08 (dd, 1H, <i>J</i><sub>6–5</sub> = 8.9 Hz, <i>J</i><sub>6–8</sub> = 2.1 Hz, H-6), 7.15–7.16 (m, 2H, ArH), 7.23 (d, 1H, <i>J</i><sub>8–6</sub> = 2,1 Hz, H-8), 7.35–7.44 (m, 3H, ArH), 8.25 (d, 1H, <i>J</i><sub>5–6</sub> = 8.9 Hz, H-5), 8.43 (d, 1H, <i>J</i><sub>4–3</sub> = 6.6 Hz, H-4), 8.60 (d, 1H, <i>J</i><sub>3–4</sub> = 6.6 Hz, H-3). <sup>13</sup>C NMR (100 MHz, CD<sub>3</sub>OD) δ (ppm): 15.6 (CH<sub>3</sub>), 25.4 (cyclohexyl), 25.6 (cyclohexyl), 25.8 (cyclohexyl), 26.2 (cyclohexyl), 29.5 (cyclohexyl), 30.2 (cyclohexyl)), 37.7 (cyclohexyl), 40.2 (cyclohexyl), 51.0 (N-CH<sub>2</sub>), 60.4 (N-CH<sub>2</sub>), 73.9 (O-CH<sub>2</sub>), 94,5 (C-8), 112.7 (C<sub>q</sub>), 113.8 (C-4 + C-6), 123.9 (C-5), 126.3 (2C-ArH), 128.5 (C-ArH), 129.2 (2C-ArH), 134.4 (C<sub>q</sub>), 134.5 (C<sub>q</sub>), 135.4 (C-3), 135.5 (C<sub>q</sub>), 139.2 (C<sub>q</sub>), 149.1 (C<sub>q</sub>), 164.1 (C<sub>q</sub>).</div></div><div id="sec4_4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> Pharmacological Evaluation. Determination of the in Vitro IC<sub>50</sub></h3><div class="NLM_p">The colorimetric MTT assay was used, as described previously.<a onclick="showRef(event, 'cit12a cit12b cit12c cit12d'); return false;" href="javascript:void(0);" class="ref cit12a cit12b cit12c cit12d">(12a-12d)</a> This test measures the number of metabolically active, living cells that are able to transform the yellow product 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) into the blue formazan dye via mitochondrial reduction. The amount of formazan obtained at the end of the experiment, measured via spectrophotometry, is directly proportional to the number of living cells. Therefore, determination of the optical density enables a quantitative measurement of the effect of the investigated compounds when compared with the control condition (untreated cells) and/or cells treated with other reference compounds.</div><div class="NLM_p">Five human cancer cell lines (two esophageal cancer and three glioma cell lines) were obtained from either the European Collection of Cell Cultures (ECACC; Salisbury, U.K.) or the American Type Culture Collection (ATCC; Manassas, VA). The two esophageal cancer cell lines were the OE21 squamous (ECACC code 96062201) and the OE33 adenocarcinoma (ECACC code 9607808) cell lines.<a onclick="showRef(event, 'cit4c'); return false;" href="javascript:void(0);" class="ref cit4c">(4c)</a> The three glioma cell lines were the Hs683 oligodendroglioma cell line<a onclick="showRef(event, 'cit12c ref14 ref17 ref18'); return false;" href="javascript:void(0);" class="ref cit12c ref14 ref17 ref18">(12c, 14, 17, 18)</a> (ATCC code HTB-138) and the U373<a onclick="showRef(event, 'cit12c ref14 ref17 ref18'); return false;" href="javascript:void(0);" class="ref cit12c ref14 ref17 ref18">(12c, 14, 17, 18)</a> (ECACC code 89081403) and T98G<a onclick="showRef(event, 'ref14 ref17'); return false;" href="javascript:void(0);" class="ref ref14 ref17">(14, 17)</a> (ATCC code CRL-1690) astroglioma cell lines.</div><div class="NLM_p last">To perform the assay, cells (5000–8000 cells/well depending on the cell line examined) were grown in a 96-well, flat-bottomed plate in 100 μL of medium. Each cell line was seeded in its appropriate culture medium. The detailed experimental procedures are provided elsewhere.<a onclick="showRef(event, 'cit12a cit12b cit12c cit12d'); return false;" href="javascript:void(0);" class="ref cit12a cit12b cit12c cit12d">(12a-12d)</a> Each experimental condition was run in six replicates.</div></div><div id="sec4_4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> Computer-Assisted Phase Contrast Microscopy (Quantitative Videomicroscopy)</h3><div class="NLM_p last">The direct visualization of compound-induced cytotoxic or cytostatic effects was performed as described elsewhere.<a onclick="showRef(event, 'cit13a cit13b cit13c cit13d'); return false;" href="javascript:void(0);" class="ref cit13a cit13b cit13c cit13d">(13a-13d)</a></div></div><div id="sec4_4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> Analyses of DYRK1A Inhibition and Kinase Profiling</h3><div class="NLM_p last">The DYRK1A inhibitory activity of the various examined β-carbolines (see Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>) was performed at ProQinase GmbH (Freiburg, Germany), as detailed previously.<a onclick="showRef(event, 'cit24a cit24b'); return false;" href="javascript:void(0);" class="ref cit24a cit24b">(24a, 24b)</a> The anti-kinase activity of <b>5k</b> was profiled on 358 kinases and 10 lipid kinases also at ProQinase. The materials and methods used by ProQinase to perform the radiometric protein kinase assay (<sup>33</sup>PanQinase activity assay) are fully detailed in the Supporting Information of refs <a onclick="showRef(event, 'cit24a'); return false;" href="javascript:void(0);" class="ref cit24a">24a</a> and <a onclick="showRef(event, 'cit24b'); return false;" href="javascript:void(0);" class="ref cit24b">24b</a>. We originally provided ProQinase with a stock solution of each compound in 100% DMSO, and the aliquots were further diluted with water in 96-well microtiter plates directly before use; 5 μL of a 2 × 10<sup>5</sup> M/10% DMSO solution was transferred to the assay plates. The final volume of the assay was 50 μL. The concentrations tested for each compound in order to determine the IC<sub>50</sub> value are detailed in the legend to Tables <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a> and <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>.</div></div><div id="sec4_4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> Western Blott Analyses with the Eukaryotic Initiation Factor 2 (eIF2)</h3><div class="NLM_p">We used a modified RIPA buffer to recover the largest part of proteins from Hs683 and U373 glioma cells. This ice cold lysis buffer is composed of 10 mM Tris (pH7.4), 100 mM NaCl, 1 mM EDTA, 1 mM EGTA, 1 mM NaF, 20 mM Na4P2O7, 2 mM Na<sub>3</sub>VO<sub>4</sub>, 0.1% SDS, 0.5% sodium deoxycholate, 1% Triton-X 100, 10% glycerol, 1 mM AEBSF (Perfabloc, Sigma), 60 μg/mL aprotinin, 10 μg/mL leupeptin, and 1 μg/mL pepstatin.</div><div class="NLM_p last">The control and treated cells were lysed in this buffer and centrifuged for 10 min at 13 000 rpm to eliminate the cellular debris. The concentration of proteins has been determined by the BCA protein assay (Thermofisher, Erembodegem, Belgium); 35 μg of proteins was loaded onto a denaturing polyacrylamide gel, and after electrophoresis, the proteins were transferred in a PVDF membrane (Thermofisher). Equal loading and integrity of proteins was verified by means of tubulin immunoblot analysis. The following primary antibodies were used for Western blot analysis: anti-eIF2α (dilution 1/1000; Abcam; Cambridge, U.K.), anti-eIF2αS1 (phospho S51) (dilution 1/1000; Abcam), and anti-α tubulin (dilution 1/2000; Abcam). Western blots were developed using the Pierce SuperSignal chemiluminescence system (Thermofisher) and the Biorad XRS+ system (Biorad, Nazareth, Belgium).</div></div><div id="sec4_4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> Solubility Measurements</h3><div class="NLM_p last">The solubility was evaluated according to a method described previously.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> HPLC measurements were done using method A.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-2"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i32"><a href="/doi/suppl/10.1021/jm300542e">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_88271" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_88271" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Detailed synthesis, characterization, and microanalysis and HPLC purity data of all reported derivatives. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm300542e/suppl_file/jm300542e_si_001.pdf">jm300542e_si_001.pdf (203.27 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm300542e" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_00352" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_00352" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Raphaël Frédérick</span> - <span class="hlFld-Affiliation affiliation">Namur Medicine and Drug Innovation
Center (NAMEDIC-NARILIS), University of Namur (FUNDP), 61, Rue de Bruxelles, 5000 Namur, Belgium</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#97e5f6e7fff6f2fbb9f1e5f2f3f2e5fef4fcd7f1e2f9f3e7b9f6f4b9f5f2b7e5fcfee4e4d7e2fbf5b9f6f4b9f5f2b7fdf8fff6f9b9e0f8e2e3f2e5e4d7f1e2f9f3e7b9f6f4b9f5f2"><span class="__cf_email__" data-cfemail="3a485b4a525b5f56145c485f5e5f485359517a5c4f545e4a145b5914585f">[email protected]</span> <span class="__cf_email__" data-cfemail="d7a5bcbea4a497a2bbb5f9b6b4f9b5b2">[email protected]</span> <span class="__cf_email__" data-cfemail="214b4e49404f0f564e54554453526147544f45510f40420f4344">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Robert Kiss</span> - <span class="hlFld-Affiliation affiliation">Laboratoire de Toxicologie, Faculté
de Pharmacie, Université Libre de Bruxelles (ULB), Boulevard du Triomphe, 1050 Brussels, Belgium</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#304251405851555c1e56425554554259535b7056455e54401e51531e525510425b59434370455c521e51531e5255105a5f58515e1e475f45445542437056455e54401e51531e5255"><span class="__cf_email__" data-cfemail="394b584951585c55175f4b5c5d5c4b505a52795f4c575d4917585a175b5c">[email protected]</span> <span class="__cf_email__" data-cfemail="e290898b9191a2978e80cc8381cc8087">[email protected]</span> <span class="__cf_email__" data-cfemail="462c292e27286831293332233435062033282236682725682423">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Johan Wouters</span> - <span class="hlFld-Affiliation affiliation">Namur Medicine and Drug Innovation
Center (NAMEDIC-NARILIS), University of Namur (FUNDP), 61, Rue de Bruxelles, 5000 Namur, Belgium</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#deacbfaeb6bfbbb2f0b8acbbbabbacb7bdb59eb8abb0baaef0bfbdf0bcbbfeacb5b7adad9eabb2bcf0bfbdf0bcbbfeb4b1b6bfb0f0a9b1abaabbacad9eb8abb0baaef0bfbdf0bcbb"><span class="__cf_email__" data-cfemail="acdecddcc4cdc9c082cadec9c8c9dec5cfc7eccad9c2c8dc82cdcf82cec9">[email protected]</span> <span class="__cf_email__" data-cfemail="bcced7d5cfcffcc9d0de92dddf92ded9">[email protected]</span> <span class="__cf_email__" data-cfemail="ff9590979e91d188908a8b9a8d8cbf998a919b8fd19e9cd19d9a">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Céline Bruyère</span> - <span class="hlFld-Affiliation affiliation">Laboratoire de Toxicologie, Faculté
de Pharmacie, Université Libre de Bruxelles (ULB), Boulevard du Triomphe, 1050 Brussels, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christelle Vancraeynest</span> - <span class="hlFld-Affiliation affiliation">Namur Medicine and Drug Innovation
Center (NAMEDIC-NARILIS), University of Namur (FUNDP), 61, Rue de Bruxelles, 5000 Namur, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jérémy Reniers</span> - <span class="hlFld-Affiliation affiliation">Namur Medicine and Drug Innovation
Center (NAMEDIC-NARILIS), University of Namur (FUNDP), 61, Rue de Bruxelles, 5000 Namur, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Céline Meinguet</span> - <span class="hlFld-Affiliation affiliation">Namur Medicine and Drug Innovation
Center (NAMEDIC-NARILIS), University of Namur (FUNDP), 61, Rue de Bruxelles, 5000 Namur, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lionel Pochet</span> - <span class="hlFld-Affiliation affiliation">Namur Medicine and Drug Innovation
Center (NAMEDIC-NARILIS), University of Namur (FUNDP), 61, Rue de Bruxelles, 5000 Namur, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Anders Backlund</span> - <span class="hlFld-Affiliation affiliation">Department of Medicinal Chemistry,
Biomedical Centre, Division of Pharmacognosy, Uppsala
University, 751 23 Uppsala, Sweden</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Bernard Masereel</span> - <span class="hlFld-Affiliation affiliation">Namur Medicine and Drug Innovation
Center (NAMEDIC-NARILIS), University of Namur (FUNDP), 61, Rue de Bruxelles, 5000 Namur, Belgium</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d2169e2528-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i33">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_24525" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_24525" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The authors thank Pierre Legrand and Eduard Dolušić for their assistance. R.F. is a Research Associate of the Fonds de la Recherche Scientifique—FNRS. This project was funded in part by the FNRS Grant FRSM 3.4525.11 and a Télévie Grant 7.4.547.11.F.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i34" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i34"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i35" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i35"> Abbreviations Used</h2><tr><td class="NLM_term">ATCC</td><td class="NLM_def"><p class="first last">American Type Culture Collection</p></td></tr><tr><td class="NLM_term">DYRK1A</td><td class="NLM_def"><p class="first last">dual-specificity tyrosine-regulated kinase 1A</p></td></tr><tr><td class="NLM_term">ECACC</td><td class="NLM_def"><p class="first last">European Collection of Cell Culture</p></td></tr><tr><td class="NLM_term">GBM</td><td class="NLM_def"><p class="first last">glioblastoma</p></td></tr><tr><td class="NLM_term">MTT</td><td class="NLM_def"><p class="first last">3-(4,5)-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide</p></td></tr><tr><td class="NLM_term">NCI</td><td class="NLM_def"><p class="first last">National Cancer Institute</p></td></tr><tr><td class="NLM_term">NSCLC</td><td class="NLM_def"><p class="first last">non-small-cell lung carcinoma</p></td></tr><tr><td class="NLM_term">OPLS-DA</td><td class="NLM_def"><p class="first last">orthogonal partial least squares discriminant analysis (sometimes interpreted as orthogonal projection of latent structures)</p></td></tr><tr><td class="NLM_term">PC1</td><td class="NLM_def"><p class="first last">principal component 1, first dimension in the ChemGPS-NP chemical property space</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure–activity relationship</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i36">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_51760" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_51760" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 25 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Savage, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stebbing, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bower, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crook, T.</span><span> </span><span class="NLM_article-title">Why does cytotoxic chemotherapy cure only some cancers?</span> <span class="citation_source-journal">Nat. Clin. Pract. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">43</span><span class="NLM_x">–</span> <span class="NLM_lpage">52</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=16&amp;doi=10.1021%2Fjm300542e&amp;key=10.1038%2Fncponc1260" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=8&amp;doi=10.1021%2Fjm300542e&amp;key=18982000" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=32&amp;doi=10.1021%2Fjm300542e&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsFWkurzP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2009&pages=43-52&author=P.+Savageauthor=J.+Stebbingauthor=M.+Bowerauthor=T.+Crook&title=Why+does+cytotoxic+chemotherapy+cure+only+some+cancers%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1aR"><div class="casContent"><span class="casTitleNuber">1a</span><div class="casTitle"><span class="NLM_cas:atitle">Why does cytotoxic chemotherapy cure only some cancers?</span></div><div class="casAuthors">Savage, Philip; Stebbing, Justin; Bower, Mark; Crook, Tim</div><div class="citationInfo"><span class="NLM_cas:title">Nature Clinical Practice Oncology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">43-52</span>CODEN:
                <span class="NLM_cas:coden">NCPOB5</span>;
        ISSN:<span class="NLM_cas:issn">1743-4254</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Despite frequent responses to chemotherapy, curative treatment remains elusive for the majority of metastatic solid tumors.  By contrast, chemotherapy routinely cures patients with testicular cancers, gestational choriocarcinoma, Hodgkin's disease and high-grade lymphomas.  Savage et al. suggest that the chemo-curability of these malignancies results from an intrinsic 'locked-in' state of sensitivity to pro-apoptotic stresses in these particular cell types, and they discuss some of the characteristics shared by the curable cancers that might explain their curability.  Despite frequent responses to chemotherapy, curative treatment remains elusive for the majority of patients with metastatic solid tumors.  By contrast, in testicular cancer, gestational choriocarcinoma, Hodgkin disease and high-grade lymphomas, chemotherapy is routinely curative, even for patients who present with widely disseminated disease.  In the common advanced cancers, however, over 40 years of cytotoxic drug development has brought no significant change in cure rates.  One interpretation is that the intrinsic properties of the malignancies themselves, rather than the qualities of individual drugs or combination therapies, are primarily responsible for their curability with chemotherapy.  We suggest that the curability of these malignancies results from an intrinsic 'locked-in' state of sensitivity to proapoptotic stresses in these cells.  A common property of such curable malignancies is that they arise from cells that undergo major genetic rearrangements or recombination as part of their normal physiol.  The absence of further genetic and epigenetic changes in genes that regulate apoptosis, DNA repair and senescence allows these cells to maintain their intrinsic sensitivity to chemotherapy.  This process allows the cells, when challenged with chemotherapy, to undergo the natural apoptotic pathways that contribute to their intrinsic qualities of chemosensitivity and high curability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqov8Vi7LfVIrVg90H21EOLACvtfcHk0lgJvD2kakUF0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsFWkurzP&md5=1ac0fd31132140d612c789fe6bb99590</span></div><a href="/servlet/linkout?suffix=cit1a&amp;dbid=16384&amp;doi=10.1038%2Fncponc1260&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncponc1260%26sid%3Dliteratum%253Aachs%26aulast%3DSavage%26aufirst%3DP.%26aulast%3DStebbing%26aufirst%3DJ.%26aulast%3DBower%26aufirst%3DM.%26aulast%3DCrook%26aufirst%3DT.%26atitle%3DWhy%2520does%2520cytotoxic%2520chemotherapy%2520cure%2520only%2520some%2520cancers%253F%26jtitle%3DNat.%2520Clin.%2520Pract.%2520Oncol.%26date%3D2009%26volume%3D6%26spage%3D43%26epage%3D52" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit1b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Wilson, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnston, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Longley, D. B.</span><span> </span><span class="NLM_article-title">Anti-apoptotic mechanisms of drug resistance in cancer</span> <span class="citation_source-journal">Curr. Cancer Drug Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">307</span><span class="NLM_x">–</span> <span class="NLM_lpage">319</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=16&amp;doi=10.1021%2Fjm300542e&amp;key=10.2174%2F156800909788166547" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=8&amp;doi=10.1021%2Fjm300542e&amp;key=19442051" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=32&amp;doi=10.1021%2Fjm300542e&amp;key=1%3ACAS%3A528%3ADC%252BD1MXmslansLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2009&pages=307-319&author=T.+R.+Wilsonauthor=P.+G.+Johnstonauthor=D.+B.+Longley&title=Anti-apoptotic+mechanisms+of+drug+resistance+in+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1bR"><div class="casContent"><span class="casTitleNuber">1b</span><div class="casTitle"><span class="NLM_cas:atitle">Anti-apoptotic mechanisms of drug resistance in cancer</span></div><div class="casAuthors">Wilson, T. R.; Johnston, P. G.; Longley, D. B.</div><div class="citationInfo"><span class="NLM_cas:title">Current Cancer Drug Targets</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">307-319</span>CODEN:
                <span class="NLM_cas:coden">CCDTB9</span>;
        ISSN:<span class="NLM_cas:issn">1568-0096</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Resistance to chemotherapy is a major obstacle in the treatment of cancer.  Despite the advent of new chemotherapies and mol.-targeted therapies, approx. 90% of patients with metastatic cancer succumb to their disease.  Drug resistance, either acquired or intrinsic, often prevents tumor cells from undergoing sufficient levels of programmed cell death or apoptosis, resulting in cancer cell survival and treatment failure.  In pre-clin. disease models, agents that target the apoptotic pathway were shown to sensitize tumor cells to chemotherapy and radiotherapy.  Such therapies include small mol. inhibitors and antisense strategies that inhibit the activity of anti-apoptotic proteins, or treatment with recombinant pro-apoptotic proteins or antibodies that can activate the apoptotic pathway.  This review will discuss apoptosis and the mechanisms by which it can become dysregulated in human cancer.  In addn., novel therapeutic strategies that target key components of the apoptotic machinery will be discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqkegczsL_lBrVg90H21EOLACvtfcHk0ljdYRjh1cyxEw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmslansLo%253D&md5=85b32e7e06a33942779c569f39f19252</span></div><a href="/servlet/linkout?suffix=cit1b&amp;dbid=16384&amp;doi=10.2174%2F156800909788166547&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156800909788166547%26sid%3Dliteratum%253Aachs%26aulast%3DWilson%26aufirst%3DT.%2BR.%26aulast%3DJohnston%26aufirst%3DP.%2BG.%26aulast%3DLongley%26aufirst%3DD.%2BB.%26atitle%3DAnti-apoptotic%2520mechanisms%2520of%2520drug%2520resistance%2520in%2520cancer%26jtitle%3DCurr.%2520Cancer%2520Drug%2520Targets%26date%3D2009%26volume%3D9%26spage%3D307%26epage%3D319" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit1c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Wong, R. S.</span><span> </span><span class="NLM_article-title">Apoptosis in cancer: from pathogenesis to treatment</span> <span class="citation_source-journal">J. Exp. Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">87</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1c&amp;dbid=16&amp;doi=10.1021%2Fjm300542e&amp;key=10.1186%2F1756-9966-30-87" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1c&amp;dbid=8&amp;doi=10.1021%2Fjm300542e&amp;key=21943236" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1c&amp;dbid=32&amp;doi=10.1021%2Fjm300542e&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlOitLzI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2011&pages=87&author=R.+S.+Wong&title=Apoptosis+in+cancer%3A+from+pathogenesis+to+treatment"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1cR"><div class="casContent"><span class="casTitleNuber">1c</span><div class="casTitle"><span class="NLM_cas:atitle">Apoptosis in cancer: from pathogenesis to treatment</span></div><div class="casAuthors">Wong, Rebecca S. Y.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Experimental & Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">87</span>CODEN:
                <span class="NLM_cas:coden">JECRDN</span>;
        ISSN:<span class="NLM_cas:issn">1756-9966</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">A review.  Apoptosis is an ordered and orchestrated cellular process that occurs in physiol. and pathol. conditions.  It is also one of the most studied topics among cell biologists.  An understanding of the underlying mechanism of apoptosis is important as it plays a pivotal role in the pathogenesis of many diseases.  In some, the problem is due to too much apoptosis, such as in the case of degenerative diseases while in others, too little apoptosis is the culprit.  Cancer is one of the scenarios where too little apoptosis occurs, resulting in malignant cells that will not die.  The mechanism of apoptosis is complex and involves many pathways.  Defects can occur at any point along these pathways, leading to malignant transformation of the affected cells, tumor metastasis and resistance to anticancer drugs.  Despite being the cause of problem, apoptosis plays an important role in the treatment of cancer as it is a popular target of many treatment strategies.  The abundance of literature suggests that targeting apoptosis in cancer is feasible.  However, many troubling questions arise with the use of new drugs or treatment strategies that are designed to enhance apoptosis and crit. tests must be passed before they can be used safely in human subjects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqy9-lLMtzN4bVg90H21EOLACvtfcHk0ljdYRjh1cyxEw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlOitLzI&md5=e53612be1ef5a3dc9da16a7cd3a3ed9c</span></div><a href="/servlet/linkout?suffix=cit1c&amp;dbid=16384&amp;doi=10.1186%2F1756-9966-30-87&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1756-9966-30-87%26sid%3Dliteratum%253Aachs%26aulast%3DWong%26aufirst%3DR.%2BS.%26atitle%3DApoptosis%2520in%2520cancer%253A%2520from%2520pathogenesis%2520to%2520treatment%26jtitle%3DJ.%2520Exp.%2520Clin.%2520Cancer%2520Res.%26date%3D2011%26volume%3D30%26spage%3D87" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Martinez-Rivera, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siddik, Z. H.</span><span> </span><span class="NLM_article-title">Resistance and gain-of-resistance phenotypes in cancers harboring wild-type p53</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">83</span><span class="NLM_x"> (</span><span class="NLM_issue">8</span><span class="NLM_x">) </span> <span class="NLM_fpage">1049</span><span class="NLM_x">–</span> <span class="NLM_lpage">1062</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=2012&pages=1049-1062&issue=8&author=M.+Martinez-Riveraauthor=Z.+H.+Siddik&title=Resistance+and+gain-of-resistance+phenotypes+in+cancers+harboring+wild-type+p53"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMartinez-Rivera%26aufirst%3DM.%26aulast%3DSiddik%26aufirst%3DZ.%2BH.%26atitle%3DResistance%2520and%2520gain-of-resistance%2520phenotypes%2520in%2520cancers%2520harboring%2520wild-type%2520p53%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2012%26volume%3D83%26issue%3D8%26spage%3D1049%26epage%3D1062" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Rosenzweig, S. A.</span><span> </span><span class="NLM_article-title">Acquired resistance to drugs targeting receptor tyrosine kinases</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">83</span><span class="NLM_x"> (</span><span class="NLM_issue">8</span><span class="NLM_x">) </span> <span class="NLM_fpage">1041</span><span class="NLM_x">–</span> <span class="NLM_lpage">1048</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=2012&pages=1041-1048&issue=8&author=S.+A.+Rosenzweig&title=Acquired+resistance+to+drugs+targeting+receptor+tyrosine+kinases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRosenzweig%26aufirst%3DS.%2BA.%26atitle%3DAcquired%2520resistance%2520to%2520drugs%2520targeting%2520receptor%2520tyrosine%2520kinases%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2012%26volume%3D83%26issue%3D8%26spage%3D1041%26epage%3D1048" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit3b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Rodrigues, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dinis, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gromicho, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martins, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laires, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rueff, J.</span><span> </span><span class="NLM_article-title">Genomics and cancer drug resistance</span> <span class="citation_source-journal">Curr. Pharm. Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">651</span><span class="NLM_x">–</span> <span class="NLM_lpage">673</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=16&amp;doi=10.1021%2Fjm300542e&amp;key=10.2174%2F138920112799857549" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=8&amp;doi=10.1021%2Fjm300542e&amp;key=22122479" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=32&amp;doi=10.1021%2Fjm300542e&amp;key=1%3ACAS%3A528%3ADC%252BC38XltFShs7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2012&pages=651-673&issue=5&author=A.+S.+Rodriguesauthor=J.+Dinisauthor=M.+Gromichoauthor=C.+Martinsauthor=A.+Lairesauthor=J.+Rueff&title=Genomics+and+cancer+drug+resistance"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3bR"><div class="casContent"><span class="casTitleNuber">3b</span><div class="casTitle"><span class="NLM_cas:atitle">Genomics and cancer drug resistance</span></div><div class="casAuthors">Rodrigues, Antonio S.; Dinis, Joana; Gromicho, Marta; Martins, Celia; Laires, Antonio; Rueff, Jose</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Biotechnology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">651-673</span>CODEN:
                <span class="NLM_cas:coden">CPBUBP</span>;
        ISSN:<span class="NLM_cas:issn">1389-2010</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">Cellular drug resistance is a major obstacle in cancer therapy.  Mechanisms of resistance can be assocd. with altered expression of ATP-binding cassette (ABC) family of transporters on cell membrane transporters, the most common cause of multi-drug resistance (MDR), but can also include alterations of DNA repair pathways, resistance to apoptosis and target modifications.  Anti-cancer treatments may be divided into different categories based on their purpose and action: chemotherapeutic agents damage and kill dividing cells; hormonal treatments prevent cancer cells from receiving signals essential for their growth; targeted drugs are a relatively new cancer treatment that targets specific proteins and pathways that are limited primarily to cancer cells or that are much more prevalent in cancer cells; and antibodies function by either depriving the cancer cells of necessary signals or by causing their direct death.  In any case, resistance to anticancer therapies leads to poor prognosis of patients.  Thus, identification of novel mol. targets is crit. in development of new, efficient and specific cancer drugs.  The aim of this review is to describe the impact of genomics in studying some of the most crit. pathways involved in cancer drug resistance and in improving drug development.  We shall also focus on the emerging role of microRNAs, as key gene expression regulators, in drug resistance.  Finally, we shall address the specific mechanisms involved in resistance to tyrosine kinase inhibitors in chronic myeloid leukemia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpqIIIVndgV7Vg90H21EOLACvtfcHk0lgk88gIHfde7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XltFShs7o%253D&md5=5e90b45ac02cdc4ef1d0f980bf46b948</span></div><a href="/servlet/linkout?suffix=cit3b&amp;dbid=16384&amp;doi=10.2174%2F138920112799857549&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138920112799857549%26sid%3Dliteratum%253Aachs%26aulast%3DRodrigues%26aufirst%3DA.%2BS.%26aulast%3DDinis%26aufirst%3DJ.%26aulast%3DGromicho%26aufirst%3DM.%26aulast%3DMartins%26aufirst%3DC.%26aulast%3DLaires%26aufirst%3DA.%26aulast%3DRueff%26aufirst%3DJ.%26atitle%3DGenomics%2520and%2520cancer%2520drug%2520resistance%26jtitle%3DCurr.%2520Pharm.%2520Biotechnol.%26date%3D2012%26volume%3D13%26issue%3D5%26spage%3D651%26epage%3D673" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Lefranc, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brotchi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiss, R.</span><span> </span><span class="NLM_article-title">Possible future issues in the treatment of glioblastomas, with a special emphasis on cell migration and the resistance of migrating glioblastoma cells to apoptosis</span> <span class="citation_source-journal">J. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">2411</span><span class="NLM_x">–</span> <span class="NLM_lpage">2422</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=16&amp;doi=10.1021%2Fjm300542e&amp;key=10.1200%2FJCO.2005.03.089" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=8&amp;doi=10.1021%2Fjm300542e&amp;key=15800333" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=32&amp;doi=10.1021%2Fjm300542e&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjsVyhsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2005&pages=2411-2422&author=F.+Lefrancauthor=J.+Brotchiauthor=R.+Kiss&title=Possible+future+issues+in+the+treatment+of+glioblastomas%2C+with+a+special+emphasis+on+cell+migration+and+the+resistance+of+migrating+glioblastoma+cells+to+apoptosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4aR"><div class="casContent"><span class="casTitleNuber">4a</span><div class="casTitle"><span class="NLM_cas:atitle">Possible future issues in the treatment of glioblastomas: Special emphasis on cell migration and the resistance of migrating glioblastoma cells to apoptosis</span></div><div class="casAuthors">Lefranc, Florence; Brotchi, Jacques; Kiss, Robert</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Oncology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2411-2422</span>CODEN:
                <span class="NLM_cas:coden">JCONDN</span>;
        ISSN:<span class="NLM_cas:issn">0732-183X</span>.
    
            (<span class="NLM_cas:orgname">American Society of Clinical Oncology</span>)
        </div><div class="casAbstract">The present review aims to emphasize that malignant gliomas are characterized by the diffuse invasion of distant brain tissue by a myriad of single migrating cells that exhibit decreased levels of apoptosis (programmed cell death type I), thus a resistance to cytotoxic insult.  The present review surveys the mol. mechanisms of migration in malignant gliomas and potential issues arising from treatments, in addn. to relationships between glioma cell migration and resistance to apoptosis in terms of the mol. signaling pathways.  Clin. and exptl. data demonstrate that glioma cell migration is a complex combination of multiple mol. processes, including the alteration of tumor cell adhesion to a modified extracellular matrix, the secretion of proteases by the cells, and modifications to the actin cytoskeleton.  Intracellular signaling pathways involved in the acquisition of resistance to apoptosis by migrating glioma cells concern Pl3K, Akt, mTOR, NF-κB, and autophagy (programmed cell death type II).  A no. of signaling pathways can be constitutively activated in migrating glioma cells, thus rendering these cells resistant to cytotoxic insults.  However, these pathways are not all constitutively activated at the same time in any one glioma.  Particular inhibitors should therefore only be chosen if the target is present in the tumor tissue, but this is only possible if individual patients are submitted to the mol. profiling of their tumors before undergoing any treatment to combat their migratory glioma cells.  Specific antimigratory compds. should be added to conventional radio- and/or chemotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRxPKR4Wm5vbVg90H21EOLACvtfcHk0lgk88gIHfde7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjsVyhsrY%253D&md5=9195f4ac3a7cccda1ca747dbb35f3023</span></div><a href="/servlet/linkout?suffix=cit4a&amp;dbid=16384&amp;doi=10.1200%2FJCO.2005.03.089&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2005.03.089%26sid%3Dliteratum%253Aachs%26aulast%3DLefranc%26aufirst%3DF.%26aulast%3DBrotchi%26aufirst%3DJ.%26aulast%3DKiss%26aufirst%3DR.%26atitle%3DPossible%2520future%2520issues%2520in%2520the%2520treatment%2520of%2520glioblastomas%252C%2520with%2520a%2520special%2520emphasis%2520on%2520cell%2520migration%2520and%2520the%2520resistance%2520of%2520migrating%2520glioblastoma%2520cells%2520to%2520apoptosis%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2005%26volume%3D23%26spage%3D2411%26epage%3D2422" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit4b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">D’Amico, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harpole, D. H.,  Jr.</span><span> </span><span class="NLM_article-title">Molecular biology of esophageal cancer</span> <span class="citation_source-journal">Chest Surg. Clin. N. Am.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">451</span><span class="NLM_x">–</span> <span class="NLM_lpage">469</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=8&amp;doi=10.1021%2Fjm300542e&amp;key=10967750" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=32&amp;doi=10.1021%2Fjm300542e&amp;key=1%3ACAS%3A280%3ADC%252BD3M%252Fmt1CrsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2000&pages=451-469&author=T.+A.+D%E2%80%99Amicoauthor=D.+H.+Harpole&title=Molecular+biology+of+esophageal+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4bR"><div class="casContent"><span class="casTitleNuber">4b</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular biology of esophageal cancer</span></div><div class="casAuthors">D'Amico T A; Harpole D H Jr</div><div class="citationInfo"><span class="NLM_cas:title">Chest surgery clinics of North America</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">451-69</span>
        ISSN:<span class="NLM_cas:issn">1052-3359</span>.
    </div><div class="casAbstract">Several mechanisms of resistance to chemotherapy have been identified among the agents that are commonly used in the systemic treatment of patients with esophageal cancer: paclitaxel, platinum, and 5-FU.  A recent study from our laboratory evaluated the initial endoscopic biopsy material from patients who subsequently underwent trimodality therapy, including chemotherapy with cisplatin and 5-FU, radiation therapy, and surgery.  IHC analysis was performed on seven markers of chemotherapy or radiation therapy resistance: P-gp, GST-pi, MT (platinum inhibitors); EGF-R, TGF-alpha, erb-B2 (activation of cell growth cascade); and p53 (interferes with chemotherapy-induced apoptosis).  In this study, elevated expression of GST-pi and P-gp were associated with decreased survival and may be markers of treatment resistance.  Expression of erb-B2 was associated with enhanced survival and may be a marker of treatment sensitivity.  Assessment of the probability of chemoresistance of a particular tumor using the expression of molecular biologic markers may allow for the selection of a more favorable chemotherapeutic agent.  Furthermore, understanding the mechanisms of resistance, including the mechanisms of DNA repair, may provide insight into mechanisms to reverse or to inhibit resistance to chemotherapy.  DNA repair mechanisms are used by cells to protect themselves against mutagens and carcinogens.  DNA repair inhibitors may increase the mutagenicity associated with DNA damage and may prove to be an ineffective oncologic treatment strategy; however, the possibility exists that DNA repair inhibition may improve the efficacy of anticancer agents, and this should be tested.  The value of this strategy may be in allowing treatment doses to be decreased and lessening side effects while maintaining therapeutic efficacy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT2CsMTXq-wgNXdcedVHT5tfW6udTcc2eZqwqua0qf9OLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3M%252Fmt1CrsA%253D%253D&md5=9c0dddf3f5a7b976e6532ee7ff43de2f</span></div><a href="/servlet/linkout?suffix=cit4b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DD%25E2%2580%2599Amico%26aufirst%3DT.%2BA.%26aulast%3DHarpole%26aufirst%3DD.%2BH.%26atitle%3DMolecular%2520biology%2520of%2520esophageal%2520cancer%26jtitle%3DChest%2520Surg.%2520Clin.%2520N.%2520Am.%26date%3D2000%26volume%3D10%26spage%3D451%26epage%3D469" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit4c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Bruyère, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lonez, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duray, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cludts, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruysschaert, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saussez, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yeaton, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiss, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mijatovic, T.</span><span> </span><span class="NLM_article-title">Considering temozolomide as a novel potential treatment for esophageal cancer</span> <span class="citation_source-journal">Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">117</span><span class="NLM_x">, </span> <span class="NLM_fpage">2004</span><span class="NLM_x">–</span> <span class="NLM_lpage">2016</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=2011&pages=2004-2016&author=C.+Bruy%C3%A8reauthor=C.+Lonezauthor=A.+Durayauthor=S.+Cludtsauthor=J.+M.+Ruysschaertauthor=S.+Saussezauthor=P.+Yeatonauthor=R.+Kissauthor=T.+Mijatovic&title=Considering+temozolomide+as+a+novel+potential+treatment+for+esophageal+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBruy%25C3%25A8re%26aufirst%3DC.%26aulast%3DLonez%26aufirst%3DC.%26aulast%3DDuray%26aufirst%3DA.%26aulast%3DCludts%26aufirst%3DS.%26aulast%3DRuysschaert%26aufirst%3DJ.%2BM.%26aulast%3DSaussez%26aufirst%3DS.%26aulast%3DYeaton%26aufirst%3DP.%26aulast%3DKiss%26aufirst%3DR.%26aulast%3DMijatovic%26aufirst%3DT.%26atitle%3DConsidering%2520temozolomide%2520as%2520a%2520novel%2520potential%2520treatment%2520for%2520esophageal%2520cancer%26jtitle%3DCancer%26date%3D2011%26volume%3D117%26spage%3D2004%26epage%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit4d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Soengas, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lowe, S. W.</span><span> </span><span class="NLM_article-title">Apoptosis and melanoma chemoresistance</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">3138</span><span class="NLM_x">–</span> <span class="NLM_lpage">3151</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2003&pages=3138-3151&author=M.+S.+Soengasauthor=S.+W.+Lowe&title=Apoptosis+and+melanoma+chemoresistance"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSoengas%26aufirst%3DM.%2BS.%26aulast%3DLowe%26aufirst%3DS.%2BW.%26atitle%3DApoptosis%2520and%2520melanoma%2520chemoresistance%26jtitle%3DOncogene%26date%3D2003%26volume%3D22%26spage%3D3138%26epage%3D3151" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit4e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Wong, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lemoine, N. R.</span><span> </span><span class="NLM_article-title">Pancreatic cancer: molecular pathogenesis and new therapeutic targets</span> <span class="citation_source-journal">Nat. Rev. Gastroenterol. Hepatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">412</span><span class="NLM_x">–</span> <span class="NLM_lpage">422</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4e&amp;dbid=16&amp;doi=10.1021%2Fjm300542e&amp;key=10.1038%2Fnrgastro.2009.89" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4e&amp;dbid=8&amp;doi=10.1021%2Fjm300542e&amp;key=19506583" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4e&amp;dbid=32&amp;doi=10.1021%2Fjm300542e&amp;key=1%3ACAS%3A528%3ADC%252BD1MXot12ltLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2009&pages=412-422&author=H.+H.+Wongauthor=N.+R.+Lemoine&title=Pancreatic+cancer%3A+molecular+pathogenesis+and+new+therapeutic+targets"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4eR"><div class="casContent"><span class="casTitleNuber">4e</span><div class="casTitle"><span class="NLM_cas:atitle">Pancreatic cancer: molecular pathogenesis and new therapeutic targets</span></div><div class="casAuthors">Wong, Han H.; Lemoine, Nicholas R.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Gastroenterology & Hepatology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">412-422</span>CODEN:
                <span class="NLM_cas:coden">NRGHA9</span>;
        ISSN:<span class="NLM_cas:issn">1759-5045</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Pancreatic cancer is lethal and notoriously difficult to treat, therefore, there is an urgent need to develop new therapeutic and diagnostic modalities.  This Review discusses the agents that have been developed to target the pathways and processes involved in pancreatic tumorigenesis, and reviews the results of lab. and clin. trials of these agents.  Future therapeutic targets are also discussed.  Patients with pancreatic cancer normally present with advanced disease that is lethal and notoriously difficult to treat.  Survival has not improved dramatically despite routine use of chemotherapy and radiotherapy; this situation signifies an urgent need for novel therapeutic approaches.  Over the past decade, a large no. of studies have been published that aimed to target the mol. abnormalities implicated in pancreatic tumor growth, invasion, metastasis, angiogenesis and resistance to apoptosis.  This research is of particular importance, as data suggest that a large no. of genetic alterations affect only a few major signaling pathways and processes involved in pancreatic tumorigenesis.  Although lab. results of targeted therapies have been impressive, until now only erlotinib, an epidermal growth factor receptor tyrosine kinase inhibitor, has demonstrated modest survival benefit in combination with gemcitabine in a phase III clin. trial.  While the failures of targeted therapies in the clin. setting are discouraging, lessons have been learnt and new therapeutic targets that hold promise for the future management of the disease are continuously emerging.  This Review describes some of the important developments and targeted agents for pancreatic cancer that have been tested in clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpm5mtPxXGCSLVg90H21EOLACvtfcHk0lh-nI-6M1cMLA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXot12ltLo%253D&md5=61183be915ad65cab453c462f046d30d</span></div><a href="/servlet/linkout?suffix=cit4e&amp;dbid=16384&amp;doi=10.1038%2Fnrgastro.2009.89&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrgastro.2009.89%26sid%3Dliteratum%253Aachs%26aulast%3DWong%26aufirst%3DH.%2BH.%26aulast%3DLemoine%26aufirst%3DN.%2BR.%26atitle%3DPancreatic%2520cancer%253A%2520molecular%2520pathogenesis%2520and%2520new%2520therapeutic%2520targets%26jtitle%3DNat.%2520Rev.%2520Gastroenterol.%2520Hepatol.%26date%3D2009%26volume%3D6%26spage%3D412%26epage%3D422" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit4f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Han, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roman, J.</span><span> </span><span class="NLM_article-title">Targeting apoptotic signaling pathways in human lung cancer</span> <span class="citation_source-journal">Curr. Cancer Drug Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">566</span><span class="NLM_x">–</span> <span class="NLM_lpage">574</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4f&amp;dbid=16&amp;doi=10.1021%2Fjm300542e&amp;key=10.2174%2F156800910791859461" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4f&amp;dbid=8&amp;doi=10.1021%2Fjm300542e&amp;key=20482489" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4f&amp;dbid=32&amp;doi=10.1021%2Fjm300542e&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFSktLfL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2010&pages=566-574&author=S.+Hanauthor=J.+Roman&title=Targeting+apoptotic+signaling+pathways+in+human+lung+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4fR"><div class="casContent"><span class="casTitleNuber">4f</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting apoptotic signaling pathways in human lung cancer</span></div><div class="casAuthors">Han, S. W.; Roman, J.</div><div class="citationInfo"><span class="NLM_cas:title">Current Cancer Drug Targets</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">566-574</span>CODEN:
                <span class="NLM_cas:coden">CCDTB9</span>;
        ISSN:<span class="NLM_cas:issn">1568-0096</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Lung carcinoma is the leading cause of carcinoma death in the world.  Despite recent advances in understanding the mol. biol. of lung cancer and the introduction of new therapeutic agents for its treatment, its dismal 5-yr survival rate has not changed substantially.  Clin. approaches have not significantly improved the survival of patients with advanced lung cancer.  However, recent discoveries about the mol. mechanisms responsible for lung cancer initiation and proliferation have unveiled new targets for therapy.  One of the hallmark features of cancer cells is their ability to evade programmed cell death or apoptosis.  Alterations in pro- and anti-apoptotic pathways are common in cancer cells and defects in regulation of apoptosis have been implicated in both lung tumorigenesis and drug resistance.  Thus, targeting apoptosis through the direct or indirect manipulation of the pro-apoptotic machinery offers a novel strategy for treatment.  This mini review summaries the mol. events that contribute to drug-induced apoptosis and how lung tumors evade apoptotic death followed by an anal. of the implications for treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpzLQx87aj_27Vg90H21EOLACvtfcHk0lh-nI-6M1cMLA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFSktLfL&md5=07bccd392be7562d070d24ecfe6277eb</span></div><a href="/servlet/linkout?suffix=cit4f&amp;dbid=16384&amp;doi=10.2174%2F156800910791859461&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156800910791859461%26sid%3Dliteratum%253Aachs%26aulast%3DHan%26aufirst%3DS.%26aulast%3DRoman%26aufirst%3DJ.%26atitle%3DTargeting%2520apoptotic%2520signaling%2520pathways%2520in%2520human%2520lung%2520cancer%26jtitle%3DCurr.%2520Cancer%2520Drug%2520Targets%26date%3D2010%26volume%3D10%26spage%3D566%26epage%3D574" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Becker, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sippl, W.</span><span> </span><span class="NLM_article-title">Activation, regulation, and inhibition of DYRK1A</span> <span class="citation_source-journal">FEBS J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">278</span><span class="NLM_x">, </span> <span class="NLM_fpage">246</span><span class="NLM_x">–</span> <span class="NLM_lpage">256</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=278&publication_year=2011&pages=246-256&author=W.+Beckerauthor=W.+Sippl&title=Activation%2C+regulation%2C+and+inhibition+of+DYRK1A"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBecker%26aufirst%3DW.%26aulast%3DSippl%26aufirst%3DW.%26atitle%3DActivation%252C%2520regulation%252C%2520and%2520inhibition%2520of%2520DYRK1A%26jtitle%3DFEBS%2520J.%26date%3D2011%26volume%3D278%26spage%3D246%26epage%3D256" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit5b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Wegiel, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gong, C. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hwang, Y. W.</span><span> </span><span class="NLM_article-title">The role of DYRK1A in neurodegenerative diseases</span> <span class="citation_source-journal">FEBS J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">278</span><span class="NLM_x">, </span> <span class="NLM_fpage">236</span><span class="NLM_x">–</span> <span class="NLM_lpage">245</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=16&amp;doi=10.1021%2Fjm300542e&amp;key=10.1111%2Fj.1742-4658.2010.07955.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=8&amp;doi=10.1021%2Fjm300542e&amp;key=21156028" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=32&amp;doi=10.1021%2Fjm300542e&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtFGru7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=278&publication_year=2011&pages=236-245&author=J.+Wegielauthor=C.+X.+Gongauthor=Y.+W.+Hwang&title=The+role+of+DYRK1A+in+neurodegenerative+diseases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5bR"><div class="casContent"><span class="casTitleNuber">5b</span><div class="casTitle"><span class="NLM_cas:atitle">The role of DYRK1A in neurodegenerative diseases</span></div><div class="casAuthors">Wegiel, Jerzy; Gong, Cheng-Xin; Hwang, Yu-Wen</div><div class="citationInfo"><span class="NLM_cas:title">FEBS Journal</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">278</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">236-245</span>CODEN:
                <span class="NLM_cas:coden">FJEOAC</span>;
        ISSN:<span class="NLM_cas:issn">1742-464X</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  Recent studies indicate that the dual-specificity tyrosine phosphorylation-regulated kinase 1A (DYRK1A) gene, which is located on chromosome 21q22.2 and is overexpressed in Down syndrome (DS), may play a significant role in developmental brain defects and in early onset neurodegeneration, neuronal loss and dementia in DS.  The identification of hundreds of genes deregulated by DYRK1A overexpression and numerous cytosolic, cytoskeletal and nuclear proteins, including transcription factors, phosphorylated by DYRK1A, indicates that DYRK1A overexpression is central for the deregulation of multiple pathways in the developing and aging DS brain, with structural and functional alterations including mental retardation and dementia.  DYRK1A overexpression in DS brains may contribute to early onset neurofibrillary degeneration directly through hyperphosphorylation of tau and indirectly through phosphorylation of alternative splicing factor, leading to an imbalance between 3R-tau and 4R-tau.  The several-fold increases in the no. of DYRK1A-pos. and 3R-tau-pos. neurofibrillary tangles in DS support this hypothesis.  Moreover, the enhanced phosphorylation of amyloid precursor protein by overexpressed DYRK1A facilitates amyloidogenic amyloid precursor protein cleavage elevating Aβ40 and 42 levels, and leading to brain β-amyloidosis.  Therefore, inhibiting DYRK1A activity in DS may serve to counteract the phenotypic effects of its overexpression and is a potential method of treatment of developmental defects and the prevention of age-assocd. neurodegeneration, including Alzheimer-type pathol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr6EhMKZ0hzPbVg90H21EOLACvtfcHk0lh-nI-6M1cMLA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtFGru7o%253D&md5=ac857b61ce21452dac070f1c26a75d38</span></div><a href="/servlet/linkout?suffix=cit5b&amp;dbid=16384&amp;doi=10.1111%2Fj.1742-4658.2010.07955.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1742-4658.2010.07955.x%26sid%3Dliteratum%253Aachs%26aulast%3DWegiel%26aufirst%3DJ.%26aulast%3DGong%26aufirst%3DC.%2BX.%26aulast%3DHwang%26aufirst%3DY.%2BW.%26atitle%3DThe%2520role%2520of%2520DYRK1A%2520in%2520neurodegenerative%2520diseases%26jtitle%3DFEBS%2520J.%26date%3D2011%26volume%3D278%26spage%3D236%26epage%3D245" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Cao, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hou, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, A.</span><span> </span><span class="NLM_article-title">Design, synthesis and in vitro and in vivo antitumor activities of novel beta-carboline derivatives</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">991</span><span class="NLM_x">–</span> <span class="NLM_lpage">1001</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2005&pages=991-1001&author=R.+Caoauthor=H.+Chenauthor=W.+Pengauthor=Y.+Maauthor=X.+Houauthor=H.+Guanauthor=X.+Liuauthor=A.+Xu&title=Design%2C+synthesis+and+in+vitro+and+in+vivo+antitumor+activities+of+novel+beta-carboline+derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCao%26aufirst%3DR.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DPeng%26aufirst%3DW.%26aulast%3DMa%26aufirst%3DY.%26aulast%3DHou%26aufirst%3DX.%26aulast%3DGuan%26aufirst%3DH.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DXu%26aufirst%3DA.%26atitle%3DDesign%252C%2520synthesis%2520and%2520in%2520vitro%2520and%2520in%2520vivo%2520antitumor%2520activities%2520of%2520novel%2520beta-carboline%2520derivatives%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2005%26volume%3D40%26spage%3D991%26epage%3D1001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Bain, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plater, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elliott, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shapiro, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hastie, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McLauchlan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klevernic, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arthur, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alessi, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, P.</span><span> </span><span class="NLM_article-title">The selectivity of protein kinase inhibitors: a further update</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">408</span><span class="NLM_x">, </span> <span class="NLM_fpage">297</span><span class="NLM_x">–</span> <span class="NLM_lpage">315</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=16&amp;doi=10.1021%2Fjm300542e&amp;key=10.1042%2FBJ20070797" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=8&amp;doi=10.1021%2Fjm300542e&amp;key=17850214" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=32&amp;doi=10.1021%2Fjm300542e&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlGmtbjE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=408&publication_year=2007&pages=297-315&author=J.+Bainauthor=L.+Platerauthor=M.+Elliottauthor=N.+Shapiroauthor=C.+J.+Hastieauthor=H.+McLauchlanauthor=I.+Klevernicauthor=J.+S.+Arthurauthor=D.+R.+Alessiauthor=P.+Cohen&title=The+selectivity+of+protein+kinase+inhibitors%3A+a+further+update"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7aR"><div class="casContent"><span class="casTitleNuber">7a</span><div class="casTitle"><span class="NLM_cas:atitle">The selectivity of protein kinase inhibitors: a further update</span></div><div class="casAuthors">Bain, Jenny; Plater, Lorna; Elliott, Matt; Shpiro, Natalia; Hastie, C. James; McLauchlan, Hilary; Klevernic, Iva; Arthur, J. Simon C.; Alessi, Dario R.; Cohen, Philip</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">408</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">297-315</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">The specificities of 65 compds. reported to be relatively specific inhibitors of protein kinases have been profiled against a panel of 70-80 protein kinases.  On the basis of this information, the effects of compds. that we have studied in cells and other data in the literature, we recommend the use of the following small-mol. inhibitors: SB 203580/SB202190 and BIRB 0796 to be used in parallel to assess the physiol. roles of p38 MAPK (mitogen-activated protein kinase) isoforms, PI-103 and wortmannin to be used in parallel to inhibit phosphatidylinositol (phosphoinositide) 3-kinases, PP1 or PP2 to be used in parallel with Src-I1 (Src inhibitor-1) to inhibit Src family members; PD 184352 or PD 0325901 to inhibit MKK1 (MAPK kinase-1) or MKK1 plus MKK5, Akt-I-1/2 to inhibit the activation of PKB (protein kinase B/Akt), rapamycin to inhibit TORC1 [mTOR (mammalian target of rapamycin)-raptor (regulatory assocd. protein of mTOR) complex], CT 99021 to inhibit GSK3 (glycogen synthase kinase 3), BI-D1870 and SL0101 or FMK (fluoromethylketone) to be used in parallel to inhibit RSK (ribosomal S6 kinase), D4476 to inhibit CK1 (casein kinase 1), VX680 to inhibit Aurora kinases, and roscovitine as a pan-CDK (cyclin-dependent kinase) inhibitor.  We have also identified harmine as a potent and specific inhibitor of DYRK1A (dual-specificity tyrosine-phosphorylated and -regulated kinase 1A) in vitro.  The results have further emphasized the need for considerable caution in using small-mol. inhibitors of protein kinases to assess the physiol. roles of these enzymes.  Despite being used widely, many of the compds. that we analyzed were too non-specific for useful conclusions to be made, other than to exclude the involvement of particular protein kinases in cellular processes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQPaieWftdVrVg90H21EOLACvtfcHk0lj1BibGdayrRg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlGmtbjE&md5=e2334e35897dd1b9770bbcca8f82bb9c</span></div><a href="/servlet/linkout?suffix=cit7a&amp;dbid=16384&amp;doi=10.1042%2FBJ20070797&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBJ20070797%26sid%3Dliteratum%253Aachs%26aulast%3DBain%26aufirst%3DJ.%26aulast%3DPlater%26aufirst%3DL.%26aulast%3DElliott%26aufirst%3DM.%26aulast%3DShapiro%26aufirst%3DN.%26aulast%3DHastie%26aufirst%3DC.%2BJ.%26aulast%3DMcLauchlan%26aufirst%3DH.%26aulast%3DKlevernic%26aufirst%3DI.%26aulast%3DArthur%26aufirst%3DJ.%2BS.%26aulast%3DAlessi%26aufirst%3DD.%2BR.%26aulast%3DCohen%26aufirst%3DP.%26atitle%3DThe%2520selectivity%2520of%2520protein%2520kinase%2520inhibitors%253A%2520a%2520further%2520update%26jtitle%3DBiochem.%2520J.%26date%3D2007%26volume%3D408%26spage%3D297%26epage%3D315" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit7b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Gockler, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fofre, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Papadopoulos, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soppa, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tejedor, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Becker, W.</span><span> </span><span class="NLM_article-title">Harmine specifically inhibits protein kinase DYRK1A and interferes with neurite formation</span> <span class="citation_source-journal">FEBS J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">276</span><span class="NLM_x">, </span> <span class="NLM_fpage">6324</span><span class="NLM_x">–</span> <span class="NLM_lpage">6337</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=2009&pages=6324-6337&author=N.+Gocklerauthor=G.+Fofreauthor=C.+Papadopoulosauthor=U.+Soppaauthor=F.+J.+Tejedorauthor=W.+Becker&title=Harmine+specifically+inhibits+protein+kinase+DYRK1A+and+interferes+with+neurite+formation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGockler%26aufirst%3DN.%26aulast%3DFofre%26aufirst%3DG.%26aulast%3DPapadopoulos%26aufirst%3DC.%26aulast%3DSoppa%26aufirst%3DU.%26aulast%3DTejedor%26aufirst%3DF.%2BJ.%26aulast%3DBecker%26aufirst%3DW.%26atitle%3DHarmine%2520specifically%2520inhibits%2520protein%2520kinase%2520DYRK1A%2520and%2520interferes%2520with%2520neurite%2520formation%26jtitle%3DFEBS%2520J.%26date%3D2009%26volume%3D276%26spage%3D6324%26epage%3D6337" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit7c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Seifert, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allan, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clarke, P. R.</span><span> </span><span class="NLM_article-title">DYRK1A phosphorylates caspase 9 at an inhibitory site and is potently inhibited in human cells by harmine</span> <span class="citation_source-journal">FEBS J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">275</span><span class="NLM_x">, </span> <span class="NLM_fpage">6268</span><span class="NLM_x">–</span> <span class="NLM_lpage">6280</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=275&publication_year=2008&pages=6268-6280&author=A.+Seifertauthor=L.+A.+Allanauthor=P.+R.+Clarke&title=DYRK1A+phosphorylates+caspase+9+at+an+inhibitory+site+and+is+potently+inhibited+in+human+cells+by+harmine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSeifert%26aufirst%3DA.%26aulast%3DAllan%26aufirst%3DL.%2BA.%26aulast%3DClarke%26aufirst%3DP.%2BR.%26atitle%3DDYRK1A%2520phosphorylates%2520caspase%25209%2520at%2520an%2520inhibitory%2520site%2520and%2520is%2520potently%2520inhibited%2520in%2520human%2520cells%2520by%2520harmine%26jtitle%3DFEBS%2520J.%26date%3D2008%26volume%3D275%26spage%3D6268%26epage%3D6280" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Laguna, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aranda, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barallobre, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barhoum, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernandez, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fotaki, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delabar, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de la Luna, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de la Villa, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arbones, M. L.</span><span> </span><span class="NLM_article-title">The protein kinase DYRK1A regulates caspase-9-mediated apoptosis during retina development</span> <span class="citation_source-journal">Dev. Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">841</span><span class="NLM_x">–</span> <span class="NLM_lpage">853</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2008&pages=841-853&author=A.+Lagunaauthor=S.+Arandaauthor=M.+J.+Barallobreauthor=R.+Barhoumauthor=E.+Fernandezauthor=V.+Fotakiauthor=J.+M.+Delabarauthor=S.+de+la+Lunaauthor=P.+de+la+Villaauthor=M.+L.+Arbones&title=The+protein+kinase+DYRK1A+regulates+caspase-9-mediated+apoptosis+during+retina+development"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLaguna%26aufirst%3DA.%26aulast%3DAranda%26aufirst%3DS.%26aulast%3DBarallobre%26aufirst%3DM.%2BJ.%26aulast%3DBarhoum%26aufirst%3DR.%26aulast%3DFernandez%26aufirst%3DE.%26aulast%3DFotaki%26aufirst%3DV.%26aulast%3DDelabar%26aufirst%3DJ.%2BM.%26aulast%3Dde%2Bla%2BLuna%26aufirst%3DS.%26aulast%3Dde%2Bla%2BVilla%26aufirst%3DP.%26aulast%3DArbones%26aufirst%3DM.%2BL.%26atitle%3DThe%2520protein%2520kinase%2520DYRK1A%2520regulates%2520caspase-9-mediated%2520apoptosis%2520during%2520retina%2520development%26jtitle%3DDev.%2520Cell%26date%3D2008%26volume%3D15%26spage%3D841%26epage%3D853" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">De Wit, N. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burtscher, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weidle, U. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruiter, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Muijen, G. N.</span><span> </span><span class="NLM_article-title">Differentially expressed genes identified in human melanoma cell lines with different metastatic behavior using high density oligonucleotide arrays</span> <span class="citation_source-journal">Melanoma Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">57</span><span class="NLM_x">–</span> <span class="NLM_lpage">69</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm300542e&amp;key=10.1097%2F00008390-200202000-00009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm300542e&amp;key=11828259" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm300542e&amp;key=1%3ACAS%3A528%3ADC%252BD38XitVCms70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2002&pages=57-69&author=N.+R.+De+Witauthor=H.+J.+Burtscherauthor=U.+H.+Weidleauthor=D.+J.+Ruiterauthor=G.+N.+van+Muijen&title=Differentially+expressed+genes+identified+in+human+melanoma+cell+lines+with+different+metastatic+behavior+using+high+density+oligonucleotide+arrays"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Differentially expressed genes identified in human melanoma cell lines with different metastatic behaviour using high density oligonucleotide arrays</span></div><div class="casAuthors">de Wit, N. J. W.; Burtscher, H. J.; Weidle, U. H.; Ruiter, D. J.; van Muijen, G. N. P.</div><div class="citationInfo"><span class="NLM_cas:title">Melanoma Research</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">57-69</span>CODEN:
                <span class="NLM_cas:coden">MREEEH</span>;
        ISSN:<span class="NLM_cas:issn">0960-8931</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">The increasing incidence of melanoma and the lack of effective treatment, with the exception of tumor excision before the onset of the metastatic phase, make it important to identify genes that may function as new mol. markers for diagnosis and/or prognosis or as new targets for therapy.  Recently, a new technique using high d. oligonucleotide arrays has been developed to simultaneously screen for the expression of thousands of genes.  We used this technique to compare the mRNA expression patterns of two human melanoma cell lines with different metastatic behavior.  Eight differentially expressed genes, namely apolipoprotein CII, tyrosinase-related protein 1, transforming growth factor-β superfamily, subtilisin-like protein, elongation factor 1 α2, α2-macroglobulin, human cell division cycle 10 and serine/threonine protein kinase (DYRK1A), were selected to validate the array results by Northern blotting and reverse transcription-polymerase chain reaction (RT-PCR).  Furthermore, a reliable correlation between differential expression of these genes in the melanoma cell lines and in fresh lesions of melanocytic tumor progression was demonstrated by RT-PCR anal.  Altogether, our data indicate that high d. oligonucleotide arrays are a valuable and reliable tool to screen for differentially expressed genes, and that our study may be considered a basic step in the characterization of genes that are involved in the (malignant) progression of melanoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0ksV0-jb2ErVg90H21EOLACvtfcHk0lj1BibGdayrRg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XitVCms70%253D&md5=435885e37026059ec6099c3b86b2fc40</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1097%2F00008390-200202000-00009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00008390-200202000-00009%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BWit%26aufirst%3DN.%2BR.%26aulast%3DBurtscher%26aufirst%3DH.%2BJ.%26aulast%3DWeidle%26aufirst%3DU.%2BH.%26aulast%3DRuiter%26aufirst%3DD.%2BJ.%26aulast%3Dvan%2BMuijen%26aufirst%3DG.%2BN.%26atitle%3DDifferentially%2520expressed%2520genes%2520identified%2520in%2520human%2520melanoma%2520cell%2520lines%2520with%2520different%2520metastatic%2520behavior%2520using%2520high%2520density%2520oligonucleotide%2520arrays%26jtitle%3DMelanoma%2520Res.%26date%3D2002%26volume%3D12%26spage%3D57%26epage%3D69" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Ma, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wink, M.</span><span> </span><span class="NLM_article-title">The beta-carboline alkaloid harmine inhibits BCRP and can reverse resistance to the anticancer drugs mitoxantrone and camptothecin in breast cancer cells</span> <span class="citation_source-journal">Phytother. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">146</span><span class="NLM_x">–</span> <span class="NLM_lpage">149</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm300542e&amp;key=10.1002%2Fptr.2860" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm300542e&amp;key=19548284" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm300542e&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhvFaisrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2010&pages=146-149&author=Y.+Maauthor=M.+Wink&title=The+beta-carboline+alkaloid+harmine+inhibits+BCRP+and+can+reverse+resistance+to+the+anticancer+drugs+mitoxantrone+and+camptothecin+in+breast+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">The beta-carboline alkaloid harmine inhibits BCRP and can reverse resistance to the anticancer drugs mitoxantrone and camptothecin in breast cancer cells</span></div><div class="casAuthors">Ma, Yonggang; Wink, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Phytotherapy Research</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">146-149</span>CODEN:
                <span class="NLM_cas:coden">PHYREH</span>;
        ISSN:<span class="NLM_cas:issn">0951-418X</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">Multidrug resistance (MDR), mediated by highly expressed ABC transporters, is one of the most important mechanisms in tumor cells.  Breast cancer resistance protein (BCRP) is a member of the ABC transporter family.  This transporter expels different kinds of lipophilic anticancer drugs, which have diffused into the cells.  In this study, 96-well plate based assays and flow cytometry anal. were employed to screen natural products for BCRP inhibition.  The beta-carboline alkaloid harmine inhibited BCRP in a BCRP overexpressing breast cancer cell line (MDA-MB-231).  Harmine reduced resistance to the anticancer drugs mitoxantrone and camptothecin mediated by BCRP and might be an interesting new reversal agent.  Harmine did not inhibit P-glycoprotein (P-gp) mediated drug efflux.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhvMeUkEGaD7Vg90H21EOLACvtfcHk0lhXYmgWF0dnoQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhvFaisrg%253D&md5=f9935424b4add4e0752713d6014724ee</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1002%2Fptr.2860&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fptr.2860%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DY.%26aulast%3DWink%26aufirst%3DM.%26atitle%3DThe%2520beta-carboline%2520alkaloid%2520harmine%2520inhibits%2520BCRP%2520and%2520can%2520reverse%2520resistance%2520to%2520the%2520anticancer%2520drugs%2520mitoxantrone%2520and%2520camptothecin%2520in%2520breast%2520cancer%2520cells%26jtitle%3DPhytother.%2520Res.%26date%3D2010%26volume%3D24%26spage%3D146%26epage%3D149" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Reniers, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robert, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frederick, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masereel, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vincent, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wouters, J.</span><span> </span><span class="NLM_article-title">Synthesis and evaluation of beta-carboline derivatives as potential monoamine oxidase inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">134</span><span class="NLM_x">–</span> <span class="NLM_lpage">144</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2011&pages=134-144&author=J.+Reniersauthor=S.+Robertauthor=R.+Frederickauthor=B.+Masereelauthor=S.+Vincentauthor=J.+Wouters&title=Synthesis+and+evaluation+of+beta-carboline+derivatives+as+potential+monoamine+oxidase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DReniers%26aufirst%3DJ.%26aulast%3DRobert%26aufirst%3DS.%26aulast%3DFrederick%26aufirst%3DR.%26aulast%3DMasereel%26aufirst%3DB.%26aulast%3DVincent%26aufirst%3DS.%26aulast%3DWouters%26aufirst%3DJ.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%2520beta-carboline%2520derivatives%2520as%2520potential%2520monoamine%2520oxidase%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2011%26volume%3D19%26spage%3D134%26epage%3D144" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Dumont, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ingrassia, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rouzeau, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ribaucour, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roland, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Darro, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lefranc, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiss, R.</span><span> </span><span class="NLM_article-title">The Amaryllidaceae isocarbostyril narciclasine induces apoptosis by activation of the death receptor and/or mitochondrial pathways in cancer cells but not in normal fibroblasts</span> <span class="citation_source-journal">Neoplasia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">766</span><span class="NLM_x">–</span> <span class="NLM_lpage">776</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2007&pages=766-776&author=P.+Dumontauthor=L.+Ingrassiaauthor=S.+Rouzeauauthor=F.+Ribaucourauthor=S.+Thomasauthor=I.+Rolandauthor=F.+Darroauthor=F.+Lefrancauthor=R.+Kiss&title=The+Amaryllidaceae+isocarbostyril+narciclasine+induces+apoptosis+by+activation+of+the+death+receptor+and%2For+mitochondrial+pathways+in+cancer+cells+but+not+in+normal+fibroblasts"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDumont%26aufirst%3DP.%26aulast%3DIngrassia%26aufirst%3DL.%26aulast%3DRouzeau%26aufirst%3DS.%26aulast%3DRibaucour%26aufirst%3DF.%26aulast%3DThomas%26aufirst%3DS.%26aulast%3DRoland%26aufirst%3DI.%26aulast%3DDarro%26aufirst%3DF.%26aulast%3DLefranc%26aufirst%3DF.%26aulast%3DKiss%26aufirst%3DR.%26atitle%3DThe%2520Amaryllidaceae%2520isocarbostyril%2520narciclasine%2520induces%2520apoptosis%2520by%2520activation%2520of%2520the%2520death%2520receptor%2520and%252For%2520mitochondrial%2520pathways%2520in%2520cancer%2520cells%2520but%2520not%2520in%2520normal%2520fibroblasts%26jtitle%3DNeoplasia%26date%3D2007%26volume%3D9%26spage%3D766%26epage%3D776" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit12b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Mathieu, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Nève, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Mercier, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dewelle, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaussin, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dehoux, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiss, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lefranc, F.</span><span> </span><span class="NLM_article-title">Combining bevacizumab with temozolomide increases the antitumor efficacy of temozolomide in a human glioblastoma orthotopic xenograft model</span> <span class="citation_source-journal">Neoplasia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">1383</span><span class="NLM_x">–</span> <span class="NLM_lpage">1392</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2008&pages=1383-1392&author=V.+Mathieuauthor=N.+De+N%C3%A8veauthor=M.+Le+Mercierauthor=J.+Dewelleauthor=J.+F.+Gaussinauthor=M.+Dehouxauthor=R.+Kissauthor=F.+Lefranc&title=Combining+bevacizumab+with+temozolomide+increases+the+antitumor+efficacy+of+temozolomide+in+a+human+glioblastoma+orthotopic+xenograft+model"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMathieu%26aufirst%3DV.%26aulast%3DDe%2BN%25C3%25A8ve%26aufirst%3DN.%26aulast%3DLe%2BMercier%26aufirst%3DM.%26aulast%3DDewelle%26aufirst%3DJ.%26aulast%3DGaussin%26aufirst%3DJ.%2BF.%26aulast%3DDehoux%26aufirst%3DM.%26aulast%3DKiss%26aufirst%3DR.%26aulast%3DLefranc%26aufirst%3DF.%26atitle%3DCombining%2520bevacizumab%2520with%2520temozolomide%2520increases%2520the%2520antitumor%2520efficacy%2520of%2520temozolomide%2520in%2520a%2520human%2520glioblastoma%2520orthotopic%2520xenograft%2520model%26jtitle%3DNeoplasia%26date%3D2008%26volume%3D10%26spage%3D1383%26epage%3D1392" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit12c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Ingrassia, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lefranc, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dewelle, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pottier, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathieu, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spiegl-Kreinecker, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sauvage, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">El Yazidi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dehoux, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berger, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Quaquebeke, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiss, R.</span><span> </span><span class="NLM_article-title">Structure–activity relationship analysis of novel derivatives of narciclasine (an Amaryllidaceae isocarbostyril derivative) as potential anticancer agents</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">1100</span><span class="NLM_x">–</span> <span class="NLM_lpage">1114</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm8013585" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=1100-1114&author=L.+Ingrassiaauthor=F.+Lefrancauthor=J.+Dewelleauthor=L.+Pottierauthor=V.+Mathieuauthor=S.+Spiegl-Kreineckerauthor=S.+Sauvageauthor=M.+El+Yazidiauthor=M.+Dehouxauthor=W.+Bergerauthor=E.+Van+Quaquebekeauthor=R.+Kiss&title=Structure%E2%80%93activity+relationship+analysis+of+novel+derivatives+of+narciclasine+%28an+Amaryllidaceae+isocarbostyril+derivative%29+as+potential+anticancer+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12c&amp;dbid=16384&amp;doi=10.1021%2Fjm8013585&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm8013585%26sid%3Dliteratum%253Aachs%26aulast%3DIngrassia%26aufirst%3DL.%26aulast%3DLefranc%26aufirst%3DF.%26aulast%3DDewelle%26aufirst%3DJ.%26aulast%3DPottier%26aufirst%3DL.%26aulast%3DMathieu%26aufirst%3DV.%26aulast%3DSpiegl-Kreinecker%26aufirst%3DS.%26aulast%3DSauvage%26aufirst%3DS.%26aulast%3DEl%2BYazidi%26aufirst%3DM.%26aulast%3DDehoux%26aufirst%3DM.%26aulast%3DBerger%26aufirst%3DW.%26aulast%3DVan%2BQuaquebeke%26aufirst%3DE.%26aulast%3DKiss%26aufirst%3DR.%26atitle%3DStructure%25E2%2580%2593activity%2520relationship%2520analysis%2520of%2520novel%2520derivatives%2520of%2520narciclasine%2520%2528an%2520Amaryllidaceae%2520isocarbostyril%2520derivative%2529%2520as%2520potential%2520anticancer%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D1100%26epage%3D1114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit12d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Lamoral-Theys, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andolfi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Goietsenoven, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cimmino, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Calvé, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wauthoz, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mégalizzi, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gras, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruyère, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dubois, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathieu, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kornienko, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiss, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evidente, A.</span><span> </span><span class="NLM_article-title">Lycorine, the main phenanthridine Amaryllidaceae alkaloid, exhibits significant antitumor activity in cancer cells that display resistance to proapoptotic stimuli: an investigation of structure–activity relationship and mechanistic insight</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">6244</span><span class="NLM_x">–</span> <span class="NLM_lpage">6256</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm901031h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=6244-6256&author=D.+Lamoral-Theysauthor=A.+Andolfiauthor=G.+Van+Goietsenovenauthor=A.+Cimminoauthor=B.+Le+Calv%C3%A9author=N.+Wauthozauthor=V.+M%C3%A9galizziauthor=T.+Grasauthor=C.+Bruy%C3%A8reauthor=J.+Duboisauthor=V.+Mathieuauthor=A.+Kornienkoauthor=R.+Kissauthor=A.+Evidente&title=Lycorine%2C+the+main+phenanthridine+Amaryllidaceae+alkaloid%2C+exhibits+significant+antitumor+activity+in+cancer+cells+that+display+resistance+to+proapoptotic+stimuli%3A+an+investigation+of+structure%E2%80%93activity+relationship+and+mechanistic+insight"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12d&amp;dbid=16384&amp;doi=10.1021%2Fjm901031h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901031h%26sid%3Dliteratum%253Aachs%26aulast%3DLamoral-Theys%26aufirst%3DD.%26aulast%3DAndolfi%26aufirst%3DA.%26aulast%3DVan%2BGoietsenoven%26aufirst%3DG.%26aulast%3DCimmino%26aufirst%3DA.%26aulast%3DLe%2BCalv%25C3%25A9%26aufirst%3DB.%26aulast%3DWauthoz%26aufirst%3DN.%26aulast%3DM%25C3%25A9galizzi%26aufirst%3DV.%26aulast%3DGras%26aufirst%3DT.%26aulast%3DBruy%25C3%25A8re%26aufirst%3DC.%26aulast%3DDubois%26aufirst%3DJ.%26aulast%3DMathieu%26aufirst%3DV.%26aulast%3DKornienko%26aufirst%3DA.%26aulast%3DKiss%26aufirst%3DR.%26aulast%3DEvidente%26aufirst%3DA.%26atitle%3DLycorine%252C%2520the%2520main%2520phenanthridine%2520Amaryllidaceae%2520alkaloid%252C%2520exhibits%2520significant%2520antitumor%2520activity%2520in%2520cancer%2520cells%2520that%2520display%2520resistance%2520to%2520proapoptotic%2520stimuli%253A%2520an%2520investigation%2520of%2520structure%25E2%2580%2593activity%2520relationship%2520and%2520mechanistic%2520insight%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D6244%26epage%3D6256" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Delbrouck, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doyen, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belot, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Decaestecker, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghanooni, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Lavareille, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaltner, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choufani, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Danguy, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vandenhoven, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gabius, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hasid, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiss, R.</span><span> </span><span class="NLM_article-title">Galectin-1 is overexpressed in nasal polyps under budesonide and inhibits eosinophil migration</span> <span class="citation_source-journal">Lab. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">82</span><span class="NLM_x">, </span> <span class="NLM_fpage">147</span><span class="NLM_x">–</span> <span class="NLM_lpage">158</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=2002&pages=147-158&author=C.+Delbrouckauthor=I.+Doyenauthor=N.+Belotauthor=C.+Decaesteckerauthor=R.+Ghanooniauthor=A.+de+Lavareilleauthor=H.+Kaltnerauthor=G.+Choufaniauthor=A.+Danguyauthor=G.+Vandenhovenauthor=H.+J.+Gabiusauthor=S.+Hasidauthor=R.+Kiss&title=Galectin-1+is+overexpressed+in+nasal+polyps+under+budesonide+and+inhibits+eosinophil+migration"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDelbrouck%26aufirst%3DC.%26aulast%3DDoyen%26aufirst%3DI.%26aulast%3DBelot%26aufirst%3DN.%26aulast%3DDecaestecker%26aufirst%3DC.%26aulast%3DGhanooni%26aufirst%3DR.%26aulast%3Dde%2BLavareille%26aufirst%3DA.%26aulast%3DKaltner%26aufirst%3DH.%26aulast%3DChoufani%26aufirst%3DG.%26aulast%3DDanguy%26aufirst%3DA.%26aulast%3DVandenhoven%26aufirst%3DG.%26aulast%3DGabius%26aufirst%3DH.%2BJ.%26aulast%3DHasid%26aufirst%3DS.%26aulast%3DKiss%26aufirst%3DR.%26atitle%3DGalectin-1%2520is%2520overexpressed%2520in%2520nasal%2520polyps%2520under%2520budesonide%2520and%2520inhibits%2520eosinophil%2520migration%26jtitle%3DLab.%2520Invest.%26date%3D2002%26volume%3D82%26spage%3D147%26epage%3D158" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit13b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Lefranc, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mijatovic, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathieu, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rorive, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Decaestecker, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Debeir, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brotchi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Ham, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salmon, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiss, R.</span><span> </span><span class="NLM_article-title">Characterization of gastrin-induced proangiogenic effects in vivo in orthotopic U373 experimental human glioblastomas and in vitro in human umbilical vein endothelial cells</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">8250</span><span class="NLM_x">–</span> <span class="NLM_lpage">8265</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13b&amp;dbid=16&amp;doi=10.1021%2Fjm300542e&amp;key=10.1158%2F1078-0432.CCR-04-0343" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13b&amp;dbid=8&amp;doi=10.1021%2Fjm300542e&amp;key=15623601" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13b&amp;dbid=32&amp;doi=10.1021%2Fjm300542e&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtFGjsrbP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2004&pages=8250-8265&author=F.+Lefrancauthor=T.+Mijatovicauthor=V.+Mathieuauthor=S.+Roriveauthor=C.+Decaesteckerauthor=O.+Debeirauthor=J.+Brotchiauthor=P.+Van+Hamauthor=I.+Salmonauthor=R.+Kiss&title=Characterization+of+gastrin-induced+proangiogenic+effects+in+vivo+in+orthotopic+U373+experimental+human+glioblastomas+and+in+vitro+in+human+umbilical+vein+endothelial+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13bR"><div class="casContent"><span class="casTitleNuber">13b</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of Gastrin-Induced Proangiogenic Effects In vivo in Orthotopic U373 Experimental Human Glioblastomas and In vitro in Human Umbilical Vein Endothelial Cells</span></div><div class="casAuthors">Lefranc, Florence; Mijatovic, Tatjana; Mathieu, Veronique; Rorive, Sandrine; Decaestecker, Christine; Debeir, Olivier; Brotchi, Jacques; Van Ham, Philippe; Salmon, Isabelle; Kiss, Robert</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">8250-8265</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">This study aims to investigate the role of gastrin-17 (G17) on angiogenesis features in gliomas both in vitro and in vivo.  The influences of G17 and G17 receptor antagonists were characterized in vitro in terms of angiogenesis on human umbilical vein endothelial cell (HUVEC) tubulogenesis processes on Matrigel and in vivo with respect to U373 orthotopic glioma xenografts.  The influence of phosphatidylinositol 3'-kinase, protein kinase C, and nuclear factor-κB inhibitors was characterized in vitro on G17-mediated HUVEC tubulogenesis.  G17-mediated release of interleukin (IL)-8 from HUVECs and G17-induced modifications in nuclear factor-κB DNA binding activity were characterized by means of specific enzyme-linked immunosorbent assays.  The influence of G17 on E- and P-selectin expression was detd. by means of computer-assisted microscopy, whereas the influence of E- and P-selectin on HUVEC migration was approached by means of antisense oligonucleotides.  The chemotactic influence of G17 and IL-8 on HUVEC migration was characterized by means of computer-assisted video microscopy with Dunn chambers.  mRNAs for cholecystokinin (CCK)A, CCKB, and CCKC receptors were present in HUVECs and microvessels dissected from a human glioblastoma.  Whereas G17 significantly increased the levels of angiogenesis in vivo in the U373 exptl. glioma model and in vitro in the HUVECs, the CCKB receptor antagonist L365,260 significantly counteracted the G17-mediated proangiogenic effects.  G17 chemoattracted HUVECs, whereas IL-8 failed to do so.  IL-8 receptor α (CXCR1) and IL-8 receptor β (CXCR2) mRNAs were not detected in these endothelial cells.  Gastrin significantly (but only transiently) decreased the level of expression of E-selectin, but not P-selectin, whereas IL-8 increased the expression of E-selectin.  Specific antisense oligonucleotides against E- and P-selectin significantly decreased HUVEC tubulogenesis processes in vitro on Matrigel.  The present study shows that gastrin has marked proangiogenic effects in vivo on exptl. gliomas and in vitro on HUVECs.  This effect depends in part on the level of E-selectin activation, but not on IL-8 expression/release by HUVECs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq8cHS8prXYSLVg90H21EOLACvtfcHk0li36K2GmlIB0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtFGjsrbP&md5=af49f260b2c7e2aa793c99bee09fe65d</span></div><a href="/servlet/linkout?suffix=cit13b&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-04-0343&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-04-0343%26sid%3Dliteratum%253Aachs%26aulast%3DLefranc%26aufirst%3DF.%26aulast%3DMijatovic%26aufirst%3DT.%26aulast%3DMathieu%26aufirst%3DV.%26aulast%3DRorive%26aufirst%3DS.%26aulast%3DDecaestecker%26aufirst%3DC.%26aulast%3DDebeir%26aufirst%3DO.%26aulast%3DBrotchi%26aufirst%3DJ.%26aulast%3DVan%2BHam%26aufirst%3DP.%26aulast%3DSalmon%26aufirst%3DI.%26aulast%3DKiss%26aufirst%3DR.%26atitle%3DCharacterization%2520of%2520gastrin-induced%2520proangiogenic%2520effects%2520in%2520vivo%2520in%2520orthotopic%2520U373%2520experimental%2520human%2520glioblastomas%2520and%2520in%2520vitro%2520in%2520human%2520umbilical%2520vein%2520endothelial%2520cells%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2004%26volume%3D10%26spage%3D8250%26epage%3D8265" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit13c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Mathieu, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pirker, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">martin de Lasalle, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vernier, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mijatovic, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Nève, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaussin, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dehoux, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lefranc, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berger, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiss, R.</span><span> </span><span class="NLM_article-title">The sodium pump alpha-1 subunit: a disease progression-related target for metastatic melanoma treatment</span> <span class="citation_source-journal">J. Cell. Mol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">3960</span><span class="NLM_x">–</span> <span class="NLM_lpage">3972</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13c&amp;dbid=16&amp;doi=10.1021%2Fjm300542e&amp;key=10.1111%2Fj.1582-4934.2009.00708.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13c&amp;dbid=8&amp;doi=10.1021%2Fjm300542e&amp;key=19243476" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13c&amp;dbid=32&amp;doi=10.1021%2Fjm300542e&amp;key=1%3ACAS%3A280%3ADC%252BC3c7kvFChsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2009&pages=3960-3972&author=V.+Mathieuauthor=C.+Pirkerauthor=E.+martin+de+Lasalleauthor=M.+Vernierauthor=T.+Mijatovicauthor=N.+De+N%C3%A8veauthor=J.+F.+Gaussinauthor=M.+Dehouxauthor=F.+Lefrancauthor=W.+Bergerauthor=R.+Kiss&title=The+sodium+pump+alpha-1+subunit%3A+a+disease+progression-related+target+for+metastatic+melanoma+treatment"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13cR"><div class="casContent"><span class="casTitleNuber">13c</span><div class="casTitle"><span class="NLM_cas:atitle">The sodium pump alpha1 sub-unit: a disease progression-related target for metastatic melanoma treatment</span></div><div class="casAuthors">Mathieu Veronique; Pirker Christine; Martin de Lassalle Elisabeth; Vernier Mathieu; Mijatovic Tatjana; DeNeve Nancy; Gaussin Jean-Francois; Dehoux Mischael; Lefranc Florence; Berger Walter; Kiss Robert</div><div class="citationInfo"><span class="NLM_cas:title">Journal of cellular and molecular medicine</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">9B</span>),
    <span class="NLM_cas:pages">3960-72</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Melanomas remain associated with dismal prognosis because they are naturally resistant to apoptosis and they markedly metastasize.  Up-regulated expression of sodium pump alpha sub-units has previously been demonstrated when comparing metastatic to non-metastatic melanomas.  Our previous data revealed that impairing sodium pump alpha1 activity by means of selective ligands, that are cardiotonic steroids, markedly impairs cell migration and kills apoptosis-resistant cancer cells.  The objective of this study was to determine the expression levels of sodium pump alpha sub-units in melanoma clinical samples and cell lines and also to characterize the role of alpha1 sub-units in melanoma cell biology.  Quantitative RT-PCR, Western blotting and immunohistochemistry were used to determine the expression levels of sodium pump alpha sub-units.  In vitro cytotoxicity of various cardenolides and of an anti-alpha1 siRNA was evaluated by means of MTT assay, quantitative videomicroscopy and through apoptosis assays.  The in vivo activity of a novel cardenolide UNBS1450 was evaluated in a melanoma brain metastasis model.  Our data show that all investigated human melanoma cell lines expressed high levels of the alpha1 sub-unit, and 33% of human melanomas displayed significant alpha1 sub-unit expression in correlation with the Breslow index.  Furthermore, cardenolides (notably UNBS1450; currently in Phase I clinical trials) displayed marked anti-tumour effects against melanomas in vitro.  This activity was closely paralleled by decreases in cMyc expression and by increases in apoptotic features.  UNBS1450 also displayed marked anti-tumour activity in the aggressive human metastatic brain melanoma model in vivo.  The alpha1 sodium pump sub-unit could represent a potential novel target for combating melanoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRCeneUQpTcEu_Q9URG6Dx8fW6udTcc2eYSnr_gM2vAe7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3c7kvFChsA%253D%253D&md5=6079d92a5eb05e978a79319a3c4db2eb</span></div><a href="/servlet/linkout?suffix=cit13c&amp;dbid=16384&amp;doi=10.1111%2Fj.1582-4934.2009.00708.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1582-4934.2009.00708.x%26sid%3Dliteratum%253Aachs%26aulast%3DMathieu%26aufirst%3DV.%26aulast%3DPirker%26aufirst%3DC.%26aulast%3Dmartin%2Bde%2BLasalle%26aufirst%3DE.%26aulast%3DVernier%26aufirst%3DM.%26aulast%3DMijatovic%26aufirst%3DT.%26aulast%3DDe%2BN%25C3%25A8ve%26aufirst%3DN.%26aulast%3DGaussin%26aufirst%3DJ.%2BF.%26aulast%3DDehoux%26aufirst%3DM.%26aulast%3DLefranc%26aufirst%3DF.%26aulast%3DBerger%26aufirst%3DW.%26aulast%3DKiss%26aufirst%3DR.%26atitle%3DThe%2520sodium%2520pump%2520alpha-1%2520subunit%253A%2520a%2520disease%2520progression-related%2520target%2520for%2520metastatic%2520melanoma%2520treatment%26jtitle%3DJ.%2520Cell.%2520Mol.%2520Med.%26date%3D2009%26volume%3D13%26spage%3D3960%26epage%3D3972" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit13d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Van Goietsenoven, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hutton, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Becker, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lallemand, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robert, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lefranc, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pirker, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vandenbussche, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Antwerpen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evidente, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berger, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prévost, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pelletier, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiss, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kinzy, T. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kornienko, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathieu, V.</span><span> </span><span class="NLM_article-title">Targeting of eEF1A with Anaryllidaceae isocarbostyrils as a strategy to combat melanomas</span> <span class="citation_source-journal">FASEB J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">4575</span><span class="NLM_x">–</span> <span class="NLM_lpage">4584</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2010&pages=4575-4584&author=G.+Van+Goietsenovenauthor=J.+Huttonauthor=J.+P.+Beckerauthor=B.+Lallemandauthor=F.+Robertauthor=F.+Lefrancauthor=C.+Pirkerauthor=G.+Vandenbusscheauthor=P.+Van+Antwerpenauthor=A.+Evidenteauthor=W.+Bergerauthor=M.+Pr%C3%A9vostauthor=J.+Pelletierauthor=R.+Kissauthor=T.+G.+Kinzyauthor=A.+Kornienkoauthor=V.+Mathieu&title=Targeting+of+eEF1A+with+Anaryllidaceae+isocarbostyrils+as+a+strategy+to+combat+melanomas"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2BGoietsenoven%26aufirst%3DG.%26aulast%3DHutton%26aufirst%3DJ.%26aulast%3DBecker%26aufirst%3DJ.%2BP.%26aulast%3DLallemand%26aufirst%3DB.%26aulast%3DRobert%26aufirst%3DF.%26aulast%3DLefranc%26aufirst%3DF.%26aulast%3DPirker%26aufirst%3DC.%26aulast%3DVandenbussche%26aufirst%3DG.%26aulast%3DVan%2BAntwerpen%26aufirst%3DP.%26aulast%3DEvidente%26aufirst%3DA.%26aulast%3DBerger%26aufirst%3DW.%26aulast%3DPr%25C3%25A9vost%26aufirst%3DM.%26aulast%3DPelletier%26aufirst%3DJ.%26aulast%3DKiss%26aufirst%3DR.%26aulast%3DKinzy%26aufirst%3DT.%2BG.%26aulast%3DKornienko%26aufirst%3DA.%26aulast%3DMathieu%26aufirst%3DV.%26atitle%3DTargeting%2520of%2520eEF1A%2520with%2520Anaryllidaceae%2520isocarbostyrils%2520as%2520a%2520strategy%2520to%2520combat%2520melanomas%26jtitle%3DFASEB%2520J.%26date%3D2010%26volume%3D24%26spage%3D4575%26epage%3D4584" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Branle, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lefranc, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Camby, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeuken, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geurts-Moespot, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sprenger, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sweep, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiss, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salmon, I.</span><span> </span><span class="NLM_article-title">Evaluation of the efficiency of chemotherapy in in vivo orthtopic models of human glioma cells with and without 1p19q deletions and in C6 rat orthotopic allografts serving for the evaluation of surgery combined with chemotherapy</span> <span class="citation_source-journal">Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">95</span><span class="NLM_x">, </span> <span class="NLM_fpage">641</span><span class="NLM_x">–</span> <span class="NLM_lpage">655</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=2002&pages=641-655&author=F.+Branleauthor=F.+Lefrancauthor=I.+Cambyauthor=J.+Jeukenauthor=A.+Geurts-Moespotauthor=S.+Sprengerauthor=F.+Sweepauthor=R.+Kissauthor=I.+Salmon&title=Evaluation+of+the+efficiency+of+chemotherapy+in+in+vivo+orthtopic+models+of+human+glioma+cells+with+and+without+1p19q+deletions+and+in+C6+rat+orthotopic+allografts+serving+for+the+evaluation+of+surgery+combined+with+chemotherapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBranle%26aufirst%3DF.%26aulast%3DLefranc%26aufirst%3DF.%26aulast%3DCamby%26aufirst%3DI.%26aulast%3DJeuken%26aufirst%3DJ.%26aulast%3DGeurts-Moespot%26aufirst%3DA.%26aulast%3DSprenger%26aufirst%3DS.%26aulast%3DSweep%26aufirst%3DF.%26aulast%3DKiss%26aufirst%3DR.%26aulast%3DSalmon%26aufirst%3DI.%26atitle%3DEvaluation%2520of%2520the%2520efficiency%2520of%2520chemotherapy%2520in%2520in%2520vivo%2520orthtopic%2520models%2520of%2520human%2520glioma%2520cells%2520with%2520and%2520without%25201p19q%2520deletions%2520and%2520in%2520C6%2520rat%2520orthotopic%2520allografts%2520serving%2520for%2520the%2520evaluation%2520of%2520surgery%2520combined%2520with%2520chemotherapy%26jtitle%3DCancer%26date%3D2002%26volume%3D95%26spage%3D641%26epage%3D655" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span>Developmental Therapeutic Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Rockville, MD, U.S. <a href="http://dtp.cancer.gov" class="extLink">http://dtp.cancer.gov</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Developmental+Therapeutic+Program%2C+Division+of+Cancer+Treatment+and+Diagnosis%2C+National+Cancer+Institute%2C+Rockville%2C+MD%2C+U.S.+http%3A%2F%2Fdtp.cancer.gov."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Larsson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gottfries, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bohlin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Backlund, A.</span><span> </span><span class="NLM_article-title">Expanding the ChemGPS chemical space with natural products</span> <span class="citation_source-journal">J. Nat. Prod.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">985</span><span class="NLM_x">–</span> <span class="NLM_lpage">991</span></span><div class="citationLinks">[<a href="/doi/10.1021/np049655u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2005&pages=985-991&author=J.+Larssonauthor=J.+Gottfriesauthor=L.+Bohlinauthor=A.+Backlund&title=Expanding+the+ChemGPS+chemical+space+with+natural+products"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16a&amp;dbid=16384&amp;doi=10.1021%2Fnp049655u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fnp049655u%26sid%3Dliteratum%253Aachs%26aulast%3DLarsson%26aufirst%3DJ.%26aulast%3DGottfries%26aufirst%3DJ.%26aulast%3DBohlin%26aufirst%3DL.%26aulast%3DBacklund%26aufirst%3DA.%26atitle%3DExpanding%2520the%2520ChemGPS%2520chemical%2520space%2520with%2520natural%2520products%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D2005%26volume%3D68%26spage%3D985%26epage%3D991" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit16b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Larsson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gottfries, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muresan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Backlund, A.</span><span> </span><span class="NLM_article-title">ChemGPS-NP: tuned for navigation in biologically relevant chemical space</span> <span class="citation_source-journal">J. Nat. Prod.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">789</span><span class="NLM_x">–</span> <span class="NLM_lpage">794</span></span><div class="citationLinks">[<a href="/doi/10.1021/np070002y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2007&pages=789-794&author=J.+Larssonauthor=J.+Gottfriesauthor=S.+Muresanauthor=A.+Backlund&title=ChemGPS-NP%3A+tuned+for+navigation+in+biologically+relevant+chemical+space"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16b&amp;dbid=16384&amp;doi=10.1021%2Fnp070002y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fnp070002y%26sid%3Dliteratum%253Aachs%26aulast%3DLarsson%26aufirst%3DJ.%26aulast%3DGottfries%26aufirst%3DJ.%26aulast%3DMuresan%26aufirst%3DS.%26aulast%3DBacklund%26aufirst%3DA.%26atitle%3DChemGPS-NP%253A%2520tuned%2520for%2520navigation%2520in%2520biologically%2520relevant%2520chemical%2520space%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D2007%26volume%3D70%26spage%3D789%26epage%3D794" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit16c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Rosen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lövgren, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kogej, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muresan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gottfries, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Backlund, A.</span><span> </span><span class="NLM_article-title">ChemGPS-NP<sub>Web</sub>: chemical space navigation online</span> <span class="citation_source-journal">J. Comput.-Aided Mol. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">253</span><span class="NLM_x">–</span> <span class="NLM_lpage">259</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2009&pages=253-259&author=J.+Rosenauthor=A.+L%C3%B6vgrenauthor=T.+Kogejauthor=S.+Muresanauthor=J.+Gottfriesauthor=A.+Backlund&title=ChemGPS-NPWeb%3A+chemical+space+navigation+online"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRosen%26aufirst%3DJ.%26aulast%3DL%25C3%25B6vgren%26aufirst%3DA.%26aulast%3DKogej%26aufirst%3DT.%26aulast%3DMuresan%26aufirst%3DS.%26aulast%3DGottfries%26aufirst%3DJ.%26aulast%3DBacklund%26aufirst%3DA.%26atitle%3DChemGPS-NPWeb%253A%2520chemical%2520space%2520navigation%2520online%26jtitle%3DJ.%2520Comput.-Aided%2520Mol.%2520Des.%26date%3D2009%26volume%3D23%26spage%3D253%26epage%3D259" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Belot, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rorive, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doyen, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lefranc, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruyneel, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dedecker, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Micik, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brotchi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Decaestecker, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salmon, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiss, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Camby, I.</span><span> </span><span class="NLM_article-title">Molecular characterization of cell substratum attachments in human glial tumors relates to prognostic features</span> <span class="citation_source-journal">Glia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">375</span><span class="NLM_x">–</span> <span class="NLM_lpage">390</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2001&pages=375-390&author=N.+Belotauthor=S.+Roriveauthor=I.+Doyenauthor=F.+Lefrancauthor=E.+Bruyneelauthor=R.+Dedeckerauthor=S.+Micikauthor=J.+Brotchiauthor=C.+Decaesteckerauthor=I.+Salmonauthor=R.+Kissauthor=I.+Camby&title=Molecular+characterization+of+cell+substratum+attachments+in+human+glial+tumors+relates+to+prognostic+features"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBelot%26aufirst%3DN.%26aulast%3DRorive%26aufirst%3DS.%26aulast%3DDoyen%26aufirst%3DI.%26aulast%3DLefranc%26aufirst%3DF.%26aulast%3DBruyneel%26aufirst%3DE.%26aulast%3DDedecker%26aufirst%3DR.%26aulast%3DMicik%26aufirst%3DS.%26aulast%3DBrotchi%26aufirst%3DJ.%26aulast%3DDecaestecker%26aufirst%3DC.%26aulast%3DSalmon%26aufirst%3DI.%26aulast%3DKiss%26aufirst%3DR.%26aulast%3DCamby%26aufirst%3DI.%26atitle%3DMolecular%2520characterization%2520of%2520cell%2520substratum%2520attachments%2520in%2520human%2520glial%2520tumors%2520relates%2520to%2520prognostic%2520features%26jtitle%3DGlia%26date%3D2001%26volume%3D36%26spage%3D375%26epage%3D390" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit17b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Sivasankaran, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Degen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghaffari, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hegi, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamou, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ionescu, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zweifel, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tolnay, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wasner, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mergenthaler, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miserez, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiss, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lino, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merlo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiquet-Ehrismann, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boulay, J. L.</span><span> </span><span class="NLM_article-title">Tenascin-C is a novel RBPJkappa-induced target gene for Notch signaling in gliomas</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x">, </span> <span class="NLM_fpage">458</span><span class="NLM_x">–</span> <span class="NLM_lpage">465</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2009&pages=458-465&author=B.+Sivasankaranauthor=M.+Degenauthor=A.+Ghaffariauthor=M.+E.+Hegiauthor=M.+F.+Hamouauthor=M.+C.+Ionescuauthor=C.+Zweifelauthor=M.+Tolnayauthor=M.+Wasnerauthor=S.+Mergenthalerauthor=A.+R.+Miserezauthor=R.+Kissauthor=M.+M.+Linoauthor=A.+Merloauthor=R.+Chiquet-Ehrismannauthor=J.+L.+Boulay&title=Tenascin-C+is+a+novel+RBPJkappa-induced+target+gene+for+Notch+signaling+in+gliomas"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSivasankaran%26aufirst%3DB.%26aulast%3DDegen%26aufirst%3DM.%26aulast%3DGhaffari%26aufirst%3DA.%26aulast%3DHegi%26aufirst%3DM.%2BE.%26aulast%3DHamou%26aufirst%3DM.%2BF.%26aulast%3DIonescu%26aufirst%3DM.%2BC.%26aulast%3DZweifel%26aufirst%3DC.%26aulast%3DTolnay%26aufirst%3DM.%26aulast%3DWasner%26aufirst%3DM.%26aulast%3DMergenthaler%26aufirst%3DS.%26aulast%3DMiserez%26aufirst%3DA.%2BR.%26aulast%3DKiss%26aufirst%3DR.%26aulast%3DLino%26aufirst%3DM.%2BM.%26aulast%3DMerlo%26aufirst%3DA.%26aulast%3DChiquet-Ehrismann%26aufirst%3DR.%26aulast%3DBoulay%26aufirst%3DJ.%2BL.%26atitle%3DTenascin-C%2520is%2520a%2520novel%2520RBPJkappa-induced%2520target%2520gene%2520for%2520Notch%2520signaling%2520in%2520gliomas%26jtitle%3DCancer%2520Res.%26date%3D2009%26volume%3D69%26spage%3D458%26epage%3D465" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Yang, B. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiao, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roa, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krammer, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hao, C.</span><span> </span><span class="NLM_article-title">Calcium/calmodulin-dependent protein kinase II regulation of c-FLIP expression and phosphorylation in modulation of Fas-mediated signaling in malignant glioma cells</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">278</span><span class="NLM_x">, </span> <span class="NLM_fpage">7043</span><span class="NLM_x">–</span> <span class="NLM_lpage">7050</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=278&publication_year=2003&pages=7043-7050&author=B.+F.+Yangauthor=C.+Xiaoauthor=W.+H.+Roaauthor=P.+H.+Krammerauthor=C.+Hao&title=Calcium%2Fcalmodulin-dependent+protein+kinase+II+regulation+of+c-FLIP+expression+and+phosphorylation+in+modulation+of+Fas-mediated+signaling+in+malignant+glioma+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DB.%2BF.%26aulast%3DXiao%26aufirst%3DC.%26aulast%3DRoa%26aufirst%3DW.%2BH.%26aulast%3DKrammer%26aufirst%3DP.%2BH.%26aulast%3DHao%26aufirst%3DC.%26atitle%3DCalcium%252Fcalmodulin-dependent%2520protein%2520kinase%2520II%2520regulation%2520of%2520c-FLIP%2520expression%2520and%2520phosphorylation%2520in%2520modulation%2520of%2520Fas-mediated%2520signaling%2520in%2520malignant%2520glioma%2520cells%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2003%26volume%3D278%26spage%3D7043%26epage%3D7050" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit18b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Takai, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ueda, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nasu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamashita, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toyofuku, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narahara, H.</span><span> </span><span class="NLM_article-title">Targeting calcium/calmodulin-dependence kinase I and II as a potential anti-proliferation remedy for endometrial carcinomas</span> <span class="citation_source-journal">Cancer Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">277</span><span class="NLM_x">, </span> <span class="NLM_fpage">235</span><span class="NLM_x">–</span> <span class="NLM_lpage">243</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18b&amp;dbid=16&amp;doi=10.1021%2Fjm300542e&amp;key=10.1016%2Fj.canlet.2008.12.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18b&amp;dbid=8&amp;doi=10.1021%2Fjm300542e&amp;key=19168280" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18b&amp;dbid=32&amp;doi=10.1021%2Fjm300542e&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjslOkur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=277&publication_year=2009&pages=235-243&author=N.+Takaiauthor=T.+Uedaauthor=K.+Nasuauthor=S.+Yamashitaauthor=M.+Toyofukuauthor=H.+Narahara&title=Targeting+calcium%2Fcalmodulin-dependence+kinase+I+and+II+as+a+potential+anti-proliferation+remedy+for+endometrial+carcinomas"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18bR"><div class="casContent"><span class="casTitleNuber">18b</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting calcium/calmodulin-dependence kinase I and II as a potential anti-proliferation remedy for endometrial carcinomas</span></div><div class="casAuthors">Takai, Noriyuki; Ueda, Tami; Nasu, Kaei; Yamashita, Satoko; Toyofuku, Mayo; Narahara, Hisashi</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (Shannon, Ireland)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">277</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">235-243</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ireland Ltd.</span>)
        </div><div class="casAbstract">Calcium/calmodulin-dependent kinase (CaMK) I and II expression in endometrial cancer cells correlates with the malignant potential of this tumor, and CaMKI and II are potential therapeutic targets in endometrial cancer.  CaMKI and II expression was significantly assocd. with PCNA-labeling index, clin. stage, histol. grade, the presence of invasion to greater than one-half the myometrium, and clin. outcome.  All endometrial cancer cell lines examd. were sensitive to the growth-inhibitory effect of KN-93, a membrane-permeant CaMKs-selective inhibitor that is competitive with calmodulin.  KN-93 induced the G0/G1 arrest and apoptosis, rising hopes that KN-93 may become a useful treatment for endometrial cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1tIL7-RVb8bVg90H21EOLACvtfcHk0lig_oi70yT2dg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjslOkur0%253D&md5=966437e19b1ecc88cc4809666f5312e9</span></div><a href="/servlet/linkout?suffix=cit18b&amp;dbid=16384&amp;doi=10.1016%2Fj.canlet.2008.12.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.canlet.2008.12.018%26sid%3Dliteratum%253Aachs%26aulast%3DTakai%26aufirst%3DN.%26aulast%3DUeda%26aufirst%3DT.%26aulast%3DNasu%26aufirst%3DK.%26aulast%3DYamashita%26aufirst%3DS.%26aulast%3DToyofuku%26aufirst%3DM.%26aulast%3DNarahara%26aufirst%3DH.%26atitle%3DTargeting%2520calcium%252Fcalmodulin-dependence%2520kinase%2520I%2520and%2520II%2520as%2520a%2520potential%2520anti-proliferation%2520remedy%2520for%2520endometrial%2520carcinomas%26jtitle%3DCancer%2520Lett.%26date%3D2009%26volume%3D277%26spage%3D235%26epage%3D243" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit18c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Han, Y. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yourek, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, Y. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia, J. G.</span><span> </span><span class="NLM_article-title">A transcribed pseudogene of MYLK promotes cell proliferation</span> <span class="citation_source-journal">FASEB J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">2305</span><span class="NLM_x">–</span> <span class="NLM_lpage">2312</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2011&pages=2305-2312&author=Y.+J.+Hanauthor=S.+F.+Maauthor=G.+Yourekauthor=Y.+D.+Parkauthor=J.+G.+Garcia&title=A+transcribed+pseudogene+of+MYLK+promotes+cell+proliferation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHan%26aufirst%3DY.%2BJ.%26aulast%3DMa%26aufirst%3DS.%2BF.%26aulast%3DYourek%26aufirst%3DG.%26aulast%3DPark%26aufirst%3DY.%2BD.%26aulast%3DGarcia%26aufirst%3DJ.%2BG.%26atitle%3DA%2520transcribed%2520pseudogene%2520of%2520MYLK%2520promotes%2520cell%2520proliferation%26jtitle%3DFASEB%2520J.%26date%3D2011%26volume%3D25%26spage%3D2305%26epage%3D2312" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit18d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Horbelt, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denkis, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knaus, P.</span><span> </span><span class="NLM_article-title">A portrait of transforming growth factor beta superfamily signaling: background matters</span> <span class="citation_source-journal">Int. J. Biochem. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">469</span><span class="NLM_x">–</span> <span class="NLM_lpage">474</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18d&amp;dbid=16&amp;doi=10.1021%2Fjm300542e&amp;key=10.1016%2Fj.biocel.2011.12.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18d&amp;dbid=8&amp;doi=10.1021%2Fjm300542e&amp;key=22226817" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18d&amp;dbid=32&amp;doi=10.1021%2Fjm300542e&amp;key=1%3ACAS%3A528%3ADC%252BC38XjtFSntrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2012&pages=469-474&author=D.+Horbeltauthor=A.+Denkisauthor=P.+Knaus&title=A+portrait+of+transforming+growth+factor+beta+superfamily+signaling%3A+background+matters"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18dR"><div class="casContent"><span class="casTitleNuber">18d</span><div class="casTitle"><span class="NLM_cas:atitle">A portrait of Transforming Growth Factor β superfamily signalling: Background matters</span></div><div class="casAuthors">Horbelt, Daniel; Denkis, Agnieszka; Knaus, Petra</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Biochemistry & Cell Biology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">469-474</span>CODEN:
                <span class="NLM_cas:coden">IJBBFU</span>;
        ISSN:<span class="NLM_cas:issn">1357-2725</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Ligands of the Transforming Growth Factor β superfamily like Transforming Growth Factor β and Bone Morphogenetic Proteins govern developmental processes and regulate adult homeostasis by controlling cellular proliferation, survival, differentiation and migration.  Aberrant signaling activity is assocd. with human disorders such as cancer, cardiovascular, musculoskeletal, or fibrotic disease.  Upon binding to specific sets of cognate cell surface receptors, family members induce highly similar pathways which include canonical SMAD dependent signaling as well as pathways without direct involvement of SMAD proteins, which activate signaling mols. like mitogen-activated protein kinases or small GTPases.  The diverse ligand functionalities are achieved through regulation and modulation of the pathways at all levels, resulting in a highly quant. and context sensitive signal integration reflecting the cellular state and background.  Strategies to target Transforming Growth Factor β or Bone Morphogenetic Protein pathways have been developed on the basis of our current understanding and have proven a highly beneficial potential.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovmtIcciglvrVg90H21EOLACvtfcHk0lipwLbbhc6OXw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XjtFSntrY%253D&md5=975270eb4bf67755263ebf5a41673644</span></div><a href="/servlet/linkout?suffix=cit18d&amp;dbid=16384&amp;doi=10.1016%2Fj.biocel.2011.12.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biocel.2011.12.013%26sid%3Dliteratum%253Aachs%26aulast%3DHorbelt%26aufirst%3DD.%26aulast%3DDenkis%26aufirst%3DA.%26aulast%3DKnaus%26aufirst%3DP.%26atitle%3DA%2520portrait%2520of%2520transforming%2520growth%2520factor%2520beta%2520superfamily%2520signaling%253A%2520background%2520matters%26jtitle%3DInt.%2520J.%2520Biochem.%2520Cell%2520Biol.%26date%3D2012%26volume%3D44%26spage%3D469%26epage%3D474" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit18e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Wang, P.; Yu, J.; Yin, Q.; Li, W.; Ren, X.; Hao, X.</span><span> </span><span class="NLM_article-title">Rosiglitazone suppresses glioma cell growth and cell cycle by blocking the transforming growth factor-beta mediated pathway</span>.  <span class="citation_source-journal">Neurochem. Res.</span> [Online early access]. DOI: <span class="refDoi"> DOI: 10.1007/s11064-012-0828-8</span> . Published Online:<span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18e&amp;dbid=16&amp;doi=10.1021%2Fjm300542e&amp;key=10.1007%2Fs11064-012-0828-8" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=P.+Wang&author=J.+Yu&author=Q.+Yin&author=W.+Li&author=X.+Ren&author=X.+Hao&title=Rosiglitazone+suppresses+glioma+cell+growth+and+cell+cycle+by+blocking+the+transforming+growth+factor-beta+mediated+pathway&doi=10.1007%2Fs11064-012-0828-8"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18e&amp;dbid=16384&amp;doi=10.1007%2Fs11064-012-0828-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11064-012-0828-8%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DP.%26atitle%3DRosiglitazone%2520suppresses%2520glioma%2520cell%2520growth%2520and%2520cell%2520cycle%2520by%2520blocking%2520the%2520transforming%2520growth%2520factor-beta%2520mediated%2520pathway%26jtitle%3DNeurochem.%2520Res.%26doi%3D10.1007%2Fs11064-012-0828-8%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit18f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Zoubeidi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rocha, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zouanat, F. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamel, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scarlata, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aprikian, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chevalier, S.</span><span> </span><span class="NLM_article-title">The Fer tyrosine kinase cooperates with interleukin-6 to activate signal transducer and activator of transcription 3 and promote human prostate cancer cell growth</span> <span class="citation_source-journal">Mol. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">142</span><span class="NLM_x">–</span> <span class="NLM_lpage">155</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18f&amp;dbid=16&amp;doi=10.1021%2Fjm300542e&amp;key=10.1158%2F1541-7786.MCR-08-0117" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18f&amp;dbid=8&amp;doi=10.1021%2Fjm300542e&amp;key=19147545" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18f&amp;dbid=32&amp;doi=10.1021%2Fjm300542e&amp;key=1%3ACAS%3A528%3ADC%252BD1MXltV2luw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2009&pages=142-155&author=A.+Zoubeidiauthor=J.+Rochaauthor=F.+Z.+Zouanatauthor=L.+Hamelauthor=E.+Scarlataauthor=A.+G.+Aprikianauthor=S.+Chevalier&title=The+Fer+tyrosine+kinase+cooperates+with+interleukin-6+to+activate+signal+transducer+and+activator+of+transcription+3+and+promote+human+prostate+cancer+cell+growth"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18fR"><div class="casContent"><span class="casTitleNuber">18f</span><div class="casTitle"><span class="NLM_cas:atitle">The Fer tyrosine kinase cooperates with interleukin-6 to activate signal transducer and activator of transcription 3 and promote human prostate cancer cell growth</span></div><div class="casAuthors">Zoubeidi, Amina; Rocha, Joice; Zouanat, Fatima Z.; Hamel, Lucie; Scarlata, Eleonora; Aprikian, Armen G.; Chevalier, Simone</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Research</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">142-155</span>CODEN:
                <span class="NLM_cas:coden">MCROC5</span>;
        ISSN:<span class="NLM_cas:issn">1541-7786</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Androgen withdrawal is the most effective form of systemic therapy for men with advanced prostate cancer.  Unfortunately, androgen-independent progression is inevitable, and the development of hormone-refractory disease and death occurs within 2 to 3 years in most men.  The understanding of mol. mechanisms promoting the growth of androgen-independent prostate cancer cells is essential for the rational design of agents to treat advanced disease.  We previously reported that Fer tyrosine kinase level correlates with the development of prostate cancer and aggressiveness of prostate cancer cell lines.  Moreover, knocking down Fer expression interferes with prostate cancer cell growth in vitro.  However, the mechanism by which Fer mediates prostate cancer progression remains elusive.  We present here that Fer and phospho-Y705 signal transducer and activator of transcription 3 (STAT3) are barely detectable in human benign prostate tissues but constitutively expressed in the cytoplasm and nucleus of the same subsets of tumor cells in human prostate cancer.  The interaction between STAT3 and Fer was obsd. in all prostate cancer cell lines tested, and this interaction is mediated via the Fer Src homol. 2 domain and modulated by interleukin-6 (IL-6).  Moreover, IL-6 triggered a rapid formation of Fer/gp130 and Fer/STAT3 complexes in a time-dependent manner and consistent with changes in Fer and STAT3 phosphorylation and cytoplasmic/nuclear distribution.  The modulation of Fer expression/activation resulted in inhibitory or stimulatory effects on STAT3 phosphorylation, nuclear translocation, and transcriptional activation.  Taken together, these results support an important function of Fer in prostate cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7W0h0Wam0bbVg90H21EOLACvtfcHk0lipwLbbhc6OXw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXltV2luw%253D%253D&md5=b603ad01ef936dad28eeaf0a63f566f9</span></div><a href="/servlet/linkout?suffix=cit18f&amp;dbid=16384&amp;doi=10.1158%2F1541-7786.MCR-08-0117&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1541-7786.MCR-08-0117%26sid%3Dliteratum%253Aachs%26aulast%3DZoubeidi%26aufirst%3DA.%26aulast%3DRocha%26aufirst%3DJ.%26aulast%3DZouanat%26aufirst%3DF.%2BZ.%26aulast%3DHamel%26aufirst%3DL.%26aulast%3DScarlata%26aufirst%3DE.%26aulast%3DAprikian%26aufirst%3DA.%2BG.%26aulast%3DChevalier%26aufirst%3DS.%26atitle%3DThe%2520Fer%2520tyrosine%2520kinase%2520cooperates%2520with%2520interleukin-6%2520to%2520activate%2520signal%2520transducer%2520and%2520activator%2520of%2520transcription%25203%2520and%2520promote%2520human%2520prostate%2520cancer%2520cell%2520growth%26jtitle%3DMol.%2520Cancer%2520Res.%26date%3D2009%26volume%3D7%26spage%3D142%26epage%3D155" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit18g"><span><span class="NLM_label">(g) </span><span class="NLM_contrib-group">Wang, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, F. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ni, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, X. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qu, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span> </span><span class="NLM_article-title">Rapid induction and activation of Tec tyrosine kinase in liver regeneration</span> <span class="citation_source-journal">J. Gastroenterol. Hepatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">668</span><span class="NLM_x">–</span> <span class="NLM_lpage">673</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18g&amp;dbid=16&amp;doi=10.1021%2Fjm300542e&amp;key=10.1111%2Fj.1440-1746.2006.04259.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18g&amp;dbid=8&amp;doi=10.1021%2Fjm300542e&amp;key=16677151" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18g&amp;dbid=32&amp;doi=10.1021%2Fjm300542e&amp;key=1%3ACAS%3A528%3ADC%252BD28XlvVSru7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2006&pages=668-673&author=S.+Y.+Wangauthor=F.+F.+Liauthor=H.+Zhengauthor=K.+K.+Yuauthor=F.+Niauthor=X.+M.+Yangauthor=C.+K.+Quauthor=J.+Li&title=Rapid+induction+and+activation+of+Tec+tyrosine+kinase+in+liver+regeneration"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18gR"><div class="casContent"><span class="casTitleNuber">18g</span><div class="casTitle"><span class="NLM_cas:atitle">Rapid induction and activation of Tec tyrosine kinase in liver regeneration</span></div><div class="casAuthors">Wang, Si-Ying; Li, Fei-Fei; Zheng, Hong; Yu, Ke-Ke; Ni, Fang; Yang, Xiao-Ming; Qu, Cheng-Kui; Li, Jun</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Gastroenterology and Hepatology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">668-673</span>CODEN:
                <span class="NLM_cas:coden">JGHEEO</span>;
        ISSN:<span class="NLM_cas:issn">0815-9319</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Asia Pty Ltd.</span>)
        </div><div class="casAbstract">Background: Previous studies have indicated that Tec tyrosine kinase is differentially expressed in the regenerating liver.  The purpose of the present study was to further investigate the potential involvement of Tec tyrosine kinase in hepatocyte proliferation and liver regeneration.  Methods: Tec kinase gene expression after partial (two-thirds) hepatectomy was examd. by representational difference anal.  Tissue distribution and potential involvement of Tec kinase in liver regeneration and hepatocyte proliferation were then detd. by northern blotting, reverse transcription-polymerase chain reaction (RT-PCR), and western blotting.  Full-length rat Tec cDNA was cloned.  Results: Using this cDNA as the probe, northern blotting showed that Tec was specifically expressed in liver and kidney, the highest expression of Tec being detected in embryonic day 15-19 fetal livers.  In contrast, the expression level of Tec in adult and neonatal rat livers was significantly decreased.  Similar results were obtained from western blotting analyzes.  It was thus hypothesized that Tec might be involved in hepatocyte proliferation.  To test this hypothesis, Tec expression was examd. in regenerating rat livers.  An increase in Tec expression and activation of Tec kinase were obsd. within 1 h after partial hepatectomy.  Moreover, it has been shown that hepatocyte growth factor (HGF) dramatically induces Tec expression in primary rat hepatocytes.  Addnl., it was obsd. that Tec gene expression in serum-starved liver tumor cell line HepG2 was substantially decreased.  Stimulation with 10% fetal bovine serum and insulin but not epidermal growth factor resulted in dramatic elevation of Tec expression in these cells.  Conclusion: Tec is an inducible early response gene that might enhance hepatocyte proliferation and liver regeneration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqytyt56t-TtbVg90H21EOLACvtfcHk0liRRSVfidiUmA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XlvVSru7Y%253D&md5=b195aac161243776f72d43184283fee1</span></div><a href="/servlet/linkout?suffix=cit18g&amp;dbid=16384&amp;doi=10.1111%2Fj.1440-1746.2006.04259.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1440-1746.2006.04259.x%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DS.%2BY.%26aulast%3DLi%26aufirst%3DF.%2BF.%26aulast%3DZheng%26aufirst%3DH.%26aulast%3DYu%26aufirst%3DK.%2BK.%26aulast%3DNi%26aufirst%3DF.%26aulast%3DYang%26aufirst%3DX.%2BM.%26aulast%3DQu%26aufirst%3DC.%2BK.%26aulast%3DLi%26aufirst%3DJ.%26atitle%3DRapid%2520induction%2520and%2520activation%2520of%2520Tec%2520tyrosine%2520kinase%2520in%2520liver%2520regeneration%26jtitle%3DJ.%2520Gastroenterol.%2520Hepatol.%26date%3D2006%26volume%3D21%26spage%3D668%26epage%3D673" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit18h"><span><span class="NLM_label">(h) </span><span class="NLM_contrib-group">Feng, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Man, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, L. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knyazev, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lei, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ullrich, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Z.</span><span> </span><span class="NLM_article-title">Overexpression of Csk-binding protein contributes to renal cell carcinogenesis</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">3320</span><span class="NLM_x">–</span> <span class="NLM_lpage">3331</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2009&pages=3320-3331&author=X.+Fengauthor=X.+Luauthor=X.+Manauthor=W.+Zhouauthor=L.+Q.+Jiangauthor=P.+Knyazevauthor=L.+Leiauthor=Q.+Huangauthor=A.+Ullrichauthor=Z.+Zhangauthor=Z.+Chen&title=Overexpression+of+Csk-binding+protein+contributes+to+renal+cell+carcinogenesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18h&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFeng%26aufirst%3DX.%26aulast%3DLu%26aufirst%3DX.%26aulast%3DMan%26aufirst%3DX.%26aulast%3DZhou%26aufirst%3DW.%26aulast%3DJiang%26aufirst%3DL.%2BQ.%26aulast%3DKnyazev%26aufirst%3DP.%26aulast%3DLei%26aufirst%3DL.%26aulast%3DHuang%26aufirst%3DQ.%26aulast%3DUllrich%26aufirst%3DA.%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DChen%26aufirst%3DZ.%26atitle%3DOverexpression%2520of%2520Csk-binding%2520protein%2520contributes%2520to%2520renal%2520cell%2520carcinogenesis%26jtitle%3DOncogene%26date%3D2009%26volume%3D28%26spage%3D3320%26epage%3D3331" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Paull, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shoemaker, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hodes, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monks, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scudiero, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rubinstein, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plowman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyd, M. R.</span><span> </span><span class="NLM_article-title">Display and analysis of patterns of differential activity of drugs against human tumor cell lines: development of mean graph and COMPARE algorithm</span> <span class="citation_source-journal">J. Natl. Cancer Inst.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">81</span><span class="NLM_x">, </span> <span class="NLM_fpage">1088</span><span class="NLM_x">–</span> <span class="NLM_lpage">1092</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Fjm300542e&amp;key=10.1093%2Fjnci%2F81.14.1088" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Fjm300542e&amp;key=2738938" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm300542e&amp;key=1%3ACAS%3A280%3ADyaL1M3ptlyrsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=1989&pages=1088-1092&author=K.+D.+Paullauthor=R.+H.+Shoemakerauthor=L.+Hodesauthor=A.+Monksauthor=D.+A.+Scudieroauthor=L.+Rubinsteinauthor=J.+Plowmanauthor=M.+R.+Boyd&title=Display+and+analysis+of+patterns+of+differential+activity+of+drugs+against+human+tumor+cell+lines%3A+development+of+mean+graph+and+COMPARE+algorithm"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Display and analysis of patterns of differential activity of drugs against human tumor cell lines: development of mean graph and COMPARE algorithm</span></div><div class="casAuthors">Paull K D; Shoemaker R H; Hodes L; Monks A; Scudiero D A; Rubinstein L; Plowman J; Boyd M R</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the National Cancer Institute</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">81</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">1088-92</span>
        ISSN:<span class="NLM_cas:issn">0027-8874</span>.
    </div><div class="casAbstract">The objective of this study was to develop and investigate an approach to optimally detect, rank, display, and analyze patterns of differential growth inhibition among cultured cell lines.  Such patterns of cellular responsiveness are produced by substances tested in vitro against disease-oriented panels of human tumor cell lines in a new anticancer screening model under development by the National Cancer Institute.  In the first phase of the study, we developed a key methodological tool, the mean graph, which allowed the transformation of the numerical cell line response data into graphic patterns.  These patterns were particularly expressive of differential cell growth inhibition and were conveniently amenable to further analyses by an algorithm we devised and implemented in the COMPARE computer program.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQUJX57ADL8cwpJitSxOdIlfW6udTcc2eY6fQFB5cH_wrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL1M3ptlyrsw%253D%253D&md5=6612f9f2a7793d1296dfa24224f09545</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1093%2Fjnci%2F81.14.1088&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjnci%252F81.14.1088%26sid%3Dliteratum%253Aachs%26aulast%3DPaull%26aufirst%3DK.%2BD.%26aulast%3DShoemaker%26aufirst%3DR.%2BH.%26aulast%3DHodes%26aufirst%3DL.%26aulast%3DMonks%26aufirst%3DA.%26aulast%3DScudiero%26aufirst%3DD.%2BA.%26aulast%3DRubinstein%26aufirst%3DL.%26aulast%3DPlowman%26aufirst%3DJ.%26aulast%3DBoyd%26aufirst%3DM.%2BR.%26atitle%3DDisplay%2520and%2520analysis%2520of%2520patterns%2520of%2520differential%2520activity%2520of%2520drugs%2520against%2520human%2520tumor%2520cell%2520lines%253A%2520development%2520of%2520mean%2520graph%2520and%2520COMPARE%2520algorithm%26jtitle%3DJ.%2520Natl.%2520Cancer%2520Inst.%26date%3D1989%26volume%3D81%26spage%3D1088%26epage%3D1092" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Chan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khan, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harvey, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merrick, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pelletier, J.</span><span> </span><span class="NLM_article-title">Eukaryotic protein synthesis inhibitors identified by comparison of cytotoxicity profiles</span> <span class="citation_source-journal">RNA</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">528</span><span class="NLM_x">–</span> <span class="NLM_lpage">543</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2004&pages=528-543&author=J.+Chanauthor=S.+N.+Khanauthor=I.+Harveyauthor=W.+Merrickauthor=J.+Pelletier&title=Eukaryotic+protein+synthesis+inhibitors+identified+by+comparison+of+cytotoxicity+profiles"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChan%26aufirst%3DJ.%26aulast%3DKhan%26aufirst%3DS.%2BN.%26aulast%3DHarvey%26aufirst%3DI.%26aulast%3DMerrick%26aufirst%3DW.%26aulast%3DPelletier%26aufirst%3DJ.%26atitle%3DEukaryotic%2520protein%2520synthesis%2520inhibitors%2520identified%2520by%2520comparison%2520of%2520cytotoxicity%2520profiles%26jtitle%3DRNA%26date%3D2004%26volume%3D10%26spage%3D528%26epage%3D543" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Gharehbaghi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paul, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelley, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barchi, J. J.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marquez, V. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooney, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monks, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scudiero, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohn, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jayaram, H. N.</span><span> </span><span class="NLM_article-title">Cytotoxicity and characterization of an active metabolite of benzamide ribosode: a novel inhibitor of IMP dehydrogenase</span> <span class="citation_source-journal">J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">892</span><span class="NLM_x">–</span> <span class="NLM_lpage">899</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21a&amp;dbid=16&amp;doi=10.1021%2Fjm300542e&amp;key=10.1002%2Fijc.2910560623" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21a&amp;dbid=8&amp;doi=10.1021%2Fjm300542e&amp;key=7907081" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21a&amp;dbid=32&amp;doi=10.1021%2Fjm300542e&amp;key=1%3ACAS%3A528%3ADyaK2cXkvF2itbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=1994&pages=892-899&author=K.+Gharehbaghiauthor=K.+Paulauthor=J.+J.+Kelleyauthor=J.+J.+Barchiauthor=V.+E.+Marquezauthor=D.+A.+Cooneyauthor=A.+Monksauthor=D.+Scudieroauthor=K.+Kohnauthor=H.+N.+Jayaram&title=Cytotoxicity+and+characterization+of+an+active+metabolite+of+benzamide+ribosode%3A+a+novel+inhibitor+of+IMP+dehydrogenase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21aR"><div class="casContent"><span class="casTitleNuber">21a</span><div class="casTitle"><span class="NLM_cas:atitle">Cytotoxicity and characterization of an active metabolite of benzamide riboside, a novel inhibitor of IMP dehydrogenase</span></div><div class="casAuthors">Gharehbaghi, Kamran; Paull, Kenneth D.; Kelley, James A.; Barchi, Joseph J. Jr.; Marquez, Victor E.; Cooney, David A.; Monks, Anne; Scudiero, Dominic; Krohn, Karsten; Jayaram, Hiremagalur N.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Cancer</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">892-9</span>CODEN:
                <span class="NLM_cas:coden">IJCNAW</span>;
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    </div><div class="casAbstract">Benzamide riboside exhibits significant cytotoxicity against a variety of human tumor cells in culture.  On the basis of metabolic studies, the primary target of this drug's action appears to be IMP dehydrogenase (IMPDH).  Incubation of human myelogenous leukemia K562 cells with an IC50 concn. of benzamide riboside resulted in an expansion of IMP pools (5.9-fold), with a parallel redn. in the concn. of GMP (90%), GDP (63%), GTP (55%) and dGTP (40%).  On kinetic grounds, it was deduced that benzamide riboside (whose Ki vs. IMPDH is 6.4 mM, while that of its 5'-monophosphate is 3.9 mM) or its 5'-monophosphate were unlikely to be responsible for inhibition of this target enzyme, IMPDH, since only micromolar concns. of benzamide riboside were needed to exert potent inhibition of tumor-cell growth.  Studies on the metab. of this C-nucleoside have revealed the presence of a new peak eluting in the nucleoside diphosphate area on HPLC.  Treatment of this peak with venom phosphodiesterase degraded it and concurrently nullified its inhibitory activity vs. IMPDH; alk. phosphatase, on the other hand, totally failed to digest the anabolite.  These results suggest that the metabolite in question is the phosphodiester, benzamide adenine dinucleotide (BAD).  Evidence that the inhibitor was an analog of NAD, wherein the nicotinamide moiety has been replaced by benzamide, was provided by both NMR and mass spectrometric anal. and confirmed by enzymic synthesis.  Further insight into the nature of the active principle was obtained from kinetic studies, which established that BAD competitively inhibited NAD utilization by partially purified IMPDH from K562 cells with a Ki of 0.118 μM.  In concert, these studies establish that benzamide riboside exhibits potent antiproliferative activity by inhibiting IMPDH through BAD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6WWo-ZuTvqbVg90H21EOLACvtfcHk0liRRSVfidiUmA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXkvF2itbo%253D&md5=3bbdd90a9a1e39d23ee1651260016ae5</span></div><a href="/servlet/linkout?suffix=cit21a&amp;dbid=16384&amp;doi=10.1002%2Fijc.2910560623&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fijc.2910560623%26sid%3Dliteratum%253Aachs%26aulast%3DGharehbaghi%26aufirst%3DK.%26aulast%3DPaul%26aufirst%3DK.%26aulast%3DKelley%26aufirst%3DJ.%2BJ.%26aulast%3DBarchi%26aufirst%3DJ.%2BJ.%26aulast%3DMarquez%26aufirst%3DV.%2BE.%26aulast%3DCooney%26aufirst%3DD.%2BA.%26aulast%3DMonks%26aufirst%3DA.%26aulast%3DScudiero%26aufirst%3DD.%26aulast%3DKohn%26aufirst%3DK.%26aulast%3DJayaram%26aufirst%3DH.%2BN.%26atitle%3DCytotoxicity%2520and%2520characterization%2520of%2520an%2520active%2520metabolite%2520of%2520benzamide%2520ribosode%253A%2520a%2520novel%2520inhibitor%2520of%2520IMP%2520dehydrogenase%26jtitle%3DJ.%2520Cancer%26date%3D1994%26volume%3D56%26spage%3D892%26epage%3D899" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit21b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Cleaveland, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monks, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaigro-Wolff, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zaharevitz, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paull, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ardalan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooney, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ford, H.,  Jr.</span><span> </span><span class="NLM_article-title">Site of action of two novel pyrimidine biosynthesis inhibitors accurately predicted by the COMPARE program</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">947</span><span class="NLM_x">–</span> <span class="NLM_lpage">954</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=1995&pages=947-954&author=E.+S.+Cleavelandauthor=A.+Monksauthor=A.+Vaigro-Wolffauthor=D.+W.+Zaharevitzauthor=K.+Paullauthor=K.+Ardalanauthor=D.+A.+Cooneyauthor=H.+Ford&title=Site+of+action+of+two+novel+pyrimidine+biosynthesis+inhibitors+accurately+predicted+by+the+COMPARE+program"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCleaveland%26aufirst%3DE.%2BS.%26aulast%3DMonks%26aufirst%3DA.%26aulast%3DVaigro-Wolff%26aufirst%3DA.%26aulast%3DZaharevitz%26aufirst%3DD.%2BW.%26aulast%3DPaull%26aufirst%3DK.%26aulast%3DArdalan%26aufirst%3DK.%26aulast%3DCooney%26aufirst%3DD.%2BA.%26aulast%3DFord%26aufirst%3DH.%26atitle%3DSite%2520of%2520action%2520of%2520two%2520novel%2520pyrimidine%2520biosynthesis%2520inhibitors%2520accurately%2520predicted%2520by%2520the%2520COMPARE%2520program%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1995%26volume%3D49%26spage%3D947%26epage%3D954" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit21c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Kohlhagen, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paull, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cushman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagafuji, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pommier, Y.</span><span> </span><span class="NLM_article-title">Protein-linked DNA strand breaks induced by NSC314622: a novel non-camptothecin topoisomerase I poison</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">50</span><span class="NLM_x">–</span> <span class="NLM_lpage">58</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=1998&pages=50-58&author=G.+Kohlhagenauthor=K.+Paullauthor=M.+Cushmanauthor=P.+Nagafujiauthor=Y.+Pommier&title=Protein-linked+DNA+strand+breaks+induced+by+NSC314622%3A+a+novel+non-camptothecin+topoisomerase+I+poison"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKohlhagen%26aufirst%3DG.%26aulast%3DPaull%26aufirst%3DK.%26aulast%3DCushman%26aufirst%3DM.%26aulast%3DNagafuji%26aufirst%3DP.%26aulast%3DPommier%26aufirst%3DY.%26atitle%3DProtein-linked%2520DNA%2520strand%2520breaks%2520induced%2520by%2520NSC314622%253A%2520a%2520novel%2520non-camptothecin%2520topoisomerase%2520I%2520poison%26jtitle%3DMol.%2520Pharmacol.%26date%3D1998%26volume%3D54%26spage%3D50%26epage%3D58" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit21d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Zaharevitz, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gussio, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loest, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Senderowicz, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lahusen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kunick, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meijer, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sausville, E. A.</span><span> </span><span class="NLM_article-title">Discovery and initial characterization of the paullones: a novel class of small-molecule inhibitors of cyclin-dependent kinases</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">2566</span><span class="NLM_x">–</span> <span class="NLM_lpage">2569</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=1999&pages=2566-2569&author=D.+W.+Zaharevitzauthor=R.+Gussioauthor=M.+Loestauthor=A.+M.+Senderowiczauthor=T.+Lahusenauthor=C.+Kunickauthor=L.+Meijerauthor=E.+A.+Sausville&title=Discovery+and+initial+characterization+of+the+paullones%3A+a+novel+class+of+small-molecule+inhibitors+of+cyclin-dependent+kinases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZaharevitz%26aufirst%3DD.%2BW.%26aulast%3DGussio%26aufirst%3DR.%26aulast%3DLoest%26aufirst%3DM.%26aulast%3DSenderowicz%26aufirst%3DA.%2BM.%26aulast%3DLahusen%26aufirst%3DT.%26aulast%3DKunick%26aufirst%3DC.%26aulast%3DMeijer%26aufirst%3DL.%26aulast%3DSausville%26aufirst%3DE.%2BA.%26atitle%3DDiscovery%2520and%2520initial%2520characterization%2520of%2520the%2520paullones%253A%2520a%2520novel%2520class%2520of%2520small-molecule%2520inhibitors%2520of%2520cyclin-dependent%2520kinases%26jtitle%3DCancer%2520Res.%26date%3D1999%26volume%3D59%26spage%3D2566%26epage%3D2569" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Kupchan, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaVoie, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Branfman, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fei, B. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bright, W. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bryan, R. F.</span><span> </span><span class="NLM_article-title">Phyllantocin, a novel bisabolane aglycone from the antileukemic glycoside, phyllantoside</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1977</span><span class="NLM_x">, </span> <span class="NLM_volume">99</span><span class="NLM_x">, </span> <span class="NLM_fpage">3199</span><span class="NLM_x">–</span> <span class="NLM_lpage">3201</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja00451a074" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=1977&pages=3199-3201&author=S.+M.+Kupchanauthor=E.+J.+LaVoieauthor=A.+R.+Branfmanauthor=B.+Y.+Feiauthor=W.+M.+Brightauthor=R.+F.+Bryan&title=Phyllantocin%2C+a+novel+bisabolane+aglycone+from+the+antileukemic+glycoside%2C+phyllantoside"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fja00451a074&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja00451a074%26sid%3Dliteratum%253Aachs%26aulast%3DKupchan%26aufirst%3DS.%2BM.%26aulast%3DLaVoie%26aufirst%3DE.%2BJ.%26aulast%3DBranfman%26aufirst%3DA.%2BR.%26aulast%3DFei%26aufirst%3DB.%2BY.%26aulast%3DBright%26aufirst%3DW.%2BM.%26aulast%3DBryan%26aufirst%3DR.%2BF.%26atitle%3DPhyllantocin%252C%2520a%2520novel%2520bisabolane%2520aglycone%2520from%2520the%2520antileukemic%2520glycoside%252C%2520phyllantoside%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1977%26volume%3D99%26spage%3D3199%26epage%3D3201" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Choi, H. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dong, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lau, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zou, M. H.</span><span> </span><span class="NLM_article-title">Reactive nitrogen species is required for the activation of the AMP-activated protein kinase by statin in vivo</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">283</span><span class="NLM_x">, </span> <span class="NLM_fpage">20186</span><span class="NLM_x">–</span> <span class="NLM_lpage">20197</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=283&publication_year=2008&pages=20186-20197&author=H.+C.+Choiauthor=P.+Songauthor=Z.+Xieauthor=Y.+Wuauthor=J.+Xuauthor=M.+Zhangauthor=Y.+Dongauthor=S.+Wangauthor=K.+Lauauthor=M.+H.+Zou&title=Reactive+nitrogen+species+is+required+for+the+activation+of+the+AMP-activated+protein+kinase+by+statin+in+vivo"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChoi%26aufirst%3DH.%2BC.%26aulast%3DSong%26aufirst%3DP.%26aulast%3DXie%26aufirst%3DZ.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DM.%26aulast%3DDong%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DLau%26aufirst%3DK.%26aulast%3DZou%26aufirst%3DM.%2BH.%26atitle%3DReactive%2520nitrogen%2520species%2520is%2520required%2520for%2520the%2520activation%2520of%2520the%2520AMP-activated%2520protein%2520kinase%2520by%2520statin%2520in%2520vivo%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2008%26volume%3D283%26spage%3D20186%26epage%3D20197" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Lamoral-Theys, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pottier, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kerff, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dufrasne, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Proutière, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wauthoz, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neven, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ingrassia, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Antwerpen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lefranc, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gelbcke, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pirotte, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kraus, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nève, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kornienko, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiss, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dubois, J.</span><span> </span><span class="NLM_article-title">Simple di- and trivanillates exhibit cytostatic properties toward cancer cells resistant to pro-apoptotic stimuli</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">3823</span><span class="NLM_x">–</span> <span class="NLM_lpage">3833</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2010&pages=3823-3833&author=D.+Lamoral-Theysauthor=L.+Pottierauthor=F.+Kerffauthor=F.+Dufrasneauthor=F.+Prouti%C3%A8reauthor=N.+Wauthozauthor=P.+Nevenauthor=L.+Ingrassiaauthor=P.+Van+Antwerpenauthor=F.+Lefrancauthor=M.+Gelbckeauthor=B.+Pirotteauthor=J.+L.+Krausauthor=J.+N%C3%A8veauthor=A.+Kornienkoauthor=R.+Kissauthor=J.+Dubois&title=Simple+di-+and+trivanillates+exhibit+cytostatic+properties+toward+cancer+cells+resistant+to+pro-apoptotic+stimuli"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLamoral-Theys%26aufirst%3DD.%26aulast%3DPottier%26aufirst%3DL.%26aulast%3DKerff%26aufirst%3DF.%26aulast%3DDufrasne%26aufirst%3DF.%26aulast%3DProuti%25C3%25A8re%26aufirst%3DF.%26aulast%3DWauthoz%26aufirst%3DN.%26aulast%3DNeven%26aufirst%3DP.%26aulast%3DIngrassia%26aufirst%3DL.%26aulast%3DVan%2BAntwerpen%26aufirst%3DP.%26aulast%3DLefranc%26aufirst%3DF.%26aulast%3DGelbcke%26aufirst%3DM.%26aulast%3DPirotte%26aufirst%3DB.%26aulast%3DKraus%26aufirst%3DJ.%2BL.%26aulast%3DN%25C3%25A8ve%26aufirst%3DJ.%26aulast%3DKornienko%26aufirst%3DA.%26aulast%3DKiss%26aufirst%3DR.%26aulast%3DDubois%26aufirst%3DJ.%26atitle%3DSimple%2520di-%2520and%2520trivanillates%2520exhibit%2520cytostatic%2520properties%2520toward%2520cancer%2520cells%2520resistant%2520to%2520pro-apoptotic%2520stimuli%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2010%26volume%3D18%26spage%3D3823%26epage%3D3833" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit24b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Lamoral-Theys, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wauthoz, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heffeter, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathieu, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jungwirth, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lefranc, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nève, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dubois, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dufrasne, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amighi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berger, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gailly, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiss, R.</span><span> </span><span class="NLM_article-title">Trivanillic polyphenols with anticancer cytostatic effects through the targeting of multiple kinases and intracellular Ca<sup>2+</sup> release</span> <span class="citation_source-journal">J. Cell. Mol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">1421</span><span class="NLM_x">–</span> <span class="NLM_lpage">1434</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24b&amp;dbid=16&amp;doi=10.1021%2Fjm300542e&amp;key=10.1111%2Fj.1582-4934.2011.01403.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24b&amp;dbid=8&amp;doi=10.1021%2Fjm300542e&amp;key=21810170" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24b&amp;dbid=32&amp;doi=10.1021%2Fjm300542e&amp;key=1%3ACAS%3A280%3ADC%252BC38zltFegtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2012&pages=1421-1434&author=D.+Lamoral-Theysauthor=N.+Wauthozauthor=P.+Heffeterauthor=V.+Mathieuauthor=U.+Jungwirthauthor=F.+Lefrancauthor=J.+N%C3%A8veauthor=J.+Duboisauthor=F.+Dufrasneauthor=K.+Amighiauthor=W.+Bergerauthor=P.+Gaillyauthor=R.+Kiss&title=Trivanillic+polyphenols+with+anticancer+cytostatic+effects+through+the+targeting+of+multiple+kinases+and+intracellular+Ca2%2B+release"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24bR"><div class="casContent"><span class="casTitleNuber">24b</span><div class="casTitle"><span class="NLM_cas:atitle">Trivanillic polyphenols with anticancer cytostatic effects through the targeting of multiple kinases and intracellular Ca2+ release</span></div><div class="casAuthors">Lamoral-Theys Delphine; Wauthoz Nathalie; Heffeter Petra; Mathieu Veronique; Jungwirth Utte; Lefranc Florence; Neve Jean; Dubois Jacques; Dufrasne Francois; Amighi Karim; Berger Walter; Gailly Philippe; Kiss Robert</div><div class="citationInfo"><span class="NLM_cas:title">Journal of cellular and molecular medicine</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1421-34</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Cancer cells exhibit de-regulation of multiple cellular signalling pathways and treatments of various types of cancers with polyphenols are promising.  We recently reported the synthesis of a series of 33 novel divanillic and trivanillic polyphenols that displayed anticancer activity, at least in vitro, through inhibiting various kinases.  This study revealed that minor chemical modifications of a trivanillate scaffold could convert cytotoxic compounds into cytostatic ones.  Compound 13c, a tri-chloro derivative of trivanillic ester, displayed marked inhibitory activities against FGF-, VEGF-, EGF- and Src-related kinases, all of which are implicated not only in angiogenesis but also in the biological aggressiveness of various cancer types.  The pan-anti-kinase activity of 13c occurs at less than one-tenth of its mean IC(50) in vitro growth inhibitory concentrations towards a panel of 12 cancer cell lines.  Of the 26 kinases for which 13c inhibited their activity by >75%, eight (Yes, Fyn, FGF-R1, EGFR, Btk, Mink, Ret and Itk) are implicated in control of the actin cytoskeleton organization to varying degrees.  Compound 13c accordingly impaired the typical organization of the actin cytoskeleton in human U373 glioblastoma cells.  The pan-anti-kinase activity and actin cytoskeleton organization impairment provoked by 13c concomitantly occurs with calcium homeostasis impairment but without provoking MDR phenotype activation.  All of these anticancer properties enabled 13c to confer therapeutic benefits in vivo in a mouse melanoma pseudometastatic lung model.  These data argue in favour of further chemically modifying trivanillates to produce novel and potent anticancer drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcROiDnH3kqdk2Zyxfu64m4ffW6udTcc2eabk7_GViKx47ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38zltFegtw%253D%253D&md5=348ffb44efeabb18fdda46e03a31690e</span></div><a href="/servlet/linkout?suffix=cit24b&amp;dbid=16384&amp;doi=10.1111%2Fj.1582-4934.2011.01403.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1582-4934.2011.01403.x%26sid%3Dliteratum%253Aachs%26aulast%3DLamoral-Theys%26aufirst%3DD.%26aulast%3DWauthoz%26aufirst%3DN.%26aulast%3DHeffeter%26aufirst%3DP.%26aulast%3DMathieu%26aufirst%3DV.%26aulast%3DJungwirth%26aufirst%3DU.%26aulast%3DLefranc%26aufirst%3DF.%26aulast%3DN%25C3%25A8ve%26aufirst%3DJ.%26aulast%3DDubois%26aufirst%3DJ.%26aulast%3DDufrasne%26aufirst%3DF.%26aulast%3DAmighi%26aufirst%3DK.%26aulast%3DBerger%26aufirst%3DW.%26aulast%3DGailly%26aufirst%3DP.%26aulast%3DKiss%26aufirst%3DR.%26atitle%3DTrivanillic%2520polyphenols%2520with%2520anticancer%2520cytostatic%2520effects%2520through%2520the%2520targeting%2520of%2520multiple%2520kinases%2520and%2520intracellular%2520Ca2%252B%2520release%26jtitle%3DJ.%2520Cell.%2520Mol.%2520Med.%26date%3D2012%26volume%3D16%26spage%3D1421%26epage%3D1434" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Dolusic, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larrieu, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moineaux, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stroobant, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pilotte, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colau, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pochet, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van den Eynde, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masereel, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wouters, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frederick, R.</span><span> </span><span class="NLM_article-title">Tryptophan 2,3-dioxygenase (TDO) inhibitors. 3-(2-(Pyridyl)ethenyl)indoles as potential anticancer immunomodulators</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x"> (</span><span class="NLM_issue">15</span><span class="NLM_x">) </span> <span class="NLM_fpage">5320</span><span class="NLM_x">–</span> <span class="NLM_lpage">5334</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm2006782" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=5320-5334&issue=15&author=E.+Dolusicauthor=P.+Larrieuauthor=L.+Moineauxauthor=V.+Stroobantauthor=L.+Pilotteauthor=D.+Colauauthor=L.+Pochetauthor=B.+Van+den+Eyndeauthor=B.+Masereelauthor=J.+Woutersauthor=R.+Frederick&title=Tryptophan+2%2C3-dioxygenase+%28TDO%29+inhibitors.+3-%282-%28Pyridyl%29ethenyl%29indoles+as+potential+anticancer+immunomodulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fjm2006782&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm2006782%26sid%3Dliteratum%253Aachs%26aulast%3DDolusic%26aufirst%3DE.%26aulast%3DLarrieu%26aufirst%3DP.%26aulast%3DMoineaux%26aufirst%3DL.%26aulast%3DStroobant%26aufirst%3DV.%26aulast%3DPilotte%26aufirst%3DL.%26aulast%3DColau%26aufirst%3DD.%26aulast%3DPochet%26aufirst%3DL.%26aulast%3DVan%2Bden%2BEynde%26aufirst%3DB.%26aulast%3DMasereel%26aufirst%3DB.%26aulast%3DWouters%26aufirst%3DJ.%26aulast%3DFrederick%26aufirst%3DR.%26atitle%3DTryptophan%25202%252C3-dioxygenase%2520%2528TDO%2529%2520inhibitors.%25203-%25282-%2528Pyridyl%2529ethenyl%2529indoles%2520as%2520potential%2520anticancer%2520immunomodulators%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26issue%3D15%26spage%3D5320%26epage%3D5334" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1a','cit1b','cit1c'],'ref2':['cit2'],'ref3':['cit3a','cit3b'],'ref4':['cit4a','cit4b','cit4c','cit4d','cit4e','cit4f'],'ref5':['cit5a','cit5b'],'ref6':['cit6'],'ref7':['cit7a','cit7b','cit7c'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12a','cit12b','cit12c','cit12d'],'ref13':['cit13a','cit13b','cit13c','cit13d'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16a','cit16b','cit16c'],'ref17':['cit17a','cit17b'],'ref18':['cit18a','cit18b','cit18c','cit18d','cit18e','cit18f','cit18g','cit18h'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21a','cit21b','cit21c','cit21d'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24a','cit24b'],'ref25':['cit25']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 58 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shi  Tang</span>, <span class="hlFld-ContribAuthor ">Jian  Wang</span>, <span class="hlFld-ContribAuthor ">Zhuang  Xiong</span>, <span class="hlFld-ContribAuthor ">Zeqiang  Xie</span>, <span class="hlFld-ContribAuthor ">Dengke  Li</span>, <span class="hlFld-ContribAuthor ">Jinbo  Huang</span>, and <span class="hlFld-ContribAuthor ">Qiang  Zhu</span>  . </span><span class="cited-content_cbyCitation_article-title">Palladium-Catalyzed Imidoylative Cyclization of Tryptophan-Derived Isocyanides: Access to β-Carbolines. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2017,</strong> <em>19 </em>
                                    (20)
                                     , 5577-5580. <a href="https://doi.org/10.1021/acs.orglett.7b02725" title="DOI URL">https://doi.org/10.1021/acs.orglett.7b02725</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.7b02725&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.7b02725%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DPalladium-Catalyzed%252BImidoylative%252BCyclization%252Bof%252BTryptophan-Derived%252BIsocyanides%25253A%252BAccess%252Bto%252B%2525CE%2525B2-Carbolines%26aulast%3DTang%26aufirst%3DShi%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D01092017%26date%3D05102017%26date%3D20102017%26volume%3D19%26issue%3D20%26spage%3D5577%26epage%3D5580" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michael  Schnekenburger</span>, <span class="hlFld-ContribAuthor ">Eric  Goffin</span>, <span class="hlFld-ContribAuthor ">Jin-Young  Lee</span>, <span class="hlFld-ContribAuthor ">Jun Young  Jang</span>, <span class="hlFld-ContribAuthor ">Aloran  Mazumder</span>, <span class="hlFld-ContribAuthor ">Seungwon  Ji</span>, <span class="hlFld-ContribAuthor ">Bernard  Rogister</span>, <span class="hlFld-ContribAuthor ">Nafila  Bouider</span>, <span class="hlFld-ContribAuthor ">Florence  Lefranc</span>, <span class="hlFld-ContribAuthor ">Walter  Miklos</span>, <span class="hlFld-ContribAuthor ">Véronique  Mathieu</span>, <span class="hlFld-ContribAuthor ">Pascal  de Tullio</span>, <span class="hlFld-ContribAuthor ">Kyu-Won  Kim</span>, <span class="hlFld-ContribAuthor ">Mario  Dicato</span>, <span class="hlFld-ContribAuthor ">Walter  Berger</span>, <span class="hlFld-ContribAuthor ">Byung Woo  Han</span>, <span class="hlFld-ContribAuthor ">Robert  Kiss</span>, <span class="hlFld-ContribAuthor ">Bernard  Pirotte</span>, and <span class="hlFld-ContribAuthor ">Marc  Diederich</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery and Characterization of R/S-N-3-Cyanophenyl-N′-(6-tert-butoxycarbonylamino-3,4-dihydro-2,2-dimethyl-2H-1-benzopyran-4-yl)urea, a New Histone Deacetylase Class III Inhibitor Exerting Antiproliferative Activity against Cancer Cell Lines. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (11)
                                     , 4714-4733. <a href="https://doi.org/10.1021/acs.jmedchem.7b00533" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b00533</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b00533&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b00533%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Band%252BCharacterization%252Bof%252BR%25252FS-N-3-Cyanophenyl-N%2525E2%252580%2525B2-%2525286-tert-butoxycarbonylamino-3%25252C4-dihydro-2%25252C2-dimethyl-2H-1-benzopyran-4-yl%252529urea%25252C%252Ba%252BNew%252BHistone%252BDeacetylase%252BClass%252BIII%252BInhibitor%252BExerting%252BAntiproliferative%252BActivity%252Bagainst%252BCancer%252BCell%252BLines%26aulast%3DSchnekenburger%26aufirst%3DMichael%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D06042017%26date%3D25052017%26date%3D08062017%26date%3D05052017%26volume%3D60%26issue%3D11%26spage%3D4714%26epage%3D4733" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">C. Henrique  Alves Esteves</span>, <span class="hlFld-ContribAuthor ">Peter D.  Smith</span>, and <span class="hlFld-ContribAuthor ">Timothy J.  Donohoe</span>  . </span><span class="cited-content_cbyCitation_article-title">Catalytic Enolate Arylation with 3-Bromoindoles Allows the Formation of β-Carbolines. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2017,</strong> <em>82 </em>
                                    (8)
                                     , 4435-4443. <a href="https://doi.org/10.1021/acs.joc.7b00299" title="DOI URL">https://doi.org/10.1021/acs.joc.7b00299</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.7b00299&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.7b00299%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DCatalytic%252BEnolate%252BArylation%252Bwith%252B3-Bromoindoles%252BAllows%252Bthe%252BFormation%252Bof%252B%2525CE%2525B2-Carbolines%26aulast%3DAlves%2BEsteves%26aufirst%3DC.%2BHenrique%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D07022017%26date%3D31032017%26date%3D21042017%26volume%3D82%26issue%3D8%26spage%3D4435%26epage%3D4443" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yong  Ling</span>, <span class="hlFld-ContribAuthor ">Chenjun  Xu</span>, <span class="hlFld-ContribAuthor ">Lin  Luo</span>, <span class="hlFld-ContribAuthor ">Jingyi  Cao</span>, <span class="hlFld-ContribAuthor ">Jiao  Feng</span>, <span class="hlFld-ContribAuthor ">Yu  Xue</span>, <span class="hlFld-ContribAuthor ">Qing  Zhu</span>, <span class="hlFld-ContribAuthor ">Caoyun  Ju</span>, <span class="hlFld-ContribAuthor ">Fengzhi  Li</span>, <span class="hlFld-ContribAuthor ">Yihua  Zhang</span>, <span class="hlFld-ContribAuthor ">Yanan  Zhang</span>, and <span class="hlFld-ContribAuthor ">Xiang  Ling</span>  . </span><span class="cited-content_cbyCitation_article-title">Novel β-Carboline/Hydroxamic Acid Hybrids Targeting Both Histone Deacetylase and DNA Display High Anticancer Activity via Regulation of the p53 Signaling Pathway. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>58 </em>
                                    (23)
                                     , 9214-9227. <a href="https://doi.org/10.1021/acs.jmedchem.5b01052" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b01052</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b01052&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.5b01052%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNovel%252B%2525CE%2525B2-Carboline%25252FHydroxamic%252BAcid%252BHybrids%252BTargeting%252BBoth%252BHistone%252BDeacetylase%252Band%252BDNA%252BDisplay%252BHigh%252BAnticancer%252BActivity%252Bvia%252BRegulation%252Bof%252Bthe%252Bp53%252BSignaling%252BPathway%26aulast%3DLing%26aufirst%3DYong%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D06072015%26date%3D24112015%26date%3D10122015%26date%3D10112015%26volume%3D58%26issue%3D23%26spage%3D9214%26epage%3D9227" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shashikant U.  Dighe</span>, <span class="hlFld-ContribAuthor ">Sajid  Khan</span>, <span class="hlFld-ContribAuthor ">Isha  Soni</span>, <span class="hlFld-ContribAuthor ">Preeti  Jain</span>, <span class="hlFld-ContribAuthor ">Samriddhi  Shukla</span>, <span class="hlFld-ContribAuthor ">Rajeev  Yadav</span>, <span class="hlFld-ContribAuthor ">Pratik  Sen</span>, <span class="hlFld-ContribAuthor ">Syed M.  Meeran</span>, and <span class="hlFld-ContribAuthor ">Sanjay  Batra</span>  . </span><span class="cited-content_cbyCitation_article-title">Synthesis of β-Carboline-Based N-Heterocyclic Carbenes and Their Antiproliferative and Antimetastatic Activities against Human Breast Cancer Cells. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>58 </em>
                                    (8)
                                     , 3485-3499. <a href="https://doi.org/10.1021/acs.jmedchem.5b00016" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b00016</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b00016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.5b00016%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Bof%252B%2525CE%2525B2-Carboline-Based%252BN-Heterocyclic%252BCarbenes%252Band%252BTheir%252BAntiproliferative%252Band%252BAntimetastatic%252BActivities%252Bagainst%252BHuman%252BBreast%252BCancer%252BCells%26aulast%3DDighe%26aufirst%3DShashikant%2BU.%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D06012015%26date%3D13042015%26date%3D23042015%26date%3D02042015%26volume%3D58%26issue%3D8%26spage%3D3485%26epage%3D3499" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Véronique  Mathieu</span>, <span class="hlFld-ContribAuthor ">Emilie  Van Den Berge</span>, <span class="hlFld-ContribAuthor ">Justine  Ceusters</span>, <span class="hlFld-ContribAuthor ">Tomasz  Konopka</span>, <span class="hlFld-ContribAuthor ">Antonin  Cops</span>, <span class="hlFld-ContribAuthor ">Céline  Bruyère</span>, <span class="hlFld-ContribAuthor ">Christine  Pirker</span>, <span class="hlFld-ContribAuthor ">Walter  Berger</span>, <span class="hlFld-ContribAuthor ">Tran  Trieu-Van</span>, <span class="hlFld-ContribAuthor ">Didier  Serteyn</span>, <span class="hlFld-ContribAuthor ">Robert  Kiss</span>, and <span class="hlFld-ContribAuthor ">Raphaël  Robiette</span>  . </span><span class="cited-content_cbyCitation_article-title">New 5-Aryl-1H-imidazoles Display in Vitro Antitumor Activity against Apoptosis-Resistant Cancer Models, Including Melanomas, through Mitochondrial Targeting. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2013,</strong> <em>56 </em>
                                    (17)
                                     , 6626-6637. <a href="https://doi.org/10.1021/jm400287v" title="DOI URL">https://doi.org/10.1021/jm400287v</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm400287v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm400287v%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNew%252B5-Aryl-1H-imidazoles%252BDisplay%252Bin%252BVitro%252BAntitumor%252BActivity%252Bagainst%252BApoptosis-Resistant%252BCancer%252BModels%25252C%252BIncluding%252BMelanomas%25252C%252Bthrough%252BMitochondrial%252BTargeting%26aulast%3DMathieu%26aufirst%3DV%25C3%25A9ronique%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D24022013%26date%3D20082013%26date%3D12092013%26date%3D11072013%26volume%3D56%26issue%3D17%26spage%3D6626%26epage%3D6637" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Peng  Wang</span>, <span class="hlFld-ContribAuthor ">Esra  Karakose</span>, <span class="hlFld-ContribAuthor ">Lauryn  Choleva</span>, <span class="hlFld-ContribAuthor ">Kunal  Kumar</span>, <span class="hlFld-ContribAuthor ">Robert J.  DeVita</span>, <span class="hlFld-ContribAuthor ">Adolfo  Garcia-Ocaña</span>, <span class="hlFld-ContribAuthor ">Andrew F.  Stewart</span>. </span><span class="cited-content_cbyCitation_article-title">Human Beta Cell Regenerative Drug Therapy for Diabetes: Past Achievements and Future Challenges. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Endocrinology</span><span> <strong>2021,</strong> <em>12 </em><a href="https://doi.org/10.3389/fendo.2021.671946" title="DOI URL">https://doi.org/10.3389/fendo.2021.671946</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fendo.2021.671946&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffendo.2021.671946%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Endocrinology%26atitle%3DHuman%252BBeta%252BCell%252BRegenerative%252BDrug%252BTherapy%252Bfor%252BDiabetes%25253A%252BPast%252BAchievements%252Band%252BFuture%252BChallenges%26aulast%3DWang%26aufirst%3DPeng%26date%3D2021%26date%3D2021%26volume%3D12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Khaoula  Khezami</span>, <span class="hlFld-ContribAuthor ">Kevser  Harmandar</span>, <span class="hlFld-ContribAuthor ">Esra  Bağda</span>, <span class="hlFld-ContribAuthor ">Efkan  Bağda</span>, <span class="hlFld-ContribAuthor ">Gamze  Şahin</span>, <span class="hlFld-ContribAuthor ">Nurşen  Karakodak</span>, <span class="hlFld-ContribAuthor ">Mahmut  Durmuş</span>. </span><span class="cited-content_cbyCitation_article-title">BSA/DNA binding behavior and the photophysicochemical properties of novel water soluble zinc(II)phthalocyanines directly substituted with piperazine groups. </span><span class="cited-content_cbyCitation_journal-name">JBIC Journal of Biological Inorganic Chemistry</span><span> <strong>2021,</strong> <em>26 </em>
                                    (4)
                                     , 455-465. <a href="https://doi.org/10.1007/s00775-021-01868-6" title="DOI URL">https://doi.org/10.1007/s00775-021-01868-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00775-021-01868-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00775-021-01868-6%26sid%3Dliteratum%253Aachs%26jtitle%3DJBIC%2520Journal%2520of%2520Biological%2520Inorganic%2520Chemistry%26atitle%3DBSA%25252FDNA%252Bbinding%252Bbehavior%252Band%252Bthe%252Bphotophysicochemical%252Bproperties%252Bof%252Bnovel%252Bwater%252Bsoluble%252Bzinc%252528II%252529phthalocyanines%252Bdirectly%252Bsubstituted%252Bwith%252Bpiperazine%252Bgroups%26aulast%3DKhezami%26aufirst%3DKhaoula%26date%3D2021%26date%3D2021%26volume%3D26%26issue%3D4%26spage%3D455%26epage%3D465" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jay Prakash  Soni</span>, <span class="hlFld-ContribAuthor ">Yogesh  Yeole</span>, <span class="hlFld-ContribAuthor ">Nagula  Shankaraiah</span>. </span><span class="cited-content_cbyCitation_article-title">β-Carboline-based molecular hybrids as anticancer agents: a brief sketch. </span><span class="cited-content_cbyCitation_journal-name">RSC Medicinal Chemistry</span><span> <strong>2021,</strong> <em>12 </em>
                                    (5)
                                     , 730-750. <a href="https://doi.org/10.1039/D0MD00422G" title="DOI URL">https://doi.org/10.1039/D0MD00422G</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0MD00422G&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0MD00422G%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Medicinal%2520Chemistry%26atitle%3D%2525CE%2525B2-Carboline-based%252Bmolecular%252Bhybrids%252Bas%252Banticancer%252Bagents%25253A%252Ba%252Bbrief%252Bsketch%26aulast%3DSoni%26aufirst%3DJay%2BPrakash%26date%3D2021%26date%3D2021%26volume%3D12%26issue%3D5%26spage%3D730%26epage%3D750" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Khan Saleha  Riyazahmed</span>, <span class="hlFld-ContribAuthor ">Darshana  Bora</span>, <span class="hlFld-ContribAuthor ">Nagula  Shankaraiah</span>. </span><span class="cited-content_cbyCitation_article-title">Application of Transition Metal‐Catalyzed C−H Activation Strategies in the Synthesis and Functionalization of β‐Carbolines. </span><span class="cited-content_cbyCitation_journal-name">Asian Journal of Organic Chemistry</span><span> <strong>2021,</strong> <em>10 </em>
                                    (5)
                                     , 1050-1066. <a href="https://doi.org/10.1002/ajoc.202100055" title="DOI URL">https://doi.org/10.1002/ajoc.202100055</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ajoc.202100055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fajoc.202100055%26sid%3Dliteratum%253Aachs%26jtitle%3DAsian%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DApplication%252Bof%252BTransition%252BMetal%2525E2%252580%252590Catalyzed%252BC%2525E2%252588%252592H%252BActivation%252BStrategies%252Bin%252Bthe%252BSynthesis%252Band%252BFunctionalization%252Bof%252B%2525CE%2525B2%2525E2%252580%252590Carbolines%26aulast%3DRiyazahmed%26aufirst%3DKhan%2BSaleha%26date%3D2021%26date%3D2021%26volume%3D10%26issue%3D5%26spage%3D1050%26epage%3D1066" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ya  Chen</span>, <span class="hlFld-ContribAuthor ">Johannes  Kirchmair</span>. </span><span class="cited-content_cbyCitation_article-title">Cheminformatics in Natural Product‐based Drug Discovery. </span><span class="cited-content_cbyCitation_journal-name">Molecular Informatics</span><span> <strong>2020,</strong> <em>39 </em>
                                    (12)
                                     , 2000171. <a href="https://doi.org/10.1002/minf.202000171" title="DOI URL">https://doi.org/10.1002/minf.202000171</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/minf.202000171&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fminf.202000171%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Informatics%26atitle%3DCheminformatics%252Bin%252BNatural%252BProduct%2525E2%252580%252590based%252BDrug%252BDiscovery%26aulast%3DChen%26aufirst%3DYa%26date%3D2020%26date%3D2020%26volume%3D39%26issue%3D12%26spage%3D2000171" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Liang  Zhang</span>, <span class="hlFld-ContribAuthor ">Dengchang  Li</span>, <span class="hlFld-ContribAuthor ">Shenglan  Yu</span>. </span><span class="cited-content_cbyCitation_article-title">Pharmacological effects of harmine and its derivatives: a review. </span><span class="cited-content_cbyCitation_journal-name">Archives of Pharmacal Research</span><span> <strong>2020,</strong> <em>43 </em>
                                    (12)
                                     , 1259-1275. <a href="https://doi.org/10.1007/s12272-020-01283-6" title="DOI URL">https://doi.org/10.1007/s12272-020-01283-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s12272-020-01283-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs12272-020-01283-6%26sid%3Dliteratum%253Aachs%26jtitle%3DArchives%2520of%2520Pharmacal%2520Research%26atitle%3DPharmacological%252Beffects%252Bof%252Bharmine%252Band%252Bits%252Bderivatives%25253A%252Ba%252Breview%26aulast%3DZhang%26aufirst%3DLiang%26date%3D2020%26date%3D2020%26volume%3D43%26issue%3D12%26spage%3D1259%26epage%3D1275" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Taoufik  Akabli</span>, <span class="hlFld-ContribAuthor ">Hamid  Toufik</span>, <span class="hlFld-ContribAuthor ">Fatima  Lamchouri</span>. </span><span class="cited-content_cbyCitation_article-title">In silico
              modeling studies of
              
                N
                9
              
              -substituted harmine derivatives as potential anticancer agents: combination of ligand-based and structure-based approaches. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biomolecular Structure and Dynamics</span><span> <strong>2020,</strong> <em>12 </em>, 1-14. <a href="https://doi.org/10.1080/07391102.2020.1852118" title="DOI URL">https://doi.org/10.1080/07391102.2020.1852118</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/07391102.2020.1852118&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F07391102.2020.1852118%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biomolecular%2520Structure%2520and%2520Dynamics%26atitle%3DIn%252Bsilico%252Bmodeling%252Bstudies%252Bof%252BN%252B9%252B-substituted%252Bharmine%252Bderivatives%252Bas%252Bpotential%252Banticancer%252Bagents%25253A%252Bcombination%252Bof%252Bligand-based%252Band%252Bstructure-based%252Bapproaches%26aulast%3DAkabli%26aufirst%3DTaoufik%26date%3D2020%26date%3D2020%26volume%3D12%26spage%3D1%26epage%3D14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Marina  Marinović</span>, <span class="hlFld-ContribAuthor ">Ivana  Perković</span>, <span class="hlFld-ContribAuthor ">Diana  Fontinha</span>, <span class="hlFld-ContribAuthor ">Miguel  Prudêncio</span>, <span class="hlFld-ContribAuthor ">Jana  Held</span>, <span class="hlFld-ContribAuthor ">Lais  Pessanha de Carvalho</span>, <span class="hlFld-ContribAuthor ">Tana  Tandarić</span>, <span class="hlFld-ContribAuthor ">Robert  Vianello</span>, <span class="hlFld-ContribAuthor ">Branka  Zorc</span>, <span class="hlFld-ContribAuthor ">Zrinka  Rajić</span>. </span><span class="cited-content_cbyCitation_article-title">Novel Harmicines with Improved Potency against Plasmodium. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2020,</strong> <em>25 </em>
                                    (19)
                                     , 4376. <a href="https://doi.org/10.3390/molecules25194376" title="DOI URL">https://doi.org/10.3390/molecules25194376</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules25194376&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules25194376%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DNovel%252BHarmicines%252Bwith%252BImproved%252BPotency%252Bagainst%252BPlasmodium%26aulast%3DMarinovi%25C4%2587%26aufirst%3DMarina%26date%3D2020%26date%3D2020%26volume%3D25%26issue%3D19%26spage%3D4376" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kesari  Lakshmi Manasa</span>, <span class="hlFld-ContribAuthor ">Sowjanya  Thatikonda</span>, <span class="hlFld-ContribAuthor ">Dilep Kumar  Sigalapalli</span>, <span class="hlFld-ContribAuthor ">Arpita  Sagar</span>, <span class="hlFld-ContribAuthor ">Gaddam  Kiranmai</span>, <span class="hlFld-ContribAuthor ">Arunasree M.  Kalle</span>, <span class="hlFld-ContribAuthor ">Mallika  Alvala</span>, <span class="hlFld-ContribAuthor ">Chandraiah  Godugu</span>, <span class="hlFld-ContribAuthor ">Narayana  Nagesh</span>, <span class="hlFld-ContribAuthor ">Bathini  Nagendra Babu</span>. </span><span class="cited-content_cbyCitation_article-title">Design and synthesis of β-carboline linked aryl sulfonyl piperazine derivatives: DNA topoisomerase II inhibition with DNA binding and apoptosis inducing ability. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2020,</strong> <em>101 </em>, 103983. <a href="https://doi.org/10.1016/j.bioorg.2020.103983" title="DOI URL">https://doi.org/10.1016/j.bioorg.2020.103983</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2020.103983&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2020.103983%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DDesign%252Band%252Bsynthesis%252Bof%252B%2525CE%2525B2-carboline%252Blinked%252Baryl%252Bsulfonyl%252Bpiperazine%252Bderivatives%25253A%252BDNA%252Btopoisomerase%252BII%252Binhibition%252Bwith%252BDNA%252Bbinding%252Band%252Bapoptosis%252Binducing%252Bability%26aulast%3DLakshmi%2BManasa%26aufirst%3DKesari%26date%3D2020%26volume%3D101%26spage%3D103983" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jacopo  Boni</span>, <span class="hlFld-ContribAuthor ">Carlota  Rubio-Perez</span>, <span class="hlFld-ContribAuthor ">Nuria  López-Bigas</span>, <span class="hlFld-ContribAuthor ">Cristina  Fillat</span>, <span class="hlFld-ContribAuthor ">Susana  de la Luna</span>. </span><span class="cited-content_cbyCitation_article-title">The DYRK Family of Kinases in Cancer: Molecular Functions and Therapeutic Opportunities. </span><span class="cited-content_cbyCitation_journal-name">Cancers</span><span> <strong>2020,</strong> <em>12 </em>
                                    (8)
                                     , 2106. <a href="https://doi.org/10.3390/cancers12082106" title="DOI URL">https://doi.org/10.3390/cancers12082106</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cancers12082106&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcancers12082106%26sid%3Dliteratum%253Aachs%26jtitle%3DCancers%26atitle%3DThe%252BDYRK%252BFamily%252Bof%252BKinases%252Bin%252BCancer%25253A%252BMolecular%252BFunctions%252Band%252BTherapeutic%252BOpportunities%26aulast%3DBoni%26aufirst%3DJacopo%26date%3D2020%26date%3D2020%26volume%3D12%26issue%3D8%26spage%3D2106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Monaj  Karar</span>, <span class="hlFld-ContribAuthor ">Provakar  Paul</span>, <span class="hlFld-ContribAuthor ">Suvendu  Paul</span>, <span class="hlFld-ContribAuthor ">Basudeb  Haldar</span>, <span class="hlFld-ContribAuthor ">Arabinda  Mallick</span>, <span class="hlFld-ContribAuthor ">Tapas  Majumdar</span>. </span><span class="cited-content_cbyCitation_article-title">Dual macro-cyclic component based logic diversity. </span><span class="cited-content_cbyCitation_journal-name">Dyes and Pigments</span><span> <strong>2020,</strong> <em>174 </em>, 108060. <a href="https://doi.org/10.1016/j.dyepig.2019.108060" title="DOI URL">https://doi.org/10.1016/j.dyepig.2019.108060</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.dyepig.2019.108060&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.dyepig.2019.108060%26sid%3Dliteratum%253Aachs%26jtitle%3DDyes%2520and%2520Pigments%26atitle%3DDual%252Bmacro-cyclic%252Bcomponent%252Bbased%252Blogic%252Bdiversity%26aulast%3DKarar%26aufirst%3DMonaj%26date%3D2020%26volume%3D174%26spage%3D108060" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ivana  Perković</span>, <span class="hlFld-ContribAuthor ">Silvana  Raić-Malić</span>, <span class="hlFld-ContribAuthor ">Diana  Fontinha</span>, <span class="hlFld-ContribAuthor ">Miguel  Prudêncio</span>, <span class="hlFld-ContribAuthor ">Lais  Pessanha de Carvalho</span>, <span class="hlFld-ContribAuthor ">Jana  Held</span>, <span class="hlFld-ContribAuthor ">Tana  Tandarić</span>, <span class="hlFld-ContribAuthor ">Robert  Vianello</span>, <span class="hlFld-ContribAuthor ">Branka  Zorc</span>, <span class="hlFld-ContribAuthor ">Zrinka  Rajić</span>. </span><span class="cited-content_cbyCitation_article-title">Harmicines − harmine and cinnamic acid hybrids as novel antiplasmodial hits. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>187 </em>, 111927. <a href="https://doi.org/10.1016/j.ejmech.2019.111927" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.111927</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.111927&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.111927%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DHarmicines%2525C2%2525A0%2525E2%252588%252592%252Bharmine%252Band%252Bcinnamic%252Bacid%252Bhybrids%252Bas%252Bnovel%252Bantiplasmodial%252Bhits%26aulast%3DPerkovi%25C4%2587%26aufirst%3DIvana%26date%3D2020%26volume%3D187%26spage%3D111927" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Elise  Pierson</span>, <span class="hlFld-ContribAuthor ">Marie  Haufroid</span>, <span class="hlFld-ContribAuthor ">Tannu Priya  Gosain</span>, <span class="hlFld-ContribAuthor ">Pankaj  Chopra</span>, <span class="hlFld-ContribAuthor ">Ramandeep  Singh</span>, <span class="hlFld-ContribAuthor ">Johan  Wouters</span>. </span><span class="cited-content_cbyCitation_article-title">Identification and Repurposing of Trisubstituted Harmine Derivatives as Novel Inhibitors of Mycobacterium tuberculosis Phosphoserine Phosphatase. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2020,</strong> <em>25 </em>
                                    (2)
                                     , 415. <a href="https://doi.org/10.3390/molecules25020415" title="DOI URL">https://doi.org/10.3390/molecules25020415</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules25020415&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules25020415%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DIdentification%252Band%252BRepurposing%252Bof%252BTrisubstituted%252BHarmine%252BDerivatives%252Bas%252BNovel%252BInhibitors%252Bof%252BMycobacterium%252Btuberculosis%252BPhosphoserine%252BPhosphatase%26aulast%3DPierson%26aufirst%3DElise%26date%3D2020%26date%3D2020%26volume%3D25%26issue%3D2%26spage%3D415" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fernanda I.  Saldívar-González</span>, <span class="hlFld-ContribAuthor ">B. Angélica  Pilón-Jiménez</span>, <span class="hlFld-ContribAuthor ">José L.  Medina-Franco</span>. </span><span class="cited-content_cbyCitation_article-title">Chemical space of naturally occurring compounds. </span><span class="cited-content_cbyCitation_journal-name">Physical Sciences Reviews</span><span> <strong>2019,</strong> <em>4 </em>
                                    (5)
                                     <a href="https://doi.org/10.1515/psr-2018-0103" title="DOI URL">https://doi.org/10.1515/psr-2018-0103</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1515/psr-2018-0103&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1515%2Fpsr-2018-0103%26sid%3Dliteratum%253Aachs%26jtitle%3DPhysical%2520Sciences%2520Reviews%26atitle%3DChemical%252Bspace%252Bof%252Bnaturally%252Boccurring%252Bcompounds%26aulast%3DSald%25C3%25ADvar-Gonz%25C3%25A1lez%26aufirst%3DFernanda%2BI.%26date%3D2019%26volume%3D4%26issue%3D5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sébastien  Marx</span>, <span class="hlFld-ContribAuthor ">Laurie  Bodart</span>, <span class="hlFld-ContribAuthor ">Nikolay  Tumanov</span>, <span class="hlFld-ContribAuthor ">Johan  Wouters</span>. </span><span class="cited-content_cbyCitation_article-title">Design and Synthesis of a New Soluble Natural β-Carboline Derivative for Preclinical Study by Intravenous Injection. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2019,</strong> <em>20 </em>
                                    (6)
                                     , 1491. <a href="https://doi.org/10.3390/ijms20061491" title="DOI URL">https://doi.org/10.3390/ijms20061491</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms20061491&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms20061491%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DDesign%252Band%252BSynthesis%252Bof%252Ba%252BNew%252BSoluble%252BNatural%252B%2525CE%2525B2-Carboline%252BDerivative%252Bfor%252BPreclinical%252BStudy%252Bby%252BIntravenous%252BInjection%26aulast%3DMarx%26aufirst%3DS%25C3%25A9bastien%26date%3D2019%26date%3D2019%26volume%3D20%26issue%3D6%26spage%3D1491" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">T.  Akabli</span>, <span class="hlFld-ContribAuthor ">H.  Toufik</span>, <span class="hlFld-ContribAuthor ">A.  Yasri</span>, <span class="hlFld-ContribAuthor ">H.  Bih</span>, <span class="hlFld-ContribAuthor ">F.  Lamchouri</span>. </span><span class="cited-content_cbyCitation_article-title">Combining ligand-based and structure-based drug design approaches to study the structure-activity relationships of a β-carboline derivative series. </span><span class="cited-content_cbyCitation_journal-name">Structural Chemistry</span><span> <strong>2018,</strong> <em>29 </em>
                                    (6)
                                     , 1637-1645. <a href="https://doi.org/10.1007/s11224-018-1141-1" title="DOI URL">https://doi.org/10.1007/s11224-018-1141-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11224-018-1141-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11224-018-1141-1%26sid%3Dliteratum%253Aachs%26jtitle%3DStructural%2520Chemistry%26atitle%3DCombining%252Bligand-based%252Band%252Bstructure-based%252Bdrug%252Bdesign%252Bapproaches%252Bto%252Bstudy%252Bthe%252Bstructure-activity%252Brelationships%252Bof%252Ba%252B%2525CE%2525B2-carboline%252Bderivative%252Bseries%26aulast%3DAkabli%26aufirst%3DT.%26date%3D2018%26date%3D2018%26volume%3D29%26issue%3D6%26spage%3D1637%26epage%3D1645" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ankita  Pathak</span>, <span class="hlFld-ContribAuthor ">Ankit  Rohilla</span>, <span class="hlFld-ContribAuthor ">Tanya  Gupta</span>, <span class="hlFld-ContribAuthor ">Md Jawaid  Akhtar</span>, <span class="hlFld-ContribAuthor ">Md Rafi  Haider</span>, <span class="hlFld-ContribAuthor ">Kalicharan  Sharma</span>, <span class="hlFld-ContribAuthor ">Kashif  Haider</span>, <span class="hlFld-ContribAuthor ">M. Shahar  Yar</span>. </span><span class="cited-content_cbyCitation_article-title">DYRK1A kinase inhibition with emphasis on neurodegeneration: A comprehensive evolution story-cum-perspective. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>158 </em>, 559-592. <a href="https://doi.org/10.1016/j.ejmech.2018.08.093" title="DOI URL">https://doi.org/10.1016/j.ejmech.2018.08.093</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2018.08.093&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2018.08.093%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDYRK1A%252Bkinase%252Binhibition%252Bwith%252Bemphasis%252Bon%252Bneurodegeneration%25253A%252BA%252Bcomprehensive%252Bevolution%252Bstory-cum-perspective%26aulast%3DPathak%26aufirst%3DAnkita%26date%3D2018%26volume%3D158%26spage%3D559%26epage%3D592" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Saqlain  Haider</span>, <span class="hlFld-ContribAuthor ">Manal  Alhusban</span>, <span class="hlFld-ContribAuthor ">Narayan D  Chaurasiya</span>, <span class="hlFld-ContribAuthor ">Babu L  Tekwani</span>, <span class="hlFld-ContribAuthor ">Amar G  Chittiboyina</span>, <span class="hlFld-ContribAuthor ">Ikhlas A  Khan</span>. </span><span class="cited-content_cbyCitation_article-title">Isoform selectivity of harmine-conjugated 1,2,3-triazoles against human monoamine oxidase. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2018,</strong> <em>10 </em>
                                    (12)
                                     , 1435-1448. <a href="https://doi.org/10.4155/fmc-2018-0006" title="DOI URL">https://doi.org/10.4155/fmc-2018-0006</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc-2018-0006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc-2018-0006%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DIsoform%252Bselectivity%252Bof%252Bharmine-conjugated%252B1%25252C2%25252C3-triazoles%252Bagainst%252Bhuman%252Bmonoamine%252Boxidase%26aulast%3DHaider%26aufirst%3DSaqlain%26date%3D2018%26volume%3D10%26issue%3D12%26spage%3D1435%26epage%3D1448" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yong  Li</span>, <span class="hlFld-ContribAuthor ">Wei  Yan</span>, <span class="hlFld-ContribAuthor ">Jianhong  Yang</span>, <span class="hlFld-ContribAuthor ">Zhuang  Yang</span>, <span class="hlFld-ContribAuthor ">Mengshi  Hu</span>, <span class="hlFld-ContribAuthor ">Peng  Bai</span>, <span class="hlFld-ContribAuthor ">Minghai  Tang</span>, <span class="hlFld-ContribAuthor ">Lijuan  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of novel β-carboline/acylhydrazone hybrids as potent antitumor agents and overcome drug resistance. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>152 </em>, 516-526. <a href="https://doi.org/10.1016/j.ejmech.2018.05.003" title="DOI URL">https://doi.org/10.1016/j.ejmech.2018.05.003</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2018.05.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2018.05.003%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Bnovel%252B%2525CE%2525B2-carboline%25252Facylhydrazone%252Bhybrids%252Bas%252Bpotent%252Bantitumor%252Bagents%252Band%252Bovercome%252Bdrug%252Bresistance%26aulast%3DLi%26aufirst%3DYong%26date%3D2018%26volume%3D152%26spage%3D516%26epage%3D526" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xinran  Geng</span>, <span class="hlFld-ContribAuthor ">Yichang  Ren</span>, <span class="hlFld-ContribAuthor ">Fangfang  Wang</span>, <span class="hlFld-ContribAuthor ">Danmei  Tian</span>, <span class="hlFld-ContribAuthor ">Xinsheng  Yao</span>, <span class="hlFld-ContribAuthor ">Youwei  Zhang</span>, <span class="hlFld-ContribAuthor ">Jinshan  Tang</span>. </span><span class="cited-content_cbyCitation_article-title">Harmines inhibit cancer cell growth through coordinated activation of apoptosis and inhibition of autophagy. </span><span class="cited-content_cbyCitation_journal-name">Biochemical and Biophysical Research Communications</span><span> <strong>2018,</strong> <em>498 </em>
                                    (1)
                                     , 99-104. <a href="https://doi.org/10.1016/j.bbrc.2018.02.205" title="DOI URL">https://doi.org/10.1016/j.bbrc.2018.02.205</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bbrc.2018.02.205&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bbrc.2018.02.205%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemical%2520and%2520Biophysical%2520Research%2520Communications%26atitle%3DHarmines%252Binhibit%252Bcancer%252Bcell%252Bgrowth%252Bthrough%252Bcoordinated%252Bactivation%252Bof%252Bapoptosis%252Band%252Binhibition%252Bof%252Bautophagy%26aulast%3DGeng%26aufirst%3DXinran%26date%3D2018%26volume%3D498%26issue%3D1%26spage%3D99%26epage%3D104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nisha  Devi</span>, <span class="hlFld-ContribAuthor ">Sunit  Kumar</span>, <span class="hlFld-ContribAuthor ">Satyendra Kumar  Pandey</span>, <span class="hlFld-ContribAuthor ">Virender  Singh</span>. </span><span class="cited-content_cbyCitation_article-title">1(3)-Formyl-β-carbolines: Potential Aldo-X Precursors for the Synthesis of β-Carboline-Based Molecular Architectures. </span><span class="cited-content_cbyCitation_journal-name">Asian Journal of Organic Chemistry</span><span> <strong>2018,</strong> <em>7 </em>
                                    (1)
                                     , 6-36. <a href="https://doi.org/10.1002/ajoc.201700477" title="DOI URL">https://doi.org/10.1002/ajoc.201700477</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ajoc.201700477&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fajoc.201700477%26sid%3Dliteratum%253Aachs%26jtitle%3DAsian%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3D1%2525283%252529-Formyl-%2525CE%2525B2-carbolines%25253A%252BPotential%252BAldo-X%252BPrecursors%252Bfor%252Bthe%252BSynthesis%252Bof%252B%2525CE%2525B2-Carboline-Based%252BMolecular%252BArchitectures%26aulast%3DDevi%26aufirst%3DNisha%26date%3D2018%26date%3D2017%26volume%3D7%26issue%3D1%26spage%3D6%26epage%3D36" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Monaj  Karar</span>, <span class="hlFld-ContribAuthor ">Suvendu  Paul</span>, <span class="hlFld-ContribAuthor ">Arabinda  Mallick</span>, <span class="hlFld-ContribAuthor ">Tapas  Majumdar</span>. </span><span class="cited-content_cbyCitation_article-title">Shipment of a photodynamic therapy agent into model membrane and its controlled release: A photophysical approach. </span><span class="cited-content_cbyCitation_journal-name">Chemistry and Physics of Lipids</span><span> <strong>2018,</strong> <em>210 </em>, 122-128. <a href="https://doi.org/10.1016/j.chemphyslip.2017.10.005" title="DOI URL">https://doi.org/10.1016/j.chemphyslip.2017.10.005</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.chemphyslip.2017.10.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.chemphyslip.2017.10.005%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520and%2520Physics%2520of%2520Lipids%26atitle%3DShipment%252Bof%252Ba%252Bphotodynamic%252Btherapy%252Bagent%252Binto%252Bmodel%252Bmembrane%252Band%252Bits%252Bcontrolled%252Brelease%25253A%252BA%252Bphotophysical%252Bapproach%26aulast%3DKarar%26aufirst%3DMonaj%26date%3D2018%26volume%3D210%26spage%3D122%26epage%3D128" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ramya  Tokala</span>, <span class="hlFld-ContribAuthor ">Sowjanya  Thatikonda</span>, <span class="hlFld-ContribAuthor ">Sravani  Sana</span>, <span class="hlFld-ContribAuthor ">Phanindranath  Regur</span>, <span class="hlFld-ContribAuthor ">Chandraiah  Godugu</span>, <span class="hlFld-ContribAuthor ">Nagula  Shankaraiah</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and
              in vitro
              cytotoxicity evaluation of β-carboline-linked 2,4-thiazolidinedione hybrids: potential DNA intercalation and apoptosis-inducing studies. </span><span class="cited-content_cbyCitation_journal-name">New Journal of Chemistry</span><span> <strong>2018,</strong> <em>42 </em>
                                    (19)
                                     , 16226-16236. <a href="https://doi.org/10.1039/C8NJ03248C" title="DOI URL">https://doi.org/10.1039/C8NJ03248C</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C8NJ03248C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC8NJ03248C%26sid%3Dliteratum%253Aachs%26jtitle%3DNew%2520Journal%2520of%2520Chemistry%26atitle%3DSynthesis%252Band%252Bin%252Bvitro%252Bcytotoxicity%252Bevaluation%252Bof%252B%2525CE%2525B2-carboline-linked%252B2%25252C4-thiazolidinedione%252Bhybrids%25253A%252Bpotential%252BDNA%252Bintercalation%252Band%252Bapoptosis-inducing%252Bstudies%26aulast%3DTokala%26aufirst%3DRamya%26date%3D2018%26date%3D2018%26volume%3D42%26issue%3D19%26spage%3D16226%26epage%3D16236" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhuo  Wang</span>, <span class="hlFld-ContribAuthor ">Tongyu  Li</span>, <span class="hlFld-ContribAuthor ">Siyang  Xing</span>, <span class="hlFld-ContribAuthor ">Bolin  Zhu</span>. </span><span class="cited-content_cbyCitation_article-title">Facile and practical synthesis of β-carbolinium salts and γ-carbolinium salts
              via
              rhodium-catalyzed three-component reactions. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2018,</strong> <em>16 </em>
                                    (27)
                                     , 5021-5026. <a href="https://doi.org/10.1039/C8OB01182F" title="DOI URL">https://doi.org/10.1039/C8OB01182F</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C8OB01182F&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC8OB01182F%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DFacile%252Band%252Bpractical%252Bsynthesis%252Bof%252B%2525CE%2525B2-carbolinium%252Bsalts%252Band%252B%2525CE%2525B3-carbolinium%252Bsalts%252Bvia%252Brhodium-catalyzed%252Bthree-component%252Breactions%26aulast%3DWang%26aufirst%3DZhuo%26date%3D2018%26date%3D2018%26volume%3D16%26issue%3D27%26spage%3D5021%26epage%3D5026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Maria Letizia  Ciavatta</span>, <span class="hlFld-ContribAuthor ">Florence  Lefranc</span>, <span class="hlFld-ContribAuthor ">Marianna  Carbone</span>, <span class="hlFld-ContribAuthor ">Ernesto  Mollo</span>, <span class="hlFld-ContribAuthor ">Margherita  Gavagnin</span>, <span class="hlFld-ContribAuthor ">Tania  Betancourt</span>, <span class="hlFld-ContribAuthor ">Ramesh  Dasari</span>, <span class="hlFld-ContribAuthor ">Alexander  Kornienko</span>, <span class="hlFld-ContribAuthor ">Robert  Kiss</span>. </span><span class="cited-content_cbyCitation_article-title">Marine Mollusk-Derived Agents with Antiproliferative Activity as Promising Anticancer Agents to Overcome Chemotherapy Resistance. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Research Reviews</span><span> <strong>2017,</strong> <em>37 </em>
                                    (4)
                                     , 702-801. <a href="https://doi.org/10.1002/med.21423" title="DOI URL">https://doi.org/10.1002/med.21423</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/med.21423&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fmed.21423%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Research%2520Reviews%26atitle%3DMarine%252BMollusk-Derived%252BAgents%252Bwith%252BAntiproliferative%252BActivity%252Bas%252BPromising%252BAnticancer%252BAgents%252Bto%252BOvercome%252BChemotherapy%252BResistance%26aulast%3DCiavatta%26aufirst%3DMaria%2BLetizia%26date%3D2017%26date%3D2016%26volume%3D37%26issue%3D4%26spage%3D702%26epage%3D801" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Annelise  Carvalho</span>, <span class="hlFld-ContribAuthor ">Jennifer  Chu</span>, <span class="hlFld-ContribAuthor ">Céline  Meinguet</span>, <span class="hlFld-ContribAuthor ">Robert  Kiss</span>, <span class="hlFld-ContribAuthor ">Guy  Vandenbussche</span>, <span class="hlFld-ContribAuthor ">Bernard  Masereel</span>, <span class="hlFld-ContribAuthor ">Johan  Wouters</span>, <span class="hlFld-ContribAuthor ">Alexander  Kornienko</span>, <span class="hlFld-ContribAuthor ">Jerry  Pelletier</span>, <span class="hlFld-ContribAuthor ">Véronique  Mathieu</span>. </span><span class="cited-content_cbyCitation_article-title">A harmine-derived beta-carboline displays anti-cancer effects in vitro by targeting protein synthesis. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Pharmacology</span><span> <strong>2017,</strong> <em>805 </em>, 25-35. <a href="https://doi.org/10.1016/j.ejphar.2017.03.034" title="DOI URL">https://doi.org/10.1016/j.ejphar.2017.03.034</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejphar.2017.03.034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejphar.2017.03.034%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Pharmacology%26atitle%3DA%252Bharmine-derived%252Bbeta-carboline%252Bdisplays%252Banti-cancer%252Beffects%252Bin%252Bvitro%252Bby%252Btargeting%252Bprotein%252Bsynthesis%26aulast%3DCarvalho%26aufirst%3DAnnelise%26date%3D2017%26volume%3D805%26spage%3D25%26epage%3D35" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shuping  Li</span>, <span class="hlFld-ContribAuthor ">Xuemei  Cheng</span>, <span class="hlFld-ContribAuthor ">Changhong  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">A review on traditional uses, phytochemistry, pharmacology, pharmacokinetics and toxicology of the genus Peganum. </span><span class="cited-content_cbyCitation_journal-name">Journal of Ethnopharmacology</span><span> <strong>2017,</strong> <em>203 </em>, 127-162. <a href="https://doi.org/10.1016/j.jep.2017.03.049" title="DOI URL">https://doi.org/10.1016/j.jep.2017.03.049</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jep.2017.03.049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jep.2017.03.049%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Ethnopharmacology%26atitle%3DA%252Breview%252Bon%252Btraditional%252Buses%25252C%252Bphytochemistry%25252C%252Bpharmacology%25252C%252Bpharmacokinetics%252Band%252Btoxicology%252Bof%252Bthe%252Bgenus%252BPeganum%26aulast%3DLi%26aufirst%3DShuping%26date%3D2017%26volume%3D203%26spage%3D127%26epage%3D162" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dharmender  Singh</span>, <span class="hlFld-ContribAuthor ">Vipin  Kumar</span>, <span class="hlFld-ContribAuthor ">Nisha  Devi</span>, <span class="hlFld-ContribAuthor ">Chandi C.  Malakar</span>, <span class="hlFld-ContribAuthor ">Ravi  Shankar</span>, <span class="hlFld-ContribAuthor ">Virender  Singh</span>. </span><span class="cited-content_cbyCitation_article-title">Metal-free Decarboxylative Amination: An Alternative Approach Towards Regioselective Synthesis of β-Carboline
              N
              -fused Imidazoles. </span><span class="cited-content_cbyCitation_journal-name">Advanced Synthesis & Catalysis</span><span> <strong>2017,</strong> <em>359 </em>
                                    (7)
                                     , 1213-1226. <a href="https://doi.org/10.1002/adsc.201600970" title="DOI URL">https://doi.org/10.1002/adsc.201600970</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/adsc.201600970&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fadsc.201600970%26sid%3Dliteratum%253Aachs%26jtitle%3DAdvanced%2520Synthesis%2520%2526%2520Catalysis%26atitle%3DMetal-free%252BDecarboxylative%252BAmination%25253A%252BAn%252BAlternative%252BApproach%252BTowards%252BRegioselective%252BSynthesis%252Bof%252B%2525CE%2525B2-Carboline%252BN%252B-fused%252BImidazoles%26aulast%3DSingh%26aufirst%3DDharmender%26date%3D2017%26date%3D2017%26volume%3D359%26issue%3D7%26spage%3D1213%26epage%3D1226" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Monaj  Karar</span>, <span class="hlFld-ContribAuthor ">Suvendu  Paul</span>, <span class="hlFld-ContribAuthor ">Arabinda  Mallick</span>, <span class="hlFld-ContribAuthor ">Tapas  Majumdar</span>. </span><span class="cited-content_cbyCitation_article-title">Interaction Behavior between Active Hydrogen Bond Donor-Acceptors as a Binding Decoration for Anion Recognition: Experimental Observation and Theoretical Validation. </span><span class="cited-content_cbyCitation_journal-name">ChemistrySelect</span><span> <strong>2017,</strong> <em>2 </em>
                                    (9)
                                     , 2815-2821. <a href="https://doi.org/10.1002/slct.201602045" title="DOI URL">https://doi.org/10.1002/slct.201602045</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/slct.201602045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fslct.201602045%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistrySelect%26atitle%3DInteraction%252BBehavior%252Bbetween%252BActive%252BHydrogen%252BBond%252BDonor-Acceptors%252Bas%252Ba%252BBinding%252BDecoration%252Bfor%252BAnion%252BRecognition%25253A%252BExperimental%252BObservation%252Band%252BTheoretical%252BValidation%26aulast%3DKarar%26aufirst%3DMonaj%26date%3D2017%26date%3D2017%26volume%3D2%26issue%3D9%26spage%3D2815%26epage%3D2821" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">P.O.  Venkataramana Reddy</span>, <span class="hlFld-ContribAuthor ">Shriprada  Mishra</span>, <span class="hlFld-ContribAuthor ">Mukund P.  Tantak</span>, <span class="hlFld-ContribAuthor ">Kumar  Nikhil</span>, <span class="hlFld-ContribAuthor ">Rachna  Sadana</span>, <span class="hlFld-ContribAuthor ">Kavita  Shah</span>, <span class="hlFld-ContribAuthor ">Dalip  Kumar</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and in vitro cytotoxicity studies of novel β -carbolinium bromides. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2017,</strong> <em>27 </em>
                                    (6)
                                     , 1379-1384. <a href="https://doi.org/10.1016/j.bmcl.2017.02.010" title="DOI URL">https://doi.org/10.1016/j.bmcl.2017.02.010</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2017.02.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2017.02.010%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bin%252Bvitro%252Bcytotoxicity%252Bstudies%252Bof%252Bnovel%252B%2525CE%2525B2%252B-carbolinium%252Bbromides%26aulast%3DVenkataramana%2BReddy%26aufirst%3DP.O.%26date%3D2017%26volume%3D27%26issue%3D6%26spage%3D1379%26epage%3D1384" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Marie  Lawson</span>, <span class="hlFld-ContribAuthor ">Jordi  Rodrigo</span>, <span class="hlFld-ContribAuthor ">Blandine  Baratte</span>, <span class="hlFld-ContribAuthor ">Thomas  Robert</span>, <span class="hlFld-ContribAuthor ">Claire  Delehouzé</span>, <span class="hlFld-ContribAuthor ">Olivier  Lozach</span>, <span class="hlFld-ContribAuthor ">Sandrine  Ruchaud</span>, <span class="hlFld-ContribAuthor ">Stéphane  Bach</span>, <span class="hlFld-ContribAuthor ">Jean-Daniel  Brion</span>, <span class="hlFld-ContribAuthor ">Mouad  Alami</span>, <span class="hlFld-ContribAuthor ">Abdallah  Hamze</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, biological evaluation and molecular modeling studies of imidazo[1,2- a ]pyridines derivatives as protein kinase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>123 </em>, 105-114. <a href="https://doi.org/10.1016/j.ejmech.2016.07.040" title="DOI URL">https://doi.org/10.1016/j.ejmech.2016.07.040</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2016.07.040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2016.07.040%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%25252C%252Bbiological%252Bevaluation%252Band%252Bmolecular%252Bmodeling%252Bstudies%252Bof%252Bimidazo%25255B1%25252C2-%252Ba%252B%25255Dpyridines%252Bderivatives%252Bas%252Bprotein%252Bkinase%252Binhibitors%26aulast%3DLawson%26aufirst%3DMarie%26date%3D2016%26volume%3D123%26spage%3D105%26epage%3D114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Insaf  Filali</span>, <span class="hlFld-ContribAuthor ">Mohamed Amine  Belkacem</span>, <span class="hlFld-ContribAuthor ">Aymen  Ben Nejma</span>, <span class="hlFld-ContribAuthor ">Jean Pierre  Souchard</span>, <span class="hlFld-ContribAuthor ">Hichem  Ben Jannet</span>, <span class="hlFld-ContribAuthor ">Jalloul  Bouajila</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, cytotoxic, anti-lipoxygenase and anti-acetylcholinesterase capacities of novel derivatives from harmine. </span><span class="cited-content_cbyCitation_journal-name">Journal of Enzyme Inhibition and Medicinal Chemistry</span><span> <strong>2016,</strong> <em>31 </em>
                                    (sup1)
                                     , 23-33. <a href="https://doi.org/10.3109/14756366.2016.1163342" title="DOI URL">https://doi.org/10.3109/14756366.2016.1163342</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3109/14756366.2016.1163342&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3109%2F14756366.2016.1163342%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Enzyme%2520Inhibition%2520and%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%25252C%252Bcytotoxic%25252C%252Banti-lipoxygenase%252Band%252Banti-acetylcholinesterase%252Bcapacities%252Bof%252Bnovel%252Bderivatives%252Bfrom%252Bharmine%26aulast%3DFilali%26aufirst%3DInsaf%26date%3D2016%26date%3D2016%26volume%3D31%26issue%3Dsup1%26spage%3D23%26epage%3D33" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hongtao  Du</span>, <span class="hlFld-ContribAuthor ">Shan  Tian</span>, <span class="hlFld-ContribAuthor ">Juncheng  Chen</span>, <span class="hlFld-ContribAuthor ">Hongling  Gu</span>, <span class="hlFld-ContribAuthor ">Na  Li</span>, <span class="hlFld-ContribAuthor ">Junru  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and biological evaluation of N9-substituted harmine derivatives as potential anticancer agents. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2016,</strong> <em>26 </em>
                                    (16)
                                     , 4015-4019. <a href="https://doi.org/10.1016/j.bmcl.2016.06.087" title="DOI URL">https://doi.org/10.1016/j.bmcl.2016.06.087</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2016.06.087&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2016.06.087%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252BN9-substituted%252Bharmine%252Bderivatives%252Bas%252Bpotential%252Banticancer%252Bagents%26aulast%3DDu%26aufirst%3DHongtao%26date%3D2016%26volume%3D26%26issue%3D16%26spage%3D4015%26epage%3D4019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Solida  Long</span>, <span class="hlFld-ContribAuthor ">Emília  Sousa</span>, <span class="hlFld-ContribAuthor ">Anake  Kijjoa</span>, <span class="hlFld-ContribAuthor ">Madalena  Pinto</span>. </span><span class="cited-content_cbyCitation_article-title">Marine Natural Products as Models to Circumvent Multidrug Resistance. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2016,</strong> <em>21 </em>
                                    (7)
                                     , 892. <a href="https://doi.org/10.3390/molecules21070892" title="DOI URL">https://doi.org/10.3390/molecules21070892</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules21070892&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules21070892%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DMarine%252BNatural%252BProducts%252Bas%252BModels%252Bto%252BCircumvent%252BMultidrug%252BResistance%26aulast%3DLong%26aufirst%3DSolida%26date%3D2016%26date%3D2016%26volume%3D21%26issue%3D7%26spage%3D892" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hongtao  Du</span>, <span class="hlFld-ContribAuthor ">Hongling  Gu</span>, <span class="hlFld-ContribAuthor ">Na  Li</span>, <span class="hlFld-ContribAuthor ">Junru  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and biological evaluation of bivalent β-carbolines as potential anticancer agents. </span><span class="cited-content_cbyCitation_journal-name">MedChemComm</span><span> <strong>2016,</strong> <em>7 </em>
                                    (4)
                                     , 636-645. <a href="https://doi.org/10.1039/C5MD00581G" title="DOI URL">https://doi.org/10.1039/C5MD00581G</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C5MD00581G&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC5MD00581G%26sid%3Dliteratum%253Aachs%26jtitle%3DMedChemComm%26atitle%3DSynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bbivalent%252B%2525CE%2525B2-carbolines%252Bas%252Bpotential%252Banticancer%252Bagents%26aulast%3DDu%26aufirst%3DHongtao%26date%3D2016%26date%3D2016%26volume%3D7%26issue%3D4%26spage%3D636%26epage%3D645" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Véronique  Mathieu</span>, <span class="hlFld-ContribAuthor ">Aurélie  Chantôme</span>, <span class="hlFld-ContribAuthor ">Florence  Lefranc</span>, <span class="hlFld-ContribAuthor ">Alessio  Cimmino</span>, <span class="hlFld-ContribAuthor ">Walter  Miklos</span>, <span class="hlFld-ContribAuthor ">Verena  Paulitschke</span>, <span class="hlFld-ContribAuthor ">Thomas  Mohr</span>, <span class="hlFld-ContribAuthor ">Lucia  Maddau</span>, <span class="hlFld-ContribAuthor ">Alexander  Kornienko</span>, <span class="hlFld-ContribAuthor ">Walter  Berger</span>, <span class="hlFld-ContribAuthor ">Christophe  Vandier</span>, <span class="hlFld-ContribAuthor ">Antonio  Evidente</span>, <span class="hlFld-ContribAuthor ">Eric  Delpire</span>, <span class="hlFld-ContribAuthor ">Robert  Kiss</span>. </span><span class="cited-content_cbyCitation_article-title">Sphaeropsidin A shows promising activity against drug-resistant cancer cells by targeting regulatory volume increase. </span><span class="cited-content_cbyCitation_journal-name">Cellular and Molecular Life Sciences</span><span> <strong>2015,</strong> <em>72 </em>
                                    (19)
                                     , 3731-3746. <a href="https://doi.org/10.1007/s00018-015-1902-6" title="DOI URL">https://doi.org/10.1007/s00018-015-1902-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00018-015-1902-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00018-015-1902-6%26sid%3Dliteratum%253Aachs%26jtitle%3DCellular%2520and%2520Molecular%2520Life%2520Sciences%26atitle%3DSphaeropsidin%252BA%252Bshows%252Bpromising%252Bactivity%252Bagainst%252Bdrug-resistant%252Bcancer%252Bcells%252Bby%252Btargeting%252Bregulatory%252Bvolume%252Bincrease%26aulast%3DMathieu%26aufirst%3DV%25C3%25A9ronique%26date%3D2015%26date%3D2015%26volume%3D72%26issue%3D19%26spage%3D3731%26epage%3D3746" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Abdolali  Alizadeh</span>, <span class="hlFld-ContribAuthor ">Fahimeh  Bayat</span>, <span class="hlFld-ContribAuthor ">Leila  Moafi</span>, <span class="hlFld-ContribAuthor ">Long-Guan  Zhu</span>. </span><span class="cited-content_cbyCitation_article-title">5-Hydroxybenzo[g]indoles formation from oxa-aza[3.3.3]propellanes. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2015,</strong> <em>71 </em>
                                    (42)
                                     , 8150-8154. <a href="https://doi.org/10.1016/j.tet.2015.08.035" title="DOI URL">https://doi.org/10.1016/j.tet.2015.08.035</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2015.08.035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2015.08.035%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3D5-Hydroxybenzo%25255Bg%25255Dindoles%252Bformation%252Bfrom%252Boxa-aza%25255B3.3.3%25255Dpropellanes%26aulast%3DAlizadeh%26aufirst%3DAbdolali%26date%3D2015%26volume%3D71%26issue%3D42%26spage%3D8150%26epage%3D8154" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Céline  Meinguet</span>, <span class="hlFld-ContribAuthor ">Bernard  Masereel</span>, <span class="hlFld-ContribAuthor ">Johan  Wouters</span>. </span><span class="cited-content_cbyCitation_article-title">Preparation and characterization of a new harmine-based antiproliferative compound in complex with cyclodextrin: Increasing solubility while maintaining biological activity. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Pharmaceutical Sciences</span><span> <strong>2015,</strong> <em>77 </em>, 135-140. <a href="https://doi.org/10.1016/j.ejps.2015.06.010" title="DOI URL">https://doi.org/10.1016/j.ejps.2015.06.010</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejps.2015.06.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejps.2015.06.010%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Pharmaceutical%2520Sciences%26atitle%3DPreparation%252Band%252Bcharacterization%252Bof%252Ba%252Bnew%252Bharmine-based%252Bantiproliferative%252Bcompound%252Bin%252Bcomplex%252Bwith%252Bcyclodextrin%25253A%252BIncreasing%252Bsolubility%252Bwhile%252Bmaintaining%252Bbiological%252Bactivity%26aulast%3DMeinguet%26aufirst%3DC%25C3%25A9line%26date%3D2015%26volume%3D77%26spage%3D135%26epage%3D140" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Diaa T.A.  Youssef</span>, <span class="hlFld-ContribAuthor ">Gamal A.  Mohamed</span>, <span class="hlFld-ContribAuthor ">Lamiaa A.  Shaala</span>, <span class="hlFld-ContribAuthor ">Jihan M.  Badr</span>, <span class="hlFld-ContribAuthor ">Faida H.  Bamanie</span>, <span class="hlFld-ContribAuthor ">Sabrin R.M.  Ibrahim</span>. </span><span class="cited-content_cbyCitation_article-title">New purine alkaloids from the Red Sea marine tunicate Symplegma rubra. </span><span class="cited-content_cbyCitation_journal-name">Phytochemistry Letters</span><span> <strong>2015,</strong> <em>13 </em>, 212-217. <a href="https://doi.org/10.1016/j.phytol.2015.06.012" title="DOI URL">https://doi.org/10.1016/j.phytol.2015.06.012</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.phytol.2015.06.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.phytol.2015.06.012%26sid%3Dliteratum%253Aachs%26jtitle%3DPhytochemistry%2520Letters%26atitle%3DNew%252Bpurine%252Balkaloids%252Bfrom%252Bthe%252BRed%252BSea%252Bmarine%252Btunicate%252BSymplegma%252Brubra%26aulast%3DYoussef%26aufirst%3DDiaa%2BT.A.%26date%3D2015%26volume%3D13%26spage%3D212%26epage%3D217" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Insaf  Filali</span>, <span class="hlFld-ContribAuthor ">Jalloul  Bouajila</span>, <span class="hlFld-ContribAuthor ">Mansour  Znati</span>, <span class="hlFld-ContribAuthor ">Fatima  Bousejra-El Garah</span>, <span class="hlFld-ContribAuthor ">Hichem  Ben Jannet</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of new isoxazoline derivatives from harmine and evaluation of their anti-Alzheimer, anti-cancer and anti-inflammatory activities. </span><span class="cited-content_cbyCitation_journal-name">Journal of Enzyme Inhibition and Medicinal Chemistry</span><span> <strong>2015,</strong> <em>30 </em>
                                    (3)
                                     , 371-376. <a href="https://doi.org/10.3109/14756366.2014.940932" title="DOI URL">https://doi.org/10.3109/14756366.2014.940932</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3109/14756366.2014.940932&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3109%2F14756366.2014.940932%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Enzyme%2520Inhibition%2520and%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Bof%252Bnew%252Bisoxazoline%252Bderivatives%252Bfrom%252Bharmine%252Band%252Bevaluation%252Bof%252Btheir%252Banti-Alzheimer%25252C%252Banti-cancer%252Band%252Banti-inflammatory%252Bactivities%26aulast%3DFilali%26aufirst%3DInsaf%26date%3D2015%26date%3D2014%26volume%3D30%26issue%3D3%26spage%3D371%26epage%3D376" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Siwen  Li</span>, <span class="hlFld-ContribAuthor ">Aqin  Wang</span>, <span class="hlFld-ContribAuthor ">Fan  Gu</span>, <span class="hlFld-ContribAuthor ">Zhaohui  Wang</span>, <span class="hlFld-ContribAuthor ">Caiping  Tian</span>, <span class="hlFld-ContribAuthor ">Zhiyu  Qian</span>, <span class="hlFld-ContribAuthor ">Liping  Tang</span>, <span class="hlFld-ContribAuthor ">Yueqing  Gu</span>. </span><span class="cited-content_cbyCitation_article-title">Novel harmine derivatives for tumor targeted therapy. </span><span class="cited-content_cbyCitation_journal-name">Oncotarget</span><span> <strong>2015,</strong> <em>6 </em>
                                    (11)
                                     , 8988-9001. <a href="https://doi.org/10.18632/oncotarget.3276" title="DOI URL">https://doi.org/10.18632/oncotarget.3276</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.18632/oncotarget.3276&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.18632%2Foncotarget.3276%26sid%3Dliteratum%253Aachs%26jtitle%3DOncotarget%26atitle%3DNovel%252Bharmine%252Bderivatives%252Bfor%252Btumor%252Btargeted%252Btherapy%26aulast%3DLi%26aufirst%3DSiwen%26date%3D2015%26date%3D2015%26volume%3D6%26issue%3D11%26spage%3D8988%26epage%3D9001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Céline  Meinguet</span>, <span class="hlFld-ContribAuthor ">Céline  Bruyère</span>, <span class="hlFld-ContribAuthor ">Raphaël  Frédérick</span>, <span class="hlFld-ContribAuthor ">Véronique  Mathieu</span>, <span class="hlFld-ContribAuthor ">Christelle  Vancraeynest</span>, <span class="hlFld-ContribAuthor ">Lionel  Pochet</span>, <span class="hlFld-ContribAuthor ">Julie  Laloy</span>, <span class="hlFld-ContribAuthor ">Jérémie  Mortier</span>, <span class="hlFld-ContribAuthor ">Gerhard  Wolber</span>, <span class="hlFld-ContribAuthor ">Robert  Kiss</span>, <span class="hlFld-ContribAuthor ">Bernard  Masereel</span>, <span class="hlFld-ContribAuthor ">Johan  Wouters</span>. </span><span class="cited-content_cbyCitation_article-title">3D-QSAR, design, synthesis and characterization of trisubstituted harmine derivatives with in vitro antiproliferative properties. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>94 </em>, 45-55. <a href="https://doi.org/10.1016/j.ejmech.2015.02.044" title="DOI URL">https://doi.org/10.1016/j.ejmech.2015.02.044</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2015.02.044&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2015.02.044%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3D3D-QSAR%25252C%252Bdesign%25252C%252Bsynthesis%252Band%252Bcharacterization%252Bof%252Btrisubstituted%252Bharmine%252Bderivatives%252Bwith%252Bin%2525C2%2525A0vitro%252Bantiproliferative%252Bproperties%26aulast%3DMeinguet%26aufirst%3DC%25C3%25A9line%26date%3D2015%26volume%3D94%26spage%3D45%26epage%3D55" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yvonnick  Loidreau</span>, <span class="hlFld-ContribAuthor ">Emmanuel  Deau</span>, <span class="hlFld-ContribAuthor ">Pascal  Marchand</span>, <span class="hlFld-ContribAuthor ">Marie-Renée  Nourrisson</span>, <span class="hlFld-ContribAuthor ">Cédric  Logé</span>, <span class="hlFld-ContribAuthor ">Gaël  Coadou</span>, <span class="hlFld-ContribAuthor ">Nadège  Loaëc</span>, <span class="hlFld-ContribAuthor ">Laurent  Meijer</span>, <span class="hlFld-ContribAuthor ">Thierry  Besson</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and molecular modelling studies of 8-arylpyrido[3′,2′:4,5]thieno[3,2-d]pyrimidin-4-amines as multitarget Ser/Thr kinases inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>92 </em>, 124-134. <a href="https://doi.org/10.1016/j.ejmech.2014.12.038" title="DOI URL">https://doi.org/10.1016/j.ejmech.2014.12.038</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2014.12.038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2014.12.038%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Bmolecular%252Bmodelling%252Bstudies%252Bof%252B8-arylpyrido%25255B3%2525E2%252580%2525B2%25252C2%2525E2%252580%2525B2%25253A4%25252C5%25255Dthieno%25255B3%25252C2-d%25255Dpyrimidin-4-amines%252Bas%252Bmultitarget%252BSer%25252FThr%252Bkinases%252Binhibitors%26aulast%3DLoidreau%26aufirst%3DYvonnick%26date%3D2015%26volume%3D92%26spage%3D124%26epage%3D134" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Binia  Drung</span>, <span class="hlFld-ContribAuthor ">Christoph  Scholz</span>, <span class="hlFld-ContribAuthor ">Valéria A.  Barbosa</span>, <span class="hlFld-ContribAuthor ">Azadeh  Nazari</span>, <span class="hlFld-ContribAuthor ">Maria H.  Sarragiotto</span>, <span class="hlFld-ContribAuthor ">Boris  Schmidt</span>. </span><span class="cited-content_cbyCitation_article-title">Computational & experimental evaluation of the structure/activity relationship of β-carbolines as DYRK1A inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2014,</strong> <em>24 </em>
                                    (20)
                                     , 4854-4860. <a href="https://doi.org/10.1016/j.bmcl.2014.08.054" title="DOI URL">https://doi.org/10.1016/j.bmcl.2014.08.054</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2014.08.054&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2014.08.054%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DComputational%252B%252526%252Bexperimental%252Bevaluation%252Bof%252Bthe%252Bstructure%25252Factivity%252Brelationship%252Bof%252B%2525CE%2525B2-carbolines%252Bas%252BDYRK1A%252Binhibitors%26aulast%3DDrung%26aufirst%3DBinia%26date%3D2014%26volume%3D24%26issue%3D20%26spage%3D4854%26epage%3D4860" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alicia  Foucourt</span>, <span class="hlFld-ContribAuthor ">Damien  Hédou</span>, <span class="hlFld-ContribAuthor ">Carole  Dubouilh-Benard</span>, <span class="hlFld-ContribAuthor ">Angélique  Girard</span>, <span class="hlFld-ContribAuthor ">Thierry  Taverne</span>, <span class="hlFld-ContribAuthor ">Anne-Sophie  Casagrande</span>, <span class="hlFld-ContribAuthor ">Laurent  Désiré</span>, <span class="hlFld-ContribAuthor ">Bertrand  Leblond</span>, <span class="hlFld-ContribAuthor ">Thierry  Besson</span>. </span><span class="cited-content_cbyCitation_article-title">Design and Synthesis of Thiazolo[5,4-f]quinazolines as DYRK1A Inhibitors, Part II. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2014,</strong> <em>19 </em>
                                    (10)
                                     , 15411-15439. <a href="https://doi.org/10.3390/molecules191015411" title="DOI URL">https://doi.org/10.3390/molecules191015411</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules191015411&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules191015411%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DDesign%252Band%252BSynthesis%252Bof%252BThiazolo%25255B5%25252C4-f%25255Dquinazolines%252Bas%252BDYRK1A%252BInhibitors%25252C%252BPart%252BII%26aulast%3DFoucourt%26aufirst%3DAlicia%26date%3D2014%26date%3D2014%26volume%3D19%26issue%3D10%26spage%3D15411%26epage%3D15439" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alicia  Foucourt</span>, <span class="hlFld-ContribAuthor ">Damien  Hédou</span>, <span class="hlFld-ContribAuthor ">Carole  Dubouilh-Benard</span>, <span class="hlFld-ContribAuthor ">Laurent  Désiré</span>, <span class="hlFld-ContribAuthor ">Anne-Sophie  Casagrande</span>, <span class="hlFld-ContribAuthor ">Bertrand  Leblond</span>, <span class="hlFld-ContribAuthor ">Nadège  Loäec</span>, <span class="hlFld-ContribAuthor ">Laurent  Meijer</span>, <span class="hlFld-ContribAuthor ">Thierry  Besson</span>. </span><span class="cited-content_cbyCitation_article-title">Design and Synthesis of Thiazolo[5,4-f]quinazolines as DYRK1A Inhibitors, Part I. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2014,</strong> <em>19 </em>
                                    (10)
                                     , 15546-15571. <a href="https://doi.org/10.3390/molecules191015546" title="DOI URL">https://doi.org/10.3390/molecules191015546</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules191015546&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules191015546%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DDesign%252Band%252BSynthesis%252Bof%252BThiazolo%25255B5%25252C4-f%25255Dquinazolines%252Bas%252BDYRK1A%252BInhibitors%25252C%252BPart%252BI%26aulast%3DFoucourt%26aufirst%3DAlicia%26date%3D2014%26date%3D2014%26volume%3D19%26issue%3D10%26spage%3D15546%26epage%3D15571" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Murat  Kucukdisli</span>, <span class="hlFld-ContribAuthor ">Till  Opatz</span>. </span><span class="cited-content_cbyCitation_article-title">Two-Step Synthesis of 2-Aminoindolizines from 2-Alkylpyridines. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Organic Chemistry</span><span> <strong>2014,</strong> <em>2014 </em>
                                    (26)
                                     , 5836-5844. <a href="https://doi.org/10.1002/ejoc.201402618" title="DOI URL">https://doi.org/10.1002/ejoc.201402618</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ejoc.201402618&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fejoc.201402618%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DTwo-Step%252BSynthesis%252Bof%252B2-Aminoindolizines%252Bfrom%252B2-Alkylpyridines%26aulast%3DKucukdisli%26aufirst%3DMurat%26date%3D2014%26date%3D2014%26volume%3D2014%26issue%3D26%26spage%3D5836%26epage%3D5844" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">James A.  DeCaprio</span>, <span class="hlFld-ContribAuthor ">Anette  Duensing</span>. </span><span class="cited-content_cbyCitation_article-title">The DREAM complex in antitumor activity of imatinib mesylate in gastrointestinal stromal tumors. </span><span class="cited-content_cbyCitation_journal-name">Current Opinion in Oncology</span><span> <strong>2014,</strong> <em>26 </em>
                                    (4)
                                     , 415-421. <a href="https://doi.org/10.1097/CCO.0000000000000090" title="DOI URL">https://doi.org/10.1097/CCO.0000000000000090</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1097/CCO.0000000000000090&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1097%2FCCO.0000000000000090%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Opinion%2520in%2520Oncology%26atitle%3DThe%252BDREAM%252Bcomplex%252Bin%252Bantitumor%252Bactivity%252Bof%252Bimatinib%252Bmesylate%252Bin%252Bgastrointestinal%252Bstromal%252Btumors%26aulast%3DDeCaprio%26aufirst%3DJames%2BA.%26date%3D2014%26volume%3D26%26issue%3D4%26spage%3D415%26epage%3D421" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pierfausto  Seneci</span>. </span><span class="cited-content_cbyCitation_article-title">Targets and Small Molecules Against Tauopathies. Part 1: From Genes to Soluble, Aggregation-Prone Tau Proteins. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2014,</strong>,, 643-715. <a href="https://doi.org/10.1016/B978-0-12-803959-5.50015-5" title="DOI URL">https://doi.org/10.1016/B978-0-12-803959-5.50015-5</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-803959-5.50015-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-803959-5.50015-5%26sid%3Dliteratum%253Aachs%26atitle%3DTargets%252Band%252BSmall%252BMolecules%252BAgainst%252BTauopathies.%252BPart%252B1%25253A%252BFrom%252BGenes%252Bto%252BSoluble%25252C%252BAggregation-Prone%252BTau%252BProteins%26aulast%3DSeneci%26aufirst%3DPierfausto%26date%3D2014%26spage%3D643%26epage%3D715%26pub%3DElsevier%26atitle%3DDrug%252BDesign%252Band%252BDiscovery%252Bin%252BAlzheimer%252527s%252BDisease%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gérard  Jaouen</span>, <span class="hlFld-ContribAuthor ">Siden  Top</span>. </span><span class="cited-content_cbyCitation_article-title">The Ferrocifen Family as Potent and Selective Antitumor Compounds: Mechanisms of Action. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2013,</strong>,, 563-580. <a href="https://doi.org/10.1002/9781118742952.ch42" title="DOI URL">https://doi.org/10.1002/9781118742952.ch42</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9781118742952.ch42&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9781118742952.ch42%26sid%3Dliteratum%253Aachs%26atitle%3DThe%252BFerrocifen%252BFamily%252Bas%252BPotent%252Band%252BSelective%252BAntitumor%252BCompounds%25253A%252BMechanisms%252Bof%252BAction%26aulast%3DJaouen%26aufirst%3DG%25C3%25A9rard%26date%3D2013%26date%3D2013%26spage%3D563%26epage%3D580%26pub%3DJohn%2520Wiley%2520%2526%2520Sons%252C%2520Inc%26atitle%3DAdvances%252Bin%252BOrganometallic%252BChemistry%252Band%252BCatalysis%26aulast%3DPombeiro%26aufirst%3DArmando%2BJ.%2BL.%26date%3D2013%26volume%3D2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Giorgio  Cozza</span>, <span class="hlFld-ContribAuthor ">Stefania  Sarno</span>, <span class="hlFld-ContribAuthor ">Maria  Ruzzene</span>, <span class="hlFld-ContribAuthor ">Cristina  Girardi</span>, <span class="hlFld-ContribAuthor ">Andrzej  Orzeszko</span>, <span class="hlFld-ContribAuthor ">Zygmunt  Kazimierczuk</span>, <span class="hlFld-ContribAuthor ">Giuseppe  Zagotto</span>, <span class="hlFld-ContribAuthor ">Emanuela  Bonaiuto</span>, <span class="hlFld-ContribAuthor ">Maria Luisa  Di Paolo</span>, <span class="hlFld-ContribAuthor ">Lorenzo A.  Pinna</span>. </span><span class="cited-content_cbyCitation_article-title">Exploiting the repertoire of CK2 inhibitors to target DYRK and PIM kinases. </span><span class="cited-content_cbyCitation_journal-name">Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics</span><span> <strong>2013,</strong> <em>1834 </em>
                                    (7)
                                     , 1402-1409. <a href="https://doi.org/10.1016/j.bbapap.2013.01.018" title="DOI URL">https://doi.org/10.1016/j.bbapap.2013.01.018</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bbapap.2013.01.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bbapap.2013.01.018%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochimica%2520et%2520Biophysica%2520Acta%2520%2528BBA%2529%2520-%2520Proteins%2520and%2520Proteomics%26atitle%3DExploiting%252Bthe%252Brepertoire%252Bof%252BCK2%252Binhibitors%252Bto%252Btarget%252BDYRK%252Band%252BPIM%252Bkinases%26aulast%3DCozza%26aufirst%3DGiorgio%26date%3D2013%26volume%3D1834%26issue%3D7%26spage%3D1402%26epage%3D1409" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yvonnick  Loidreau</span>, <span class="hlFld-ContribAuthor ">Pascal  Marchand</span>, <span class="hlFld-ContribAuthor ">Carole  Dubouilh-Benard</span>, <span class="hlFld-ContribAuthor ">Marie-Renée  Nourrisson</span>, <span class="hlFld-ContribAuthor ">Muriel  Duflos</span>, <span class="hlFld-ContribAuthor ">Nadège  Loaëc</span>, <span class="hlFld-ContribAuthor ">Laurent  Meijer</span>, <span class="hlFld-ContribAuthor ">Thierry  Besson</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and biological evaluation of N-aryl-7-methoxybenzo[b]furo[3,2-d]pyrimidin-4-amines and their N-arylbenzo[b]thieno[3,2-d]pyrimidin-4-amine analogues as dual inhibitors of CLK1 and DYRK1A kinases. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2013,</strong> <em>59 </em>, 283-295. <a href="https://doi.org/10.1016/j.ejmech.2012.11.030" title="DOI URL">https://doi.org/10.1016/j.ejmech.2012.11.030</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2012.11.030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2012.11.030%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252BN-aryl-7-methoxybenzo%25255Bb%25255Dfuro%25255B3%25252C2-d%25255Dpyrimidin-4-amines%252Band%252Btheir%252BN-arylbenzo%25255Bb%25255Dthieno%25255B3%25252C2-d%25255Dpyrimidin-4-amine%252Banalogues%252Bas%252Bdual%252Binhibitors%252Bof%252BCLK1%252Band%252BDYRK1A%252Bkinases%26aulast%3DLoidreau%26aufirst%3DYvonnick%26date%3D2013%26volume%3D59%26spage%3D283%26epage%3D295" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-14/jm300542e/production/images/medium/jm-2012-00542e_0007.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-14/jm300542e/production/images/large/jm-2012-00542e_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300542e&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-14/jm300542e/production/images/medium/jm-2012-00542e_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-14/jm300542e/production/images/large/jm-2012-00542e_0002.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of β-Carbolines <b>3a</b>–<b>n</b>, <b>4a</b>–<b>g</b>, and <b>5a</b>–<b>za</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-14/jm300542e/production/images/large/jm-2012-00542e_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300542e&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) HBr, HAc, reflux, overnight ; (b) Cs<sub>2</sub>CO<sub>3</sub>, R<sub>1</sub>X, DMF, rt or Δ ; (c) <b>3g</b>, NaH, iodopropane, DMF, 24 h; (d) KOH (5 equiv), DMF, rt, 30 min, then R<sub>1</sub>(=R<sub>2</sub>)-Br, rt, 24 h (procedure A); (e) R<sub>3</sub>-Br (10 equiv), THF, Δ, 48 h (procedure B), or microwave, 155 °C, 4 h (procedure C); (f) <b>4a</b>, Pd/C (10%), MeOH, rt, 48 h.</p></p></figure><figure data-id="fig1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-14/jm300542e/production/images/medium/jm-2012-00542e_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-14/jm300542e/production/images/large/jm-2012-00542e_0003.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Quantitative videomicroscopy analyses of the in vitro anticancer activity of harmine (<b>1</b>) and <b>5a</b> in the human U373 glioblastoma cell line. Compounds <b>1</b> and <b>5a</b> were assayed at their respective in vitro growth inhibitory IC<sub>50</sub> value, as determined using the MTT assay in U373 glioma cells (see Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-14/jm300542e/production/images/large/jm-2012-00542e_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300542e&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-14/jm300542e/production/images/medium/jm-2012-00542e_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-14/jm300542e/production/images/large/jm-2012-00542e_0004.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. (A) ChemGPS-NP mapping of compounds investigated in the present study. Blue dots indicate the compounds with less in vitro growth inhibitory activity in five human cancer cell lines, and red dots indicate the compounds with more inhibitory activity (see Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). (B) ChemGPS-NP mapping of compounds investigated in this study combined with a small reference set of approximately 20 000 compounds from the ZINC-NP database (<a href="http://zinc.docking.org" class="extLink">http://zinc.docking.org</a>), which can be considered a simple generalization of “natural products”. The red box indicates PC1 (size, weight, etc.). The yellow box indicates PC2 (aromaticity, rigidity, etc.), and the green box indicates PC3 (lipophilicity, etc.).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-14/jm300542e/production/images/large/jm-2012-00542e_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300542e&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-14/jm300542e/production/images/medium/jm-2012-00542e_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-14/jm300542e/production/images/large/jm-2012-00542e_0005.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Characterization of the effects induced by 10 μM <b>5a</b> (A) and 10 μM <b>5o</b> (B) in the NCI 60-cell-line panel.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-14/jm300542e/production/images/large/jm-2012-00542e_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300542e&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-14/jm300542e/production/images/medium/jm-2012-00542e_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-14/jm300542e/production/images/large/jm-2012-00542e_0006.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Western blotting analyses of the effects of <b>5a</b>, <b>5k</b>, and <b>5o</b> on the activity (phosphorylation levels) and expression of the eukaryotic initiation factor 2 (eIF2). Each compound was assayed at its IC<sub>50</sub> growth inhibitory concentration in Hs683 and U373 glioma cells as determined by means of the MTT colorimetric assay (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>), i.e., 0.5 μM <b>5a</b>, 5 μM <b>5k</b>, and 0.5 μM <b>5o</b> in Hs683 cancer cells and 0.5 μM <b>5a</b>, 1 μM <b>5k</b>, and 0.5 μM <b>5o</b> in U373 ones.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-14/jm300542e/production/images/large/jm-2012-00542e_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300542e&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i36">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_11674" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_11674" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 25 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Savage, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stebbing, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bower, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crook, T.</span><span> </span><span class="NLM_article-title">Why does cytotoxic chemotherapy cure only some cancers?</span> <span class="citation_source-journal">Nat. Clin. Pract. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">43</span><span class="NLM_x">–</span> <span class="NLM_lpage">52</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=16&amp;doi=10.1021%2Fjm300542e&amp;key=10.1038%2Fncponc1260" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=8&amp;doi=10.1021%2Fjm300542e&amp;key=18982000" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=32&amp;doi=10.1021%2Fjm300542e&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsFWkurzP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2009&pages=43-52&author=P.+Savageauthor=J.+Stebbingauthor=M.+Bowerauthor=T.+Crook&title=Why+does+cytotoxic+chemotherapy+cure+only+some+cancers%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1aR"><div class="casContent"><span class="casTitleNuber">1a</span><div class="casTitle"><span class="NLM_cas:atitle">Why does cytotoxic chemotherapy cure only some cancers?</span></div><div class="casAuthors">Savage, Philip; Stebbing, Justin; Bower, Mark; Crook, Tim</div><div class="citationInfo"><span class="NLM_cas:title">Nature Clinical Practice Oncology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">43-52</span>CODEN:
                <span class="NLM_cas:coden">NCPOB5</span>;
        ISSN:<span class="NLM_cas:issn">1743-4254</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Despite frequent responses to chemotherapy, curative treatment remains elusive for the majority of metastatic solid tumors.  By contrast, chemotherapy routinely cures patients with testicular cancers, gestational choriocarcinoma, Hodgkin's disease and high-grade lymphomas.  Savage et al. suggest that the chemo-curability of these malignancies results from an intrinsic 'locked-in' state of sensitivity to pro-apoptotic stresses in these particular cell types, and they discuss some of the characteristics shared by the curable cancers that might explain their curability.  Despite frequent responses to chemotherapy, curative treatment remains elusive for the majority of patients with metastatic solid tumors.  By contrast, in testicular cancer, gestational choriocarcinoma, Hodgkin disease and high-grade lymphomas, chemotherapy is routinely curative, even for patients who present with widely disseminated disease.  In the common advanced cancers, however, over 40 years of cytotoxic drug development has brought no significant change in cure rates.  One interpretation is that the intrinsic properties of the malignancies themselves, rather than the qualities of individual drugs or combination therapies, are primarily responsible for their curability with chemotherapy.  We suggest that the curability of these malignancies results from an intrinsic 'locked-in' state of sensitivity to proapoptotic stresses in these cells.  A common property of such curable malignancies is that they arise from cells that undergo major genetic rearrangements or recombination as part of their normal physiol.  The absence of further genetic and epigenetic changes in genes that regulate apoptosis, DNA repair and senescence allows these cells to maintain their intrinsic sensitivity to chemotherapy.  This process allows the cells, when challenged with chemotherapy, to undergo the natural apoptotic pathways that contribute to their intrinsic qualities of chemosensitivity and high curability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqov8Vi7LfVIrVg90H21EOLACvtfcHk0ljIVFKm6Jq01Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsFWkurzP&md5=1ac0fd31132140d612c789fe6bb99590</span></div><a href="/servlet/linkout?suffix=cit1a&amp;dbid=16384&amp;doi=10.1038%2Fncponc1260&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncponc1260%26sid%3Dliteratum%253Aachs%26aulast%3DSavage%26aufirst%3DP.%26aulast%3DStebbing%26aufirst%3DJ.%26aulast%3DBower%26aufirst%3DM.%26aulast%3DCrook%26aufirst%3DT.%26atitle%3DWhy%2520does%2520cytotoxic%2520chemotherapy%2520cure%2520only%2520some%2520cancers%253F%26jtitle%3DNat.%2520Clin.%2520Pract.%2520Oncol.%26date%3D2009%26volume%3D6%26spage%3D43%26epage%3D52" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit1b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Wilson, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnston, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Longley, D. B.</span><span> </span><span class="NLM_article-title">Anti-apoptotic mechanisms of drug resistance in cancer</span> <span class="citation_source-journal">Curr. Cancer Drug Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">307</span><span class="NLM_x">–</span> <span class="NLM_lpage">319</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=16&amp;doi=10.1021%2Fjm300542e&amp;key=10.2174%2F156800909788166547" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=8&amp;doi=10.1021%2Fjm300542e&amp;key=19442051" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=32&amp;doi=10.1021%2Fjm300542e&amp;key=1%3ACAS%3A528%3ADC%252BD1MXmslansLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2009&pages=307-319&author=T.+R.+Wilsonauthor=P.+G.+Johnstonauthor=D.+B.+Longley&title=Anti-apoptotic+mechanisms+of+drug+resistance+in+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1bR"><div class="casContent"><span class="casTitleNuber">1b</span><div class="casTitle"><span class="NLM_cas:atitle">Anti-apoptotic mechanisms of drug resistance in cancer</span></div><div class="casAuthors">Wilson, T. R.; Johnston, P. G.; Longley, D. B.</div><div class="citationInfo"><span class="NLM_cas:title">Current Cancer Drug Targets</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">307-319</span>CODEN:
                <span class="NLM_cas:coden">CCDTB9</span>;
        ISSN:<span class="NLM_cas:issn">1568-0096</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Resistance to chemotherapy is a major obstacle in the treatment of cancer.  Despite the advent of new chemotherapies and mol.-targeted therapies, approx. 90% of patients with metastatic cancer succumb to their disease.  Drug resistance, either acquired or intrinsic, often prevents tumor cells from undergoing sufficient levels of programmed cell death or apoptosis, resulting in cancer cell survival and treatment failure.  In pre-clin. disease models, agents that target the apoptotic pathway were shown to sensitize tumor cells to chemotherapy and radiotherapy.  Such therapies include small mol. inhibitors and antisense strategies that inhibit the activity of anti-apoptotic proteins, or treatment with recombinant pro-apoptotic proteins or antibodies that can activate the apoptotic pathway.  This review will discuss apoptosis and the mechanisms by which it can become dysregulated in human cancer.  In addn., novel therapeutic strategies that target key components of the apoptotic machinery will be discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqkegczsL_lBrVg90H21EOLACvtfcHk0ljIVFKm6Jq01Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmslansLo%253D&md5=85b32e7e06a33942779c569f39f19252</span></div><a href="/servlet/linkout?suffix=cit1b&amp;dbid=16384&amp;doi=10.2174%2F156800909788166547&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156800909788166547%26sid%3Dliteratum%253Aachs%26aulast%3DWilson%26aufirst%3DT.%2BR.%26aulast%3DJohnston%26aufirst%3DP.%2BG.%26aulast%3DLongley%26aufirst%3DD.%2BB.%26atitle%3DAnti-apoptotic%2520mechanisms%2520of%2520drug%2520resistance%2520in%2520cancer%26jtitle%3DCurr.%2520Cancer%2520Drug%2520Targets%26date%3D2009%26volume%3D9%26spage%3D307%26epage%3D319" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit1c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Wong, R. S.</span><span> </span><span class="NLM_article-title">Apoptosis in cancer: from pathogenesis to treatment</span> <span class="citation_source-journal">J. Exp. Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">87</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1c&amp;dbid=16&amp;doi=10.1021%2Fjm300542e&amp;key=10.1186%2F1756-9966-30-87" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1c&amp;dbid=8&amp;doi=10.1021%2Fjm300542e&amp;key=21943236" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1c&amp;dbid=32&amp;doi=10.1021%2Fjm300542e&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlOitLzI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2011&pages=87&author=R.+S.+Wong&title=Apoptosis+in+cancer%3A+from+pathogenesis+to+treatment"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1cR"><div class="casContent"><span class="casTitleNuber">1c</span><div class="casTitle"><span class="NLM_cas:atitle">Apoptosis in cancer: from pathogenesis to treatment</span></div><div class="casAuthors">Wong, Rebecca S. Y.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Experimental & Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">87</span>CODEN:
                <span class="NLM_cas:coden">JECRDN</span>;
        ISSN:<span class="NLM_cas:issn">1756-9966</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">A review.  Apoptosis is an ordered and orchestrated cellular process that occurs in physiol. and pathol. conditions.  It is also one of the most studied topics among cell biologists.  An understanding of the underlying mechanism of apoptosis is important as it plays a pivotal role in the pathogenesis of many diseases.  In some, the problem is due to too much apoptosis, such as in the case of degenerative diseases while in others, too little apoptosis is the culprit.  Cancer is one of the scenarios where too little apoptosis occurs, resulting in malignant cells that will not die.  The mechanism of apoptosis is complex and involves many pathways.  Defects can occur at any point along these pathways, leading to malignant transformation of the affected cells, tumor metastasis and resistance to anticancer drugs.  Despite being the cause of problem, apoptosis plays an important role in the treatment of cancer as it is a popular target of many treatment strategies.  The abundance of literature suggests that targeting apoptosis in cancer is feasible.  However, many troubling questions arise with the use of new drugs or treatment strategies that are designed to enhance apoptosis and crit. tests must be passed before they can be used safely in human subjects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqy9-lLMtzN4bVg90H21EOLACvtfcHk0lgPfIISAK9J5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlOitLzI&md5=e53612be1ef5a3dc9da16a7cd3a3ed9c</span></div><a href="/servlet/linkout?suffix=cit1c&amp;dbid=16384&amp;doi=10.1186%2F1756-9966-30-87&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1756-9966-30-87%26sid%3Dliteratum%253Aachs%26aulast%3DWong%26aufirst%3DR.%2BS.%26atitle%3DApoptosis%2520in%2520cancer%253A%2520from%2520pathogenesis%2520to%2520treatment%26jtitle%3DJ.%2520Exp.%2520Clin.%2520Cancer%2520Res.%26date%3D2011%26volume%3D30%26spage%3D87" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Martinez-Rivera, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siddik, Z. H.</span><span> </span><span class="NLM_article-title">Resistance and gain-of-resistance phenotypes in cancers harboring wild-type p53</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">83</span><span class="NLM_x"> (</span><span class="NLM_issue">8</span><span class="NLM_x">) </span> <span class="NLM_fpage">1049</span><span class="NLM_x">–</span> <span class="NLM_lpage">1062</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=2012&pages=1049-1062&issue=8&author=M.+Martinez-Riveraauthor=Z.+H.+Siddik&title=Resistance+and+gain-of-resistance+phenotypes+in+cancers+harboring+wild-type+p53"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMartinez-Rivera%26aufirst%3DM.%26aulast%3DSiddik%26aufirst%3DZ.%2BH.%26atitle%3DResistance%2520and%2520gain-of-resistance%2520phenotypes%2520in%2520cancers%2520harboring%2520wild-type%2520p53%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2012%26volume%3D83%26issue%3D8%26spage%3D1049%26epage%3D1062" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Rosenzweig, S. A.</span><span> </span><span class="NLM_article-title">Acquired resistance to drugs targeting receptor tyrosine kinases</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">83</span><span class="NLM_x"> (</span><span class="NLM_issue">8</span><span class="NLM_x">) </span> <span class="NLM_fpage">1041</span><span class="NLM_x">–</span> <span class="NLM_lpage">1048</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=2012&pages=1041-1048&issue=8&author=S.+A.+Rosenzweig&title=Acquired+resistance+to+drugs+targeting+receptor+tyrosine+kinases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRosenzweig%26aufirst%3DS.%2BA.%26atitle%3DAcquired%2520resistance%2520to%2520drugs%2520targeting%2520receptor%2520tyrosine%2520kinases%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2012%26volume%3D83%26issue%3D8%26spage%3D1041%26epage%3D1048" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit3b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Rodrigues, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dinis, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gromicho, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martins, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laires, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rueff, J.</span><span> </span><span class="NLM_article-title">Genomics and cancer drug resistance</span> <span class="citation_source-journal">Curr. Pharm. Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">651</span><span class="NLM_x">–</span> <span class="NLM_lpage">673</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=16&amp;doi=10.1021%2Fjm300542e&amp;key=10.2174%2F138920112799857549" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=8&amp;doi=10.1021%2Fjm300542e&amp;key=22122479" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=32&amp;doi=10.1021%2Fjm300542e&amp;key=1%3ACAS%3A528%3ADC%252BC38XltFShs7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2012&pages=651-673&issue=5&author=A.+S.+Rodriguesauthor=J.+Dinisauthor=M.+Gromichoauthor=C.+Martinsauthor=A.+Lairesauthor=J.+Rueff&title=Genomics+and+cancer+drug+resistance"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3bR"><div class="casContent"><span class="casTitleNuber">3b</span><div class="casTitle"><span class="NLM_cas:atitle">Genomics and cancer drug resistance</span></div><div class="casAuthors">Rodrigues, Antonio S.; Dinis, Joana; Gromicho, Marta; Martins, Celia; Laires, Antonio; Rueff, Jose</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Biotechnology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">651-673</span>CODEN:
                <span class="NLM_cas:coden">CPBUBP</span>;
        ISSN:<span class="NLM_cas:issn">1389-2010</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">Cellular drug resistance is a major obstacle in cancer therapy.  Mechanisms of resistance can be assocd. with altered expression of ATP-binding cassette (ABC) family of transporters on cell membrane transporters, the most common cause of multi-drug resistance (MDR), but can also include alterations of DNA repair pathways, resistance to apoptosis and target modifications.  Anti-cancer treatments may be divided into different categories based on their purpose and action: chemotherapeutic agents damage and kill dividing cells; hormonal treatments prevent cancer cells from receiving signals essential for their growth; targeted drugs are a relatively new cancer treatment that targets specific proteins and pathways that are limited primarily to cancer cells or that are much more prevalent in cancer cells; and antibodies function by either depriving the cancer cells of necessary signals or by causing their direct death.  In any case, resistance to anticancer therapies leads to poor prognosis of patients.  Thus, identification of novel mol. targets is crit. in development of new, efficient and specific cancer drugs.  The aim of this review is to describe the impact of genomics in studying some of the most crit. pathways involved in cancer drug resistance and in improving drug development.  We shall also focus on the emerging role of microRNAs, as key gene expression regulators, in drug resistance.  Finally, we shall address the specific mechanisms involved in resistance to tyrosine kinase inhibitors in chronic myeloid leukemia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpqIIIVndgV7Vg90H21EOLACvtfcHk0lgPfIISAK9J5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XltFShs7o%253D&md5=5e90b45ac02cdc4ef1d0f980bf46b948</span></div><a href="/servlet/linkout?suffix=cit3b&amp;dbid=16384&amp;doi=10.2174%2F138920112799857549&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138920112799857549%26sid%3Dliteratum%253Aachs%26aulast%3DRodrigues%26aufirst%3DA.%2BS.%26aulast%3DDinis%26aufirst%3DJ.%26aulast%3DGromicho%26aufirst%3DM.%26aulast%3DMartins%26aufirst%3DC.%26aulast%3DLaires%26aufirst%3DA.%26aulast%3DRueff%26aufirst%3DJ.%26atitle%3DGenomics%2520and%2520cancer%2520drug%2520resistance%26jtitle%3DCurr.%2520Pharm.%2520Biotechnol.%26date%3D2012%26volume%3D13%26issue%3D5%26spage%3D651%26epage%3D673" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Lefranc, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brotchi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiss, R.</span><span> </span><span class="NLM_article-title">Possible future issues in the treatment of glioblastomas, with a special emphasis on cell migration and the resistance of migrating glioblastoma cells to apoptosis</span> <span class="citation_source-journal">J. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">2411</span><span class="NLM_x">–</span> <span class="NLM_lpage">2422</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=16&amp;doi=10.1021%2Fjm300542e&amp;key=10.1200%2FJCO.2005.03.089" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=8&amp;doi=10.1021%2Fjm300542e&amp;key=15800333" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=32&amp;doi=10.1021%2Fjm300542e&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjsVyhsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2005&pages=2411-2422&author=F.+Lefrancauthor=J.+Brotchiauthor=R.+Kiss&title=Possible+future+issues+in+the+treatment+of+glioblastomas%2C+with+a+special+emphasis+on+cell+migration+and+the+resistance+of+migrating+glioblastoma+cells+to+apoptosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4aR"><div class="casContent"><span class="casTitleNuber">4a</span><div class="casTitle"><span class="NLM_cas:atitle">Possible future issues in the treatment of glioblastomas: Special emphasis on cell migration and the resistance of migrating glioblastoma cells to apoptosis</span></div><div class="casAuthors">Lefranc, Florence; Brotchi, Jacques; Kiss, Robert</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Oncology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2411-2422</span>CODEN:
                <span class="NLM_cas:coden">JCONDN</span>;
        ISSN:<span class="NLM_cas:issn">0732-183X</span>.
    
            (<span class="NLM_cas:orgname">American Society of Clinical Oncology</span>)
        </div><div class="casAbstract">The present review aims to emphasize that malignant gliomas are characterized by the diffuse invasion of distant brain tissue by a myriad of single migrating cells that exhibit decreased levels of apoptosis (programmed cell death type I), thus a resistance to cytotoxic insult.  The present review surveys the mol. mechanisms of migration in malignant gliomas and potential issues arising from treatments, in addn. to relationships between glioma cell migration and resistance to apoptosis in terms of the mol. signaling pathways.  Clin. and exptl. data demonstrate that glioma cell migration is a complex combination of multiple mol. processes, including the alteration of tumor cell adhesion to a modified extracellular matrix, the secretion of proteases by the cells, and modifications to the actin cytoskeleton.  Intracellular signaling pathways involved in the acquisition of resistance to apoptosis by migrating glioma cells concern Pl3K, Akt, mTOR, NF-κB, and autophagy (programmed cell death type II).  A no. of signaling pathways can be constitutively activated in migrating glioma cells, thus rendering these cells resistant to cytotoxic insults.  However, these pathways are not all constitutively activated at the same time in any one glioma.  Particular inhibitors should therefore only be chosen if the target is present in the tumor tissue, but this is only possible if individual patients are submitted to the mol. profiling of their tumors before undergoing any treatment to combat their migratory glioma cells.  Specific antimigratory compds. should be added to conventional radio- and/or chemotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRxPKR4Wm5vbVg90H21EOLACvtfcHk0lgPfIISAK9J5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjsVyhsrY%253D&md5=9195f4ac3a7cccda1ca747dbb35f3023</span></div><a href="/servlet/linkout?suffix=cit4a&amp;dbid=16384&amp;doi=10.1200%2FJCO.2005.03.089&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2005.03.089%26sid%3Dliteratum%253Aachs%26aulast%3DLefranc%26aufirst%3DF.%26aulast%3DBrotchi%26aufirst%3DJ.%26aulast%3DKiss%26aufirst%3DR.%26atitle%3DPossible%2520future%2520issues%2520in%2520the%2520treatment%2520of%2520glioblastomas%252C%2520with%2520a%2520special%2520emphasis%2520on%2520cell%2520migration%2520and%2520the%2520resistance%2520of%2520migrating%2520glioblastoma%2520cells%2520to%2520apoptosis%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2005%26volume%3D23%26spage%3D2411%26epage%3D2422" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit4b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">D’Amico, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harpole, D. H.,  Jr.</span><span> </span><span class="NLM_article-title">Molecular biology of esophageal cancer</span> <span class="citation_source-journal">Chest Surg. Clin. N. Am.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">451</span><span class="NLM_x">–</span> <span class="NLM_lpage">469</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=8&amp;doi=10.1021%2Fjm300542e&amp;key=10967750" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=32&amp;doi=10.1021%2Fjm300542e&amp;key=1%3ACAS%3A280%3ADC%252BD3M%252Fmt1CrsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2000&pages=451-469&author=T.+A.+D%E2%80%99Amicoauthor=D.+H.+Harpole&title=Molecular+biology+of+esophageal+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4bR"><div class="casContent"><span class="casTitleNuber">4b</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular biology of esophageal cancer</span></div><div class="casAuthors">D'Amico T A; Harpole D H Jr</div><div class="citationInfo"><span class="NLM_cas:title">Chest surgery clinics of North America</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">451-69</span>
        ISSN:<span class="NLM_cas:issn">1052-3359</span>.
    </div><div class="casAbstract">Several mechanisms of resistance to chemotherapy have been identified among the agents that are commonly used in the systemic treatment of patients with esophageal cancer: paclitaxel, platinum, and 5-FU.  A recent study from our laboratory evaluated the initial endoscopic biopsy material from patients who subsequently underwent trimodality therapy, including chemotherapy with cisplatin and 5-FU, radiation therapy, and surgery.  IHC analysis was performed on seven markers of chemotherapy or radiation therapy resistance: P-gp, GST-pi, MT (platinum inhibitors); EGF-R, TGF-alpha, erb-B2 (activation of cell growth cascade); and p53 (interferes with chemotherapy-induced apoptosis).  In this study, elevated expression of GST-pi and P-gp were associated with decreased survival and may be markers of treatment resistance.  Expression of erb-B2 was associated with enhanced survival and may be a marker of treatment sensitivity.  Assessment of the probability of chemoresistance of a particular tumor using the expression of molecular biologic markers may allow for the selection of a more favorable chemotherapeutic agent.  Furthermore, understanding the mechanisms of resistance, including the mechanisms of DNA repair, may provide insight into mechanisms to reverse or to inhibit resistance to chemotherapy.  DNA repair mechanisms are used by cells to protect themselves against mutagens and carcinogens.  DNA repair inhibitors may increase the mutagenicity associated with DNA damage and may prove to be an ineffective oncologic treatment strategy; however, the possibility exists that DNA repair inhibition may improve the efficacy of anticancer agents, and this should be tested.  The value of this strategy may be in allowing treatment doses to be decreased and lessening side effects while maintaining therapeutic efficacy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT2CsMTXq-wgNXdcedVHT5tfW6udTcc2ebnNPtDl8fY_Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3M%252Fmt1CrsA%253D%253D&md5=9c0dddf3f5a7b976e6532ee7ff43de2f</span></div><a href="/servlet/linkout?suffix=cit4b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DD%25E2%2580%2599Amico%26aufirst%3DT.%2BA.%26aulast%3DHarpole%26aufirst%3DD.%2BH.%26atitle%3DMolecular%2520biology%2520of%2520esophageal%2520cancer%26jtitle%3DChest%2520Surg.%2520Clin.%2520N.%2520Am.%26date%3D2000%26volume%3D10%26spage%3D451%26epage%3D469" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit4c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Bruyère, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lonez, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duray, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cludts, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruysschaert, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saussez, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yeaton, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiss, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mijatovic, T.</span><span> </span><span class="NLM_article-title">Considering temozolomide as a novel potential treatment for esophageal cancer</span> <span class="citation_source-journal">Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">117</span><span class="NLM_x">, </span> <span class="NLM_fpage">2004</span><span class="NLM_x">–</span> <span class="NLM_lpage">2016</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=2011&pages=2004-2016&author=C.+Bruy%C3%A8reauthor=C.+Lonezauthor=A.+Durayauthor=S.+Cludtsauthor=J.+M.+Ruysschaertauthor=S.+Saussezauthor=P.+Yeatonauthor=R.+Kissauthor=T.+Mijatovic&title=Considering+temozolomide+as+a+novel+potential+treatment+for+esophageal+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBruy%25C3%25A8re%26aufirst%3DC.%26aulast%3DLonez%26aufirst%3DC.%26aulast%3DDuray%26aufirst%3DA.%26aulast%3DCludts%26aufirst%3DS.%26aulast%3DRuysschaert%26aufirst%3DJ.%2BM.%26aulast%3DSaussez%26aufirst%3DS.%26aulast%3DYeaton%26aufirst%3DP.%26aulast%3DKiss%26aufirst%3DR.%26aulast%3DMijatovic%26aufirst%3DT.%26atitle%3DConsidering%2520temozolomide%2520as%2520a%2520novel%2520potential%2520treatment%2520for%2520esophageal%2520cancer%26jtitle%3DCancer%26date%3D2011%26volume%3D117%26spage%3D2004%26epage%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit4d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Soengas, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lowe, S. W.</span><span> </span><span class="NLM_article-title">Apoptosis and melanoma chemoresistance</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">3138</span><span class="NLM_x">–</span> <span class="NLM_lpage">3151</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2003&pages=3138-3151&author=M.+S.+Soengasauthor=S.+W.+Lowe&title=Apoptosis+and+melanoma+chemoresistance"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSoengas%26aufirst%3DM.%2BS.%26aulast%3DLowe%26aufirst%3DS.%2BW.%26atitle%3DApoptosis%2520and%2520melanoma%2520chemoresistance%26jtitle%3DOncogene%26date%3D2003%26volume%3D22%26spage%3D3138%26epage%3D3151" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit4e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Wong, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lemoine, N. R.</span><span> </span><span class="NLM_article-title">Pancreatic cancer: molecular pathogenesis and new therapeutic targets</span> <span class="citation_source-journal">Nat. Rev. Gastroenterol. Hepatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">412</span><span class="NLM_x">–</span> <span class="NLM_lpage">422</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4e&amp;dbid=16&amp;doi=10.1021%2Fjm300542e&amp;key=10.1038%2Fnrgastro.2009.89" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4e&amp;dbid=8&amp;doi=10.1021%2Fjm300542e&amp;key=19506583" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4e&amp;dbid=32&amp;doi=10.1021%2Fjm300542e&amp;key=1%3ACAS%3A528%3ADC%252BD1MXot12ltLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2009&pages=412-422&author=H.+H.+Wongauthor=N.+R.+Lemoine&title=Pancreatic+cancer%3A+molecular+pathogenesis+and+new+therapeutic+targets"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4eR"><div class="casContent"><span class="casTitleNuber">4e</span><div class="casTitle"><span class="NLM_cas:atitle">Pancreatic cancer: molecular pathogenesis and new therapeutic targets</span></div><div class="casAuthors">Wong, Han H.; Lemoine, Nicholas R.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Gastroenterology & Hepatology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">412-422</span>CODEN:
                <span class="NLM_cas:coden">NRGHA9</span>;
        ISSN:<span class="NLM_cas:issn">1759-5045</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Pancreatic cancer is lethal and notoriously difficult to treat, therefore, there is an urgent need to develop new therapeutic and diagnostic modalities.  This Review discusses the agents that have been developed to target the pathways and processes involved in pancreatic tumorigenesis, and reviews the results of lab. and clin. trials of these agents.  Future therapeutic targets are also discussed.  Patients with pancreatic cancer normally present with advanced disease that is lethal and notoriously difficult to treat.  Survival has not improved dramatically despite routine use of chemotherapy and radiotherapy; this situation signifies an urgent need for novel therapeutic approaches.  Over the past decade, a large no. of studies have been published that aimed to target the mol. abnormalities implicated in pancreatic tumor growth, invasion, metastasis, angiogenesis and resistance to apoptosis.  This research is of particular importance, as data suggest that a large no. of genetic alterations affect only a few major signaling pathways and processes involved in pancreatic tumorigenesis.  Although lab. results of targeted therapies have been impressive, until now only erlotinib, an epidermal growth factor receptor tyrosine kinase inhibitor, has demonstrated modest survival benefit in combination with gemcitabine in a phase III clin. trial.  While the failures of targeted therapies in the clin. setting are discouraging, lessons have been learnt and new therapeutic targets that hold promise for the future management of the disease are continuously emerging.  This Review describes some of the important developments and targeted agents for pancreatic cancer that have been tested in clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpm5mtPxXGCSLVg90H21EOLACvtfcHk0ljUa3KAvWHoHg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXot12ltLo%253D&md5=61183be915ad65cab453c462f046d30d</span></div><a href="/servlet/linkout?suffix=cit4e&amp;dbid=16384&amp;doi=10.1038%2Fnrgastro.2009.89&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrgastro.2009.89%26sid%3Dliteratum%253Aachs%26aulast%3DWong%26aufirst%3DH.%2BH.%26aulast%3DLemoine%26aufirst%3DN.%2BR.%26atitle%3DPancreatic%2520cancer%253A%2520molecular%2520pathogenesis%2520and%2520new%2520therapeutic%2520targets%26jtitle%3DNat.%2520Rev.%2520Gastroenterol.%2520Hepatol.%26date%3D2009%26volume%3D6%26spage%3D412%26epage%3D422" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit4f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Han, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roman, J.</span><span> </span><span class="NLM_article-title">Targeting apoptotic signaling pathways in human lung cancer</span> <span class="citation_source-journal">Curr. Cancer Drug Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">566</span><span class="NLM_x">–</span> <span class="NLM_lpage">574</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4f&amp;dbid=16&amp;doi=10.1021%2Fjm300542e&amp;key=10.2174%2F156800910791859461" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4f&amp;dbid=8&amp;doi=10.1021%2Fjm300542e&amp;key=20482489" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4f&amp;dbid=32&amp;doi=10.1021%2Fjm300542e&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFSktLfL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2010&pages=566-574&author=S.+Hanauthor=J.+Roman&title=Targeting+apoptotic+signaling+pathways+in+human+lung+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4fR"><div class="casContent"><span class="casTitleNuber">4f</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting apoptotic signaling pathways in human lung cancer</span></div><div class="casAuthors">Han, S. W.; Roman, J.</div><div class="citationInfo"><span class="NLM_cas:title">Current Cancer Drug Targets</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">566-574</span>CODEN:
                <span class="NLM_cas:coden">CCDTB9</span>;
        ISSN:<span class="NLM_cas:issn">1568-0096</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Lung carcinoma is the leading cause of carcinoma death in the world.  Despite recent advances in understanding the mol. biol. of lung cancer and the introduction of new therapeutic agents for its treatment, its dismal 5-yr survival rate has not changed substantially.  Clin. approaches have not significantly improved the survival of patients with advanced lung cancer.  However, recent discoveries about the mol. mechanisms responsible for lung cancer initiation and proliferation have unveiled new targets for therapy.  One of the hallmark features of cancer cells is their ability to evade programmed cell death or apoptosis.  Alterations in pro- and anti-apoptotic pathways are common in cancer cells and defects in regulation of apoptosis have been implicated in both lung tumorigenesis and drug resistance.  Thus, targeting apoptosis through the direct or indirect manipulation of the pro-apoptotic machinery offers a novel strategy for treatment.  This mini review summaries the mol. events that contribute to drug-induced apoptosis and how lung tumors evade apoptotic death followed by an anal. of the implications for treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpzLQx87aj_27Vg90H21EOLACvtfcHk0ljUa3KAvWHoHg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFSktLfL&md5=07bccd392be7562d070d24ecfe6277eb</span></div><a href="/servlet/linkout?suffix=cit4f&amp;dbid=16384&amp;doi=10.2174%2F156800910791859461&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156800910791859461%26sid%3Dliteratum%253Aachs%26aulast%3DHan%26aufirst%3DS.%26aulast%3DRoman%26aufirst%3DJ.%26atitle%3DTargeting%2520apoptotic%2520signaling%2520pathways%2520in%2520human%2520lung%2520cancer%26jtitle%3DCurr.%2520Cancer%2520Drug%2520Targets%26date%3D2010%26volume%3D10%26spage%3D566%26epage%3D574" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Becker, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sippl, W.</span><span> </span><span class="NLM_article-title">Activation, regulation, and inhibition of DYRK1A</span> <span class="citation_source-journal">FEBS J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">278</span><span class="NLM_x">, </span> <span class="NLM_fpage">246</span><span class="NLM_x">–</span> <span class="NLM_lpage">256</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=278&publication_year=2011&pages=246-256&author=W.+Beckerauthor=W.+Sippl&title=Activation%2C+regulation%2C+and+inhibition+of+DYRK1A"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBecker%26aufirst%3DW.%26aulast%3DSippl%26aufirst%3DW.%26atitle%3DActivation%252C%2520regulation%252C%2520and%2520inhibition%2520of%2520DYRK1A%26jtitle%3DFEBS%2520J.%26date%3D2011%26volume%3D278%26spage%3D246%26epage%3D256" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit5b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Wegiel, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gong, C. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hwang, Y. W.</span><span> </span><span class="NLM_article-title">The role of DYRK1A in neurodegenerative diseases</span> <span class="citation_source-journal">FEBS J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">278</span><span class="NLM_x">, </span> <span class="NLM_fpage">236</span><span class="NLM_x">–</span> <span class="NLM_lpage">245</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=16&amp;doi=10.1021%2Fjm300542e&amp;key=10.1111%2Fj.1742-4658.2010.07955.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=8&amp;doi=10.1021%2Fjm300542e&amp;key=21156028" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=32&amp;doi=10.1021%2Fjm300542e&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtFGru7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=278&publication_year=2011&pages=236-245&author=J.+Wegielauthor=C.+X.+Gongauthor=Y.+W.+Hwang&title=The+role+of+DYRK1A+in+neurodegenerative+diseases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5bR"><div class="casContent"><span class="casTitleNuber">5b</span><div class="casTitle"><span class="NLM_cas:atitle">The role of DYRK1A in neurodegenerative diseases</span></div><div class="casAuthors">Wegiel, Jerzy; Gong, Cheng-Xin; Hwang, Yu-Wen</div><div class="citationInfo"><span class="NLM_cas:title">FEBS Journal</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">278</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">236-245</span>CODEN:
                <span class="NLM_cas:coden">FJEOAC</span>;
        ISSN:<span class="NLM_cas:issn">1742-464X</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  Recent studies indicate that the dual-specificity tyrosine phosphorylation-regulated kinase 1A (DYRK1A) gene, which is located on chromosome 21q22.2 and is overexpressed in Down syndrome (DS), may play a significant role in developmental brain defects and in early onset neurodegeneration, neuronal loss and dementia in DS.  The identification of hundreds of genes deregulated by DYRK1A overexpression and numerous cytosolic, cytoskeletal and nuclear proteins, including transcription factors, phosphorylated by DYRK1A, indicates that DYRK1A overexpression is central for the deregulation of multiple pathways in the developing and aging DS brain, with structural and functional alterations including mental retardation and dementia.  DYRK1A overexpression in DS brains may contribute to early onset neurofibrillary degeneration directly through hyperphosphorylation of tau and indirectly through phosphorylation of alternative splicing factor, leading to an imbalance between 3R-tau and 4R-tau.  The several-fold increases in the no. of DYRK1A-pos. and 3R-tau-pos. neurofibrillary tangles in DS support this hypothesis.  Moreover, the enhanced phosphorylation of amyloid precursor protein by overexpressed DYRK1A facilitates amyloidogenic amyloid precursor protein cleavage elevating Aβ40 and 42 levels, and leading to brain β-amyloidosis.  Therefore, inhibiting DYRK1A activity in DS may serve to counteract the phenotypic effects of its overexpression and is a potential method of treatment of developmental defects and the prevention of age-assocd. neurodegeneration, including Alzheimer-type pathol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr6EhMKZ0hzPbVg90H21EOLACvtfcHk0lj68M-WXARxlg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtFGru7o%253D&md5=ac857b61ce21452dac070f1c26a75d38</span></div><a href="/servlet/linkout?suffix=cit5b&amp;dbid=16384&amp;doi=10.1111%2Fj.1742-4658.2010.07955.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1742-4658.2010.07955.x%26sid%3Dliteratum%253Aachs%26aulast%3DWegiel%26aufirst%3DJ.%26aulast%3DGong%26aufirst%3DC.%2BX.%26aulast%3DHwang%26aufirst%3DY.%2BW.%26atitle%3DThe%2520role%2520of%2520DYRK1A%2520in%2520neurodegenerative%2520diseases%26jtitle%3DFEBS%2520J.%26date%3D2011%26volume%3D278%26spage%3D236%26epage%3D245" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Cao, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hou, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, A.</span><span> </span><span class="NLM_article-title">Design, synthesis and in vitro and in vivo antitumor activities of novel beta-carboline derivatives</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">991</span><span class="NLM_x">–</span> <span class="NLM_lpage">1001</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2005&pages=991-1001&author=R.+Caoauthor=H.+Chenauthor=W.+Pengauthor=Y.+Maauthor=X.+Houauthor=H.+Guanauthor=X.+Liuauthor=A.+Xu&title=Design%2C+synthesis+and+in+vitro+and+in+vivo+antitumor+activities+of+novel+beta-carboline+derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCao%26aufirst%3DR.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DPeng%26aufirst%3DW.%26aulast%3DMa%26aufirst%3DY.%26aulast%3DHou%26aufirst%3DX.%26aulast%3DGuan%26aufirst%3DH.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DXu%26aufirst%3DA.%26atitle%3DDesign%252C%2520synthesis%2520and%2520in%2520vitro%2520and%2520in%2520vivo%2520antitumor%2520activities%2520of%2520novel%2520beta-carboline%2520derivatives%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2005%26volume%3D40%26spage%3D991%26epage%3D1001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Bain, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plater, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elliott, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shapiro, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hastie, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McLauchlan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klevernic, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arthur, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alessi, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, P.</span><span> </span><span class="NLM_article-title">The selectivity of protein kinase inhibitors: a further update</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">408</span><span class="NLM_x">, </span> <span class="NLM_fpage">297</span><span class="NLM_x">–</span> <span class="NLM_lpage">315</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=16&amp;doi=10.1021%2Fjm300542e&amp;key=10.1042%2FBJ20070797" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=8&amp;doi=10.1021%2Fjm300542e&amp;key=17850214" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=32&amp;doi=10.1021%2Fjm300542e&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlGmtbjE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=408&publication_year=2007&pages=297-315&author=J.+Bainauthor=L.+Platerauthor=M.+Elliottauthor=N.+Shapiroauthor=C.+J.+Hastieauthor=H.+McLauchlanauthor=I.+Klevernicauthor=J.+S.+Arthurauthor=D.+R.+Alessiauthor=P.+Cohen&title=The+selectivity+of+protein+kinase+inhibitors%3A+a+further+update"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7aR"><div class="casContent"><span class="casTitleNuber">7a</span><div class="casTitle"><span class="NLM_cas:atitle">The selectivity of protein kinase inhibitors: a further update</span></div><div class="casAuthors">Bain, Jenny; Plater, Lorna; Elliott, Matt; Shpiro, Natalia; Hastie, C. James; McLauchlan, Hilary; Klevernic, Iva; Arthur, J. Simon C.; Alessi, Dario R.; Cohen, Philip</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">408</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">297-315</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">The specificities of 65 compds. reported to be relatively specific inhibitors of protein kinases have been profiled against a panel of 70-80 protein kinases.  On the basis of this information, the effects of compds. that we have studied in cells and other data in the literature, we recommend the use of the following small-mol. inhibitors: SB 203580/SB202190 and BIRB 0796 to be used in parallel to assess the physiol. roles of p38 MAPK (mitogen-activated protein kinase) isoforms, PI-103 and wortmannin to be used in parallel to inhibit phosphatidylinositol (phosphoinositide) 3-kinases, PP1 or PP2 to be used in parallel with Src-I1 (Src inhibitor-1) to inhibit Src family members; PD 184352 or PD 0325901 to inhibit MKK1 (MAPK kinase-1) or MKK1 plus MKK5, Akt-I-1/2 to inhibit the activation of PKB (protein kinase B/Akt), rapamycin to inhibit TORC1 [mTOR (mammalian target of rapamycin)-raptor (regulatory assocd. protein of mTOR) complex], CT 99021 to inhibit GSK3 (glycogen synthase kinase 3), BI-D1870 and SL0101 or FMK (fluoromethylketone) to be used in parallel to inhibit RSK (ribosomal S6 kinase), D4476 to inhibit CK1 (casein kinase 1), VX680 to inhibit Aurora kinases, and roscovitine as a pan-CDK (cyclin-dependent kinase) inhibitor.  We have also identified harmine as a potent and specific inhibitor of DYRK1A (dual-specificity tyrosine-phosphorylated and -regulated kinase 1A) in vitro.  The results have further emphasized the need for considerable caution in using small-mol. inhibitors of protein kinases to assess the physiol. roles of these enzymes.  Despite being used widely, many of the compds. that we analyzed were too non-specific for useful conclusions to be made, other than to exclude the involvement of particular protein kinases in cellular processes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQPaieWftdVrVg90H21EOLACvtfcHk0lj68M-WXARxlg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlGmtbjE&md5=e2334e35897dd1b9770bbcca8f82bb9c</span></div><a href="/servlet/linkout?suffix=cit7a&amp;dbid=16384&amp;doi=10.1042%2FBJ20070797&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBJ20070797%26sid%3Dliteratum%253Aachs%26aulast%3DBain%26aufirst%3DJ.%26aulast%3DPlater%26aufirst%3DL.%26aulast%3DElliott%26aufirst%3DM.%26aulast%3DShapiro%26aufirst%3DN.%26aulast%3DHastie%26aufirst%3DC.%2BJ.%26aulast%3DMcLauchlan%26aufirst%3DH.%26aulast%3DKlevernic%26aufirst%3DI.%26aulast%3DArthur%26aufirst%3DJ.%2BS.%26aulast%3DAlessi%26aufirst%3DD.%2BR.%26aulast%3DCohen%26aufirst%3DP.%26atitle%3DThe%2520selectivity%2520of%2520protein%2520kinase%2520inhibitors%253A%2520a%2520further%2520update%26jtitle%3DBiochem.%2520J.%26date%3D2007%26volume%3D408%26spage%3D297%26epage%3D315" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit7b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Gockler, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fofre, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Papadopoulos, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soppa, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tejedor, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Becker, W.</span><span> </span><span class="NLM_article-title">Harmine specifically inhibits protein kinase DYRK1A and interferes with neurite formation</span> <span class="citation_source-journal">FEBS J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">276</span><span class="NLM_x">, </span> <span class="NLM_fpage">6324</span><span class="NLM_x">–</span> <span class="NLM_lpage">6337</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=2009&pages=6324-6337&author=N.+Gocklerauthor=G.+Fofreauthor=C.+Papadopoulosauthor=U.+Soppaauthor=F.+J.+Tejedorauthor=W.+Becker&title=Harmine+specifically+inhibits+protein+kinase+DYRK1A+and+interferes+with+neurite+formation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGockler%26aufirst%3DN.%26aulast%3DFofre%26aufirst%3DG.%26aulast%3DPapadopoulos%26aufirst%3DC.%26aulast%3DSoppa%26aufirst%3DU.%26aulast%3DTejedor%26aufirst%3DF.%2BJ.%26aulast%3DBecker%26aufirst%3DW.%26atitle%3DHarmine%2520specifically%2520inhibits%2520protein%2520kinase%2520DYRK1A%2520and%2520interferes%2520with%2520neurite%2520formation%26jtitle%3DFEBS%2520J.%26date%3D2009%26volume%3D276%26spage%3D6324%26epage%3D6337" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit7c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Seifert, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allan, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clarke, P. R.</span><span> </span><span class="NLM_article-title">DYRK1A phosphorylates caspase 9 at an inhibitory site and is potently inhibited in human cells by harmine</span> <span class="citation_source-journal">FEBS J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">275</span><span class="NLM_x">, </span> <span class="NLM_fpage">6268</span><span class="NLM_x">–</span> <span class="NLM_lpage">6280</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=275&publication_year=2008&pages=6268-6280&author=A.+Seifertauthor=L.+A.+Allanauthor=P.+R.+Clarke&title=DYRK1A+phosphorylates+caspase+9+at+an+inhibitory+site+and+is+potently+inhibited+in+human+cells+by+harmine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSeifert%26aufirst%3DA.%26aulast%3DAllan%26aufirst%3DL.%2BA.%26aulast%3DClarke%26aufirst%3DP.%2BR.%26atitle%3DDYRK1A%2520phosphorylates%2520caspase%25209%2520at%2520an%2520inhibitory%2520site%2520and%2520is%2520potently%2520inhibited%2520in%2520human%2520cells%2520by%2520harmine%26jtitle%3DFEBS%2520J.%26date%3D2008%26volume%3D275%26spage%3D6268%26epage%3D6280" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Laguna, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aranda, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barallobre, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barhoum, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernandez, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fotaki, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delabar, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de la Luna, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de la Villa, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arbones, M. L.</span><span> </span><span class="NLM_article-title">The protein kinase DYRK1A regulates caspase-9-mediated apoptosis during retina development</span> <span class="citation_source-journal">Dev. Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">841</span><span class="NLM_x">–</span> <span class="NLM_lpage">853</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2008&pages=841-853&author=A.+Lagunaauthor=S.+Arandaauthor=M.+J.+Barallobreauthor=R.+Barhoumauthor=E.+Fernandezauthor=V.+Fotakiauthor=J.+M.+Delabarauthor=S.+de+la+Lunaauthor=P.+de+la+Villaauthor=M.+L.+Arbones&title=The+protein+kinase+DYRK1A+regulates+caspase-9-mediated+apoptosis+during+retina+development"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLaguna%26aufirst%3DA.%26aulast%3DAranda%26aufirst%3DS.%26aulast%3DBarallobre%26aufirst%3DM.%2BJ.%26aulast%3DBarhoum%26aufirst%3DR.%26aulast%3DFernandez%26aufirst%3DE.%26aulast%3DFotaki%26aufirst%3DV.%26aulast%3DDelabar%26aufirst%3DJ.%2BM.%26aulast%3Dde%2Bla%2BLuna%26aufirst%3DS.%26aulast%3Dde%2Bla%2BVilla%26aufirst%3DP.%26aulast%3DArbones%26aufirst%3DM.%2BL.%26atitle%3DThe%2520protein%2520kinase%2520DYRK1A%2520regulates%2520caspase-9-mediated%2520apoptosis%2520during%2520retina%2520development%26jtitle%3DDev.%2520Cell%26date%3D2008%26volume%3D15%26spage%3D841%26epage%3D853" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">De Wit, N. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burtscher, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weidle, U. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruiter, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Muijen, G. N.</span><span> </span><span class="NLM_article-title">Differentially expressed genes identified in human melanoma cell lines with different metastatic behavior using high density oligonucleotide arrays</span> <span class="citation_source-journal">Melanoma Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">57</span><span class="NLM_x">–</span> <span class="NLM_lpage">69</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm300542e&amp;key=10.1097%2F00008390-200202000-00009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm300542e&amp;key=11828259" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm300542e&amp;key=1%3ACAS%3A528%3ADC%252BD38XitVCms70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2002&pages=57-69&author=N.+R.+De+Witauthor=H.+J.+Burtscherauthor=U.+H.+Weidleauthor=D.+J.+Ruiterauthor=G.+N.+van+Muijen&title=Differentially+expressed+genes+identified+in+human+melanoma+cell+lines+with+different+metastatic+behavior+using+high+density+oligonucleotide+arrays"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Differentially expressed genes identified in human melanoma cell lines with different metastatic behaviour using high density oligonucleotide arrays</span></div><div class="casAuthors">de Wit, N. J. W.; Burtscher, H. J.; Weidle, U. H.; Ruiter, D. J.; van Muijen, G. N. P.</div><div class="citationInfo"><span class="NLM_cas:title">Melanoma Research</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">57-69</span>CODEN:
                <span class="NLM_cas:coden">MREEEH</span>;
        ISSN:<span class="NLM_cas:issn">0960-8931</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">The increasing incidence of melanoma and the lack of effective treatment, with the exception of tumor excision before the onset of the metastatic phase, make it important to identify genes that may function as new mol. markers for diagnosis and/or prognosis or as new targets for therapy.  Recently, a new technique using high d. oligonucleotide arrays has been developed to simultaneously screen for the expression of thousands of genes.  We used this technique to compare the mRNA expression patterns of two human melanoma cell lines with different metastatic behavior.  Eight differentially expressed genes, namely apolipoprotein CII, tyrosinase-related protein 1, transforming growth factor-β superfamily, subtilisin-like protein, elongation factor 1 α2, α2-macroglobulin, human cell division cycle 10 and serine/threonine protein kinase (DYRK1A), were selected to validate the array results by Northern blotting and reverse transcription-polymerase chain reaction (RT-PCR).  Furthermore, a reliable correlation between differential expression of these genes in the melanoma cell lines and in fresh lesions of melanocytic tumor progression was demonstrated by RT-PCR anal.  Altogether, our data indicate that high d. oligonucleotide arrays are a valuable and reliable tool to screen for differentially expressed genes, and that our study may be considered a basic step in the characterization of genes that are involved in the (malignant) progression of melanoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0ksV0-jb2ErVg90H21EOLACvtfcHk0lh5vLUyFjMT6A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XitVCms70%253D&md5=435885e37026059ec6099c3b86b2fc40</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1097%2F00008390-200202000-00009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00008390-200202000-00009%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BWit%26aufirst%3DN.%2BR.%26aulast%3DBurtscher%26aufirst%3DH.%2BJ.%26aulast%3DWeidle%26aufirst%3DU.%2BH.%26aulast%3DRuiter%26aufirst%3DD.%2BJ.%26aulast%3Dvan%2BMuijen%26aufirst%3DG.%2BN.%26atitle%3DDifferentially%2520expressed%2520genes%2520identified%2520in%2520human%2520melanoma%2520cell%2520lines%2520with%2520different%2520metastatic%2520behavior%2520using%2520high%2520density%2520oligonucleotide%2520arrays%26jtitle%3DMelanoma%2520Res.%26date%3D2002%26volume%3D12%26spage%3D57%26epage%3D69" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Ma, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wink, M.</span><span> </span><span class="NLM_article-title">The beta-carboline alkaloid harmine inhibits BCRP and can reverse resistance to the anticancer drugs mitoxantrone and camptothecin in breast cancer cells</span> <span class="citation_source-journal">Phytother. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">146</span><span class="NLM_x">–</span> <span class="NLM_lpage">149</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm300542e&amp;key=10.1002%2Fptr.2860" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm300542e&amp;key=19548284" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm300542e&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhvFaisrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2010&pages=146-149&author=Y.+Maauthor=M.+Wink&title=The+beta-carboline+alkaloid+harmine+inhibits+BCRP+and+can+reverse+resistance+to+the+anticancer+drugs+mitoxantrone+and+camptothecin+in+breast+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">The beta-carboline alkaloid harmine inhibits BCRP and can reverse resistance to the anticancer drugs mitoxantrone and camptothecin in breast cancer cells</span></div><div class="casAuthors">Ma, Yonggang; Wink, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Phytotherapy Research</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">146-149</span>CODEN:
                <span class="NLM_cas:coden">PHYREH</span>;
        ISSN:<span class="NLM_cas:issn">0951-418X</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">Multidrug resistance (MDR), mediated by highly expressed ABC transporters, is one of the most important mechanisms in tumor cells.  Breast cancer resistance protein (BCRP) is a member of the ABC transporter family.  This transporter expels different kinds of lipophilic anticancer drugs, which have diffused into the cells.  In this study, 96-well plate based assays and flow cytometry anal. were employed to screen natural products for BCRP inhibition.  The beta-carboline alkaloid harmine inhibited BCRP in a BCRP overexpressing breast cancer cell line (MDA-MB-231).  Harmine reduced resistance to the anticancer drugs mitoxantrone and camptothecin mediated by BCRP and might be an interesting new reversal agent.  Harmine did not inhibit P-glycoprotein (P-gp) mediated drug efflux.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhvMeUkEGaD7Vg90H21EOLACvtfcHk0lh5vLUyFjMT6A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhvFaisrg%253D&md5=f9935424b4add4e0752713d6014724ee</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1002%2Fptr.2860&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fptr.2860%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DY.%26aulast%3DWink%26aufirst%3DM.%26atitle%3DThe%2520beta-carboline%2520alkaloid%2520harmine%2520inhibits%2520BCRP%2520and%2520can%2520reverse%2520resistance%2520to%2520the%2520anticancer%2520drugs%2520mitoxantrone%2520and%2520camptothecin%2520in%2520breast%2520cancer%2520cells%26jtitle%3DPhytother.%2520Res.%26date%3D2010%26volume%3D24%26spage%3D146%26epage%3D149" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Reniers, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robert, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frederick, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masereel, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vincent, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wouters, J.</span><span> </span><span class="NLM_article-title">Synthesis and evaluation of beta-carboline derivatives as potential monoamine oxidase inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">134</span><span class="NLM_x">–</span> <span class="NLM_lpage">144</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2011&pages=134-144&author=J.+Reniersauthor=S.+Robertauthor=R.+Frederickauthor=B.+Masereelauthor=S.+Vincentauthor=J.+Wouters&title=Synthesis+and+evaluation+of+beta-carboline+derivatives+as+potential+monoamine+oxidase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DReniers%26aufirst%3DJ.%26aulast%3DRobert%26aufirst%3DS.%26aulast%3DFrederick%26aufirst%3DR.%26aulast%3DMasereel%26aufirst%3DB.%26aulast%3DVincent%26aufirst%3DS.%26aulast%3DWouters%26aufirst%3DJ.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%2520beta-carboline%2520derivatives%2520as%2520potential%2520monoamine%2520oxidase%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2011%26volume%3D19%26spage%3D134%26epage%3D144" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Dumont, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ingrassia, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rouzeau, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ribaucour, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roland, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Darro, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lefranc, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiss, R.</span><span> </span><span class="NLM_article-title">The Amaryllidaceae isocarbostyril narciclasine induces apoptosis by activation of the death receptor and/or mitochondrial pathways in cancer cells but not in normal fibroblasts</span> <span class="citation_source-journal">Neoplasia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">766</span><span class="NLM_x">–</span> <span class="NLM_lpage">776</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2007&pages=766-776&author=P.+Dumontauthor=L.+Ingrassiaauthor=S.+Rouzeauauthor=F.+Ribaucourauthor=S.+Thomasauthor=I.+Rolandauthor=F.+Darroauthor=F.+Lefrancauthor=R.+Kiss&title=The+Amaryllidaceae+isocarbostyril+narciclasine+induces+apoptosis+by+activation+of+the+death+receptor+and%2For+mitochondrial+pathways+in+cancer+cells+but+not+in+normal+fibroblasts"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDumont%26aufirst%3DP.%26aulast%3DIngrassia%26aufirst%3DL.%26aulast%3DRouzeau%26aufirst%3DS.%26aulast%3DRibaucour%26aufirst%3DF.%26aulast%3DThomas%26aufirst%3DS.%26aulast%3DRoland%26aufirst%3DI.%26aulast%3DDarro%26aufirst%3DF.%26aulast%3DLefranc%26aufirst%3DF.%26aulast%3DKiss%26aufirst%3DR.%26atitle%3DThe%2520Amaryllidaceae%2520isocarbostyril%2520narciclasine%2520induces%2520apoptosis%2520by%2520activation%2520of%2520the%2520death%2520receptor%2520and%252For%2520mitochondrial%2520pathways%2520in%2520cancer%2520cells%2520but%2520not%2520in%2520normal%2520fibroblasts%26jtitle%3DNeoplasia%26date%3D2007%26volume%3D9%26spage%3D766%26epage%3D776" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit12b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Mathieu, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Nève, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Mercier, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dewelle, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaussin, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dehoux, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiss, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lefranc, F.</span><span> </span><span class="NLM_article-title">Combining bevacizumab with temozolomide increases the antitumor efficacy of temozolomide in a human glioblastoma orthotopic xenograft model</span> <span class="citation_source-journal">Neoplasia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">1383</span><span class="NLM_x">–</span> <span class="NLM_lpage">1392</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2008&pages=1383-1392&author=V.+Mathieuauthor=N.+De+N%C3%A8veauthor=M.+Le+Mercierauthor=J.+Dewelleauthor=J.+F.+Gaussinauthor=M.+Dehouxauthor=R.+Kissauthor=F.+Lefranc&title=Combining+bevacizumab+with+temozolomide+increases+the+antitumor+efficacy+of+temozolomide+in+a+human+glioblastoma+orthotopic+xenograft+model"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMathieu%26aufirst%3DV.%26aulast%3DDe%2BN%25C3%25A8ve%26aufirst%3DN.%26aulast%3DLe%2BMercier%26aufirst%3DM.%26aulast%3DDewelle%26aufirst%3DJ.%26aulast%3DGaussin%26aufirst%3DJ.%2BF.%26aulast%3DDehoux%26aufirst%3DM.%26aulast%3DKiss%26aufirst%3DR.%26aulast%3DLefranc%26aufirst%3DF.%26atitle%3DCombining%2520bevacizumab%2520with%2520temozolomide%2520increases%2520the%2520antitumor%2520efficacy%2520of%2520temozolomide%2520in%2520a%2520human%2520glioblastoma%2520orthotopic%2520xenograft%2520model%26jtitle%3DNeoplasia%26date%3D2008%26volume%3D10%26spage%3D1383%26epage%3D1392" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit12c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Ingrassia, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lefranc, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dewelle, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pottier, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathieu, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spiegl-Kreinecker, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sauvage, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">El Yazidi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dehoux, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berger, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Quaquebeke, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiss, R.</span><span> </span><span class="NLM_article-title">Structure–activity relationship analysis of novel derivatives of narciclasine (an Amaryllidaceae isocarbostyril derivative) as potential anticancer agents</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">1100</span><span class="NLM_x">–</span> <span class="NLM_lpage">1114</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm8013585" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=1100-1114&author=L.+Ingrassiaauthor=F.+Lefrancauthor=J.+Dewelleauthor=L.+Pottierauthor=V.+Mathieuauthor=S.+Spiegl-Kreineckerauthor=S.+Sauvageauthor=M.+El+Yazidiauthor=M.+Dehouxauthor=W.+Bergerauthor=E.+Van+Quaquebekeauthor=R.+Kiss&title=Structure%E2%80%93activity+relationship+analysis+of+novel+derivatives+of+narciclasine+%28an+Amaryllidaceae+isocarbostyril+derivative%29+as+potential+anticancer+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12c&amp;dbid=16384&amp;doi=10.1021%2Fjm8013585&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm8013585%26sid%3Dliteratum%253Aachs%26aulast%3DIngrassia%26aufirst%3DL.%26aulast%3DLefranc%26aufirst%3DF.%26aulast%3DDewelle%26aufirst%3DJ.%26aulast%3DPottier%26aufirst%3DL.%26aulast%3DMathieu%26aufirst%3DV.%26aulast%3DSpiegl-Kreinecker%26aufirst%3DS.%26aulast%3DSauvage%26aufirst%3DS.%26aulast%3DEl%2BYazidi%26aufirst%3DM.%26aulast%3DDehoux%26aufirst%3DM.%26aulast%3DBerger%26aufirst%3DW.%26aulast%3DVan%2BQuaquebeke%26aufirst%3DE.%26aulast%3DKiss%26aufirst%3DR.%26atitle%3DStructure%25E2%2580%2593activity%2520relationship%2520analysis%2520of%2520novel%2520derivatives%2520of%2520narciclasine%2520%2528an%2520Amaryllidaceae%2520isocarbostyril%2520derivative%2529%2520as%2520potential%2520anticancer%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D1100%26epage%3D1114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit12d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Lamoral-Theys, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andolfi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Goietsenoven, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cimmino, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Calvé, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wauthoz, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mégalizzi, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gras, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruyère, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dubois, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathieu, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kornienko, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiss, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evidente, A.</span><span> </span><span class="NLM_article-title">Lycorine, the main phenanthridine Amaryllidaceae alkaloid, exhibits significant antitumor activity in cancer cells that display resistance to proapoptotic stimuli: an investigation of structure–activity relationship and mechanistic insight</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">6244</span><span class="NLM_x">–</span> <span class="NLM_lpage">6256</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm901031h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=6244-6256&author=D.+Lamoral-Theysauthor=A.+Andolfiauthor=G.+Van+Goietsenovenauthor=A.+Cimminoauthor=B.+Le+Calv%C3%A9author=N.+Wauthozauthor=V.+M%C3%A9galizziauthor=T.+Grasauthor=C.+Bruy%C3%A8reauthor=J.+Duboisauthor=V.+Mathieuauthor=A.+Kornienkoauthor=R.+Kissauthor=A.+Evidente&title=Lycorine%2C+the+main+phenanthridine+Amaryllidaceae+alkaloid%2C+exhibits+significant+antitumor+activity+in+cancer+cells+that+display+resistance+to+proapoptotic+stimuli%3A+an+investigation+of+structure%E2%80%93activity+relationship+and+mechanistic+insight"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12d&amp;dbid=16384&amp;doi=10.1021%2Fjm901031h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901031h%26sid%3Dliteratum%253Aachs%26aulast%3DLamoral-Theys%26aufirst%3DD.%26aulast%3DAndolfi%26aufirst%3DA.%26aulast%3DVan%2BGoietsenoven%26aufirst%3DG.%26aulast%3DCimmino%26aufirst%3DA.%26aulast%3DLe%2BCalv%25C3%25A9%26aufirst%3DB.%26aulast%3DWauthoz%26aufirst%3DN.%26aulast%3DM%25C3%25A9galizzi%26aufirst%3DV.%26aulast%3DGras%26aufirst%3DT.%26aulast%3DBruy%25C3%25A8re%26aufirst%3DC.%26aulast%3DDubois%26aufirst%3DJ.%26aulast%3DMathieu%26aufirst%3DV.%26aulast%3DKornienko%26aufirst%3DA.%26aulast%3DKiss%26aufirst%3DR.%26aulast%3DEvidente%26aufirst%3DA.%26atitle%3DLycorine%252C%2520the%2520main%2520phenanthridine%2520Amaryllidaceae%2520alkaloid%252C%2520exhibits%2520significant%2520antitumor%2520activity%2520in%2520cancer%2520cells%2520that%2520display%2520resistance%2520to%2520proapoptotic%2520stimuli%253A%2520an%2520investigation%2520of%2520structure%25E2%2580%2593activity%2520relationship%2520and%2520mechanistic%2520insight%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D6244%26epage%3D6256" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Delbrouck, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doyen, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belot, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Decaestecker, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghanooni, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Lavareille, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaltner, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choufani, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Danguy, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vandenhoven, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gabius, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hasid, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiss, R.</span><span> </span><span class="NLM_article-title">Galectin-1 is overexpressed in nasal polyps under budesonide and inhibits eosinophil migration</span> <span class="citation_source-journal">Lab. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">82</span><span class="NLM_x">, </span> <span class="NLM_fpage">147</span><span class="NLM_x">–</span> <span class="NLM_lpage">158</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=2002&pages=147-158&author=C.+Delbrouckauthor=I.+Doyenauthor=N.+Belotauthor=C.+Decaesteckerauthor=R.+Ghanooniauthor=A.+de+Lavareilleauthor=H.+Kaltnerauthor=G.+Choufaniauthor=A.+Danguyauthor=G.+Vandenhovenauthor=H.+J.+Gabiusauthor=S.+Hasidauthor=R.+Kiss&title=Galectin-1+is+overexpressed+in+nasal+polyps+under+budesonide+and+inhibits+eosinophil+migration"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDelbrouck%26aufirst%3DC.%26aulast%3DDoyen%26aufirst%3DI.%26aulast%3DBelot%26aufirst%3DN.%26aulast%3DDecaestecker%26aufirst%3DC.%26aulast%3DGhanooni%26aufirst%3DR.%26aulast%3Dde%2BLavareille%26aufirst%3DA.%26aulast%3DKaltner%26aufirst%3DH.%26aulast%3DChoufani%26aufirst%3DG.%26aulast%3DDanguy%26aufirst%3DA.%26aulast%3DVandenhoven%26aufirst%3DG.%26aulast%3DGabius%26aufirst%3DH.%2BJ.%26aulast%3DHasid%26aufirst%3DS.%26aulast%3DKiss%26aufirst%3DR.%26atitle%3DGalectin-1%2520is%2520overexpressed%2520in%2520nasal%2520polyps%2520under%2520budesonide%2520and%2520inhibits%2520eosinophil%2520migration%26jtitle%3DLab.%2520Invest.%26date%3D2002%26volume%3D82%26spage%3D147%26epage%3D158" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit13b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Lefranc, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mijatovic, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathieu, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rorive, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Decaestecker, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Debeir, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brotchi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Ham, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salmon, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiss, R.</span><span> </span><span class="NLM_article-title">Characterization of gastrin-induced proangiogenic effects in vivo in orthotopic U373 experimental human glioblastomas and in vitro in human umbilical vein endothelial cells</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">8250</span><span class="NLM_x">–</span> <span class="NLM_lpage">8265</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13b&amp;dbid=16&amp;doi=10.1021%2Fjm300542e&amp;key=10.1158%2F1078-0432.CCR-04-0343" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13b&amp;dbid=8&amp;doi=10.1021%2Fjm300542e&amp;key=15623601" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13b&amp;dbid=32&amp;doi=10.1021%2Fjm300542e&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtFGjsrbP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2004&pages=8250-8265&author=F.+Lefrancauthor=T.+Mijatovicauthor=V.+Mathieuauthor=S.+Roriveauthor=C.+Decaesteckerauthor=O.+Debeirauthor=J.+Brotchiauthor=P.+Van+Hamauthor=I.+Salmonauthor=R.+Kiss&title=Characterization+of+gastrin-induced+proangiogenic+effects+in+vivo+in+orthotopic+U373+experimental+human+glioblastomas+and+in+vitro+in+human+umbilical+vein+endothelial+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13bR"><div class="casContent"><span class="casTitleNuber">13b</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of Gastrin-Induced Proangiogenic Effects In vivo in Orthotopic U373 Experimental Human Glioblastomas and In vitro in Human Umbilical Vein Endothelial Cells</span></div><div class="casAuthors">Lefranc, Florence; Mijatovic, Tatjana; Mathieu, Veronique; Rorive, Sandrine; Decaestecker, Christine; Debeir, Olivier; Brotchi, Jacques; Van Ham, Philippe; Salmon, Isabelle; Kiss, Robert</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">8250-8265</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">This study aims to investigate the role of gastrin-17 (G17) on angiogenesis features in gliomas both in vitro and in vivo.  The influences of G17 and G17 receptor antagonists were characterized in vitro in terms of angiogenesis on human umbilical vein endothelial cell (HUVEC) tubulogenesis processes on Matrigel and in vivo with respect to U373 orthotopic glioma xenografts.  The influence of phosphatidylinositol 3'-kinase, protein kinase C, and nuclear factor-κB inhibitors was characterized in vitro on G17-mediated HUVEC tubulogenesis.  G17-mediated release of interleukin (IL)-8 from HUVECs and G17-induced modifications in nuclear factor-κB DNA binding activity were characterized by means of specific enzyme-linked immunosorbent assays.  The influence of G17 on E- and P-selectin expression was detd. by means of computer-assisted microscopy, whereas the influence of E- and P-selectin on HUVEC migration was approached by means of antisense oligonucleotides.  The chemotactic influence of G17 and IL-8 on HUVEC migration was characterized by means of computer-assisted video microscopy with Dunn chambers.  mRNAs for cholecystokinin (CCK)A, CCKB, and CCKC receptors were present in HUVECs and microvessels dissected from a human glioblastoma.  Whereas G17 significantly increased the levels of angiogenesis in vivo in the U373 exptl. glioma model and in vitro in the HUVECs, the CCKB receptor antagonist L365,260 significantly counteracted the G17-mediated proangiogenic effects.  G17 chemoattracted HUVECs, whereas IL-8 failed to do so.  IL-8 receptor α (CXCR1) and IL-8 receptor β (CXCR2) mRNAs were not detected in these endothelial cells.  Gastrin significantly (but only transiently) decreased the level of expression of E-selectin, but not P-selectin, whereas IL-8 increased the expression of E-selectin.  Specific antisense oligonucleotides against E- and P-selectin significantly decreased HUVEC tubulogenesis processes in vitro on Matrigel.  The present study shows that gastrin has marked proangiogenic effects in vivo on exptl. gliomas and in vitro on HUVECs.  This effect depends in part on the level of E-selectin activation, but not on IL-8 expression/release by HUVECs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq8cHS8prXYSLVg90H21EOLACvtfcHk0lhCSAMX6nlnog"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtFGjsrbP&md5=af49f260b2c7e2aa793c99bee09fe65d</span></div><a href="/servlet/linkout?suffix=cit13b&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-04-0343&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-04-0343%26sid%3Dliteratum%253Aachs%26aulast%3DLefranc%26aufirst%3DF.%26aulast%3DMijatovic%26aufirst%3DT.%26aulast%3DMathieu%26aufirst%3DV.%26aulast%3DRorive%26aufirst%3DS.%26aulast%3DDecaestecker%26aufirst%3DC.%26aulast%3DDebeir%26aufirst%3DO.%26aulast%3DBrotchi%26aufirst%3DJ.%26aulast%3DVan%2BHam%26aufirst%3DP.%26aulast%3DSalmon%26aufirst%3DI.%26aulast%3DKiss%26aufirst%3DR.%26atitle%3DCharacterization%2520of%2520gastrin-induced%2520proangiogenic%2520effects%2520in%2520vivo%2520in%2520orthotopic%2520U373%2520experimental%2520human%2520glioblastomas%2520and%2520in%2520vitro%2520in%2520human%2520umbilical%2520vein%2520endothelial%2520cells%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2004%26volume%3D10%26spage%3D8250%26epage%3D8265" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit13c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Mathieu, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pirker, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">martin de Lasalle, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vernier, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mijatovic, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Nève, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaussin, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dehoux, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lefranc, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berger, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiss, R.</span><span> </span><span class="NLM_article-title">The sodium pump alpha-1 subunit: a disease progression-related target for metastatic melanoma treatment</span> <span class="citation_source-journal">J. Cell. Mol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">3960</span><span class="NLM_x">–</span> <span class="NLM_lpage">3972</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13c&amp;dbid=16&amp;doi=10.1021%2Fjm300542e&amp;key=10.1111%2Fj.1582-4934.2009.00708.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13c&amp;dbid=8&amp;doi=10.1021%2Fjm300542e&amp;key=19243476" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13c&amp;dbid=32&amp;doi=10.1021%2Fjm300542e&amp;key=1%3ACAS%3A280%3ADC%252BC3c7kvFChsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2009&pages=3960-3972&author=V.+Mathieuauthor=C.+Pirkerauthor=E.+martin+de+Lasalleauthor=M.+Vernierauthor=T.+Mijatovicauthor=N.+De+N%C3%A8veauthor=J.+F.+Gaussinauthor=M.+Dehouxauthor=F.+Lefrancauthor=W.+Bergerauthor=R.+Kiss&title=The+sodium+pump+alpha-1+subunit%3A+a+disease+progression-related+target+for+metastatic+melanoma+treatment"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13cR"><div class="casContent"><span class="casTitleNuber">13c</span><div class="casTitle"><span class="NLM_cas:atitle">The sodium pump alpha1 sub-unit: a disease progression-related target for metastatic melanoma treatment</span></div><div class="casAuthors">Mathieu Veronique; Pirker Christine; Martin de Lassalle Elisabeth; Vernier Mathieu; Mijatovic Tatjana; DeNeve Nancy; Gaussin Jean-Francois; Dehoux Mischael; Lefranc Florence; Berger Walter; Kiss Robert</div><div class="citationInfo"><span class="NLM_cas:title">Journal of cellular and molecular medicine</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">9B</span>),
    <span class="NLM_cas:pages">3960-72</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Melanomas remain associated with dismal prognosis because they are naturally resistant to apoptosis and they markedly metastasize.  Up-regulated expression of sodium pump alpha sub-units has previously been demonstrated when comparing metastatic to non-metastatic melanomas.  Our previous data revealed that impairing sodium pump alpha1 activity by means of selective ligands, that are cardiotonic steroids, markedly impairs cell migration and kills apoptosis-resistant cancer cells.  The objective of this study was to determine the expression levels of sodium pump alpha sub-units in melanoma clinical samples and cell lines and also to characterize the role of alpha1 sub-units in melanoma cell biology.  Quantitative RT-PCR, Western blotting and immunohistochemistry were used to determine the expression levels of sodium pump alpha sub-units.  In vitro cytotoxicity of various cardenolides and of an anti-alpha1 siRNA was evaluated by means of MTT assay, quantitative videomicroscopy and through apoptosis assays.  The in vivo activity of a novel cardenolide UNBS1450 was evaluated in a melanoma brain metastasis model.  Our data show that all investigated human melanoma cell lines expressed high levels of the alpha1 sub-unit, and 33% of human melanomas displayed significant alpha1 sub-unit expression in correlation with the Breslow index.  Furthermore, cardenolides (notably UNBS1450; currently in Phase I clinical trials) displayed marked anti-tumour effects against melanomas in vitro.  This activity was closely paralleled by decreases in cMyc expression and by increases in apoptotic features.  UNBS1450 also displayed marked anti-tumour activity in the aggressive human metastatic brain melanoma model in vivo.  The alpha1 sodium pump sub-unit could represent a potential novel target for combating melanoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRCeneUQpTcEu_Q9URG6Dx8fW6udTcc2ea303j9ljLmdLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3c7kvFChsA%253D%253D&md5=6079d92a5eb05e978a79319a3c4db2eb</span></div><a href="/servlet/linkout?suffix=cit13c&amp;dbid=16384&amp;doi=10.1111%2Fj.1582-4934.2009.00708.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1582-4934.2009.00708.x%26sid%3Dliteratum%253Aachs%26aulast%3DMathieu%26aufirst%3DV.%26aulast%3DPirker%26aufirst%3DC.%26aulast%3Dmartin%2Bde%2BLasalle%26aufirst%3DE.%26aulast%3DVernier%26aufirst%3DM.%26aulast%3DMijatovic%26aufirst%3DT.%26aulast%3DDe%2BN%25C3%25A8ve%26aufirst%3DN.%26aulast%3DGaussin%26aufirst%3DJ.%2BF.%26aulast%3DDehoux%26aufirst%3DM.%26aulast%3DLefranc%26aufirst%3DF.%26aulast%3DBerger%26aufirst%3DW.%26aulast%3DKiss%26aufirst%3DR.%26atitle%3DThe%2520sodium%2520pump%2520alpha-1%2520subunit%253A%2520a%2520disease%2520progression-related%2520target%2520for%2520metastatic%2520melanoma%2520treatment%26jtitle%3DJ.%2520Cell.%2520Mol.%2520Med.%26date%3D2009%26volume%3D13%26spage%3D3960%26epage%3D3972" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit13d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Van Goietsenoven, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hutton, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Becker, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lallemand, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robert, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lefranc, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pirker, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vandenbussche, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Antwerpen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evidente, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berger, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prévost, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pelletier, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiss, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kinzy, T. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kornienko, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathieu, V.</span><span> </span><span class="NLM_article-title">Targeting of eEF1A with Anaryllidaceae isocarbostyrils as a strategy to combat melanomas</span> <span class="citation_source-journal">FASEB J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">4575</span><span class="NLM_x">–</span> <span class="NLM_lpage">4584</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2010&pages=4575-4584&author=G.+Van+Goietsenovenauthor=J.+Huttonauthor=J.+P.+Beckerauthor=B.+Lallemandauthor=F.+Robertauthor=F.+Lefrancauthor=C.+Pirkerauthor=G.+Vandenbusscheauthor=P.+Van+Antwerpenauthor=A.+Evidenteauthor=W.+Bergerauthor=M.+Pr%C3%A9vostauthor=J.+Pelletierauthor=R.+Kissauthor=T.+G.+Kinzyauthor=A.+Kornienkoauthor=V.+Mathieu&title=Targeting+of+eEF1A+with+Anaryllidaceae+isocarbostyrils+as+a+strategy+to+combat+melanomas"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2BGoietsenoven%26aufirst%3DG.%26aulast%3DHutton%26aufirst%3DJ.%26aulast%3DBecker%26aufirst%3DJ.%2BP.%26aulast%3DLallemand%26aufirst%3DB.%26aulast%3DRobert%26aufirst%3DF.%26aulast%3DLefranc%26aufirst%3DF.%26aulast%3DPirker%26aufirst%3DC.%26aulast%3DVandenbussche%26aufirst%3DG.%26aulast%3DVan%2BAntwerpen%26aufirst%3DP.%26aulast%3DEvidente%26aufirst%3DA.%26aulast%3DBerger%26aufirst%3DW.%26aulast%3DPr%25C3%25A9vost%26aufirst%3DM.%26aulast%3DPelletier%26aufirst%3DJ.%26aulast%3DKiss%26aufirst%3DR.%26aulast%3DKinzy%26aufirst%3DT.%2BG.%26aulast%3DKornienko%26aufirst%3DA.%26aulast%3DMathieu%26aufirst%3DV.%26atitle%3DTargeting%2520of%2520eEF1A%2520with%2520Anaryllidaceae%2520isocarbostyrils%2520as%2520a%2520strategy%2520to%2520combat%2520melanomas%26jtitle%3DFASEB%2520J.%26date%3D2010%26volume%3D24%26spage%3D4575%26epage%3D4584" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Branle, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lefranc, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Camby, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeuken, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geurts-Moespot, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sprenger, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sweep, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiss, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salmon, I.</span><span> </span><span class="NLM_article-title">Evaluation of the efficiency of chemotherapy in in vivo orthtopic models of human glioma cells with and without 1p19q deletions and in C6 rat orthotopic allografts serving for the evaluation of surgery combined with chemotherapy</span> <span class="citation_source-journal">Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">95</span><span class="NLM_x">, </span> <span class="NLM_fpage">641</span><span class="NLM_x">–</span> <span class="NLM_lpage">655</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=2002&pages=641-655&author=F.+Branleauthor=F.+Lefrancauthor=I.+Cambyauthor=J.+Jeukenauthor=A.+Geurts-Moespotauthor=S.+Sprengerauthor=F.+Sweepauthor=R.+Kissauthor=I.+Salmon&title=Evaluation+of+the+efficiency+of+chemotherapy+in+in+vivo+orthtopic+models+of+human+glioma+cells+with+and+without+1p19q+deletions+and+in+C6+rat+orthotopic+allografts+serving+for+the+evaluation+of+surgery+combined+with+chemotherapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBranle%26aufirst%3DF.%26aulast%3DLefranc%26aufirst%3DF.%26aulast%3DCamby%26aufirst%3DI.%26aulast%3DJeuken%26aufirst%3DJ.%26aulast%3DGeurts-Moespot%26aufirst%3DA.%26aulast%3DSprenger%26aufirst%3DS.%26aulast%3DSweep%26aufirst%3DF.%26aulast%3DKiss%26aufirst%3DR.%26aulast%3DSalmon%26aufirst%3DI.%26atitle%3DEvaluation%2520of%2520the%2520efficiency%2520of%2520chemotherapy%2520in%2520in%2520vivo%2520orthtopic%2520models%2520of%2520human%2520glioma%2520cells%2520with%2520and%2520without%25201p19q%2520deletions%2520and%2520in%2520C6%2520rat%2520orthotopic%2520allografts%2520serving%2520for%2520the%2520evaluation%2520of%2520surgery%2520combined%2520with%2520chemotherapy%26jtitle%3DCancer%26date%3D2002%26volume%3D95%26spage%3D641%26epage%3D655" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span>Developmental Therapeutic Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Rockville, MD, U.S. <a href="http://dtp.cancer.gov" class="extLink">http://dtp.cancer.gov</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Developmental+Therapeutic+Program%2C+Division+of+Cancer+Treatment+and+Diagnosis%2C+National+Cancer+Institute%2C+Rockville%2C+MD%2C+U.S.+http%3A%2F%2Fdtp.cancer.gov."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Larsson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gottfries, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bohlin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Backlund, A.</span><span> </span><span class="NLM_article-title">Expanding the ChemGPS chemical space with natural products</span> <span class="citation_source-journal">J. Nat. Prod.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">985</span><span class="NLM_x">–</span> <span class="NLM_lpage">991</span></span><div class="citationLinks">[<a href="/doi/10.1021/np049655u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2005&pages=985-991&author=J.+Larssonauthor=J.+Gottfriesauthor=L.+Bohlinauthor=A.+Backlund&title=Expanding+the+ChemGPS+chemical+space+with+natural+products"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16a&amp;dbid=16384&amp;doi=10.1021%2Fnp049655u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fnp049655u%26sid%3Dliteratum%253Aachs%26aulast%3DLarsson%26aufirst%3DJ.%26aulast%3DGottfries%26aufirst%3DJ.%26aulast%3DBohlin%26aufirst%3DL.%26aulast%3DBacklund%26aufirst%3DA.%26atitle%3DExpanding%2520the%2520ChemGPS%2520chemical%2520space%2520with%2520natural%2520products%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D2005%26volume%3D68%26spage%3D985%26epage%3D991" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit16b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Larsson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gottfries, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muresan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Backlund, A.</span><span> </span><span class="NLM_article-title">ChemGPS-NP: tuned for navigation in biologically relevant chemical space</span> <span class="citation_source-journal">J. Nat. Prod.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">789</span><span class="NLM_x">–</span> <span class="NLM_lpage">794</span></span><div class="citationLinks">[<a href="/doi/10.1021/np070002y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2007&pages=789-794&author=J.+Larssonauthor=J.+Gottfriesauthor=S.+Muresanauthor=A.+Backlund&title=ChemGPS-NP%3A+tuned+for+navigation+in+biologically+relevant+chemical+space"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16b&amp;dbid=16384&amp;doi=10.1021%2Fnp070002y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fnp070002y%26sid%3Dliteratum%253Aachs%26aulast%3DLarsson%26aufirst%3DJ.%26aulast%3DGottfries%26aufirst%3DJ.%26aulast%3DMuresan%26aufirst%3DS.%26aulast%3DBacklund%26aufirst%3DA.%26atitle%3DChemGPS-NP%253A%2520tuned%2520for%2520navigation%2520in%2520biologically%2520relevant%2520chemical%2520space%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D2007%26volume%3D70%26spage%3D789%26epage%3D794" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit16c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Rosen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lövgren, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kogej, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muresan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gottfries, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Backlund, A.</span><span> </span><span class="NLM_article-title">ChemGPS-NP<sub>Web</sub>: chemical space navigation online</span> <span class="citation_source-journal">J. Comput.-Aided Mol. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">253</span><span class="NLM_x">–</span> <span class="NLM_lpage">259</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2009&pages=253-259&author=J.+Rosenauthor=A.+L%C3%B6vgrenauthor=T.+Kogejauthor=S.+Muresanauthor=J.+Gottfriesauthor=A.+Backlund&title=ChemGPS-NPWeb%3A+chemical+space+navigation+online"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRosen%26aufirst%3DJ.%26aulast%3DL%25C3%25B6vgren%26aufirst%3DA.%26aulast%3DKogej%26aufirst%3DT.%26aulast%3DMuresan%26aufirst%3DS.%26aulast%3DGottfries%26aufirst%3DJ.%26aulast%3DBacklund%26aufirst%3DA.%26atitle%3DChemGPS-NPWeb%253A%2520chemical%2520space%2520navigation%2520online%26jtitle%3DJ.%2520Comput.-Aided%2520Mol.%2520Des.%26date%3D2009%26volume%3D23%26spage%3D253%26epage%3D259" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Belot, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rorive, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doyen, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lefranc, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruyneel, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dedecker, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Micik, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brotchi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Decaestecker, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salmon, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiss, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Camby, I.</span><span> </span><span class="NLM_article-title">Molecular characterization of cell substratum attachments in human glial tumors relates to prognostic features</span> <span class="citation_source-journal">Glia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">375</span><span class="NLM_x">–</span> <span class="NLM_lpage">390</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2001&pages=375-390&author=N.+Belotauthor=S.+Roriveauthor=I.+Doyenauthor=F.+Lefrancauthor=E.+Bruyneelauthor=R.+Dedeckerauthor=S.+Micikauthor=J.+Brotchiauthor=C.+Decaesteckerauthor=I.+Salmonauthor=R.+Kissauthor=I.+Camby&title=Molecular+characterization+of+cell+substratum+attachments+in+human+glial+tumors+relates+to+prognostic+features"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBelot%26aufirst%3DN.%26aulast%3DRorive%26aufirst%3DS.%26aulast%3DDoyen%26aufirst%3DI.%26aulast%3DLefranc%26aufirst%3DF.%26aulast%3DBruyneel%26aufirst%3DE.%26aulast%3DDedecker%26aufirst%3DR.%26aulast%3DMicik%26aufirst%3DS.%26aulast%3DBrotchi%26aufirst%3DJ.%26aulast%3DDecaestecker%26aufirst%3DC.%26aulast%3DSalmon%26aufirst%3DI.%26aulast%3DKiss%26aufirst%3DR.%26aulast%3DCamby%26aufirst%3DI.%26atitle%3DMolecular%2520characterization%2520of%2520cell%2520substratum%2520attachments%2520in%2520human%2520glial%2520tumors%2520relates%2520to%2520prognostic%2520features%26jtitle%3DGlia%26date%3D2001%26volume%3D36%26spage%3D375%26epage%3D390" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit17b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Sivasankaran, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Degen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghaffari, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hegi, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamou, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ionescu, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zweifel, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tolnay, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wasner, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mergenthaler, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miserez, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiss, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lino, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merlo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiquet-Ehrismann, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boulay, J. L.</span><span> </span><span class="NLM_article-title">Tenascin-C is a novel RBPJkappa-induced target gene for Notch signaling in gliomas</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x">, </span> <span class="NLM_fpage">458</span><span class="NLM_x">–</span> <span class="NLM_lpage">465</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2009&pages=458-465&author=B.+Sivasankaranauthor=M.+Degenauthor=A.+Ghaffariauthor=M.+E.+Hegiauthor=M.+F.+Hamouauthor=M.+C.+Ionescuauthor=C.+Zweifelauthor=M.+Tolnayauthor=M.+Wasnerauthor=S.+Mergenthalerauthor=A.+R.+Miserezauthor=R.+Kissauthor=M.+M.+Linoauthor=A.+Merloauthor=R.+Chiquet-Ehrismannauthor=J.+L.+Boulay&title=Tenascin-C+is+a+novel+RBPJkappa-induced+target+gene+for+Notch+signaling+in+gliomas"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSivasankaran%26aufirst%3DB.%26aulast%3DDegen%26aufirst%3DM.%26aulast%3DGhaffari%26aufirst%3DA.%26aulast%3DHegi%26aufirst%3DM.%2BE.%26aulast%3DHamou%26aufirst%3DM.%2BF.%26aulast%3DIonescu%26aufirst%3DM.%2BC.%26aulast%3DZweifel%26aufirst%3DC.%26aulast%3DTolnay%26aufirst%3DM.%26aulast%3DWasner%26aufirst%3DM.%26aulast%3DMergenthaler%26aufirst%3DS.%26aulast%3DMiserez%26aufirst%3DA.%2BR.%26aulast%3DKiss%26aufirst%3DR.%26aulast%3DLino%26aufirst%3DM.%2BM.%26aulast%3DMerlo%26aufirst%3DA.%26aulast%3DChiquet-Ehrismann%26aufirst%3DR.%26aulast%3DBoulay%26aufirst%3DJ.%2BL.%26atitle%3DTenascin-C%2520is%2520a%2520novel%2520RBPJkappa-induced%2520target%2520gene%2520for%2520Notch%2520signaling%2520in%2520gliomas%26jtitle%3DCancer%2520Res.%26date%3D2009%26volume%3D69%26spage%3D458%26epage%3D465" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Yang, B. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiao, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roa, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krammer, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hao, C.</span><span> </span><span class="NLM_article-title">Calcium/calmodulin-dependent protein kinase II regulation of c-FLIP expression and phosphorylation in modulation of Fas-mediated signaling in malignant glioma cells</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">278</span><span class="NLM_x">, </span> <span class="NLM_fpage">7043</span><span class="NLM_x">–</span> <span class="NLM_lpage">7050</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=278&publication_year=2003&pages=7043-7050&author=B.+F.+Yangauthor=C.+Xiaoauthor=W.+H.+Roaauthor=P.+H.+Krammerauthor=C.+Hao&title=Calcium%2Fcalmodulin-dependent+protein+kinase+II+regulation+of+c-FLIP+expression+and+phosphorylation+in+modulation+of+Fas-mediated+signaling+in+malignant+glioma+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DB.%2BF.%26aulast%3DXiao%26aufirst%3DC.%26aulast%3DRoa%26aufirst%3DW.%2BH.%26aulast%3DKrammer%26aufirst%3DP.%2BH.%26aulast%3DHao%26aufirst%3DC.%26atitle%3DCalcium%252Fcalmodulin-dependent%2520protein%2520kinase%2520II%2520regulation%2520of%2520c-FLIP%2520expression%2520and%2520phosphorylation%2520in%2520modulation%2520of%2520Fas-mediated%2520signaling%2520in%2520malignant%2520glioma%2520cells%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2003%26volume%3D278%26spage%3D7043%26epage%3D7050" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit18b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Takai, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ueda, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nasu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamashita, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toyofuku, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narahara, H.</span><span> </span><span class="NLM_article-title">Targeting calcium/calmodulin-dependence kinase I and II as a potential anti-proliferation remedy for endometrial carcinomas</span> <span class="citation_source-journal">Cancer Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">277</span><span class="NLM_x">, </span> <span class="NLM_fpage">235</span><span class="NLM_x">–</span> <span class="NLM_lpage">243</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18b&amp;dbid=16&amp;doi=10.1021%2Fjm300542e&amp;key=10.1016%2Fj.canlet.2008.12.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18b&amp;dbid=8&amp;doi=10.1021%2Fjm300542e&amp;key=19168280" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18b&amp;dbid=32&amp;doi=10.1021%2Fjm300542e&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjslOkur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=277&publication_year=2009&pages=235-243&author=N.+Takaiauthor=T.+Uedaauthor=K.+Nasuauthor=S.+Yamashitaauthor=M.+Toyofukuauthor=H.+Narahara&title=Targeting+calcium%2Fcalmodulin-dependence+kinase+I+and+II+as+a+potential+anti-proliferation+remedy+for+endometrial+carcinomas"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18bR"><div class="casContent"><span class="casTitleNuber">18b</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting calcium/calmodulin-dependence kinase I and II as a potential anti-proliferation remedy for endometrial carcinomas</span></div><div class="casAuthors">Takai, Noriyuki; Ueda, Tami; Nasu, Kaei; Yamashita, Satoko; Toyofuku, Mayo; Narahara, Hisashi</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (Shannon, Ireland)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">277</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">235-243</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ireland Ltd.</span>)
        </div><div class="casAbstract">Calcium/calmodulin-dependent kinase (CaMK) I and II expression in endometrial cancer cells correlates with the malignant potential of this tumor, and CaMKI and II are potential therapeutic targets in endometrial cancer.  CaMKI and II expression was significantly assocd. with PCNA-labeling index, clin. stage, histol. grade, the presence of invasion to greater than one-half the myometrium, and clin. outcome.  All endometrial cancer cell lines examd. were sensitive to the growth-inhibitory effect of KN-93, a membrane-permeant CaMKs-selective inhibitor that is competitive with calmodulin.  KN-93 induced the G0/G1 arrest and apoptosis, rising hopes that KN-93 may become a useful treatment for endometrial cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1tIL7-RVb8bVg90H21EOLACvtfcHk0lh8uJgqyiZkMg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjslOkur0%253D&md5=966437e19b1ecc88cc4809666f5312e9</span></div><a href="/servlet/linkout?suffix=cit18b&amp;dbid=16384&amp;doi=10.1016%2Fj.canlet.2008.12.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.canlet.2008.12.018%26sid%3Dliteratum%253Aachs%26aulast%3DTakai%26aufirst%3DN.%26aulast%3DUeda%26aufirst%3DT.%26aulast%3DNasu%26aufirst%3DK.%26aulast%3DYamashita%26aufirst%3DS.%26aulast%3DToyofuku%26aufirst%3DM.%26aulast%3DNarahara%26aufirst%3DH.%26atitle%3DTargeting%2520calcium%252Fcalmodulin-dependence%2520kinase%2520I%2520and%2520II%2520as%2520a%2520potential%2520anti-proliferation%2520remedy%2520for%2520endometrial%2520carcinomas%26jtitle%3DCancer%2520Lett.%26date%3D2009%26volume%3D277%26spage%3D235%26epage%3D243" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit18c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Han, Y. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yourek, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, Y. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia, J. G.</span><span> </span><span class="NLM_article-title">A transcribed pseudogene of MYLK promotes cell proliferation</span> <span class="citation_source-journal">FASEB J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">2305</span><span class="NLM_x">–</span> <span class="NLM_lpage">2312</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2011&pages=2305-2312&author=Y.+J.+Hanauthor=S.+F.+Maauthor=G.+Yourekauthor=Y.+D.+Parkauthor=J.+G.+Garcia&title=A+transcribed+pseudogene+of+MYLK+promotes+cell+proliferation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHan%26aufirst%3DY.%2BJ.%26aulast%3DMa%26aufirst%3DS.%2BF.%26aulast%3DYourek%26aufirst%3DG.%26aulast%3DPark%26aufirst%3DY.%2BD.%26aulast%3DGarcia%26aufirst%3DJ.%2BG.%26atitle%3DA%2520transcribed%2520pseudogene%2520of%2520MYLK%2520promotes%2520cell%2520proliferation%26jtitle%3DFASEB%2520J.%26date%3D2011%26volume%3D25%26spage%3D2305%26epage%3D2312" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit18d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Horbelt, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denkis, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knaus, P.</span><span> </span><span class="NLM_article-title">A portrait of transforming growth factor beta superfamily signaling: background matters</span> <span class="citation_source-journal">Int. J. Biochem. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">469</span><span class="NLM_x">–</span> <span class="NLM_lpage">474</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18d&amp;dbid=16&amp;doi=10.1021%2Fjm300542e&amp;key=10.1016%2Fj.biocel.2011.12.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18d&amp;dbid=8&amp;doi=10.1021%2Fjm300542e&amp;key=22226817" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18d&amp;dbid=32&amp;doi=10.1021%2Fjm300542e&amp;key=1%3ACAS%3A528%3ADC%252BC38XjtFSntrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2012&pages=469-474&author=D.+Horbeltauthor=A.+Denkisauthor=P.+Knaus&title=A+portrait+of+transforming+growth+factor+beta+superfamily+signaling%3A+background+matters"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18dR"><div class="casContent"><span class="casTitleNuber">18d</span><div class="casTitle"><span class="NLM_cas:atitle">A portrait of Transforming Growth Factor β superfamily signalling: Background matters</span></div><div class="casAuthors">Horbelt, Daniel; Denkis, Agnieszka; Knaus, Petra</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Biochemistry & Cell Biology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">469-474</span>CODEN:
                <span class="NLM_cas:coden">IJBBFU</span>;
        ISSN:<span class="NLM_cas:issn">1357-2725</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Ligands of the Transforming Growth Factor β superfamily like Transforming Growth Factor β and Bone Morphogenetic Proteins govern developmental processes and regulate adult homeostasis by controlling cellular proliferation, survival, differentiation and migration.  Aberrant signaling activity is assocd. with human disorders such as cancer, cardiovascular, musculoskeletal, or fibrotic disease.  Upon binding to specific sets of cognate cell surface receptors, family members induce highly similar pathways which include canonical SMAD dependent signaling as well as pathways without direct involvement of SMAD proteins, which activate signaling mols. like mitogen-activated protein kinases or small GTPases.  The diverse ligand functionalities are achieved through regulation and modulation of the pathways at all levels, resulting in a highly quant. and context sensitive signal integration reflecting the cellular state and background.  Strategies to target Transforming Growth Factor β or Bone Morphogenetic Protein pathways have been developed on the basis of our current understanding and have proven a highly beneficial potential.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovmtIcciglvrVg90H21EOLACvtfcHk0lh8uJgqyiZkMg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XjtFSntrY%253D&md5=975270eb4bf67755263ebf5a41673644</span></div><a href="/servlet/linkout?suffix=cit18d&amp;dbid=16384&amp;doi=10.1016%2Fj.biocel.2011.12.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biocel.2011.12.013%26sid%3Dliteratum%253Aachs%26aulast%3DHorbelt%26aufirst%3DD.%26aulast%3DDenkis%26aufirst%3DA.%26aulast%3DKnaus%26aufirst%3DP.%26atitle%3DA%2520portrait%2520of%2520transforming%2520growth%2520factor%2520beta%2520superfamily%2520signaling%253A%2520background%2520matters%26jtitle%3DInt.%2520J.%2520Biochem.%2520Cell%2520Biol.%26date%3D2012%26volume%3D44%26spage%3D469%26epage%3D474" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit18e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Wang, P.; Yu, J.; Yin, Q.; Li, W.; Ren, X.; Hao, X.</span><span> </span><span class="NLM_article-title">Rosiglitazone suppresses glioma cell growth and cell cycle by blocking the transforming growth factor-beta mediated pathway</span>.  <span class="citation_source-journal">Neurochem. Res.</span> [Online early access]. DOI: <span class="refDoi"> DOI: 10.1007/s11064-012-0828-8</span> . Published Online:<span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18e&amp;dbid=16&amp;doi=10.1021%2Fjm300542e&amp;key=10.1007%2Fs11064-012-0828-8" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=P.+Wang&author=J.+Yu&author=Q.+Yin&author=W.+Li&author=X.+Ren&author=X.+Hao&title=Rosiglitazone+suppresses+glioma+cell+growth+and+cell+cycle+by+blocking+the+transforming+growth+factor-beta+mediated+pathway&doi=10.1007%2Fs11064-012-0828-8"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18e&amp;dbid=16384&amp;doi=10.1007%2Fs11064-012-0828-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11064-012-0828-8%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DP.%26atitle%3DRosiglitazone%2520suppresses%2520glioma%2520cell%2520growth%2520and%2520cell%2520cycle%2520by%2520blocking%2520the%2520transforming%2520growth%2520factor-beta%2520mediated%2520pathway%26jtitle%3DNeurochem.%2520Res.%26doi%3D10.1007%2Fs11064-012-0828-8%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit18f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Zoubeidi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rocha, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zouanat, F. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamel, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scarlata, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aprikian, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chevalier, S.</span><span> </span><span class="NLM_article-title">The Fer tyrosine kinase cooperates with interleukin-6 to activate signal transducer and activator of transcription 3 and promote human prostate cancer cell growth</span> <span class="citation_source-journal">Mol. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">142</span><span class="NLM_x">–</span> <span class="NLM_lpage">155</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18f&amp;dbid=16&amp;doi=10.1021%2Fjm300542e&amp;key=10.1158%2F1541-7786.MCR-08-0117" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18f&amp;dbid=8&amp;doi=10.1021%2Fjm300542e&amp;key=19147545" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18f&amp;dbid=32&amp;doi=10.1021%2Fjm300542e&amp;key=1%3ACAS%3A528%3ADC%252BD1MXltV2luw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2009&pages=142-155&author=A.+Zoubeidiauthor=J.+Rochaauthor=F.+Z.+Zouanatauthor=L.+Hamelauthor=E.+Scarlataauthor=A.+G.+Aprikianauthor=S.+Chevalier&title=The+Fer+tyrosine+kinase+cooperates+with+interleukin-6+to+activate+signal+transducer+and+activator+of+transcription+3+and+promote+human+prostate+cancer+cell+growth"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18fR"><div class="casContent"><span class="casTitleNuber">18f</span><div class="casTitle"><span class="NLM_cas:atitle">The Fer tyrosine kinase cooperates with interleukin-6 to activate signal transducer and activator of transcription 3 and promote human prostate cancer cell growth</span></div><div class="casAuthors">Zoubeidi, Amina; Rocha, Joice; Zouanat, Fatima Z.; Hamel, Lucie; Scarlata, Eleonora; Aprikian, Armen G.; Chevalier, Simone</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Research</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">142-155</span>CODEN:
                <span class="NLM_cas:coden">MCROC5</span>;
        ISSN:<span class="NLM_cas:issn">1541-7786</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Androgen withdrawal is the most effective form of systemic therapy for men with advanced prostate cancer.  Unfortunately, androgen-independent progression is inevitable, and the development of hormone-refractory disease and death occurs within 2 to 3 years in most men.  The understanding of mol. mechanisms promoting the growth of androgen-independent prostate cancer cells is essential for the rational design of agents to treat advanced disease.  We previously reported that Fer tyrosine kinase level correlates with the development of prostate cancer and aggressiveness of prostate cancer cell lines.  Moreover, knocking down Fer expression interferes with prostate cancer cell growth in vitro.  However, the mechanism by which Fer mediates prostate cancer progression remains elusive.  We present here that Fer and phospho-Y705 signal transducer and activator of transcription 3 (STAT3) are barely detectable in human benign prostate tissues but constitutively expressed in the cytoplasm and nucleus of the same subsets of tumor cells in human prostate cancer.  The interaction between STAT3 and Fer was obsd. in all prostate cancer cell lines tested, and this interaction is mediated via the Fer Src homol. 2 domain and modulated by interleukin-6 (IL-6).  Moreover, IL-6 triggered a rapid formation of Fer/gp130 and Fer/STAT3 complexes in a time-dependent manner and consistent with changes in Fer and STAT3 phosphorylation and cytoplasmic/nuclear distribution.  The modulation of Fer expression/activation resulted in inhibitory or stimulatory effects on STAT3 phosphorylation, nuclear translocation, and transcriptional activation.  Taken together, these results support an important function of Fer in prostate cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7W0h0Wam0bbVg90H21EOLACvtfcHk0lihcPf_kZyGHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXltV2luw%253D%253D&md5=b603ad01ef936dad28eeaf0a63f566f9</span></div><a href="/servlet/linkout?suffix=cit18f&amp;dbid=16384&amp;doi=10.1158%2F1541-7786.MCR-08-0117&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1541-7786.MCR-08-0117%26sid%3Dliteratum%253Aachs%26aulast%3DZoubeidi%26aufirst%3DA.%26aulast%3DRocha%26aufirst%3DJ.%26aulast%3DZouanat%26aufirst%3DF.%2BZ.%26aulast%3DHamel%26aufirst%3DL.%26aulast%3DScarlata%26aufirst%3DE.%26aulast%3DAprikian%26aufirst%3DA.%2BG.%26aulast%3DChevalier%26aufirst%3DS.%26atitle%3DThe%2520Fer%2520tyrosine%2520kinase%2520cooperates%2520with%2520interleukin-6%2520to%2520activate%2520signal%2520transducer%2520and%2520activator%2520of%2520transcription%25203%2520and%2520promote%2520human%2520prostate%2520cancer%2520cell%2520growth%26jtitle%3DMol.%2520Cancer%2520Res.%26date%3D2009%26volume%3D7%26spage%3D142%26epage%3D155" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit18g"><span><span class="NLM_label">(g) </span><span class="NLM_contrib-group">Wang, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, F. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ni, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, X. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qu, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span> </span><span class="NLM_article-title">Rapid induction and activation of Tec tyrosine kinase in liver regeneration</span> <span class="citation_source-journal">J. Gastroenterol. Hepatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">668</span><span class="NLM_x">–</span> <span class="NLM_lpage">673</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18g&amp;dbid=16&amp;doi=10.1021%2Fjm300542e&amp;key=10.1111%2Fj.1440-1746.2006.04259.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18g&amp;dbid=8&amp;doi=10.1021%2Fjm300542e&amp;key=16677151" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18g&amp;dbid=32&amp;doi=10.1021%2Fjm300542e&amp;key=1%3ACAS%3A528%3ADC%252BD28XlvVSru7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2006&pages=668-673&author=S.+Y.+Wangauthor=F.+F.+Liauthor=H.+Zhengauthor=K.+K.+Yuauthor=F.+Niauthor=X.+M.+Yangauthor=C.+K.+Quauthor=J.+Li&title=Rapid+induction+and+activation+of+Tec+tyrosine+kinase+in+liver+regeneration"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18gR"><div class="casContent"><span class="casTitleNuber">18g</span><div class="casTitle"><span class="NLM_cas:atitle">Rapid induction and activation of Tec tyrosine kinase in liver regeneration</span></div><div class="casAuthors">Wang, Si-Ying; Li, Fei-Fei; Zheng, Hong; Yu, Ke-Ke; Ni, Fang; Yang, Xiao-Ming; Qu, Cheng-Kui; Li, Jun</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Gastroenterology and Hepatology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">668-673</span>CODEN:
                <span class="NLM_cas:coden">JGHEEO</span>;
        ISSN:<span class="NLM_cas:issn">0815-9319</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Asia Pty Ltd.</span>)
        </div><div class="casAbstract">Background: Previous studies have indicated that Tec tyrosine kinase is differentially expressed in the regenerating liver.  The purpose of the present study was to further investigate the potential involvement of Tec tyrosine kinase in hepatocyte proliferation and liver regeneration.  Methods: Tec kinase gene expression after partial (two-thirds) hepatectomy was examd. by representational difference anal.  Tissue distribution and potential involvement of Tec kinase in liver regeneration and hepatocyte proliferation were then detd. by northern blotting, reverse transcription-polymerase chain reaction (RT-PCR), and western blotting.  Full-length rat Tec cDNA was cloned.  Results: Using this cDNA as the probe, northern blotting showed that Tec was specifically expressed in liver and kidney, the highest expression of Tec being detected in embryonic day 15-19 fetal livers.  In contrast, the expression level of Tec in adult and neonatal rat livers was significantly decreased.  Similar results were obtained from western blotting analyzes.  It was thus hypothesized that Tec might be involved in hepatocyte proliferation.  To test this hypothesis, Tec expression was examd. in regenerating rat livers.  An increase in Tec expression and activation of Tec kinase were obsd. within 1 h after partial hepatectomy.  Moreover, it has been shown that hepatocyte growth factor (HGF) dramatically induces Tec expression in primary rat hepatocytes.  Addnl., it was obsd. that Tec gene expression in serum-starved liver tumor cell line HepG2 was substantially decreased.  Stimulation with 10% fetal bovine serum and insulin but not epidermal growth factor resulted in dramatic elevation of Tec expression in these cells.  Conclusion: Tec is an inducible early response gene that might enhance hepatocyte proliferation and liver regeneration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqytyt56t-TtbVg90H21EOLACvtfcHk0lihcPf_kZyGHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XlvVSru7Y%253D&md5=b195aac161243776f72d43184283fee1</span></div><a href="/servlet/linkout?suffix=cit18g&amp;dbid=16384&amp;doi=10.1111%2Fj.1440-1746.2006.04259.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1440-1746.2006.04259.x%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DS.%2BY.%26aulast%3DLi%26aufirst%3DF.%2BF.%26aulast%3DZheng%26aufirst%3DH.%26aulast%3DYu%26aufirst%3DK.%2BK.%26aulast%3DNi%26aufirst%3DF.%26aulast%3DYang%26aufirst%3DX.%2BM.%26aulast%3DQu%26aufirst%3DC.%2BK.%26aulast%3DLi%26aufirst%3DJ.%26atitle%3DRapid%2520induction%2520and%2520activation%2520of%2520Tec%2520tyrosine%2520kinase%2520in%2520liver%2520regeneration%26jtitle%3DJ.%2520Gastroenterol.%2520Hepatol.%26date%3D2006%26volume%3D21%26spage%3D668%26epage%3D673" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit18h"><span><span class="NLM_label">(h) </span><span class="NLM_contrib-group">Feng, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Man, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, L. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knyazev, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lei, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ullrich, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Z.</span><span> </span><span class="NLM_article-title">Overexpression of Csk-binding protein contributes to renal cell carcinogenesis</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">3320</span><span class="NLM_x">–</span> <span class="NLM_lpage">3331</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2009&pages=3320-3331&author=X.+Fengauthor=X.+Luauthor=X.+Manauthor=W.+Zhouauthor=L.+Q.+Jiangauthor=P.+Knyazevauthor=L.+Leiauthor=Q.+Huangauthor=A.+Ullrichauthor=Z.+Zhangauthor=Z.+Chen&title=Overexpression+of+Csk-binding+protein+contributes+to+renal+cell+carcinogenesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18h&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFeng%26aufirst%3DX.%26aulast%3DLu%26aufirst%3DX.%26aulast%3DMan%26aufirst%3DX.%26aulast%3DZhou%26aufirst%3DW.%26aulast%3DJiang%26aufirst%3DL.%2BQ.%26aulast%3DKnyazev%26aufirst%3DP.%26aulast%3DLei%26aufirst%3DL.%26aulast%3DHuang%26aufirst%3DQ.%26aulast%3DUllrich%26aufirst%3DA.%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DChen%26aufirst%3DZ.%26atitle%3DOverexpression%2520of%2520Csk-binding%2520protein%2520contributes%2520to%2520renal%2520cell%2520carcinogenesis%26jtitle%3DOncogene%26date%3D2009%26volume%3D28%26spage%3D3320%26epage%3D3331" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Paull, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shoemaker, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hodes, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monks, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scudiero, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rubinstein, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plowman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyd, M. R.</span><span> </span><span class="NLM_article-title">Display and analysis of patterns of differential activity of drugs against human tumor cell lines: development of mean graph and COMPARE algorithm</span> <span class="citation_source-journal">J. Natl. Cancer Inst.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">81</span><span class="NLM_x">, </span> <span class="NLM_fpage">1088</span><span class="NLM_x">–</span> <span class="NLM_lpage">1092</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Fjm300542e&amp;key=10.1093%2Fjnci%2F81.14.1088" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Fjm300542e&amp;key=2738938" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm300542e&amp;key=1%3ACAS%3A280%3ADyaL1M3ptlyrsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=1989&pages=1088-1092&author=K.+D.+Paullauthor=R.+H.+Shoemakerauthor=L.+Hodesauthor=A.+Monksauthor=D.+A.+Scudieroauthor=L.+Rubinsteinauthor=J.+Plowmanauthor=M.+R.+Boyd&title=Display+and+analysis+of+patterns+of+differential+activity+of+drugs+against+human+tumor+cell+lines%3A+development+of+mean+graph+and+COMPARE+algorithm"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Display and analysis of patterns of differential activity of drugs against human tumor cell lines: development of mean graph and COMPARE algorithm</span></div><div class="casAuthors">Paull K D; Shoemaker R H; Hodes L; Monks A; Scudiero D A; Rubinstein L; Plowman J; Boyd M R</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the National Cancer Institute</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">81</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">1088-92</span>
        ISSN:<span class="NLM_cas:issn">0027-8874</span>.
    </div><div class="casAbstract">The objective of this study was to develop and investigate an approach to optimally detect, rank, display, and analyze patterns of differential growth inhibition among cultured cell lines.  Such patterns of cellular responsiveness are produced by substances tested in vitro against disease-oriented panels of human tumor cell lines in a new anticancer screening model under development by the National Cancer Institute.  In the first phase of the study, we developed a key methodological tool, the mean graph, which allowed the transformation of the numerical cell line response data into graphic patterns.  These patterns were particularly expressive of differential cell growth inhibition and were conveniently amenable to further analyses by an algorithm we devised and implemented in the COMPARE computer program.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQUJX57ADL8cwpJitSxOdIlfW6udTcc2eZK6SKsMLnkQLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL1M3ptlyrsw%253D%253D&md5=6612f9f2a7793d1296dfa24224f09545</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1093%2Fjnci%2F81.14.1088&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjnci%252F81.14.1088%26sid%3Dliteratum%253Aachs%26aulast%3DPaull%26aufirst%3DK.%2BD.%26aulast%3DShoemaker%26aufirst%3DR.%2BH.%26aulast%3DHodes%26aufirst%3DL.%26aulast%3DMonks%26aufirst%3DA.%26aulast%3DScudiero%26aufirst%3DD.%2BA.%26aulast%3DRubinstein%26aufirst%3DL.%26aulast%3DPlowman%26aufirst%3DJ.%26aulast%3DBoyd%26aufirst%3DM.%2BR.%26atitle%3DDisplay%2520and%2520analysis%2520of%2520patterns%2520of%2520differential%2520activity%2520of%2520drugs%2520against%2520human%2520tumor%2520cell%2520lines%253A%2520development%2520of%2520mean%2520graph%2520and%2520COMPARE%2520algorithm%26jtitle%3DJ.%2520Natl.%2520Cancer%2520Inst.%26date%3D1989%26volume%3D81%26spage%3D1088%26epage%3D1092" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Chan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khan, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harvey, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merrick, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pelletier, J.</span><span> </span><span class="NLM_article-title">Eukaryotic protein synthesis inhibitors identified by comparison of cytotoxicity profiles</span> <span class="citation_source-journal">RNA</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">528</span><span class="NLM_x">–</span> <span class="NLM_lpage">543</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2004&pages=528-543&author=J.+Chanauthor=S.+N.+Khanauthor=I.+Harveyauthor=W.+Merrickauthor=J.+Pelletier&title=Eukaryotic+protein+synthesis+inhibitors+identified+by+comparison+of+cytotoxicity+profiles"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChan%26aufirst%3DJ.%26aulast%3DKhan%26aufirst%3DS.%2BN.%26aulast%3DHarvey%26aufirst%3DI.%26aulast%3DMerrick%26aufirst%3DW.%26aulast%3DPelletier%26aufirst%3DJ.%26atitle%3DEukaryotic%2520protein%2520synthesis%2520inhibitors%2520identified%2520by%2520comparison%2520of%2520cytotoxicity%2520profiles%26jtitle%3DRNA%26date%3D2004%26volume%3D10%26spage%3D528%26epage%3D543" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Gharehbaghi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paul, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelley, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barchi, J. J.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marquez, V. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooney, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monks, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scudiero, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohn, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jayaram, H. N.</span><span> </span><span class="NLM_article-title">Cytotoxicity and characterization of an active metabolite of benzamide ribosode: a novel inhibitor of IMP dehydrogenase</span> <span class="citation_source-journal">J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">892</span><span class="NLM_x">–</span> <span class="NLM_lpage">899</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21a&amp;dbid=16&amp;doi=10.1021%2Fjm300542e&amp;key=10.1002%2Fijc.2910560623" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21a&amp;dbid=8&amp;doi=10.1021%2Fjm300542e&amp;key=7907081" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21a&amp;dbid=32&amp;doi=10.1021%2Fjm300542e&amp;key=1%3ACAS%3A528%3ADyaK2cXkvF2itbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=1994&pages=892-899&author=K.+Gharehbaghiauthor=K.+Paulauthor=J.+J.+Kelleyauthor=J.+J.+Barchiauthor=V.+E.+Marquezauthor=D.+A.+Cooneyauthor=A.+Monksauthor=D.+Scudieroauthor=K.+Kohnauthor=H.+N.+Jayaram&title=Cytotoxicity+and+characterization+of+an+active+metabolite+of+benzamide+ribosode%3A+a+novel+inhibitor+of+IMP+dehydrogenase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21aR"><div class="casContent"><span class="casTitleNuber">21a</span><div class="casTitle"><span class="NLM_cas:atitle">Cytotoxicity and characterization of an active metabolite of benzamide riboside, a novel inhibitor of IMP dehydrogenase</span></div><div class="casAuthors">Gharehbaghi, Kamran; Paull, Kenneth D.; Kelley, James A.; Barchi, Joseph J. Jr.; Marquez, Victor E.; Cooney, David A.; Monks, Anne; Scudiero, Dominic; Krohn, Karsten; Jayaram, Hiremagalur N.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Cancer</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">892-9</span>CODEN:
                <span class="NLM_cas:coden">IJCNAW</span>;
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    </div><div class="casAbstract">Benzamide riboside exhibits significant cytotoxicity against a variety of human tumor cells in culture.  On the basis of metabolic studies, the primary target of this drug's action appears to be IMP dehydrogenase (IMPDH).  Incubation of human myelogenous leukemia K562 cells with an IC50 concn. of benzamide riboside resulted in an expansion of IMP pools (5.9-fold), with a parallel redn. in the concn. of GMP (90%), GDP (63%), GTP (55%) and dGTP (40%).  On kinetic grounds, it was deduced that benzamide riboside (whose Ki vs. IMPDH is 6.4 mM, while that of its 5'-monophosphate is 3.9 mM) or its 5'-monophosphate were unlikely to be responsible for inhibition of this target enzyme, IMPDH, since only micromolar concns. of benzamide riboside were needed to exert potent inhibition of tumor-cell growth.  Studies on the metab. of this C-nucleoside have revealed the presence of a new peak eluting in the nucleoside diphosphate area on HPLC.  Treatment of this peak with venom phosphodiesterase degraded it and concurrently nullified its inhibitory activity vs. IMPDH; alk. phosphatase, on the other hand, totally failed to digest the anabolite.  These results suggest that the metabolite in question is the phosphodiester, benzamide adenine dinucleotide (BAD).  Evidence that the inhibitor was an analog of NAD, wherein the nicotinamide moiety has been replaced by benzamide, was provided by both NMR and mass spectrometric anal. and confirmed by enzymic synthesis.  Further insight into the nature of the active principle was obtained from kinetic studies, which established that BAD competitively inhibited NAD utilization by partially purified IMPDH from K562 cells with a Ki of 0.118 μM.  In concert, these studies establish that benzamide riboside exhibits potent antiproliferative activity by inhibiting IMPDH through BAD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6WWo-ZuTvqbVg90H21EOLACvtfcHk0ljikaKLDYyWyw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXkvF2itbo%253D&md5=3bbdd90a9a1e39d23ee1651260016ae5</span></div><a href="/servlet/linkout?suffix=cit21a&amp;dbid=16384&amp;doi=10.1002%2Fijc.2910560623&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fijc.2910560623%26sid%3Dliteratum%253Aachs%26aulast%3DGharehbaghi%26aufirst%3DK.%26aulast%3DPaul%26aufirst%3DK.%26aulast%3DKelley%26aufirst%3DJ.%2BJ.%26aulast%3DBarchi%26aufirst%3DJ.%2BJ.%26aulast%3DMarquez%26aufirst%3DV.%2BE.%26aulast%3DCooney%26aufirst%3DD.%2BA.%26aulast%3DMonks%26aufirst%3DA.%26aulast%3DScudiero%26aufirst%3DD.%26aulast%3DKohn%26aufirst%3DK.%26aulast%3DJayaram%26aufirst%3DH.%2BN.%26atitle%3DCytotoxicity%2520and%2520characterization%2520of%2520an%2520active%2520metabolite%2520of%2520benzamide%2520ribosode%253A%2520a%2520novel%2520inhibitor%2520of%2520IMP%2520dehydrogenase%26jtitle%3DJ.%2520Cancer%26date%3D1994%26volume%3D56%26spage%3D892%26epage%3D899" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit21b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Cleaveland, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monks, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaigro-Wolff, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zaharevitz, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paull, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ardalan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooney, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ford, H.,  Jr.</span><span> </span><span class="NLM_article-title">Site of action of two novel pyrimidine biosynthesis inhibitors accurately predicted by the COMPARE program</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">947</span><span class="NLM_x">–</span> <span class="NLM_lpage">954</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=1995&pages=947-954&author=E.+S.+Cleavelandauthor=A.+Monksauthor=A.+Vaigro-Wolffauthor=D.+W.+Zaharevitzauthor=K.+Paullauthor=K.+Ardalanauthor=D.+A.+Cooneyauthor=H.+Ford&title=Site+of+action+of+two+novel+pyrimidine+biosynthesis+inhibitors+accurately+predicted+by+the+COMPARE+program"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCleaveland%26aufirst%3DE.%2BS.%26aulast%3DMonks%26aufirst%3DA.%26aulast%3DVaigro-Wolff%26aufirst%3DA.%26aulast%3DZaharevitz%26aufirst%3DD.%2BW.%26aulast%3DPaull%26aufirst%3DK.%26aulast%3DArdalan%26aufirst%3DK.%26aulast%3DCooney%26aufirst%3DD.%2BA.%26aulast%3DFord%26aufirst%3DH.%26atitle%3DSite%2520of%2520action%2520of%2520two%2520novel%2520pyrimidine%2520biosynthesis%2520inhibitors%2520accurately%2520predicted%2520by%2520the%2520COMPARE%2520program%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1995%26volume%3D49%26spage%3D947%26epage%3D954" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit21c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Kohlhagen, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paull, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cushman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagafuji, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pommier, Y.</span><span> </span><span class="NLM_article-title">Protein-linked DNA strand breaks induced by NSC314622: a novel non-camptothecin topoisomerase I poison</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">50</span><span class="NLM_x">–</span> <span class="NLM_lpage">58</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=1998&pages=50-58&author=G.+Kohlhagenauthor=K.+Paullauthor=M.+Cushmanauthor=P.+Nagafujiauthor=Y.+Pommier&title=Protein-linked+DNA+strand+breaks+induced+by+NSC314622%3A+a+novel+non-camptothecin+topoisomerase+I+poison"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKohlhagen%26aufirst%3DG.%26aulast%3DPaull%26aufirst%3DK.%26aulast%3DCushman%26aufirst%3DM.%26aulast%3DNagafuji%26aufirst%3DP.%26aulast%3DPommier%26aufirst%3DY.%26atitle%3DProtein-linked%2520DNA%2520strand%2520breaks%2520induced%2520by%2520NSC314622%253A%2520a%2520novel%2520non-camptothecin%2520topoisomerase%2520I%2520poison%26jtitle%3DMol.%2520Pharmacol.%26date%3D1998%26volume%3D54%26spage%3D50%26epage%3D58" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit21d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Zaharevitz, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gussio, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loest, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Senderowicz, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lahusen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kunick, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meijer, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sausville, E. A.</span><span> </span><span class="NLM_article-title">Discovery and initial characterization of the paullones: a novel class of small-molecule inhibitors of cyclin-dependent kinases</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">2566</span><span class="NLM_x">–</span> <span class="NLM_lpage">2569</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=1999&pages=2566-2569&author=D.+W.+Zaharevitzauthor=R.+Gussioauthor=M.+Loestauthor=A.+M.+Senderowiczauthor=T.+Lahusenauthor=C.+Kunickauthor=L.+Meijerauthor=E.+A.+Sausville&title=Discovery+and+initial+characterization+of+the+paullones%3A+a+novel+class+of+small-molecule+inhibitors+of+cyclin-dependent+kinases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZaharevitz%26aufirst%3DD.%2BW.%26aulast%3DGussio%26aufirst%3DR.%26aulast%3DLoest%26aufirst%3DM.%26aulast%3DSenderowicz%26aufirst%3DA.%2BM.%26aulast%3DLahusen%26aufirst%3DT.%26aulast%3DKunick%26aufirst%3DC.%26aulast%3DMeijer%26aufirst%3DL.%26aulast%3DSausville%26aufirst%3DE.%2BA.%26atitle%3DDiscovery%2520and%2520initial%2520characterization%2520of%2520the%2520paullones%253A%2520a%2520novel%2520class%2520of%2520small-molecule%2520inhibitors%2520of%2520cyclin-dependent%2520kinases%26jtitle%3DCancer%2520Res.%26date%3D1999%26volume%3D59%26spage%3D2566%26epage%3D2569" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Kupchan, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaVoie, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Branfman, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fei, B. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bright, W. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bryan, R. F.</span><span> </span><span class="NLM_article-title">Phyllantocin, a novel bisabolane aglycone from the antileukemic glycoside, phyllantoside</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1977</span><span class="NLM_x">, </span> <span class="NLM_volume">99</span><span class="NLM_x">, </span> <span class="NLM_fpage">3199</span><span class="NLM_x">–</span> <span class="NLM_lpage">3201</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja00451a074" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=1977&pages=3199-3201&author=S.+M.+Kupchanauthor=E.+J.+LaVoieauthor=A.+R.+Branfmanauthor=B.+Y.+Feiauthor=W.+M.+Brightauthor=R.+F.+Bryan&title=Phyllantocin%2C+a+novel+bisabolane+aglycone+from+the+antileukemic+glycoside%2C+phyllantoside"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fja00451a074&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja00451a074%26sid%3Dliteratum%253Aachs%26aulast%3DKupchan%26aufirst%3DS.%2BM.%26aulast%3DLaVoie%26aufirst%3DE.%2BJ.%26aulast%3DBranfman%26aufirst%3DA.%2BR.%26aulast%3DFei%26aufirst%3DB.%2BY.%26aulast%3DBright%26aufirst%3DW.%2BM.%26aulast%3DBryan%26aufirst%3DR.%2BF.%26atitle%3DPhyllantocin%252C%2520a%2520novel%2520bisabolane%2520aglycone%2520from%2520the%2520antileukemic%2520glycoside%252C%2520phyllantoside%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1977%26volume%3D99%26spage%3D3199%26epage%3D3201" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Choi, H. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dong, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lau, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zou, M. H.</span><span> </span><span class="NLM_article-title">Reactive nitrogen species is required for the activation of the AMP-activated protein kinase by statin in vivo</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">283</span><span class="NLM_x">, </span> <span class="NLM_fpage">20186</span><span class="NLM_x">–</span> <span class="NLM_lpage">20197</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=283&publication_year=2008&pages=20186-20197&author=H.+C.+Choiauthor=P.+Songauthor=Z.+Xieauthor=Y.+Wuauthor=J.+Xuauthor=M.+Zhangauthor=Y.+Dongauthor=S.+Wangauthor=K.+Lauauthor=M.+H.+Zou&title=Reactive+nitrogen+species+is+required+for+the+activation+of+the+AMP-activated+protein+kinase+by+statin+in+vivo"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChoi%26aufirst%3DH.%2BC.%26aulast%3DSong%26aufirst%3DP.%26aulast%3DXie%26aufirst%3DZ.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DM.%26aulast%3DDong%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DLau%26aufirst%3DK.%26aulast%3DZou%26aufirst%3DM.%2BH.%26atitle%3DReactive%2520nitrogen%2520species%2520is%2520required%2520for%2520the%2520activation%2520of%2520the%2520AMP-activated%2520protein%2520kinase%2520by%2520statin%2520in%2520vivo%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2008%26volume%3D283%26spage%3D20186%26epage%3D20197" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Lamoral-Theys, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pottier, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kerff, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dufrasne, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Proutière, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wauthoz, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neven, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ingrassia, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Antwerpen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lefranc, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gelbcke, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pirotte, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kraus, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nève, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kornienko, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiss, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dubois, J.</span><span> </span><span class="NLM_article-title">Simple di- and trivanillates exhibit cytostatic properties toward cancer cells resistant to pro-apoptotic stimuli</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">3823</span><span class="NLM_x">–</span> <span class="NLM_lpage">3833</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2010&pages=3823-3833&author=D.+Lamoral-Theysauthor=L.+Pottierauthor=F.+Kerffauthor=F.+Dufrasneauthor=F.+Prouti%C3%A8reauthor=N.+Wauthozauthor=P.+Nevenauthor=L.+Ingrassiaauthor=P.+Van+Antwerpenauthor=F.+Lefrancauthor=M.+Gelbckeauthor=B.+Pirotteauthor=J.+L.+Krausauthor=J.+N%C3%A8veauthor=A.+Kornienkoauthor=R.+Kissauthor=J.+Dubois&title=Simple+di-+and+trivanillates+exhibit+cytostatic+properties+toward+cancer+cells+resistant+to+pro-apoptotic+stimuli"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLamoral-Theys%26aufirst%3DD.%26aulast%3DPottier%26aufirst%3DL.%26aulast%3DKerff%26aufirst%3DF.%26aulast%3DDufrasne%26aufirst%3DF.%26aulast%3DProuti%25C3%25A8re%26aufirst%3DF.%26aulast%3DWauthoz%26aufirst%3DN.%26aulast%3DNeven%26aufirst%3DP.%26aulast%3DIngrassia%26aufirst%3DL.%26aulast%3DVan%2BAntwerpen%26aufirst%3DP.%26aulast%3DLefranc%26aufirst%3DF.%26aulast%3DGelbcke%26aufirst%3DM.%26aulast%3DPirotte%26aufirst%3DB.%26aulast%3DKraus%26aufirst%3DJ.%2BL.%26aulast%3DN%25C3%25A8ve%26aufirst%3DJ.%26aulast%3DKornienko%26aufirst%3DA.%26aulast%3DKiss%26aufirst%3DR.%26aulast%3DDubois%26aufirst%3DJ.%26atitle%3DSimple%2520di-%2520and%2520trivanillates%2520exhibit%2520cytostatic%2520properties%2520toward%2520cancer%2520cells%2520resistant%2520to%2520pro-apoptotic%2520stimuli%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2010%26volume%3D18%26spage%3D3823%26epage%3D3833" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit24b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Lamoral-Theys, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wauthoz, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heffeter, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathieu, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jungwirth, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lefranc, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nève, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dubois, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dufrasne, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amighi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berger, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gailly, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiss, R.</span><span> </span><span class="NLM_article-title">Trivanillic polyphenols with anticancer cytostatic effects through the targeting of multiple kinases and intracellular Ca<sup>2+</sup> release</span> <span class="citation_source-journal">J. Cell. Mol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">1421</span><span class="NLM_x">–</span> <span class="NLM_lpage">1434</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24b&amp;dbid=16&amp;doi=10.1021%2Fjm300542e&amp;key=10.1111%2Fj.1582-4934.2011.01403.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24b&amp;dbid=8&amp;doi=10.1021%2Fjm300542e&amp;key=21810170" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24b&amp;dbid=32&amp;doi=10.1021%2Fjm300542e&amp;key=1%3ACAS%3A280%3ADC%252BC38zltFegtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2012&pages=1421-1434&author=D.+Lamoral-Theysauthor=N.+Wauthozauthor=P.+Heffeterauthor=V.+Mathieuauthor=U.+Jungwirthauthor=F.+Lefrancauthor=J.+N%C3%A8veauthor=J.+Duboisauthor=F.+Dufrasneauthor=K.+Amighiauthor=W.+Bergerauthor=P.+Gaillyauthor=R.+Kiss&title=Trivanillic+polyphenols+with+anticancer+cytostatic+effects+through+the+targeting+of+multiple+kinases+and+intracellular+Ca2%2B+release"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24bR"><div class="casContent"><span class="casTitleNuber">24b</span><div class="casTitle"><span class="NLM_cas:atitle">Trivanillic polyphenols with anticancer cytostatic effects through the targeting of multiple kinases and intracellular Ca2+ release</span></div><div class="casAuthors">Lamoral-Theys Delphine; Wauthoz Nathalie; Heffeter Petra; Mathieu Veronique; Jungwirth Utte; Lefranc Florence; Neve Jean; Dubois Jacques; Dufrasne Francois; Amighi Karim; Berger Walter; Gailly Philippe; Kiss Robert</div><div class="citationInfo"><span class="NLM_cas:title">Journal of cellular and molecular medicine</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1421-34</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Cancer cells exhibit de-regulation of multiple cellular signalling pathways and treatments of various types of cancers with polyphenols are promising.  We recently reported the synthesis of a series of 33 novel divanillic and trivanillic polyphenols that displayed anticancer activity, at least in vitro, through inhibiting various kinases.  This study revealed that minor chemical modifications of a trivanillate scaffold could convert cytotoxic compounds into cytostatic ones.  Compound 13c, a tri-chloro derivative of trivanillic ester, displayed marked inhibitory activities against FGF-, VEGF-, EGF- and Src-related kinases, all of which are implicated not only in angiogenesis but also in the biological aggressiveness of various cancer types.  The pan-anti-kinase activity of 13c occurs at less than one-tenth of its mean IC(50) in vitro growth inhibitory concentrations towards a panel of 12 cancer cell lines.  Of the 26 kinases for which 13c inhibited their activity by >75%, eight (Yes, Fyn, FGF-R1, EGFR, Btk, Mink, Ret and Itk) are implicated in control of the actin cytoskeleton organization to varying degrees.  Compound 13c accordingly impaired the typical organization of the actin cytoskeleton in human U373 glioblastoma cells.  The pan-anti-kinase activity and actin cytoskeleton organization impairment provoked by 13c concomitantly occurs with calcium homeostasis impairment but without provoking MDR phenotype activation.  All of these anticancer properties enabled 13c to confer therapeutic benefits in vivo in a mouse melanoma pseudometastatic lung model.  These data argue in favour of further chemically modifying trivanillates to produce novel and potent anticancer drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcROiDnH3kqdk2Zyxfu64m4ffW6udTcc2ebui8FzVbjFmLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38zltFegtw%253D%253D&md5=348ffb44efeabb18fdda46e03a31690e</span></div><a href="/servlet/linkout?suffix=cit24b&amp;dbid=16384&amp;doi=10.1111%2Fj.1582-4934.2011.01403.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1582-4934.2011.01403.x%26sid%3Dliteratum%253Aachs%26aulast%3DLamoral-Theys%26aufirst%3DD.%26aulast%3DWauthoz%26aufirst%3DN.%26aulast%3DHeffeter%26aufirst%3DP.%26aulast%3DMathieu%26aufirst%3DV.%26aulast%3DJungwirth%26aufirst%3DU.%26aulast%3DLefranc%26aufirst%3DF.%26aulast%3DN%25C3%25A8ve%26aufirst%3DJ.%26aulast%3DDubois%26aufirst%3DJ.%26aulast%3DDufrasne%26aufirst%3DF.%26aulast%3DAmighi%26aufirst%3DK.%26aulast%3DBerger%26aufirst%3DW.%26aulast%3DGailly%26aufirst%3DP.%26aulast%3DKiss%26aufirst%3DR.%26atitle%3DTrivanillic%2520polyphenols%2520with%2520anticancer%2520cytostatic%2520effects%2520through%2520the%2520targeting%2520of%2520multiple%2520kinases%2520and%2520intracellular%2520Ca2%252B%2520release%26jtitle%3DJ.%2520Cell.%2520Mol.%2520Med.%26date%3D2012%26volume%3D16%26spage%3D1421%26epage%3D1434" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Dolusic, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larrieu, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moineaux, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stroobant, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pilotte, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colau, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pochet, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van den Eynde, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masereel, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wouters, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frederick, R.</span><span> </span><span class="NLM_article-title">Tryptophan 2,3-dioxygenase (TDO) inhibitors. 3-(2-(Pyridyl)ethenyl)indoles as potential anticancer immunomodulators</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x"> (</span><span class="NLM_issue">15</span><span class="NLM_x">) </span> <span class="NLM_fpage">5320</span><span class="NLM_x">–</span> <span class="NLM_lpage">5334</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm2006782" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=5320-5334&issue=15&author=E.+Dolusicauthor=P.+Larrieuauthor=L.+Moineauxauthor=V.+Stroobantauthor=L.+Pilotteauthor=D.+Colauauthor=L.+Pochetauthor=B.+Van+den+Eyndeauthor=B.+Masereelauthor=J.+Woutersauthor=R.+Frederick&title=Tryptophan+2%2C3-dioxygenase+%28TDO%29+inhibitors.+3-%282-%28Pyridyl%29ethenyl%29indoles+as+potential+anticancer+immunomodulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fjm2006782&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm2006782%26sid%3Dliteratum%253Aachs%26aulast%3DDolusic%26aufirst%3DE.%26aulast%3DLarrieu%26aufirst%3DP.%26aulast%3DMoineaux%26aufirst%3DL.%26aulast%3DStroobant%26aufirst%3DV.%26aulast%3DPilotte%26aufirst%3DL.%26aulast%3DColau%26aufirst%3DD.%26aulast%3DPochet%26aufirst%3DL.%26aulast%3DVan%2Bden%2BEynde%26aufirst%3DB.%26aulast%3DMasereel%26aufirst%3DB.%26aulast%3DWouters%26aufirst%3DJ.%26aulast%3DFrederick%26aufirst%3DR.%26atitle%3DTryptophan%25202%252C3-dioxygenase%2520%2528TDO%2529%2520inhibitors.%25203-%25282-%2528Pyridyl%2529ethenyl%2529indoles%2520as%2520potential%2520anticancer%2520immunomodulators%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26issue%3D15%26spage%3D5320%26epage%3D5334" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-2"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i32"><a href="/doi/suppl/10.1021/jm300542e">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_06661"></div></div></div></div></div><hr /></hr><p class="last">Detailed synthesis, characterization, and microanalysis and HPLC purity data of all reported derivatives. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm300542e/suppl_file/jm300542e_si_001.pdf">jm300542e_si_001.pdf (203.27 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm300542e&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2012.55.issue-14%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Barticle%3Aarticle%3A10.1021%2Fjm300542e" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm300542e" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                3MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67998525ffae3dc4","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
